run:
Loading parser from serialized file edu/stanford/nlp/models/lexparser/englishPCFG.ser.gz ... done [2.4 sec].

1 The favorable clinical response of tumors harboring the common exon 19 deletions or the L858R mutation correlates with the high TKI sensitivity of these EGFR mutant proteins at the molecular level 
Added to queryTripless!! : ?function textMine:amod ?positive. ?G textMine:prep ?function. ?G textMine:nsubj ?F. ?B textMine:partmod ?H. ?H textMine:dobj ?D. ?F textMine:prep ?B. ?D textMine:amod ?mutation. 
1

2 Although the frequency of HGF expression among cases of acquired resistance is unclear because of scarcity of reports, the frequency of coexistence of HGF expression with T790M mutations could possibly be high   
[?B textMine:prep ?function, ?E textMine:num ?mutation, ?impact textMine:nsubj ?F, ?function textMine:prep ?E, ?F textMine:prep ?B]
Added to queryTripless!! : ?B textMine:prep ?function. ?E textMine:num ?mutation. ?positive textMine:nsubj ?F. ?function textMine:prep ?E. ?F textMine:prep ?B. 
2

3 PLX4032 was recently demonstrated to reduce the uptake of 2(18F)fluoro 2 deoxy D glucose (18F FDG) in melanoma cells, whereas inducible expression of V600E BRAF increased the glucose uptake rate and decreased O 2  consumption in thyroid cancer cells   
[?function textMine:prep ?B, ?impact textMine:nsubj ?function, ?B textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:prep ?B. ?negative textMine:nsubj ?function. ?B textMine:nn ?mutation. 
3

4 Our previous data suggested that the amount of HGF bound to c Met N375S was much lower when compared with c Met WT, thereby demonstrating a loss of affinity for HGF in the case of c Met N375S mutant  
[?G textMine:prep ?function, ?A textMine:prep ?I, ?C textMine:rcmod ?impact, ?I textMine:partmod ?J, ?E textMine:dobj ?G, ?D textMine:dep ?E, ?J textMine:prep ?C, ?impact textMine:ccomp ?D, ?B textMine:nn ?mutation, ?B textMine:nsubj ?A]
Added to queryTripless!! : ?G textMine:prep ?function. ?A textMine:prep ?I. ?C textMine:rcmod ?negative. ?I textMine:partmod ?J. ?E textMine:dobj ?G. ?D textMine:dep ?E. ?J textMine:prep ?C. ?negative textMine:ccomp ?D. ?B textMine:nn ?mutation. ?B textMine:nsubj ?A. 
4

5 T790M in the context of either transiently expressed wild type EGFR or the mutant alleles del L474–E749;A750P or L858R impairs inhibition by gefitinib or erlotinib as assessed by autophosphorylation 
[?function textMine:nn ?mutation, ?function textMine:nn ?impact]
Added to queryTripless!! : ?function textMine:nn ?mutation. ?function textMine:nn ?negative. 
5

6 One Akt mutant (E17K), found in a subset of human cancers, displays higher PIP3 binding, membrane localization, and activation (Brazil et al , ; Varnai et al, ) 
[?function textMine:amod ?impact, ?B textMine:appos ?mutation, ?C textMine:dobj ?function, ?C textMine:nsubj ?B]
Added to queryTripless!! : ?function textMine:amod ?positive. ?B textMine:appos ?mutation. ?C textMine:dobj ?function. ?C textMine:nsubj ?B. 
6

7 Our results indicated that CIMP H status was significantly associated with serrated polyps, proximal location,  BRAF  V600E mutations, and increase in polyp size 
[?function textMine:prep ?impact, ?function textMine:prep ?D, ?function textMine:prep ?C, ?C textMine:conj ?impact, ?C textMine:conj ?D, ?D textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:prep ?positive. ?function textMine:prep ?D. ?function textMine:prep ?C. ?C textMine:conj ?positive. ?C textMine:conj ?D. ?D textMine:nn ?mutation. 
7

8 Hence, the double mutation L858R+E884K modulated basal and stimulated downstream EGFR signaling differentially with differential effects on the AKT (down regulated), CBL and MAPK ERK1/2 phosphorylation (up regulated) 
[?impact textMine:xcomp ?B, ?impact textMine:nsubj ?mutation, ?B textMine:prep ?function]
Added to queryTripless!! : ?unknown textMine:xcomp ?B. ?unknown textMine:nsubj ?mutation. ?B textMine:prep ?function. 
8

9 Hence, the E884K mutation, when in  cis  with L858R, modulates the sensitivity of the mutant receptor towards ERBB family kinase inhibitors in an inhibitor specific fashion 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?A, ?A textMine:amod ?mutation]
Added to queryTripless!! : ?unknown textMine:dobj ?function. ?unknown textMine:nsubj ?A. ?A textMine:amod ?mutation. 
9

10 Consistent with published data  , PLX4032 abolished the ERK1/2 activating phosphorylation in BRAF V600E/K  melanoma cells ( Figure 2 , pERK, YULAC, YURIF, YUMAC and YUGEN8) 
[?impact textMine:dobj ?function, ?function textMine:prep ?D, ?D textMine:nn ?mutation]
Added to queryTripless!! : ?negative textMine:dobj ?function. ?function textMine:prep ?D. ?D textMine:nn ?mutation. 
10

11 It can be also postulated when an amino acid is altered for example G691S, depending on the genotype, could subtly alter the function of the RET protein if located in a critical domain 
[?A textMine:prep ?mutation, ?impact textMine:dobj ?function, ?impact textMine:advcl ?A]
Added to queryTripless!! : ?A textMine:prep ?mutation. ?unknown textMine:dobj ?function. ?unknown textMine:advcl ?A. 
11

12 Moreover, the E884K alone and L858R+E884K double mutant EGFR remained sensitive to EGF, and the E884K mutation cooperates with L858R when in  cis  to enhance the mutational effects on downstream phosphoprotein activation 
[?impact textMine:prep ?function, ?impact textMine:xsubj ?D, ?D textMine:nn ?mutation]
Added to queryTripless!! : ?positive textMine:prep ?function. ?positive textMine:xsubj ?D. ?D textMine:nn ?mutation. 
12

13 These shape changes lead to palatine bones that are laterally displaced, with an associated increase in the width of the inter palatine suture in  Fgfr2 +/S252W   mice ( Fig  2B , top right) relative to  Fgfr2 +/P253R   mutant mice ( Fig 2Ba ) 
[?impact textMine:prep ?D, ?impact textMine:amod ?function, ?E textMine:prep ?B, ?B textMine:nn ?mutation, ?D textMine:prep ?E]
Added to queryTripless!! : ?positive textMine:prep ?D. ?positive textMine:amod ?function. ?E textMine:prep ?B. ?B textMine:nn ?mutation. ?D textMine:prep ?E. 
13

14 In preclinical studies, T cell viability and function was preserved when peripheral blood mononuclear cells and BRAF V600E  mutant melanoma cells were exposed to clinically relevant concentrations of vemurafenib in vitro   
[?impact textMine:advcl ?C, ?impact textMine:nsubjpass ?function, ?E textMine:num ?mutation, ?C textMine:nsubjpass ?E]
Added to queryTripless!! : ?neutral textMine:advcl ?C. ?neutral textMine:nsubjpass ?function. ?E textMine:num ?mutation. ?C textMine:nsubjpass ?E. 
14

15 Another study found uncoupling in rare TnC variants identified in DCM: cTnC Y5H, M103I, and I148V either decreased or abolished the effects of PKA phosphorylation on Ca 2+  sensitivity (Pinto et al,  2011 ) 
[?impact textMine:conj ?D, ?impact textMine:nsubj ?mutation, ?impact textMine:nsubj ?B, ?D textMine:dobj ?function, ?D textMine:nsubj ?B, ?B textMine:conj ?mutation]
Added to queryTripless!! : ?negative textMine:conj ?D. ?negative textMine:nsubj ?mutation. ?negative textMine:nsubj ?B. ?D textMine:dobj ?function. ?D textMine:nsubj ?B. ?B textMine:conj ?mutation. 
15

16 We employed the human mast cell leukemia cell line  1 (HMC 1) model, which harbors KIT D816V and V560G mutations, and depends on signaling from these constitutively active KIT receptors for growth and survival [ 4 ] 
[?F textMine:conj ?E, ?F textMine:dobj ?A, ?A textMine:nn ?mutation, ?function textMine:advmod ?impact, ?B textMine:prep ?C, ?E textMine:prepc ?B, ?C textMine:amod ?function]
Added to queryTripless!! : ?F textMine:conj ?E. ?F textMine:dobj ?A. ?A textMine:nn ?mutation. ?function textMine:advmod ?positive. ?B textMine:prep ?C. ?E textMine:prepc ?B. ?C textMine:amod ?function. 
16

17 BA/F3 cells expressing empty vector (control), BCR/ABL wild type or imatinib resistant mutations (BCR/ABL E255K and T315I) were a kind gift of Dr Brian Druker (Oregon Health Science University, Portland, OR, USA) and maintained as described 
[?function textMine:dobj ?A, ?A textMine:dep ?mutation, ?impact textMine:nsubj ?D, ?D textMine:partmod ?function]
Added to queryTripless!! : ?function textMine:dobj ?A. ?A textMine:dep ?mutation. ?neutral textMine:nsubj ?D. ?D textMine:partmod ?function. 
17

18 Our main observation is that residue F595, residing in the middle of the pseudokinase domain αC helix, plays a key role in the constitutive activation of JAK2 V617F 
[?function textMine:amod ?impact, ?function textMine:prep ?mutation]
Added to queryTripless!! : ?function textMine:amod ?positive. ?function textMine:prep ?mutation. 
18

19 In vitro studies by Guo and colleagues suggested that Nilotinib in cell lines transfected with a KIT gene containing an exon 9 or 11 mutation with an exon 17 mutation (D820Y and N822 K) demonstrated significant kinase inhibition as well as decreased cell proliferation The Japanese study also documented a partial response in patients whose GIST contained a KIT exon 11 (dup 567–576) and exon 17 (D820G) mutation   
[?F textMine:dobj ?B, ?function textMine:amod ?impact, ?G textMine:nsubj ?C, ?G textMine:dobj ?function, ?B textMine:appos ?mutation, ?J textMine:dep ?F, ?C textMine:partmod ?E, ?E textMine:dobj ?A, ?A textMine:prep ?J]
Added to queryTripless!! : ?F textMine:dobj ?B. ?function textMine:amod ?negative. ?G textMine:nsubj ?C. ?G textMine:dobj ?function. ?B textMine:appos ?mutation. ?J textMine:dep ?F. ?C textMine:partmod ?E. ?E textMine:dobj ?A. ?A textMine:prep ?J. 
19

20 These results suggest that the G518L mutation enhances EphA3 ephrin binding in  cis  and supports the involvement in the  cis  interface of the conserved glycine in the second fibronectin type III domain   
[?B textMine:amod ?function, ?impact textMine:dobj ?B, ?impact textMine:nsubj ?D, ?D textMine:nn ?mutation]
Added to queryTripless!! : ?B textMine:amod ?function. ?positive textMine:dobj ?B. ?positive textMine:nsubj ?D. ?D textMine:nn ?mutation. 
20

21 Insertion mutant autophosphorylation is less sensitive to inhibition by gefitinib than that of L858R, but CL 387,785 is more effective than gefitinib at inhibiting insertion mutant (and L858R) autophosphorylation 
[?B textMine:prep ?C, ?function textMine:conj ?B, ?function textMine:advmod ?impact, ?C textMine:dep ?mutation]
Added to queryTripless!! : ?B textMine:prep ?C. ?function textMine:conj ?B. ?function textMine:advmod ?negative. ?C textMine:dep ?mutation. 
21

22 Furthermore, MEK inhibition alone caused regression of xenografted and orthotopically transplanted tumors, and reduced proliferation in tumors of Braf LSL V637E/   +  mice (orthologous to human  BRAF  V600E mutation)   
[?C textMine:prep ?A, ?function textMine:dep ?C, ?function textMine:amod ?impact, ?A textMine:nn ?mutation]
Added to queryTripless!! : ?C textMine:prep ?A. ?function textMine:dep ?C. ?function textMine:amod ?negative. ?A textMine:nn ?mutation. 
22

23 In the cases of mutation M918T, constitutive RET activation probably results from disruption of an auto inhibited head to tail RET tyrosine kinase homodimer   
[?C textMine:nsubj ?function, ?C textMine:prep ?A, ?function textMine:amod ?impact, ?A textMine:prep ?mutation]
Added to queryTripless!! : ?C textMine:nsubj ?function. ?C textMine:prep ?A. ?function textMine:amod ?positive. ?A textMine:prep ?mutation. 
23

24 The mutations E255V, M244V, T315A, Y253H, experience increased vdW interactions with Met290 and the mutation M244V experiences increased vdW interactions with Ile293 
[?C textMine:appos ?mutation, ?B textMine:dobj ?function, ?G textMine:dep ?C, ?E textMine:ccomp ?B, ?E textMine:nsubj ?G, ?function textMine:amod ?impact]
Added to queryTripless!! : ?C textMine:appos ?mutation. ?B textMine:dobj ?function. ?G textMine:dep ?C. ?E textMine:ccomp ?B. ?E textMine:nsubj ?G. ?function textMine:amod ?positive. 
24

25 In that context, we demonstrate that inhibition of SIRT1 with genetic or pharmacological approaches additively enhances the efficacy of PLX4032 of melanoma cells but more importantly that it rescues the sensitivity to PLX4032 of the resistant BRAF V600E  mutated melanoma cells 
[?B textMine:prep ?E, ?impact textMine:nsubj ?function, ?impact textMine:conj ?B, ?E textMine:prep ?mutation]
Added to queryTripless!! : ?B textMine:prep ?E. ?positive textMine:nsubj ?function. ?positive textMine:conj ?B. ?E textMine:prep ?mutation. 
25

26 The sensitivity of mass spectrometric genotyping technologies such as OncoMap or Asan Panel is known to be approximately 1–5%  , and so detection of the T790M mutation could be increased if more sensitive techniqueswere used 
[?C textMine:amod ?function, ?impact textMine:advcl ?E, ?impact textMine:nsubjpass ?B, ?G textMine:nn ?mutation, ?B textMine:prep ?G, ?E textMine:nsubj ?C]
Added to queryTripless!! : ?C textMine:amod ?function. ?positive textMine:advcl ?E. ?positive textMine:nsubjpass ?B. ?G textMine:nn ?mutation. ?B textMine:prep ?G. ?E textMine:nsubj ?C. 
26

27 ERK dependent resistance mechanisms can occur via activating MEK1  mutations  , activating NRAS  mutations  , COT  overexpression  , elevated CRAS activity  , BRAF  V600E alternative splicing or amplification   
[?function textMine:amod ?impact, ?D textMine:dobj ?function, ?D textMine:dobj ?E, ?E textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:amod ?positive. ?D textMine:dobj ?function. ?D textMine:dobj ?E. ?E textMine:nn ?mutation. 
27

28 T790M may increase the GTP affinity in the tyrosine kinase domain of the EGFR, or hindrance to TKI binding to the tyrosine kinase domain   
[?impact textMine:nsubj ?mutation, ?impact textMine:dobj ?function]
Added to queryTripless!! : ?positive textMine:nsubj ?mutation. ?positive textMine:dobj ?function. 
28

29 BCR ABL mutations respond differently to three tyrosine kinase inhibitors approved for first line treatment of CML, e g, Y253F and G250E mutations resistant to imatinib can respond to nilotinib or/and dasatinib, T315A shows better response to imatinib though resistant to Dasatinib and Nilotinib, while some mutations are less sensitive to nilotinib (E255K/V and F359V/C) or dasatinib (F317L and V299L)  
[?B textMine:cop ?impact, ?B textMine:advmod ?function]
Added to queryTripless!! : ?B textMine:cop ?negative. ?B textMine:advmod ?function. 
29

30 At a later time point in pancreas development, S33Y mutant β cat expression enhanced islet cell proliferation and increased the size of pancreas [ 49 ] 
[?impact textMine:nsubj ?D, ?impact textMine:dobj ?function, ?D textMine:num ?mutation]
Added to queryTripless!! : ?positive textMine:nsubj ?D. ?positive textMine:dobj ?function. ?D textMine:num ?mutation. 
30

31 JAK2 K539L, T875N and R683G were shown to exhibit constitutive STAT5 activation and to transform Ba/F3 cells expressing the EpoR to cytokine independence     
[?D textMine:dobj ?function, ?E textMine:ccomp ?D, ?E textMine:nsubjpass ?mutation, ?function textMine:amod ?impact]
Added to queryTripless!! : ?D textMine:dobj ?function. ?E textMine:ccomp ?D. ?E textMine:nsubjpass ?mutation. ?function textMine:amod ?positive. 
31

92 Non hotspot AKT1 PH domain mutants L52R, C77F, and Q79K increase Akt1 activation and downstream signaling
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation]
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation, ]
Match 


32 We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated (native) BCR/ABL ( 15 – 17 ) 
[?D textMine:dobj ?A, ?D textMine:nsubj ?F, ?A textMine:infmod ?B, ?A textMine:amod ?impact, ?F textMine:nn ?mutation, ?B textMine:advcl ?function]
Added to queryTripless!! : ?D textMine:dobj ?A. ?D textMine:nsubj ?F. ?A textMine:infmod ?B. ?A textMine:amod ?positive. ?F textMine:nn ?mutation. ?B textMine:advcl ?function. 
32

33 In terms of EGFR TKI sensitivity, Kancha et al have identified 4 sets of mutations based on their drug sensitivity profiles: (a) mutations that are very sensitive to all 3 drugs tested with IC50 values in the low nanomolar range (L858R and Del 747 753insS), (b) mutations that are less sensitive to gefitinib (IC50 >100 nmol/l) but sensitive to both erlotinib and AEE788 (G719S, V742A, and R776C; IC50 < 100 nmol/l), (c) mutations that are less sensitive to both gefitinib and erlotinib but sensitive to AEE788 (D761N, S768I, S784F, L838V, and L861Q), and (d) mutations that are resistant to all three drugs tested (N826S and T790M)   
[?D textMine:xcomp ?function, ?D textMine:advmod ?impact, ?D textMine:dep ?E, ?E textMine:dobj ?I, ?F textMine:prep ?C, ?A textMine:rcmod ?F, ?C textMine:dep ?H, ?H textMine:nn ?mutation, ?I textMine:prep ?A]
Added to queryTripless!! : ?D textMine:xcomp ?function. ?D textMine:advmod ?negative. ?D textMine:dep ?E. ?E textMine:dobj ?I. ?F textMine:prep ?C. ?A textMine:rcmod ?F. ?C textMine:dep ?H. ?H textMine:nn ?mutation. ?I textMine:prep ?A. 
33

34 Despite achieving correct topology, however, G85E and G91R still disrupt CFTR folding and trafficking (Xiong et al , ; Patrick et al, ) 
[?impact textMine:nsubj ?mutation, ?impact textMine:dobj ?function]
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation, ]
Match 


35 In this study, we used functional mutagenesis to investigate the involvement of the JH2 αC helix in the constitutive activation of JAK2 V617F 
[?function textMine:amod ?impact, ?function textMine:prep ?mutation]
[?function textMine:amod ?impact, ?function textMine:prep ?mutation, ]
Match 


36 In contrast to the isolated L858R kinase domain results, we observe that mutation of residues in the dimer interface in tEGFR dramatically reduces the activity of both the L858R and Δ746–750 tEGFRs, indicating that this dimerization event is critical for activation of both of these oncogenic mutants 
[?D textMine:ccomp ?E, ?impact textMine:dobj ?C, ?impact textMine:partmod ?D, ?E textMine:prep ?function, ?C textMine:prep ?mutation]
Added to queryTripless!! : ?D textMine:ccomp ?E. ?negative textMine:dobj ?C. ?negative textMine:partmod ?D. ?E textMine:prep ?function. ?C textMine:prep ?mutation. 
34

37 Since residue V617 is located in the pseudokinase domain of JAK2, this lack of information has hindered a detailed understanding of the mechanism of activation of JAK2 V617F 
[?impact textMine:dobj ?C, ?C textMine:prep ?E, ?function textMine:prep ?mutation, ?E textMine:prep ?function]
Added to queryTripless!! : ?negative textMine:dobj ?C. ?C textMine:prep ?E. ?function textMine:prep ?mutation. ?E textMine:prep ?function. 
35

38 Webster and Donoghue proposed that the G380R mutation enhances FGFR3 dimerization, likely due to hydrogen bonding of the mutant R380 to the neighboring receptor in the dimer  
[?impact textMine:acomp ?C, ?impact textMine:nsubj ?F, ?A textMine:prep ?function, ?F textMine:nn ?mutation, ?C textMine:prep ?A]
Added to queryTripless!! : ?positive textMine:acomp ?C. ?positive textMine:nsubj ?F. ?A textMine:prep ?function. ?F textMine:nn ?mutation. ?C textMine:prep ?A. 
36

39 The Th  ALK F1174L   mutation leads to the constitutive activation of the  ALK  protein in neuroblastoma  [29] – [32] , and the vascular phenotype associated with amplified or wild type (WT)  ALK  expression is currently unknown 
[?E textMine:prep ?function, ?E textMine:nsubj ?B, ?B textMine:nn ?mutation, ?function textMine:amod ?impact]
Added to queryTripless!! : ?E textMine:prep ?function. ?E textMine:nsubj ?B. ?B textMine:nn ?mutation. ?function textMine:amod ?positive. 
37

40 We hypothesized that the R958D substitution would disrupt the ion pair with E884 through electrostatic repulsion, in a way similar to the effect of the E884K substitution 
[?A textMine:nn ?mutation, ?B textMine:amod ?E, ?E textMine:prep ?function, ?function textMine:prep ?A, ?impact textMine:prep ?B]
Added to queryTripless!! : ?A textMine:nn ?mutation. ?B textMine:amod ?E. ?E textMine:prep ?function. ?function textMine:prep ?A. ?negative textMine:prep ?B. 
38

41 This uncoupling of the LKB1 AMPK complex allows BRAF V600E  oncogene driven cancer cells to become resistant to energy stress and avoid apoptosis   
[?B textMine:partmod ?A, ?B textMine:nn ?mutation, ?A textMine:xcomp ?impact, ?impact textMine:dobj ?function]
Added to queryTripless!! : ?B textMine:partmod ?A. ?B textMine:nn ?mutation. ?A textMine:xcomp ?negative. ?negative textMine:dobj ?function. 
39

42 The data suggest that low BRCA1 level may neutralize the negative effects of the EGFR T790M mutation on erlotinib sensitivity and that high BRCA1 expression may lead to de novo EGFR TKI resistance potentially through increased DNA damage repair capacity   
[?A textMine:nn ?mutation, ?function textMine:amod ?impact, ?function textMine:prep ?A]
Added to queryTripless!! : ?A textMine:nn ?mutation. ?function textMine:amod ?negative. ?function textMine:prep ?A. 
40

43 Survival for CML CP patients with the T315I point mutation treated with TKIs is estimated to be reduced by 50% compared with patients without the T315I mutation (median survival of 22 months vs  more than 10 years for TKI responsive CML patients; Nicolini et al, 2009) 
[?E textMine:dep ?function, ?E textMine:prep ?B, ?B textMine:nn ?mutation, ?impact textMine:pobj ?E]
Added to queryTripless!! : ?E textMine:dep ?function. ?E textMine:prep ?B. ?B textMine:nn ?mutation. ?negative textMine:pobj ?E. 
41

44 The most common mutation is V600E, which dramatically enhances BRAF enzyme activity, and thus induces tumorous transformation 
[?mutation textMine:rcmod ?impact, ?impact textMine:dobj ?function]
Added to queryTripless!! : ?mutation textMine:rcmod ?positive. ?positive textMine:dobj ?function. 
42

45 In colorectal cancer patients, a mutation in the extracellular domain of EGFR (S492R), which abrogates cetuximab binding but retains panitumumab sensitivity, has been recently described as a mechanism of acquired resistance   (Fig  2c ) 
[?E textMine:appos ?mutation, ?F textMine:prep ?C, ?F textMine:rcmod ?D, ?F textMine:rcmod ?impact, ?D textMine:dobj ?function, ?impact textMine:conj ?D, ?C textMine:prep ?E]
Added to queryTripless!! : ?E textMine:appos ?mutation. ?F textMine:prep ?C. ?F textMine:rcmod ?D. ?F textMine:rcmod ?negative. ?D textMine:dobj ?function. ?negative textMine:conj ?D. ?C textMine:prep ?E. 
43

46 Thus, in the proliferative environment of the regenerating tail fin, sufficient cellular controls are maintained to prevent tumorigenesis in BRAF V600E   and RAS V12  expressing melanocytes 
[?impact textMine:xcomp ?B, ?function textMine:nsubj ?mutation, ?B textMine:prepc ?function]
Added to queryTripless!! : ?neutral textMine:xcomp ?B. ?function textMine:nsubj ?mutation. ?B textMine:prepc ?function. 
44

47 When expressed in MCF 7 PIK3CAWT  the E17K mutant led to increased activation of Akt under low serum conditions, as measured by phosphorylation of serine 473 and threonine 308, when compared to empty vector control (Figure  1  and  Supplemental Figure 1A ) 
[?B textMine:prep ?function, ?function textMine:amod ?impact, ?C textMine:partmod ?B, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?B textMine:prep ?function. ?function textMine:amod ?positive. ?C textMine:partmod ?B. ?C textMine:nn ?mutation. 
45

48 Co expression of Braf V600E  and activated KRAS significantly reduced tumor formation, with this very low tumor burden precluding our ability to observe progression to the adenocarcinoma stage as would be predicted 
[?D textMine:prep ?C, ?D textMine:prep ?mutation, ?impact textMine:nsubj ?D, ?C textMine:amod ?function, ?mutation textMine:conj ?C]
Added to queryTripless!! : ?D textMine:prep ?C. ?D textMine:prep ?mutation. ?negative textMine:nsubj ?D. ?C textMine:amod ?function. ?mutation textMine:conj ?C. 
46

49 We also find that a melanoma associated mutation within the pseudosubstrate sequence, P52L, disrupts PAK6 autoinhibition enhancing its kinase activity, potentially correlating with increased expression of PAK6 in prostate cancer, and implied alterations in kinase activity  
[?D textMine:prep ?function, ?D textMine:dobj ?F, ?F textMine:prep ?B, ?B textMine:amod ?impact, ?B textMine:appos ?mutation]
Added to queryTripless!! : ?D textMine:prep ?function. ?D textMine:dobj ?F. ?F textMine:prep ?B. ?B textMine:amod ?negative. ?B textMine:appos ?mutation. 
47

50 Expression of the deletion mutant was comparable to that of L858R EGFR, whereas expression of the insertion mutant was lower, as reflected in the  EGFR  expression levels of the clonal cell lines ( Figure 2 A and unpublished data) 
[?D textMine:nn ?function, ?G textMine:prep ?D, ?B textMine:prep ?F, ?H textMine:advcl ?impact, ?H textMine:prep ?B, ?F textMine:nn ?mutation, ?impact textMine:advcl ?G]
Added to queryTripless!! : ?D textMine:nn ?function. ?G textMine:prep ?D. ?B textMine:prep ?F. ?H textMine:advcl ?negative. ?H textMine:prep ?B. ?F textMine:nn ?mutation. ?negative textMine:advcl ?G. 
48

51 Dyn1(T141A) mCherry, a mutant with reduced affinity for GTP but greater rate of GTP hydrolysis, was surprisingly similar to dyn1(S61D/T65D/T65H) ( Figure 2D ) 
[?D textMine:prep ?function, ?A textMine:amod ?D, ?function textMine:amod ?impact, ?C textMine:appos ?A, ?C textMine:appos ?mutation]
Added to queryTripless!! : ?D textMine:prep ?function. ?A textMine:amod ?D. ?function textMine:amod ?negative. ?C textMine:appos ?A. ?C textMine:appos ?mutation. 
49

52 Nevertheless, preliminary analysis of the overall survival based on the CMC counts within our tested cohort of patients indicated a negative trend between survival and CMC counts in all patients (p = 0 12) and particularly for  BRAF V600E   cutaneous melanoma patients (p = 006) 
[?D textMine:prep ?I, ?D textMine:dobj ?C, ?C textMine:prep ?E, ?C textMine:amod ?impact, ?F textMine:nn ?mutation, ?I textMine:amod ?B, ?E textMine:nn ?function, ?B textMine:prep ?F]
Added to queryTripless!! : ?D textMine:prep ?I. ?D textMine:dobj ?C. ?C textMine:prep ?E. ?C textMine:amod ?negative. ?F textMine:nn ?mutation. ?I textMine:amod ?B. ?E textMine:nn ?function. ?B textMine:prep ?F. 
50

53 BRAF V600E  constitutively activates the MEK ERK signaling pathway, promoting ERK dependent transcriptional activity, which regulates cell growth, cell proliferation, apoptosis evasion, replicative potential, angiogenesis, and tissue invasion  
[?C textMine:partmod ?A, ?C textMine:advmod ?impact, ?C textMine:nsubj ?mutation, ?A textMine:dobj ?function]
Added to queryTripless!! : ?C textMine:partmod ?A. ?C textMine:advmod ?positive. ?C textMine:nsubj ?mutation. ?A textMine:dobj ?function. 
51

54 Expression of the p61 BRAF V600E  splice variant shows enhanced dimerization rendering a subset of melanoma patients resistant to vemurafenib  
[?A textMine:nn ?mutation, ?E textMine:prep ?A, ?function textMine:amod ?impact, ?D textMine:dobj ?function, ?D textMine:nsubj ?E]
Added to queryTripless!! : ?A textMine:nn ?mutation. ?E textMine:prep ?A. ?function textMine:amod ?positive. ?D textMine:dobj ?function. ?D textMine:nsubj ?E. 
52

55 While BRAF V600E  inhibition has been previously shown to increase tumor infiltrating lymphocytes, it has also been shown to induce the expression of T cell exhaustion markers including PD L1, TIM3 and PD1 in melanoma patients [ 53 ] 
[?function textMine:nn ?mutation, ?impact textMine:xsubj ?function]
Added to queryTripless!! : ?function textMine:nn ?mutation. ?positive textMine:xsubj ?function. 
53

56 This study finds that the two most common EGFR mutations in non small cell lung cancer (L858R and Δ746–750) result in EGF–independent tEGFR activities comparable to, or greater than, the activity of EGF–stimulated WT EGFR, and that tEGFR activation resulting from these mutations remains strongly coupled to asymmetric kinase dimer formation ( Fig 3d ) 
[?B textMine:dep ?mutation, ?impact textMine:nsubj ?function, ?C textMine:conj ?impact, ?C textMine:nsubj ?B]
Added to queryTripless!! : ?B textMine:dep ?mutation. ?neutral textMine:nsubj ?function. ?C textMine:conj ?neutral. ?C textMine:nsubj ?B. 
54

57 Compared to L858R alone, the L858R+E884K dual mutant was less sensitive to erlotinib in the inhibition of tyrosine phosphorylation of EGFR 
[?B textMine:nn ?mutation, ?function textMine:advmod ?impact, ?function textMine:nsubj ?B]
Added to queryTripless!! : ?B textMine:nn ?mutation. ?function textMine:advmod ?negative. ?function textMine:nsubj ?B. 
55

58 9   Preclinical studies have shown superior activity of afatinib over first generation TKIs, mainly due to (1) irreversible binding, which confers stronger binding affinity and potency, (2) ability to circumvent first generation TKI resistance mechanism T790M mutation in exon 20, and (3) effectiveness against multiple HER endothelial growth factor receptors   10  
[?A textMine:dobj ?D, ?A textMine:dep ?G, ?C textMine:conj ?I, ?C textMine:amod ?impact, ?E textMine:rcmod ?J, ?I textMine:dep ?function, ?J textMine:dobj ?I, ?J textMine:dobj ?C, ?D textMine:nn ?mutation, ?G textMine:prep ?E]
Added to queryTripless!! : ?A textMine:dobj ?D. ?A textMine:dep ?G. ?C textMine:conj ?I. ?C textMine:amod ?positive. ?E textMine:rcmod ?J. ?I textMine:dep ?function. ?J textMine:dobj ?I. ?J textMine:dobj ?C. ?D textMine:nn ?mutation. ?G textMine:prep ?E. 
56

59 These data suggest that Lyn is constitutively activated in PVTL 1 cells and activates signaling pathways involving the SHP2/Gab2 and CrkL/c Cbl complexes as well as SHP1 among others, while Jak2 V617F uniquely activates STAT5 and is partly involved in phosphorylation of SHP2 
[?A textMine:conj ?C, ?A textMine:advmod ?impact, ?E textMine:prep ?H, ?H textMine:dep ?function, ?D textMine:nn ?mutation, ?C textMine:ccomp ?E, ?function textMine:nsubj ?D]
Added to queryTripless!! : ?A textMine:conj ?C. ?A textMine:advmod ?positive. ?E textMine:prep ?H. ?H textMine:dep ?function. ?D textMine:nn ?mutation. ?C textMine:ccomp ?E. ?function textMine:nsubj ?D. 
57

60 In contrast, the silencing of  BRAF   V600E   by transfecting siBRAF resulted in an increase in the inactivating phosphorylation (S127) and cytosolic translocation of YAP1 ( Figures 3c and d ) 
[?D textMine:prep ?mutation, ?function textMine:prep ?impact, ?function textMine:nsubj ?D]
Added to queryTripless!! : ?D textMine:prep ?mutation. ?function textMine:prep ?positive. ?function textMine:nsubj ?D. 
58

61 Moreover, upon IBR2 treatment, the HR activity in T315I was reduced to a level comparable to that in parental cells, while the latter was relatively insensitive to the treatment, suggesting a potential therapeutic window (Supporting Information  Fig S9 ) 
[?impact textMine:nsubjpass ?function, ?function textMine:prep ?mutation]
Added to queryTripless!! : ?negative textMine:nsubjpass ?function. ?function textMine:prep ?mutation. 
59

62 By contrast, in V600E mutated melanoma cells, IC 50  values were lower than 100 n M , whereas V600E unmutated cells (including cells carrying other  BRAF  mutations) required more than 1 μ M  to display any sensitivity 
[?C textMine:dobj ?function, ?C textMine:xsubj ?F, ?A textMine:xcomp ?C, ?A textMine:nsubj ?F, ?impact textMine:advcl ?A, ?F textMine:num ?mutation]
Added to queryTripless!! : ?C textMine:dobj ?function. ?C textMine:xsubj ?F. ?A textMine:xcomp ?C. ?A textMine:nsubj ?F. ?negative textMine:advcl ?A. ?F textMine:num ?mutation. 
60

63 Furthermore, some activating mutations in EGFR, mainly deletion mutations in exon 19 and the single L858R point mutation in exon 21, are associated with increased response and survival after tyrosine kinase inhibitor therapy, whereas the T790M point mutation or insertion mutations in exon 20 of EGFR, are associated with failure to respond   
[?E textMine:nsubjpass ?B, ?H textMine:conj ?function, ?H textMine:amod ?impact, ?D textMine:nsubj ?mutation, ?B textMine:dep ?D, ?C textMine:advcl ?E, ?C textMine:prep ?function, ?C textMine:prep ?H]
Added to queryTripless!! : ?E textMine:nsubjpass ?B. ?H textMine:conj ?function. ?H textMine:amod ?positive. ?D textMine:nsubj ?mutation. ?B textMine:dep ?D. ?C textMine:advcl ?E. ?C textMine:prep ?function. ?C textMine:prep ?H. 
61

64 For instance, the A391E mutation in FGFR3 increases FGFR3 phosphorylation at low ligand concentration, similarly to the G380R and G375C ACH mutations studied here  
[?C textMine:amod ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?C]
Query : [?C textMine:amod ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?C]
Existing trips : 
?A textMine:amod ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?A. 
Similar Query!!!!


65 Increased activation of Akt1 by E17K, L52R, C77F, and Q79K mutants led, as expected, to increased phosphorylation of Akt target proteins including FOXO1/3 and PRAS40 
[?G textMine:nn ?mutation, ?function textMine:amod ?impact, ?A textMine:prep ?function, ?A textMine:nsubj ?E, ?B textMine:prep ?G, ?E textMine:prep ?B]
Added to queryTripless!! : ?G textMine:nn ?mutation. ?function textMine:amod ?positive. ?A textMine:prep ?function. ?A textMine:nsubj ?E. ?B textMine:prep ?G. ?E textMine:prep ?B. 
62

66 In most of adult forms of indolent systemic mastocytosis, KIT is constitutively activated as a consequence of D816V mutation, whereas in pediatric forms of mastocytosis extracellular and juxtamembrane mutations are more common    
[?E textMine:amod ?mutation, ?function textMine:prep ?A, ?function textMine:advmod ?impact, ?A textMine:prep ?E]
Added to queryTripless!! : ?E textMine:amod ?mutation. ?function textMine:prep ?A. ?function textMine:advmod ?positive. ?A textMine:prep ?E. 
63

67 In preclinical studies, T cell viability and function was preserved when peripheral blood mononuclear cells and BRAF V600E  mutant melanoma cells were exposed to clinically relevant concentrations of vemurafenib  in vitro    
[?impact textMine:advcl ?C, ?impact textMine:nsubjpass ?function, ?E textMine:num ?mutation, ?C textMine:nsubjpass ?E]
[?C textMine:nsubjpass ?E, ?E textMine:num ?mutation, ?impact textMine:advcl ?C, ?impact textMine:nsubjpass ?function, ]
Match 


68 The second, incidentally found during study of the pathogenic Sec23A F382L mutation ( 56 ), is that Sar1B Sec23 Sec24 pre budding complexes have lower affinity for Sec13/Sec31A than equivalent Sar1A Sec23 Sec24 complexes, reducing Sec23 mediated hydrolysis of GTP on Sar1 
[?D textMine:ccomp ?J, ?function textMine:amod ?impact, ?B textMine:prep ?E, ?G textMine:ccomp ?D, ?G textMine:nsubj ?C, ?J textMine:dobj ?function, ?C textMine:partmod ?I, ?I textMine:prep ?B, ?E textMine:nn ?mutation]
Added to queryTripless!! : ?D textMine:ccomp ?J. ?function textMine:amod ?negative. ?B textMine:prep ?E. ?G textMine:ccomp ?D. ?G textMine:nsubj ?C. ?J textMine:dobj ?function. ?C textMine:partmod ?I. ?I textMine:prep ?B. ?E textMine:nn ?mutation. 
64

69 T875N is located in the kinase domain of JAK2, in a loop predicted to be within interaction distance of the linker region between the kinase and pseudokinase domains ( Figure 4C, right panel ) and could induce constitutive activity of JAK2 by triggering a conformational change of the pseudokinase domain 
[?D textMine:nsubj ?mutation, ?D textMine:dobj ?function, ?function textMine:amod ?impact]
Added to queryTripless!! : ?D textMine:nsubj ?mutation. ?D textMine:dobj ?function. ?function textMine:amod ?positive. 
65

70 Sumimoto et al ( 15 ) have shown that BRAF V600E  knock down decreased phospho ERK1/2 protein levels and inhibited invasion of melanoma cells accompanied by a decrease of matrix metalloproteinase activity and ITGβ1 expression 
[?E textMine:dobj ?C, ?E textMine:nsubj ?mutation, ?A textMine:agent ?impact, ?D textMine:partmod ?A, ?C textMine:prep ?D, ?C textMine:amod ?function]
Added to queryTripless!! : ?E textMine:dobj ?C. ?E textMine:nsubj ?mutation. ?A textMine:agent ?negative. ?D textMine:partmod ?A. ?C textMine:prep ?D. ?C textMine:amod ?function. 
66

71 Finally, the researchers identified a new TKI resistance mutation (L747S, substitution of serine for leucine at position 747) in a patient whose TKI sensitive NSCLC had become resistant to gefitinib, and showed that this resistance mutation also reduced TKI induced apoptosis in cells growing in dishes by interfering with BIM up regulation 
[?B textMine:ccomp ?impact, ?C textMine:conj ?B, ?C textMine:dobj ?E, ?E textMine:dep ?F, ?G textMine:nn ?function, ?impact textMine:nsubj ?G, ?F textMine:nn ?mutation]
Added to queryTripless!! : ?B textMine:ccomp ?negative. ?C textMine:conj ?B. ?C textMine:dobj ?E. ?E textMine:dep ?F. ?G textMine:nn ?function. ?negative textMine:nsubj ?G. ?F textMine:nn ?mutation. 
67

72 Regarding the interference with the ERK signaling, cell lines with BRAF V600D/R  mutations presented a faster and stronger inhibition of phosphorylated ERK as compared to control cells with a wild type  BRAF  (Figure  1 C) 
[?C textMine:nsubj ?function, ?C textMine:prep ?E, ?function textMine:amod ?impact, ?E textMine:prep ?D, ?B textMine:prep ?A, ?A textMine:nn ?mutation, ?D textMine:appos ?B]
Added to queryTripless!! : ?C textMine:nsubj ?function. ?C textMine:prep ?E. ?function textMine:amod ?positive. ?E textMine:prep ?D. ?B textMine:prep ?A. ?A textMine:nn ?mutation. ?D textMine:appos ?B. 
68

73 We found that SOCS3  and  SPI1  expression were significantly elevated in  JAK2  V617F positive patients 
[?C textMine:num ?mutation, ?impact textMine:prep ?C, ?impact textMine:nsubj ?function]
Added to queryTripless!! : ?C textMine:num ?mutation. ?positive textMine:prep ?C. ?positive textMine:nsubj ?function. 
69

74 In C618R  , R618 moves toward E543/D544 and forms strong salt bridges with them, disrupting the interaction between R564 and E543 
[?impact textMine:dobj ?function, ?B textMine:conj ?D, ?B textMine:prep ?mutation, ?D textMine:partmod ?impact]
Added to queryTripless!! : ?negative textMine:dobj ?function. ?B textMine:conj ?D. ?B textMine:prep ?mutation. ?D textMine:partmod ?negative. 
70

75 Our model suggests that the enhanced sensitivity of SAR302503 for the variants D839G and Y842H is due to the destabilization of the inactive conformation by these mutations that in effect would stabilize the open and active conformation to which the drug preferentially binds, thus conferring hypersensitive response ( Figures 2d and e ) 
[?C textMine:prep ?A, ?C textMine:nsubj ?E, ?E textMine:prep ?G, ?G textMine:prep ?mutation, ?A textMine:rcmod ?function, ?function textMine:prep ?F]
Added to queryTripless!! : ?C textMine:prep ?A. ?C textMine:nsubj ?E. ?E textMine:prep ?G. ?G textMine:prep ?mutation. ?A textMine:rcmod ?function. ?function textMine:prep ?F. 
71

76 Interestingly, SIRT1 level and activity are enhanced in the PLX4032 resistant BRAF V600E  mutated melanoma cells compared with their sensitive counterpart 
[?impact textMine:nsubjpass ?function, ?impact textMine:prep ?mutation]
Added to queryTripless!! : ?positive textMine:nsubjpass ?function. ?positive textMine:prep ?mutation. 
72

77 The EphA3 G518L lung cancer mutation enhances  cis  interaction with ephrin A3 
[?C textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?C]
Added to queryTripless!! : ?C textMine:nn ?mutation. ?positive textMine:dobj ?function. ?positive textMine:nsubj ?C. 
73

78 Furthermore, from a gefitinib resistant patient carrying the activating L858R mutation, we identified a novel secondary resistant mutation, L747S in cis to the activating mutation, which attenuated the up regulation of BIM and reduced apoptosis 
[?D textMine:appos ?mutation, ?function textMine:amod ?impact, ?A textMine:rcmod ?C, ?H textMine:prep ?A, ?H textMine:dobj ?D, ?C textMine:dobj ?E, ?E textMine:prep ?function]
Added to queryTripless!! : ?D textMine:appos ?mutation. ?function textMine:amod ?negative. ?A textMine:rcmod ?C. ?H textMine:prep ?A. ?H textMine:dobj ?D. ?C textMine:dobj ?E. ?E textMine:prep ?function. 
74

79 ( B ) Endogenous TAK1 interacts with kinase dead (K508M), wild type, and constitutively active (K650E) FGFR3 in HeLa cells 
[?function textMine:dep ?mutation, ?function textMine:advmod ?impact]
Added to queryTripless!! : ?function textMine:dep ?mutation. ?function textMine:advmod ?positive. 
75

81 Intriguingly, a recent study indicates that the G2385R risk variant causes a partial loss of kinase activity, highlighting the possibility that both too much or too little LRRK2 kinase activity may be detrimental   
[?impact textMine:nsubj ?function, ?B textMine:nn ?mutation, ?D textMine:partmod ?E, ?D textMine:nsubj ?B, ?E textMine:ccomp ?impact]
Added to queryTripless!! : ?negative textMine:nsubj ?function. ?B textMine:nn ?mutation. ?D textMine:partmod ?E. ?D textMine:nsubj ?B. ?E textMine:ccomp ?negative. 
76

82 Furthermore, expression of CDK1 was increased in S249C and Y375C cells, and the difference was particularly pronounced when the cells were starved in depleted medium to block stimulation by other growth factors 
[?D textMine:nn ?mutation, ?impact textMine:prep ?D, ?impact textMine:nsubjpass ?function]
Added to queryTripless!! : ?D textMine:nn ?mutation. ?positive textMine:prep ?D. ?positive textMine:nsubjpass ?function. 
77

83 The mutants T316A, K323A and R326A, which were engineered to abrogate the hydrophilic interactions, also moderately impaired the kinase activity 
[?C textMine:num ?mutation, ?impact textMine:dobj ?function, ?impact textMine:xsubj ?C]
Added to queryTripless!! : ?C textMine:num ?mutation. ?negative textMine:dobj ?function. ?negative textMine:xsubj ?C. 
78

84 NFAT transcriptional activity was approximately 10 fold higher in A375 cells and approximately 70 fold higher in WM266 4 cells compared with  BRAF  wild type CHL 1 cells ( Figure 1A ), consistent with increased B RAF activity of BRAF V600D  compared with BRAF V600E  ( Wan  et al , 2004 ) 
[?A textMine:amod ?D, ?G textMine:pobj ?mutation, ?C textMine:nsubj ?A, ?C textMine:ccomp ?impact, ?function textMine:prep ?G, ?D textMine:prep ?function]
Added to queryTripless!! : ?A textMine:amod ?D. ?G textMine:pobj ?mutation. ?C textMine:nsubj ?A. ?C textMine:ccomp ?positive. ?function textMine:prep ?G. ?D textMine:prep ?function. 
79

85 While RalB GTP levels were generally difficult to detect, with only one cell line exhibiting detectable RalB GTP, either the amount of RalA GTP (normalized to actin) or the ratio of RalA GTP to total RalA (normalized to control cells) was higher in one of three  NRAS/BRAF , three of four  NRAS Q61L/R /BRAF  and two of five  NRAS/BRAF   V600E   human melanoma cell lines compared to the control melanocytes ( Figure 1 ) 
[?D textMine:num ?mutation, ?impact textMine:nsubj ?H, ?H textMine:partmod ?function, ?I textMine:rcmod ?impact, ?A textMine:prep ?D, ?F textMine:dobj ?A, ?F textMine:advcl ?B, ?B textMine:prep ?I]
Added to queryTripless!! : ?D textMine:num ?mutation. ?positive textMine:nsubj ?H. ?H textMine:partmod ?function. ?I textMine:rcmod ?positive. ?A textMine:prep ?D. ?F textMine:dobj ?A. ?F textMine:advcl ?B. ?B textMine:prep ?I. 
80

86 The most notable change was seen in F1174L mutation which was well supported by an increase in binding energy and loss of hydrogen bond interaction with the neighboring protein when compared to the native protein 
[?D textMine:agent ?impact, ?E textMine:rcmod ?D, ?E textMine:amod ?mutation, ?impact textMine:prep ?function]
Added to queryTripless!! : ?D textMine:agent ?positive. ?E textMine:rcmod ?D. ?E textMine:amod ?mutation. ?positive textMine:prep ?function. 
81

87 The result is the disruption of the I 1 interactions, indicating that H587N is a deleterious mutation 
[?D textMine:ccomp ?A, ?impact textMine:partmod ?D, ?impact textMine:nsubj ?function, ?A textMine:nsubj ?mutation]
Added to queryTripless!! : ?D textMine:ccomp ?A. ?negative textMine:partmod ?D. ?negative textMine:nsubj ?function. ?A textMine:nsubj ?mutation. 
82

88 It was noted that PLX4720 also reduced pRB protein phosphorylation, increased p27 expression, suppressed cyclin D1 expression and induced cleavage of PARP only in melanoma cell lines harbouring the  BRAF  V600E mutation ( Figure 1D ) 
[?C textMine:nn ?mutation, ?B textMine:nn ?function, ?impact textMine:ccomp ?E, ?A textMine:dobj ?C, ?F textMine:partmod ?A, ?E textMine:prep ?F, ?E textMine:dobj ?B]
Added to queryTripless!! : ?C textMine:nn ?mutation. ?B textMine:nn ?function. ?negative textMine:ccomp ?E. ?A textMine:dobj ?C. ?F textMine:partmod ?A. ?E textMine:prep ?F. ?E textMine:dobj ?B. 
83

89 The results showed increased phosphorylation of Erk1/2 and p38 in  Fgfr2 +/S252W   mice BMSCs, which indicated that Erk1/2 and p38 signaling may participate in the regulation of endochondral bone formation by FGFR2 
[?function textMine:prep ?A, ?function textMine:amod ?impact, ?A textMine:nn ?mutation]
[?A textMine:nn ?mutation, ?function textMine:amod ?impact, ?function textMine:prep ?A, ]
Match 


90 Structurally, this residue lies in the substrate binding pocket of the kinase, and the M918T mutation appears to increase RET–ATP binding affinity and the stability of the active ATP bound form, effectively making RET more active, more of the time ( 48 )–( 51 ) 
[?C textMine:partmod ?D, ?D textMine:dobj ?E, ?E textMine:amod ?function, ?B textMine:nn ?mutation, ?impact textMine:dobj ?C, ?impact textMine:xsubj ?B]
Added to queryTripless!! : ?C textMine:partmod ?D. ?D textMine:dobj ?E. ?E textMine:amod ?function. ?B textMine:nn ?mutation. ?positive textMine:dobj ?C. ?positive textMine:xsubj ?B. 
84

91 Furthermore, we show that proliferation of cells derived from  JAK2 V617F   patients is increased when they were co cultured with macrophages 
[?impact textMine:nsubjpass ?function, ?E textMine:nn ?mutation, ?A textMine:prep ?E, ?function textMine:prep ?B, ?B textMine:partmod ?A]
Added to queryTripless!! : ?positive textMine:nsubjpass ?function. ?E textMine:nn ?mutation. ?A textMine:prep ?E. ?function textMine:prep ?B. ?B textMine:partmod ?A. 
85

93 On the other hand, Y375C and K652E FGFR3 showed increased levels of phosphorylation in response to ligand stimulation ( Figure 4a ) 
[?A textMine:dobj ?D, ?A textMine:nsubj ?B, ?B textMine:nn ?mutation, ?D textMine:prep ?function, ?D textMine:amod ?impact]
Added to queryTripless!! : ?A textMine:dobj ?D. ?A textMine:nsubj ?B. ?B textMine:nn ?mutation. ?D textMine:prep ?function. ?D textMine:amod ?positive. 
86

94 In a panel of human kinases, TAK 285 showed weak inhibition (0‒50%) against 88 of 96 kinases tested, moderate inhibition (50 80%) against EGFR (L858R) and alkaline phosphatase, and strong inhibition (80‒100%) against HER family kinases including EGFR(L861Q) as well as against CDK3/cyclin E and Flt3 (Figure  1 ) 
Apr 12, 2016 8:26:45 PM edu.stanford.nlp.process.PTBLexer next
WARNING: Untokenizable: ‒ (U+2012, decimal: 8210)
[?I textMine:conj ?function, ?I textMine:appos ?mutation, ?B textMine:prep ?E, ?B textMine:dobj ?J, ?G textMine:partmod ?C, ?E textMine:prep ?G, ?J textMine:amod ?impact, ?C textMine:dobj ?D, ?D textMine:prep ?function, ?D textMine:prep ?I]
Added to queryTripless!! : ?I textMine:conj ?function. ?I textMine:appos ?mutation. ?B textMine:prep ?E. ?B textMine:dobj ?J. ?G textMine:partmod ?C. ?E textMine:prep ?G. ?J textMine:amod ?negative. ?C textMine:dobj ?D. ?D textMine:prep ?function. ?D textMine:prep ?I. 
87

95 If exon 19 deletion results in EGFR structural alterations which bind TKIs more tightly than L858R mutation, it could support our hypothesis 
[?B textMine:prep ?A, ?B textMine:nsubj ?function, ?A textMine:amod ?mutation, ?impact textMine:rcmod ?B]
Added to queryTripless!! : ?B textMine:prep ?A. ?B textMine:nsubj ?function. ?A textMine:amod ?mutation. ?unknown textMine:rcmod ?B. 
88

96 Ki67 labeling revealed an enhanced proliferation index in JoMa1 ALK F1174L derived tumors (48%) compared to JoMa1 ALK R1275Q  (40%), and JoMa1 ALK wt derived tumors (38%) (Figure  3b ), suggesting that the accelerated tumor growth of JoMa1 ALK F1174L tumors may partly result from their increased proliferation capacity 
[?D textMine:amod ?impact, ?E textMine:nn ?function, ?I textMine:nn ?mutation, ?J textMine:conj ?G, ?J textMine:dobj ?D, ?G textMine:partmod ?K, ?C textMine:prep ?I, ?A textMine:prep ?E, ?A textMine:nsubj ?C, ?K textMine:ccomp ?A]
Added to queryTripless!! : ?D textMine:amod ?positive. ?E textMine:nn ?function. ?I textMine:nn ?mutation. ?J textMine:conj ?G. ?J textMine:dobj ?D. ?G textMine:partmod ?K. ?C textMine:prep ?I. ?A textMine:prep ?E. ?A textMine:nsubj ?C. ?K textMine:ccomp ?A. 
89

97 The mutations E255V, M244V, T315A, Y253H, experience increased vdW interactions with Met290 and the mutation M244V experiences increased vdW interactions with Ile293 
[?C textMine:nn ?mutation, ?B textMine:dobj ?function, ?G textMine:dep ?C, ?E textMine:ccomp ?B, ?E textMine:nsubj ?G, ?function textMine:amod ?impact]
Added to queryTripless!! : ?C textMine:nn ?mutation. ?B textMine:dobj ?function. ?G textMine:dep ?C. ?E textMine:ccomp ?B. ?E textMine:nsubj ?G. ?function textMine:amod ?positive. 
90

98 From  Table 2 , we observed that Leu298 has stable interactions with CF 3  throughout MD simulations in all mutations, while Leu354 experiences increased vdW interactions with mutations E255K and T315A 
[?impact textMine:dobj ?function, ?impact textMine:prep ?mutation]
Added to queryTripless!! : ?positive textMine:dobj ?function. ?positive textMine:prep ?mutation. 
91

99 Webster and Donoghue proposed that the G380R mutation enhances FGFR3 dimerization, likely due to hydrogen bonding of the mutant R380 to the neighboring receptor in the dimer  
[?impact textMine:acomp ?C, ?impact textMine:nsubj ?F, ?A textMine:prep ?function, ?F textMine:nn ?mutation, ?C textMine:prep ?A]
[?A textMine:prep ?function, ?C textMine:prep ?A, ?F textMine:nn ?mutation, ?impact textMine:acomp ?C, ?impact textMine:nsubj ?F, ]
Match 


100 Herein, we show that inhibition of PI3K/AKT signaling by MK 2206 affected the growth of both  JAK2 V617F or  MPL W515L expressing cells via reduced phosphorylation of AKT and inhibition of its downstream signaling molecules 
[?D textMine:prep ?function, ?function textMine:amod ?impact, ?E textMine:dobj ?D, ?C textMine:xcomp ?E, ?C textMine:dobj ?B, ?B textMine:prep ?mutation]
Added to queryTripless!! : ?D textMine:prep ?function. ?function textMine:amod ?negative. ?E textMine:dobj ?D. ?C textMine:xcomp ?E. ?C textMine:dobj ?B. ?B textMine:prep ?mutation. 
92

101 BRAF  V600E mutation is associated with reduced survival (overall survival, disease free survival, or cancer specific survival) especially in MSS tumors (Table  1 )   
[?D textMine:prep ?C, ?D textMine:nsubjpass ?A, ?A textMine:nn ?mutation, ?C textMine:dep ?function, ?C textMine:amod ?impact]
Added to queryTripless!! : ?D textMine:prep ?C. ?D textMine:nsubjpass ?A. ?A textMine:nn ?mutation. ?C textMine:dep ?function. ?C textMine:amod ?negative. 
93

102 TBP 3868 exhibits high basal Ras activity relative to the PLX4720 sensitive line, TBP 3743 suggesting that the resistance to BRAF V600E  inhibition in TBP 3868 may be attributed to Ras dependent transactivation of RAF dimers 
[?E textMine:prep ?A, ?J textMine:advmod ?F, ?J textMine:amod ?impact, ?B textMine:nsubjpass ?E, ?K textMine:appos ?C, ?K textMine:amod ?function, ?F textMine:prep ?K, ?C textMine:partmod ?I, ?I textMine:ccomp ?B, ?A textMine:nn ?mutation]
Added to queryTripless!! : ?E textMine:prep ?A. ?J textMine:advmod ?F. ?J textMine:amod ?positive. ?B textMine:nsubjpass ?E. ?K textMine:appos ?C. ?K textMine:amod ?function. ?F textMine:prep ?K. ?C textMine:partmod ?I. ?I textMine:ccomp ?B. ?A textMine:nn ?mutation. 
94

103 Our biochemical studies here now show that E884K mutation in  cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone, through differential inhibition of the pro survival AKT and STAT3 signaling pathways associated with altered induction of cleaved PARP(Asp214) 
[?B textMine:partmod ?C, ?C textMine:prep ?A, ?A textMine:amod ?impact, ?E textMine:prep ?B, ?E textMine:pobj ?mutation, ?E textMine:dobj ?function]
Added to queryTripless!! : ?B textMine:partmod ?C. ?C textMine:prep ?A. ?A textMine:amod ?unknown. ?E textMine:prep ?B. ?E textMine:pobj ?mutation. ?E textMine:dobj ?function. 
95

104 This mutation ( E17K ) increases recruitment of AKT1 to the membrane, increases AKT1 phosphorylation and activity, transforms Rat1 fibroblasts, and induces leukaemia in transgenic mice ( Carpten  et al , 2007 ) 
[?A textMine:appos ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?A]
Added to queryTripless!! : ?A textMine:appos ?mutation. ?positive textMine:dobj ?function. ?positive textMine:nsubj ?A. 
96

105 Sumimoto et al ( 15 ) have shown that BRAF V600E  knock down decreased phospho ERK1/2 protein levels and inhibited invasion of melanoma cells accompanied by a decrease of matrix metalloproteinase activity and ITGβ1 expression 
[?E textMine:partmod ?A, ?D textMine:prep ?E, ?A textMine:agent ?impact, ?F textMine:dobj ?D, ?F textMine:nsubj ?mutation, ?impact textMine:prep ?function]
Added to queryTripless!! : ?E textMine:partmod ?A. ?D textMine:prep ?E. ?A textMine:agent ?negative. ?F textMine:dobj ?D. ?F textMine:nsubj ?mutation. ?negative textMine:prep ?function. 
97

106 In line with previous observations   the T790M mutation abrogated erlotinib sensitivity 
[?D textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?D]
Query : [?D textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?D]
Existing trips : 
?C textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?C. 
Similar Query!!!!


107 In vitro analyses showed that in the absence of ligand (EGF), an enhanced tyrosine autophosphorylation can be observed in cells transfected with the plasmid containing EGFR R776G when compared to those transfected with wild type EGFR (Figure  2 ) 
[?function textMine:amod ?impact, ?G textMine:dobj ?mutation, ?A textMine:prep ?H, ?A textMine:nsubjpass ?function, ?H textMine:partmod ?D, ?E textMine:partmod ?G, ?D textMine:prep ?E]
Added to queryTripless!! : ?function textMine:amod ?positive. ?G textMine:dobj ?mutation. ?A textMine:prep ?H. ?A textMine:nsubjpass ?function. ?H textMine:partmod ?D. ?E textMine:partmod ?G. ?D textMine:prep ?E. 
98

108 RNase L R462Q has reduced enzyme activity and doubles the risk of prostate cancer when homozygous   
[?impact textMine:nsubj ?mutation, ?impact textMine:dobj ?function]
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation, ]
Match 


109 In addition, the  JAK2  V617F  mutation may increase the stability of the JAK2 protein by rendering it resistant to the effect of SOCS3 binding, as overexpression of SOCS3 results in increased SOCS3 and  JAK2  V617F  phosphorylation [ 68 ] 
[?G textMine:num ?mutation, ?A textMine:amod ?impact, ?B textMine:prep ?A, ?function textMine:conj ?G, ?function textMine:prep ?F, ?F textMine:prep ?B]
Added to queryTripless!! : ?G textMine:num ?mutation. ?A textMine:amod ?positive. ?B textMine:prep ?A. ?function textMine:conj ?G. ?function textMine:prep ?F. ?F textMine:prep ?B. 
99

110 In fact, the T141A and L153A mutations appeared to increase binding slightly ( Fig 2J ) 
[?B textMine:nn ?mutation, ?impact textMine:acomp ?function, ?impact textMine:xsubj ?B]
Added to queryTripless!! : ?B textMine:nn ?mutation. ?positive textMine:acomp ?function. ?positive textMine:xsubj ?B. 
100

111 Previously, we reported that the V617F mutation caused the constitutive activation of JAK2 when Epo receptor (EpoR) was coexpressed, and JAK2 (V617F) exhibited cytokine independent survival and the proliferation of JAK2 deficient erythroid progenitor cells  
[?E textMine:appos ?mutation, ?A textMine:dobj ?function, ?G textMine:nsubj ?E, ?F textMine:conj ?G, ?F textMine:ccomp ?A, ?function textMine:amod ?impact]
Added to queryTripless!! : ?E textMine:appos ?mutation. ?A textMine:dobj ?function. ?G textMine:nsubj ?E. ?F textMine:conj ?G. ?F textMine:ccomp ?A. ?function textMine:amod ?positive. 
101

112 Similar to  Figure 1B , STAT3, Akt and Erk phosphorylation in EGFR L858R and, more significantly, Δ746 750 expressing cells remained relatively high when compared to vector and wtEGFR expressing cells upon serum deprivation ( Figure 7A ) 
[?impact textMine:nsubj ?B, ?B textMine:prep ?function, ?function textMine:prep ?mutation]
Added to queryTripless!! : ?positive textMine:nsubj ?B. ?B textMine:prep ?function. ?function textMine:prep ?mutation. 
102

113 Structurally, this residue lies in the substrate binding pocket of the kinase, and the M918T mutation appears to increase RET–ATP binding affinity and the stability of the active ATP bound form, effectively making RET more active, more of the time ( 48 )–( 51 ) 
[?D textMine:dep ?A, ?impact textMine:dobj ?D, ?impact textMine:xsubj ?C, ?A textMine:amod ?function, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?D textMine:dep ?A. ?positive textMine:dobj ?D. ?positive textMine:xsubj ?C. ?A textMine:amod ?function. ?C textMine:nn ?mutation. 
103

114 The striking stability of our gene expression results on  PDGFRA  mutated tumors could be explained by the D842V mutation found on 4/5 samples 
[?F textMine:agent ?A, ?F textMine:nsubjpass ?B, ?A textMine:amod ?mutation, ?B textMine:prep ?E, ?E textMine:nn ?function]
Added to queryTripless!! : ?F textMine:agent ?A. ?F textMine:nsubjpass ?B. ?A textMine:amod ?mutation. ?B textMine:prep ?E. ?E textMine:nn ?function. 
104

115 F1174L may therefore stabilize an active conformation that is both more oncogenic and less favored for crizotinib binding 
[?E textMine:amod ?function, ?A textMine:prep ?E, ?F textMine:rcmod ?A, ?B textMine:dobj ?F, ?B textMine:nsubj ?mutation]
Added to queryTripless!! : ?E textMine:amod ?function. ?A textMine:prep ?E. ?F textMine:rcmod ?A. ?B textMine:dobj ?F. ?B textMine:nsubj ?mutation. 
105

116 Further, combined treatment with these inhibitors results in a robust cytotoxic response and decreased tumor volume in a preclinical model of aggressive BRAF V600E  positive ATC 
[?C textMine:nn ?mutation, ?impact textMine:prep ?A, ?A textMine:prep ?C, ?function textMine:conj ?impact]
Added to queryTripless!! : ?C textMine:nn ?mutation. ?negative textMine:prep ?A. ?A textMine:prep ?C. ?function textMine:conj ?negative. 
106

117 The T790M  EGFR  mutant exhibited higher level of tyrosine phosphorylation than wild type  EGFR , and the T790M/L858R double mutant exhibited a substantial increase in phosphorylation levels compared with the L858R mutant alone  
[?A textMine:nn ?mutation, ?function textMine:dobj ?impact, ?function textMine:pobj ?A]
Added to queryTripless!! : ?A textMine:nn ?mutation. ?function textMine:dobj ?positive. ?function textMine:pobj ?A. 
107

118 The enhanced tyrosine phosphorylation of PECAM 1 by the E255K and T315I mutants may be at least partly due to their enhanced activities ( 15 – 17 ) 
[?D textMine:nn ?mutation, ?A textMine:prep ?function, ?A textMine:nsubj ?F, ?F textMine:prep ?D, ?function textMine:amod ?impact]
Added to queryTripless!! : ?D textMine:nn ?mutation. ?A textMine:prep ?function. ?A textMine:nsubj ?F. ?F textMine:prep ?D. ?function textMine:amod ?positive. 
108

119 Consistent with this, we found that the introduction of R1275Q into EML4 ALK had no negative impact on sensitivity to crizotinib (IC 50  47 ± 8 n m ) 
[?E textMine:prep ?mutation, ?C textMine:prep ?function, ?C textMine:amod ?impact, ?F textMine:dobj ?C, ?F textMine:nsubj ?E]
Added to queryTripless!! : ?E textMine:prep ?mutation. ?C textMine:prep ?function. ?C textMine:amod ?negative. ?F textMine:dobj ?C. ?F textMine:nsubj ?E. 
109

120 CNP and meclozine increased the Alcian blue staining of ATDC5 cells expressing FGFR3 G380R and –K650E in micromass culture 
[?impact textMine:dobj ?D, ?A textMine:dep ?mutation, ?D textMine:prep ?E, ?E textMine:partmod ?function, ?function textMine:dobj ?A]
Added to queryTripless!! : ?positive textMine:dobj ?D. ?A textMine:dep ?mutation. ?D textMine:prep ?E. ?E textMine:partmod ?function. ?function textMine:dobj ?A. 
110

121 The T315I cells exhibit increased proliferation rate (Supporting Information Fig S8 ), elevated basal expressions of Rad51 and γ H2AX ( Fig 5A ) and display increased endogenous DNA damage response, indicated by increased Rad51 and γ H2AX foci ( Fig 5B and C ), when compared with parental cells 
[?D textMine:prep ?B, ?F textMine:ccomp ?D, ?F textMine:nsubj ?function, ?function textMine:nn ?mutation, ?B textMine:amod ?impact]
Added to queryTripless!! : ?D textMine:prep ?B. ?F textMine:ccomp ?D. ?F textMine:nsubj ?function. ?function textMine:nn ?mutation. ?B textMine:amod ?positive. 
111

122 Complete abrogation of EphA3 function was achieved by the mutation of both Y602 and Y779, similar to that of the kinase inactive mutants K653R and Y596F ( Fig 7 ) 
[?A textMine:dep ?D, ?A textMine:nsubjpass ?impact, ?D textMine:nsubj ?mutation, ?impact textMine:prep ?function]
Added to queryTripless!! : ?A textMine:dep ?D. ?A textMine:nsubjpass ?negative. ?D textMine:nsubj ?mutation. ?negative textMine:prep ?function. 
112

123 BCR ABL mutations respond differently to three tyrosine kinase inhibitors approved for first line treatment of CML, e g, Y253F and G250E mutations resistant to imatinib can respond to nilotinib or/and dasatinib, T315A shows better response to imatinib though resistant to Dasatinib and Nilotinib, while some mutations are less sensitive to nilotinib (E255K/V and F359V/C) or dasatinib (F317L and V299L)  
[?B textMine:cop ?impact, ?B textMine:advmod ?function]
[?B textMine:advmod ?function, ?B textMine:cop ?impact, ]
Match 


124 These two mutations, resulting in L1198F and G1201E amino acid changes, respectively, both reside within the ALK tyrosine kinase domain where they dramatically increased tyrosine kinase activities 
[?impact textMine:dobj ?function, ?A textMine:nn ?mutation, ?D textMine:advcl ?impact, ?D textMine:partmod ?F, ?F textMine:prep ?A]
Added to queryTripless!! : ?positive textMine:dobj ?function. ?A textMine:nn ?mutation. ?D textMine:advcl ?positive. ?D textMine:partmod ?F. ?F textMine:prep ?A. 
113

189 The goals of these methods are to increase sensitivity, specificity and to accurately quantify mutations of B Raf V600E 
[?C textMine:dobj ?A, ?A textMine:prep ?mutation, ?impact textMine:conj ?C, ?impact textMine:dobj ?function]
Added to queryTripless!! : ?C textMine:dobj ?A. ?A textMine:prep ?mutation. ?positive textMine:conj ?C. ?positive textMine:dobj ?function. 
114

125 FLT3 ITD and FLT3 with an activating amino acid substitution in the tyrosine kinase domain, such as FLT3 D835Y, also constitutively activate the PI3K/Akt and MEK/Erk signaling pathways as well as STAT5 to stimulate proliferation and enhance survival of hematopoietic cells 
[?D textMine:prep ?mutation, ?function textMine:advmod ?impact, ?function textMine:nsubj ?E, ?E textMine:prep ?D]
Added to queryTripless!! : ?D textMine:prep ?mutation. ?function textMine:advmod ?positive. ?function textMine:nsubj ?E. ?E textMine:prep ?D. 
115

126 Strongly reduced activity of the PPARγ K365R mutant contradicts the results of Pascual  et al who reported similar activation of the Aox tk  luciferase construct by wild type PPARγ and by the PPARγ K365R mutant 
[?E textMine:prep ?C, ?E textMine:nsubj ?function, ?D textMine:ccomp ?E, ?impact textMine:dep ?D, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?E textMine:prep ?C. ?E textMine:nsubj ?function. ?D textMine:ccomp ?E. ?negative textMine:dep ?D. ?C textMine:nn ?mutation. 
116

127 The phosphorylation of Akt induced by S768I was abrogated by 100 nM erlotinib, and fibril formation was noted upon treatment with 1 μM or higher concentration of the drug 
[?C textMine:prep ?D, ?D textMine:partmod ?function, ?function textMine:agent ?mutation, ?impact textMine:nsubjpass ?C]
Added to queryTripless!! : ?C textMine:prep ?D. ?D textMine:partmod ?function. ?function textMine:agent ?mutation. ?negative textMine:nsubjpass ?C. 
117

128 Survival for CML CP patients with the T315I point mutation treated with TKIs is estimated to be reduced by 50% compared with patients without the T315I mutation (median survival of 22 months vs  more than 10 years for TKI responsive CML patients; Nicolini et al, 2009) 
[?E textMine:dep ?function, ?E textMine:prep ?B, ?B textMine:nn ?mutation, ?impact textMine:pobj ?E]
[?B textMine:nn ?mutation, ?E textMine:dep ?function, ?E textMine:prep ?B, ?impact textMine:pobj ?E, ]
Match 


129 Bone marrow derived pro B cell line BaF3 stably expressing wild type  JAK3  or mutant  JAK3  (V674A) were obtained from Dr Hiroyuki Mano   and maintained in RPMI 1640 containing 10% FBS 
[?impact textMine:nsubjpass ?A, ?A textMine:appos ?mutation, ?A textMine:partmod ?E, ?E textMine:xcomp ?function]
Added to queryTripless!! : ?neutral textMine:nsubjpass ?A. ?A textMine:appos ?mutation. ?A textMine:partmod ?E. ?E textMine:xcomp ?function. 
118

130 Another study found uncoupling in rare TnC variants identified in DCM: cTnC Y5H, M103I, and I148V either decreased or abolished the effects of PKA phosphorylation on Ca 2+  sensitivity (Pinto et al,  2011 ) 
[?E textMine:prep ?function, ?impact textMine:conj ?D, ?impact textMine:nsubj ?mutation, ?impact textMine:nsubj ?B, ?D textMine:dobj ?E, ?D textMine:nsubj ?B, ?B textMine:conj ?mutation]
Added to queryTripless!! : ?E textMine:prep ?function. ?negative textMine:conj ?D. ?negative textMine:nsubj ?mutation. ?negative textMine:nsubj ?B. ?D textMine:dobj ?E. ?D textMine:nsubj ?B. ?B textMine:conj ?mutation. 
119

131 Furthermore, we show that the R728L variant decreases overall receptor levels and cellular receptor activity 
[?B textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?B]
Query : [?B textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?B]
Existing trips : 
?C textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?C. 
Similar Query!!!!


132 In particular, our data are consistent with the identification of ETV1 and ETV5 in screens for mRNAs whose expression was decreased by BRAF(V600E)/MEK [MAPK (mitogen activated protein kinase)/ERK kinase] inhibitors in melanoma cells   
[?D textMine:appos ?mutation, ?impact textMine:agent ?D, ?impact textMine:nsubjpass ?function]
Added to queryTripless!! : ?D textMine:appos ?mutation. ?negative textMine:agent ?D. ?negative textMine:nsubjpass ?function. 
120

133 The activity of DAS is maintained despite the presence of mutations that confer resistance to IM with the exception of the T315I mutation, and to a large degree, mutations affecting the residue 317 (F317L, F317V) 
[?A textMine:prep ?I, ?A textMine:dobj ?function, ?H textMine:nn ?mutation, ?B textMine:prep ?H, ?impact textMine:prep ?F, ?I textMine:prep ?B, ?F textMine:prep ?G, ?G textMine:rcmod ?A]
Added to queryTripless!! : ?A textMine:prep ?I. ?A textMine:dobj ?function. ?H textMine:nn ?mutation. ?B textMine:prep ?H. ?neutral textMine:prep ?F. ?I textMine:prep ?B. ?F textMine:prep ?G. ?G textMine:rcmod ?A. 
121

134 However, the ability of crizotinib to inhibit ALK phosphorylation was substantially reduced in all mutants tested, with IC 50 s >1000 n m  for L1196M and G1269S ( Table 2 ) 
[?B textMine:prep ?H, ?H textMine:infmod ?C, ?C textMine:ccomp ?impact, ?D textMine:dobj ?E, ?D textMine:nsubj ?B, ?E textMine:prep ?mutation, ?impact textMine:nsubjpass ?function]
Added to queryTripless!! : ?B textMine:prep ?H. ?H textMine:infmod ?C. ?C textMine:ccomp ?negative. ?D textMine:dobj ?E. ?D textMine:nsubj ?B. ?E textMine:prep ?mutation. ?negative textMine:nsubjpass ?function. 
122

135 Previous studies demonstrated that expression of AKT1 E17K protein in NIH 3T3 cells increased AKT phosphorylation in those cells ( Carpten  et al , 2007 ) 
[?function textMine:prep ?A, ?impact textMine:nsubj ?function, ?A textMine:nn ?mutation]
Query : [?function textMine:prep ?A, ?impact textMine:nsubj ?function, ?A textMine:nn ?mutation]
Existing trips : 
?B textMine:nn ?mutation. ?function textMine:prep ?B. ?impact textMine:nsubj ?function. 
Similar Query!!!!


136 This analysis revealed that the GST–JNK2 mutants D162N or D326N, residing within the ED and CD domains respectively, had reduced association with Myc 1018 C ( Figure 6 B, lanes 3–5) 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation]
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation, ]
Match 


137 Here we provide the first evidence that  V600E BRAF causes the upregulation of genes involved in glycolysis, whereas knock down of  V600E BRAF in melanoma cells conversely reduces the expression of these genes, lowers the rate of glycolysis and causes the reversal of the Warburg phenotype 
[?E textMine:nn ?mutation, ?D textMine:prep ?E, ?impact textMine:advcl ?A, ?A textMine:dobj ?function, ?A textMine:csubj ?D]
Added to queryTripless!! : ?E textMine:nn ?mutation. ?D textMine:prep ?E. ?negative textMine:advcl ?A. ?A textMine:dobj ?function. ?A textMine:csubj ?D. 
123

138 The mutation of arginine at position 24 into cysteine (CDK4 R24C ) or histidine (CDK4 R24C ) renders the protein insensitive to regulation by p16 INK4a  but preserves interaction between CDK4 and cyclin D1 leading to constitutive activation of the complex and aberrant proliferation, through retinoblastoma protein inactivation and E2F activation 
[?F textMine:prep ?G, ?G textMine:prep ?A, ?B textMine:prep ?F, ?A textMine:appos ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?B]
Added to queryTripless!! : ?F textMine:prep ?G. ?G textMine:prep ?A. ?B textMine:prep ?F. ?A textMine:appos ?mutation. ?neutral textMine:dobj ?function. ?neutral textMine:nsubj ?B. 
124

139 The mutations T315I, E255V, F317L and F317V contribute to decreased vdW interactions with Ala269 
[?D textMine:prep ?function, ?D textMine:dep ?E, ?function textMine:amod ?impact, ?E textMine:dep ?mutation]
Added to queryTripless!! : ?D textMine:prep ?function. ?D textMine:dep ?E. ?function textMine:amod ?negative. ?E textMine:dep ?mutation. 
125

140 As shown in  Figure 3a–b , the kinase activities of L858R/V948R tEGFR in its EGF– and Cetuximab–bound forms were reduced substantially compared to that of L858R tEGFR, indicating that mutation of either the N lobe or C lobe face of the dimer interface of L858R results in a 10  to 30 fold decrease in catalytic rate 
[?C textMine:dep ?E, ?B textMine:prep ?K, ?function textMine:num ?mutation, ?K textMine:partmod ?M, ?E textMine:prep ?B, ?J textMine:parataxis ?D, ?J textMine:prep ?C, ?D textMine:ccomp ?G, ?G textMine:dobj ?I, ?M textMine:ccomp ?impact, ?H textMine:prep ?function, ?I textMine:prep ?H]
Added to queryTripless!! : ?C textMine:dep ?E. ?B textMine:prep ?K. ?function textMine:num ?mutation. ?K textMine:partmod ?M. ?E textMine:prep ?B. ?J textMine:parataxis ?D. ?J textMine:prep ?C. ?D textMine:ccomp ?G. ?G textMine:dobj ?I. ?M textMine:ccomp ?negative. ?H textMine:prep ?function. ?I textMine:prep ?H. 
126

141 We also found that all of the  NRAS  mutated melanoma lines evaluated (or included in our panel) had low expression of CDK2, whereas there was some variability within the  BRAF  V600E mutated group, with some cell lines harboring high expression of CDK2 and some with low expression 
[?F textMine:conj ?C, ?F textMine:amod ?impact, ?I textMine:prep ?K, ?K textMine:nn ?mutation, ?B textMine:dobj ?C, ?B textMine:dobj ?F, ?J textMine:prep ?G, ?J textMine:ccomp ?H, ?A textMine:nsubj ?I, ?G textMine:partmod ?B, ?H textMine:advcl ?A, ?C textMine:prep ?function]
Added to queryTripless!! : ?F textMine:conj ?C. ?F textMine:amod ?positive. ?I textMine:prep ?K. ?K textMine:nn ?mutation. ?B textMine:dobj ?C. ?B textMine:dobj ?F. ?J textMine:prep ?G. ?J textMine:ccomp ?H. ?A textMine:nsubj ?I. ?G textMine:partmod ?B. ?H textMine:advcl ?A. ?C textMine:prep ?function. 
127

142 The expression of the G719C transcript was high compared to the S768I transcript throughout the tumor section 
[?C textMine:amod ?mutation, ?impact textMine:pobj ?C, ?impact textMine:nsubj ?function]
Added to queryTripless!! : ?C textMine:amod ?mutation. ?positive textMine:pobj ?C. ?positive textMine:nsubj ?function. 
128

143 Hence, E884K mutation can work in concert with L858R to modulate mutant receptor sensitivity to different targeted inhibitors 
[?A textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:xsubj ?A]
Added to queryTripless!! : ?A textMine:nn ?mutation. ?unknown textMine:dobj ?function. ?unknown textMine:xsubj ?A. 
129

144 Hence, the double mutation L858R+E884K modulated downstream EGFR signaling differentially with distinctly different effects on the AKT (downregulated) and MAPK ERK1/2 phosphorylation (upregulated) 
[?E textMine:partmod ?A, ?impact textMine:dobj ?E, ?impact textMine:nsubj ?D, ?D textMine:nn ?mutation, ?A textMine:prep ?function]
Added to queryTripless!! : ?E textMine:partmod ?A. ?unknown textMine:dobj ?E. ?unknown textMine:nsubj ?D. ?D textMine:nn ?mutation. ?A textMine:prep ?function. 
130

145 We found high levels of active Caspase 3 in the regressing tumors compared with  BRAF   V600E   mitf  melanomas at <26 °C ( n =5 in each group;  Figure 5c ) 
[?G textMine:prep ?H, ?G textMine:amod ?impact, ?C textMine:prep ?D, ?C textMine:dobj ?G, ?H textMine:amod ?function, ?E textMine:nn ?mutation, ?D textMine:pobj ?E]
Added to queryTripless!! : ?G textMine:prep ?H. ?G textMine:amod ?positive. ?C textMine:prep ?D. ?C textMine:dobj ?G. ?H textMine:amod ?function. ?E textMine:nn ?mutation. ?D textMine:pobj ?E. 
131

146 Thus, certain P loop mutations (Y253F, E255K) and the T315I mutation display a high oncogenic potential, which is consistent with the clinical observation of a poor outcome concerning overall and progression free survival   
[?D textMine:xcomp ?E, ?E textMine:dobj ?function, ?F textMine:appos ?mutation, ?G textMine:rcmod ?D, ?G textMine:amod ?impact, ?B textMine:dobj ?G, ?B textMine:nsubj ?F]
Added to queryTripless!! : ?D textMine:xcomp ?E. ?E textMine:dobj ?function. ?F textMine:appos ?mutation. ?G textMine:rcmod ?D. ?G textMine:amod ?positive. ?B textMine:dobj ?G. ?B textMine:nsubj ?F. 
132

147 In non small lung cancer, a missense mutation ( T790M)  within the EGFR kinase domain has been shown to emerge in lesions that progress while on TKIs, yielding a protein with reduced binding to drug  
[?C textMine:prep ?impact, ?G textMine:appos ?mutation, ?D textMine:dobj ?F, ?D textMine:xsubj ?G, ?F textMine:partmod ?C, ?impact textMine:amod ?function]
Added to queryTripless!! : ?C textMine:prep ?negative. ?G textMine:appos ?mutation. ?D textMine:dobj ?F. ?D textMine:xsubj ?G. ?F textMine:partmod ?C. ?negative textMine:amod ?function. 
133

148 These observations suggested that the increased nuclear expression of YAP1 might promote the invasion of  BRAF   V600E   (+) PTC into adjacent tissues 
[?C textMine:nn ?mutation, ?function textMine:amod ?impact, ?B textMine:dobj ?A, ?B textMine:nsubj ?function, ?A textMine:prep ?C]
Added to queryTripless!! : ?C textMine:nn ?mutation. ?function textMine:amod ?positive. ?B textMine:dobj ?A. ?B textMine:nsubj ?function. ?A textMine:prep ?C. 
134

149 A somatic mutation of JAK2 , coding for constitutively activated Jak2 V617F, is frequently observed in  BCR/ABL1  negative myeloproliferative neoplasms (MPNs): 96% in polycythemia vera (PV), 55% in essential thrombocythemia (ET), and 65% in primary myelofibrosis (PMF)  
[?mutation textMine:amod ?function, ?mutation textMine:amod ?impact]
Added to queryTripless!! : ?mutation textMine:amod ?function. ?mutation textMine:amod ?positive. 
135

150 Conversely, E884K worked in concert with L858R in  cis  to further enhance the sensitivity of the mutant receptor to gefitinib inhibition ( Fig 1A, B ) 
[?impact textMine:prep ?function, ?impact textMine:xsubj ?mutation]
Added to queryTripless!! : ?positive textMine:prep ?function. ?positive textMine:xsubj ?mutation. 
136

151 In an  in vitro  study, these two types of EGFR mutants demonstrated an enhanced TK activity in response to EGF and increased sensitivity to inhibition by TKI, although the biological activity between tumours with L858R and those with deletions was different ( Paez  et al , 2004 ;  Pao  et al , 2004 ) 
[?D textMine:prep ?mutation, ?E textMine:prep ?D, ?C textMine:nsubj ?E, ?function textMine:advcl ?C, ?impact textMine:xcomp ?function]
Added to queryTripless!! : ?D textMine:prep ?mutation. ?E textMine:prep ?D. ?C textMine:nsubj ?E. ?function textMine:advcl ?C. ?positive textMine:xcomp ?function. 
137

152 Tyrosine phosphorylation of STAT5 was also enhanced, though not as significantly as that of PECAM 1, in cells expressing the E255K or T315I mutant ( Fig 4C ) 
[?impact textMine:prep ?E, ?impact textMine:nsubjpass ?function, ?F textMine:dobj ?C, ?E textMine:partmod ?F, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?positive textMine:prep ?E. ?positive textMine:nsubjpass ?function. ?F textMine:dobj ?C. ?E textMine:partmod ?F. ?C textMine:nn ?mutation. 
138

153 The enhanced tyrosine phosphorylation of PECAM 1 by the E255K and T315I mutants may be at least partly due to their enhanced activities ( 15 – 17 ) 
[?D textMine:nn ?mutation, ?A textMine:prep ?E, ?A textMine:nsubj ?function, ?function textMine:prep ?D, ?E textMine:amod ?impact]
Added to queryTripless!! : ?D textMine:nn ?mutation. ?A textMine:prep ?E. ?A textMine:nsubj ?function. ?function textMine:prep ?D. ?E textMine:amod ?positive. 
139

154 The result is the disruption of the I 1 interactions, indicating that H587N is a deleterious mutation 
[?C textMine:ccomp ?A, ?impact textMine:partmod ?C, ?impact textMine:prep ?function, ?A textMine:nsubj ?mutation]
Added to queryTripless!! : ?C textMine:ccomp ?A. ?negative textMine:partmod ?C. ?negative textMine:prep ?function. ?A textMine:nsubj ?mutation. 
140

155 FLT3  D835V and  KIT  D816Y) retained some level of sensitivity with regard to induction of apoptosis 
[?B textMine:prep ?function, ?impact textMine:dobj ?B, ?impact textMine:nsubj ?mutation]
Added to queryTripless!! : ?B textMine:prep ?function. ?neutral textMine:dobj ?B. ?neutral textMine:nsubj ?mutation. 
141

156 (A) Treatment of BaF3 JAK3 V674A  cells with NSC114792 results in a decrease in phosphorylated JAK3 and STAT5 levels in a dose dependent manner 
[?impact textMine:prep ?G, ?D textMine:prep ?impact, ?B textMine:prep ?D, ?B textMine:prep ?C, ?C textMine:nn ?mutation, ?G textMine:amod ?function]
Added to queryTripless!! : ?negative textMine:prep ?G. ?D textMine:prep ?negative. ?B textMine:prep ?D. ?B textMine:prep ?C. ?C textMine:nn ?mutation. ?G textMine:amod ?function. 
142

157 Our biochemical studies here now show that E884K mutation in  cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone, through differential inhibition of the pro survival AKT and STAT3 signaling pathways associated with altered induction of cleaved PARP(Asp214) 
[?F textMine:amod ?mutation, ?B textMine:prep ?A, ?E textMine:prep ?function, ?E textMine:nsubj ?F, ?A textMine:amod ?impact, ?function textMine:partmod ?B]
Added to queryTripless!! : ?F textMine:amod ?mutation. ?B textMine:prep ?A. ?E textMine:prep ?function. ?E textMine:nsubj ?F. ?A textMine:amod ?unknown. ?function textMine:partmod ?B. 
143

158 In our models, MEK inhibitors produced a much stronger effect than WZ4002, which targets the EGFR[T790M] mutation   Fig 4C ) 
[?G textMine:rcmod ?A, ?D textMine:prep ?G, ?D textMine:dobj ?function, ?A textMine:dobj ?E, ?E textMine:nn ?mutation, ?function textMine:amod ?impact]
Added to queryTripless!! : ?G textMine:rcmod ?A. ?D textMine:prep ?G. ?D textMine:dobj ?function. ?A textMine:dobj ?E. ?E textMine:nn ?mutation. ?function textMine:amod ?positive. 
144

159 In particular, an activating point mutation in JAK2 (JAK2 V617F ) has been described with high frequency in chronic myeloproliferative disorders (MPD) and constitutive JAK2 activation caused by chromosomal translocations has been reported in various types of leukemia     
[?function textMine:amod ?impact, ?A textMine:conj ?function, ?A textMine:appos ?mutation]
Added to queryTripless!! : ?function textMine:amod ?positive. ?A textMine:conj ?function. ?A textMine:appos ?mutation. 
145

160 The E17K mutation constitutively activates Akt1 by altering the kinetics and specificity of phospholipid binding, increasing the binding to PIP2, the more abundant plasma membrane phospholipid in the absence of PI3 kinase activation  
[?F textMine:dobj ?function, ?B textMine:nn ?mutation, ?A textMine:partmod ?F, ?A textMine:prepc ?impact, ?A textMine:nsubj ?B]
Added to queryTripless!! : ?F textMine:dobj ?function. ?B textMine:nn ?mutation. ?A textMine:partmod ?F. ?A textMine:prepc ?unknown. ?A textMine:nsubj ?B. 
146

161 Some mutations (P112Q, R895C, E897K) enhance angiotensin II receptor mediated activation of TRPC6 when expressed in HEK293 cells, while neither the S270T nor the N143S missense mutations, nor a 57 amino acid truncation mutation (K874X), altered the channel activity   
[?C textMine:partmod ?E, ?C textMine:nn ?impact, ?function textMine:advcl ?F, ?F textMine:nsubj ?mutation, ?E textMine:advcl ?function]
Added to queryTripless!! : ?C textMine:partmod ?E. ?C textMine:nn ?positive. ?function textMine:advcl ?F. ?F textMine:nsubj ?mutation. ?E textMine:advcl ?function. 
147

162 Some mutations (P112Q, R895C, E897K) enhance angiotensin II receptor mediated activation of TRPC6 when expressed in HEK293 cells, while neither the S270T nor the N143S missense mutations, nor a 57 amino acid truncation mutation (K874X), altered the channel activity   
[?impact textMine:nsubj ?C, ?E textMine:advcl ?function, ?C textMine:partmod ?E, ?function textMine:advcl ?F, ?F textMine:nsubj ?mutation]
Added to queryTripless!! : ?unknown textMine:nsubj ?C. ?E textMine:advcl ?function. ?C textMine:partmod ?E. ?function textMine:advcl ?F. ?F textMine:nsubj ?mutation. 
148

163 One hypothesis may state that induction of apoptosis is mediated via Thr308: We observed a particular high phosphorylation pattern of Thr308 in cells transfected with the tyrosine kinase domain (TKD) mutated  FLT3  D835V and  KIT  D816Y isoforms in our assays (see Figure  6 ) 
[?G textMine:partmod ?D, ?B textMine:nn ?function, ?B textMine:amod ?impact, ?A textMine:dobj ?H, ?H textMine:nn ?mutation, ?D textMine:prep ?F, ?F textMine:partmod ?A, ?J textMine:prep ?G, ?J textMine:dobj ?B]
Added to queryTripless!! : ?G textMine:partmod ?D. ?B textMine:nn ?function. ?B textMine:amod ?positive. ?A textMine:dobj ?H. ?H textMine:nn ?mutation. ?D textMine:prep ?F. ?F textMine:partmod ?A. ?J textMine:prep ?G. ?J textMine:dobj ?B. 
149

164 It appears that PtdIns binding is enhanced in the E416A mutant for two reasons; (i) the Arg 380 –Glu 416  salt bridge, which otherwise blocks the entrance to the binding pocket, is broken, and (ii) the sentry glutamate residue, Glu 416 , is replaced by an alanine in this open state, which further increases the accessibility of the binding site for negatively charged lipid headgroups 
[?E textMine:prep ?A, ?H textMine:rcmod ?impact, ?G textMine:agent ?I, ?A textMine:amod ?function, ?I textMine:prep ?H, ?D textMine:nn ?mutation, ?J textMine:conj ?G, ?J textMine:ccomp ?C, ?impact textMine:dobj ?E, ?C textMine:prep ?D]
Added to queryTripless!! : ?E textMine:prep ?A. ?H textMine:rcmod ?positive. ?G textMine:agent ?I. ?A textMine:amod ?function. ?I textMine:prep ?H. ?D textMine:nn ?mutation. ?J textMine:conj ?G. ?J textMine:ccomp ?C. ?positive textMine:dobj ?E. ?C textMine:prep ?D. 
150

165 BRAF V600E  has elevated kinase activity, when compared with wild type  BRAF ; 1  and it induces constitutive ERK signaling, through hyperactivation of the RAS/RAF/MEK/ERK pathway, stimulating proliferation, survival and transformation 
[?function textMine:amod ?impact, ?A textMine:dobj ?function, ?A textMine:nsubj ?mutation]
Query : [?function textMine:amod ?impact, ?A textMine:dobj ?function, ?A textMine:nsubj ?mutation]
Existing trips : 
?D textMine:dobj ?function. ?D textMine:nsubj ?mutation. ?function textMine:amod ?impact. 
Similar Query!!!!


166 The enhanced tyrosine phosphorylation of PECAM 1 by the E255K and T315I mutants may be at least partly due to their enhanced activities ( 15 – 17 ) 
[?D textMine:nn ?mutation, ?A textMine:prep ?E, ?A textMine:nsubj ?function, ?function textMine:prep ?D, ?E textMine:amod ?impact]
[?A textMine:nsubj ?function, ?A textMine:prep ?E, ?D textMine:nn ?mutation, ?E textMine:amod ?impact, ?function textMine:prep ?D, ]
Match 


168 Although inhibition of MEK and ERK phosphorylation was achieved in BRAF V600E/K  mutant melanoma, significantly increased tumour growth was seen in BRAF wild type melanomas with upstream RAS mutations 
[?impact textMine:advcl ?B, ?B textMine:prep ?C, ?B textMine:nsubjpass ?function, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?positive textMine:advcl ?B. ?B textMine:prep ?C. ?B textMine:nsubjpass ?function. ?C textMine:nn ?mutation. 
151

169 Similar to E884K, R958D modulated the sensitizing effect of L858R differentially to reversible EGFR inhibitors when in  cis  (with L858R) 
[?A textMine:nn ?mutation, ?E textMine:amod ?function, ?B textMine:prep ?A, ?impact textMine:dobj ?E, ?impact textMine:nsubj ?B]
Added to queryTripless!! : ?A textMine:nn ?mutation. ?E textMine:amod ?function. ?B textMine:prep ?A. ?unknown textMine:dobj ?E. ?unknown textMine:nsubj ?B. 
152

170 Accordingly, there was higher Congo red binding of aggregated R248Q p53C than aggregated WT p53C at pH 7 2 ( Fig 2  A ) 
[?function textMine:prep ?D, ?function textMine:amod ?impact, ?D textMine:nn ?mutation]
Query : [?function textMine:prep ?D, ?function textMine:amod ?impact, ?D textMine:nn ?mutation]
Existing trips : 
?A textMine:nn ?mutation. ?function textMine:amod ?impact. ?function textMine:prep ?A. 
Similar Query!!!!


171 The constitutive increase in EGFR activity appears to be ligand independent, as a combination of neutralizing antibodies against EGF, TGFα, and EGFR failed to inhibit elevated basal levels of L858R autophosphorylation ( Figure 2 B) 
[?function textMine:amod ?mutation, ?C textMine:prep ?function, ?C textMine:amod ?impact]
Added to queryTripless!! : ?function textMine:amod ?mutation. ?C textMine:prep ?function. ?C textMine:amod ?positive. 
153

172 In such a case, although she died of progressive disease of T790M mutated tumor cells in her thorax, EGFR TKI, which was effective in the brain metastases, was beneficial for her to improve her quality of life 
[?D textMine:prep ?F, ?F textMine:nn ?mutation, ?impact textMine:nsubj ?G, ?impact textMine:advcl ?E, ?G textMine:rcmod ?function, ?E textMine:prep ?D]
Added to queryTripless!! : ?D textMine:prep ?F. ?F textMine:nn ?mutation. ?positive textMine:nsubj ?G. ?positive textMine:advcl ?E. ?G textMine:rcmod ?function. ?E textMine:prep ?D. 
154

173 Other mutations, outside the active site (secondary mutations), can increase resistance in the presence of major primary mutations like L10I/V, K20M/L/T, and I54V, as well as additional primary mutations such as M46I, and V82A/F/L/T 
[?impact textMine:dobj ?function, ?impact textMine:prep ?E, ?A textMine:nn ?mutation, ?E textMine:prep ?A]
Added to queryTripless!! : ?positive textMine:dobj ?function. ?positive textMine:prep ?E. ?A textMine:nn ?mutation. ?E textMine:prep ?A. 
155

174 In this regard, there has been some controversy regarding the enhanced kinase activity of T790M mutant EGFR   
[?B textMine:nn ?mutation, ?function textMine:prep ?B, ?function textMine:amod ?impact]
Query : [?B textMine:nn ?mutation, ?function textMine:prep ?B, ?function textMine:amod ?impact]
Existing trips : 
?A textMine:nn ?mutation. ?function textMine:amod ?impact. ?function textMine:prep ?A. 
Similar Query!!!!


175 Onitsuka et al examined clinical specimens of the acquired resistance cases and found that certain lung adenocarcinoma tissues have the T790M mutation and high levels of HGF expression 
[?B textMine:amod ?mutation, ?B textMine:conj ?E, ?E textMine:amod ?impact, ?E textMine:prep ?function]
Added to queryTripless!! : ?B textMine:amod ?mutation. ?B textMine:conj ?E. ?E textMine:amod ?positive. ?E textMine:prep ?function. 
156

176 The mutations E255K, F317L and F317V experience increased electrostatic interactions with Tyr253 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:amod ?E, ?E textMine:dep ?mutation]
Added to queryTripless!! : ?positive textMine:dobj ?function. ?positive textMine:nsubj ?B. ?B textMine:amod ?E. ?E textMine:dep ?mutation. 
157

177 Consistent with our hierarchical clustering analysis, introduction of the R164Q mutation led to relatively few changes in gene expression or showed reduced pathway activation compared with the other mutants studied 
[?G textMine:nn ?mutation, ?F textMine:conj ?C, ?F textMine:nsubj ?A, ?C textMine:dobj ?function, ?function textMine:amod ?impact, ?A textMine:prep ?G]
Added to queryTripless!! : ?G textMine:nn ?mutation. ?F textMine:conj ?C. ?F textMine:nsubj ?A. ?C textMine:dobj ?function. ?function textMine:amod ?negative. ?A textMine:prep ?G. 
158

178 Here, we observed that expression of both Snail (sixfold) and Slug (twofold) was increased in BRAF V600E  murine thyroid tumor tissue compared to normal thyroid (Figure  3 C) 
[?A textMine:nn ?mutation, ?impact textMine:prep ?A, ?impact textMine:nsubjpass ?function]
Query : [?A textMine:nn ?mutation, ?impact textMine:prep ?A, ?impact textMine:nsubjpass ?function]
Existing trips : 
?D textMine:nn ?mutation. ?impact textMine:nsubjpass ?function. ?impact textMine:prep ?D. 
Similar Query!!!!


180 By contrast, both ALK F1174I  and ALK F1174L  displayed robust foci formation, although ALK M1166R  showed rather weak foci formation ability in comparison with ALK F1174S  ( Fig 5A ) 
[?function textMine:amod ?impact, ?B textMine:dobj ?function, ?B textMine:prep ?mutation]
Added to queryTripless!! : ?function textMine:amod ?negative. ?B textMine:dobj ?function. ?B textMine:prep ?mutation. 
159

181 In terms of EGFR TKI sensitivity, Kancha et al have identified 4 sets of mutations based on their drug sensitivity profiles: (a) mutations that are very sensitive to all 3 drugs tested with IC50 values in the low nanomolar range (L858R and Del 747 753insS), (b) mutations that are less sensitive to gefitinib (IC50 >100 nmol/l) but sensitive to both erlotinib and AEE788 (G719S, V742A, and R776C; IC50 < 100 nmol/l), (c) mutations that are less sensitive to both gefitinib and erlotinib but sensitive to AEE788 (D761N, S768I, S784F, L838V, and L861Q), and (d) mutations that are resistant to all three drugs tested (N826S and T790M)   
[?A textMine:conj ?D, ?A textMine:xcomp ?function, ?A textMine:advmod ?impact, ?D textMine:dep ?mutation]
Added to queryTripless!! : ?A textMine:conj ?D. ?A textMine:xcomp ?function. ?A textMine:advmod ?negative. ?D textMine:dep ?mutation. 
160

182 Consistent with these results, luciferase reporter analysis showed that BRAF K601E CT with K483R or K578R mutation failed to induce AP 1 dependent luciferase reporter gene expression whereas BRAF K601E CT and other mutants induced a higher level of AP 1 reporter activity in HEK 293T cells ( Fig S1B ) 
[?A textMine:dobj ?B, ?A textMine:nsubj ?D, ?I textMine:xcomp ?C, ?D textMine:nn ?mutation, ?C textMine:advcl ?A, ?E textMine:nsubj ?function, ?E textMine:ccomp ?I, ?B textMine:amod ?impact]
Added to queryTripless!! : ?A textMine:dobj ?B. ?A textMine:nsubj ?D. ?I textMine:xcomp ?C. ?D textMine:nn ?mutation. ?C textMine:advcl ?A. ?E textMine:nsubj ?function. ?E textMine:ccomp ?I. ?B textMine:amod ?positive. 
161

183 The role of  BRAF  and  KRAS  oncogenes in altering cytoskeletal properties was further emphasized following depletion of BRAF V600E  by shRNA in HT29 cells, where migration ability of HT ShBR3 cells, with downregulated expression of mt BRAF  gene, was significantly impaired as compared to the empty vector control HT ps cells 
[?F textMine:nn ?function, ?D textMine:rcmod ?impact, ?mutation textMine:prep ?A, ?A textMine:prep ?D, ?impact textMine:nsubj ?F]
Added to queryTripless!! : ?F textMine:nn ?function. ?D textMine:rcmod ?negative. ?mutation textMine:prep ?A. ?A textMine:prep ?D. ?negative textMine:nsubj ?F. 
162

184 BRAF V600E  elicits a strong kinase activity (increased phosphorylation, PO4−) compared with wild type (wt) BRAF and activates MEK1/2 to phospho MEK1/2 and ERK1/2 to phospho ERK1/2, which may be involved in the up regulation of some ECM remodeling genes (ie 
[?function textMine:amod ?impact, ?C textMine:dep ?function, ?C textMine:nsubj ?mutation]
Added to queryTripless!! : ?function textMine:amod ?positive. ?C textMine:dep ?function. ?C textMine:nsubj ?mutation. 
163

185 For instance, the A391E mutation in FGFR3 increases FGFR3 phosphorylation at low ligand concentration, similarly to the G380R and G375C ACH mutations studied here  
[?impact textMine:prep ?B, ?impact textMine:dobj ?function, ?A textMine:amod ?E, ?B textMine:appos ?A, ?G textMine:nn ?mutation, ?E textMine:prep ?G]
Added to queryTripless!! : ?positive textMine:prep ?B. ?positive textMine:dobj ?function. ?A textMine:amod ?E. ?B textMine:appos ?A. ?G textMine:nn ?mutation. ?E textMine:prep ?G. 
164

186 Here, we test the hypothesis that E1271K mutation of MET, analogous to E884K EGFR, can also differentially alter inhibitory sensitivity towards selective MET inhibitors ( Figure 6 ) 
[?A textMine:prep ?E, ?F textMine:amod ?A, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?F, ?E textMine:nn ?mutation]
Added to queryTripless!! : ?A textMine:prep ?E. ?F textMine:amod ?A. ?unknown textMine:dobj ?function. ?unknown textMine:nsubj ?F. ?E textMine:nn ?mutation. 
165

187 E884K EGFR modulates inhibitor sensitivity effects in an inhibitor specific fashion
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:nn ?mutation]
Query : [?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:nn ?mutation]
Existing trips : 
?C textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?C. 
Similar Query!!!!


188 The G380R mutation has been shown to increase FGFR3 phosphorylation and thus shorten the proliferative phase in chondrocyte development, but the cause for the increased receptor phosphorylation is under debate 
[?A textMine:prep ?function, ?G textMine:conj ?F, ?G textMine:nsubjpass ?B, ?F textMine:nsubj ?A, ?function textMine:amod ?impact, ?B textMine:nn ?mutation]
Added to queryTripless!! : ?A textMine:prep ?function. ?G textMine:conj ?F. ?G textMine:nsubjpass ?B. ?F textMine:nsubj ?A. ?function textMine:amod ?positive. ?B textMine:nn ?mutation. 
166

191 These studies also described a correlation between PRV1  expression and the JAK2 V617F allele burden, as well as between  PRV1  overexpression and elevated JAK2 tyrosine kinase activity   
[?B textMine:nn ?mutation, ?impact textMine:dobj ?function, ?C textMine:conj ?impact, ?C textMine:prep ?B]
Added to queryTripless!! : ?B textMine:nn ?mutation. ?positive textMine:dobj ?function. ?C textMine:conj ?positive. ?C textMine:prep ?B. 
167

192 Knockdown or inhibition of FGFR3 signalling in the FGFR3 mutant UC cell lines MGHU3 (Y375C), 97 7 (S249C) and UMUC14 (S249C) is accompanied by diminished cell proliferation and/or anchorage dependent growth  in vitro  in all, although with different efficacy   
[?G textMine:agent ?function, ?G textMine:nsubjpass ?A, ?C textMine:partmod ?F, ?F textMine:prep ?D, ?D textMine:appos ?mutation, ?A textMine:prep ?C, ?function textMine:amod ?impact]
Added to queryTripless!! : ?G textMine:agent ?function. ?G textMine:nsubjpass ?A. ?C textMine:partmod ?F. ?F textMine:prep ?D. ?D textMine:appos ?mutation. ?A textMine:prep ?C. ?function textMine:amod ?negative. 
168

193 Consistent with published data  , PLX4032 abolished the ERK1/2 activating phosphorylation in BRAF V600E/K  melanoma cells ( Figure 2 , pERK, YULAC, YURIF, YUMAC and YUGEN8) 
[?impact textMine:dobj ?function, ?function textMine:prep ?D, ?D textMine:nn ?mutation]
[?D textMine:nn ?mutation, ?function textMine:prep ?D, ?impact textMine:dobj ?function, ]
Match 


194 The Y931C mutation might disrupt the π–π interaction between tyrosine ring and the inhibitor ring structure, thus weakening the inhibitor binding and resulting in easy expulsion from the pocket 
[?E textMine:ccomp ?function, ?B textMine:nn ?mutation, ?impact textMine:parataxis ?E, ?impact textMine:nsubj ?B]
Added to queryTripless!! : ?E textMine:ccomp ?function. ?B textMine:nn ?mutation. ?negative textMine:parataxis ?E. ?negative textMine:nsubj ?B. 
169

195 In TERT NHUC, abolishing PLCγ1 phosphorylation significantly reduced the increase in saturation density associated with S249C FGFR3 (13% vs  24%, p=005) ( Figure 6a ), suggesting that PLCγ1 signaling contributes to this phenotype 
[?C textMine:partmod ?B, ?G textMine:nn ?mutation, ?E textMine:prep ?C, ?E textMine:nsubj ?function, ?function textMine:amod ?impact, ?B textMine:prep ?G]
Added to queryTripless!! : ?C textMine:partmod ?B. ?G textMine:nn ?mutation. ?E textMine:prep ?C. ?E textMine:nsubj ?function. ?function textMine:amod ?negative. ?B textMine:prep ?G. 
170

196 The substitution of a thymidine to adenine in exon 15 results in an amino acid sequence change of valine to glutamate (V600E); this alteration makes  BRAF  constitutively active   with a higher affinity for MEK1 and MEK2 and with a potent activating effect on MAPK pathway 
[?E textMine:amod ?function, ?L textMine:infmod ?C, ?C textMine:dobj ?A, ?H textMine:appos ?mutation, ?A textMine:prep ?D, ?B textMine:prep ?E, ?B textMine:advmod ?impact, ?G textMine:xcomp ?B, ?G textMine:nsubj ?K, ?K textMine:prep ?L, ?D textMine:prep ?H]
Added to queryTripless!! : ?E textMine:amod ?function. ?L textMine:infmod ?C. ?C textMine:dobj ?A. ?H textMine:appos ?mutation. ?A textMine:prep ?D. ?B textMine:prep ?E. ?B textMine:advmod ?positive. ?G textMine:xcomp ?B. ?G textMine:nsubj ?K. ?K textMine:prep ?L. ?D textMine:prep ?H. 
171

197 The patient remained on this regimen for 7 mo with an excellent performance status, exceeding the expected survival of a patient expressing B RAF V600E colon cancer 
[?C textMine:dobj ?function, ?function textMine:prep ?E, ?E textMine:nn ?mutation, ?impact textMine:xcomp ?C]
Added to queryTripless!! : ?C textMine:dobj ?function. ?function textMine:prep ?E. ?E textMine:nn ?mutation. ?neutral textMine:xcomp ?C. 
172

198 Very high response rates and improved survival have been noted with the administration of the type I BRAF inhibitor vemurafenib (formerly PLX4032/RG7204) to patients with BRAF V600E  mutant cutaneous metastatic melanoma   
[?D textMine:prep ?H, ?D textMine:nsubjpass ?function, ?D textMine:nsubjpass ?I, ?A textMine:rcmod ?B, ?H textMine:prep ?A, ?C textMine:nn ?mutation, ?I textMine:conj ?function, ?I textMine:amod ?impact, ?B textMine:prep ?G, ?G textMine:prep ?C]
Added to queryTripless!! : ?D textMine:prep ?H. ?D textMine:nsubjpass ?function. ?D textMine:nsubjpass ?I. ?A textMine:rcmod ?B. ?H textMine:prep ?A. ?C textMine:nn ?mutation. ?I textMine:conj ?function. ?I textMine:amod ?positive. ?B textMine:prep ?G. ?G textMine:prep ?C. 
173

199 The T790M mutation may result in an alteration of EGFR topology that precludes the binding of reversible EGFR TKIs through steric hindrance, or T790M may increase the affinity of the kinase domain for ATP  
[?impact textMine:nsubj ?mutation, ?impact textMine:dobj ?function]
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation, ]
Match 


200 E884K is activating, and can work cooperatively with L858R to differentially modulate downstream signal transduction
[?function textMine:amod ?impact, ?A textMine:prep ?function, ?A textMine:prep ?mutation]
Added to queryTripless!! : ?function textMine:amod ?unknown. ?A textMine:prep ?function. ?A textMine:prep ?mutation. 
174

201 The activity against the resistance mutation T790M and cell lines with downstream resistance mechanisms was, however, only slightly better than the reversible TKIs 
[?A textMine:prep ?D, ?F textMine:conj ?A, ?F textMine:prep ?mutation, ?D textMine:nn ?function, ?impact textMine:nsubj ?A, ?impact textMine:nsubj ?F]
Added to queryTripless!! : ?A textMine:prep ?D. ?F textMine:conj ?A. ?F textMine:prep ?mutation. ?D textMine:nn ?function. ?positive textMine:nsubj ?A. ?positive textMine:nsubj ?F. 
175

202 In numerous studies, the  JAK2  V617F allele has been variably associated with higher indices of erythropoiesis, unchanged or decreased platelet counts, greater occurrence of thrombosis, increased BM fibrosis or cytoreductive treatments, older age, longer disease duration, or poorer survival in MPN   
[?impact textMine:nsubjpass ?C, ?function textMine:conj ?impact, ?function textMine:nsubjpass ?C, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?negative textMine:nsubjpass ?C. ?function textMine:conj ?negative. ?function textMine:nsubjpass ?C. ?C textMine:nn ?mutation. 
176

203 To gain insight into the mechanism of E884K modulation of EGFR tyrosine kinase inhibitor (TKI) sensitivity, we further studied its effect on downstream AKT and STAT3 signaling pathways with TKI inhibition 
[?impact textMine:amod ?mutation, ?impact textMine:prep ?function]
Added to queryTripless!! : ?unknown textMine:amod ?mutation. ?unknown textMine:prep ?function. 
177

204 However, this resistance to EGFR TKI has been many times lower than the resistance in cells harbouring both the L858R and T790M mutations 
[?C textMine:nn ?mutation, ?function textMine:prep ?A, ?impact textMine:prep ?function, ?F textMine:dobj ?C, ?A textMine:partmod ?F]
Added to queryTripless!! : ?C textMine:nn ?mutation. ?function textMine:prep ?A. ?negative textMine:prep ?function. ?F textMine:dobj ?C. ?A textMine:partmod ?F. 
178

205 We hypothesised that patients with low or heterogeneous expression of mutant BRAF V600E  protein would have a poor response to treatment with BRAF inhibitors and reduced survival, compared with patients with high and homogeneous expression 
[?C textMine:prep ?F, ?function textMine:amod ?impact, ?F textMine:nn ?mutation, ?A textMine:prep ?C, ?E textMine:prep ?function, ?E textMine:nsubj ?A]
Added to queryTripless!! : ?C textMine:prep ?F. ?function textMine:amod ?negative. ?F textMine:nn ?mutation. ?A textMine:prep ?C. ?E textMine:prep ?function. ?E textMine:nsubj ?A. 
179

206 Moreover, the introduction of  miR 146b  into PTC mutated cells (BRAF V600E  or RET/PTC1) enhances cell invasiveness and migration [ 53 ] 
[?E textMine:nsubj ?function, ?impact textMine:ccomp ?E, ?impact textMine:nsubj ?D, ?F textMine:dep ?mutation, ?D textMine:prep ?F]
Added to queryTripless!! : ?E textMine:nsubj ?function. ?positive textMine:ccomp ?E. ?positive textMine:nsubj ?D. ?F textMine:dep ?mutation. ?D textMine:prep ?F. 
180

207 In the current study, Liu and colleagues show that mutant V600E BRAF enhances STAT3 phosphorylation and increases PAX3 expression in melanocytes 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:nn ?mutation]
Query : [?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:nn ?mutation]
Existing trips : 
?C textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?C. 
Similar Query!!!!


208 The S252W mutation enhanced cell proliferation in fibroblasts, even in critical culture conditions, such as 05% FBS medium, but it had a negative effect on MSCs in 20% FBS culture environment 
[?impact textMine:dep ?C, ?impact textMine:nsubj ?B, ?B textMine:nn ?mutation, ?C textMine:nsubj ?function]
Added to queryTripless!! : ?positive textMine:dep ?C. ?positive textMine:nsubj ?B. ?B textMine:nn ?mutation. ?C textMine:nsubj ?function. 
181

209 In contrast to the isolated L858R kinase domain results, we observe that mutation of residues in the dimer interface in tEGFR dramatically reduces the activity of both the L858R and Δ746–750 tEGFRs, indicating that this dimerization event is critical for activation of both of these oncogenic mutants 
[?D textMine:ccomp ?E, ?impact textMine:dobj ?C, ?impact textMine:partmod ?D, ?E textMine:prep ?function, ?C textMine:prep ?mutation]
[?C textMine:prep ?mutation, ?D textMine:ccomp ?E, ?E textMine:prep ?function, ?impact textMine:dobj ?C, ?impact textMine:partmod ?D, ]
Match 


210 The mutation Y253F (−0.22 kcal/mol) experiences increased electrostatic interactions, Y253H experiences increased electrostatic interactions (−0 3 kcal/mol) and decreased vdW (−131 kcal/mol) when binding to ponatinib 
[?C textMine:nn ?mutation, ?impact textMine:nsubj ?C, ?impact textMine:dobj ?function]
[?C textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ]
Match 


211 Coincident with the inability to produce conidiospores on Aspergillus Minimal Medium ( Figure 3 ), the G70R mutation results in a remarkable decrease in the capability of the FlbB bZip to bind previously defined DNA targets compared to the wild type protein    
[?function textMine:amod ?mutation, ?function textMine:prep ?impact]
Added to queryTripless!! : ?function textMine:amod ?mutation. ?function textMine:prep ?negative. 
182

212 This led us to question whether in solution, perturbation of the autoP trajectory by RET M918T could arise through presentation of a better intermolecular substrate by favoring an “AL out” conformer presenting Y900 or Y905 as a substrate to an active RET kinase in  trans  
[?B textMine:partmod ?A, ?C textMine:prep ?mutation, ?A textMine:prep ?function, ?E textMine:prep ?C, ?impact textMine:dobj ?B, ?D textMine:prepc ?impact, ?D textMine:nsubj ?E]
Added to queryTripless!! : ?B textMine:partmod ?A. ?C textMine:prep ?mutation. ?A textMine:prep ?function. ?E textMine:prep ?C. ?positive textMine:dobj ?B. ?D textMine:prepc ?positive. ?D textMine:nsubj ?E. 
183

213 Both effects were readily abrogated by the TKI resistant mutation T790M 
[?impact textMine:nsubjpass ?function, ?impact textMine:agent ?mutation]
Added to queryTripless!! : ?negative textMine:nsubjpass ?function. ?negative textMine:agent ?mutation. 
184

214 Therefore, even with a higher sensitivity permitting detection of 1% mutant DNA, as is reached with SARMS and PNA based PCR clamping, detection of the T790M mutation in cfDNA remains difficult 
[?B textMine:prep ?C, ?function textMine:amod ?impact, ?G textMine:nsubj ?B, ?G textMine:advcl ?E, ?E textMine:nsubj ?function, ?C textMine:amod ?mutation]
Added to queryTripless!! : ?B textMine:prep ?C. ?function textMine:amod ?positive. ?G textMine:nsubj ?B. ?G textMine:advcl ?E. ?E textMine:nsubj ?function. ?C textMine:amod ?mutation. 
185

215 RET MEN2B ( RET  M918T) is more effectively autophosphorylated at RET Y1062 than is RET MEN2A, which subsequently leads to increased constitutive activation of the Ras/mitogen activated protein kinase (MAPK) and PI3K/AKT/mTOR signaling cascades   
[?G textMine:advcl ?E, ?G textMine:nsubj ?C, ?F textMine:prep ?A, ?E textMine:rcmod ?F, ?A textMine:prep ?H, ?A textMine:amod ?impact, ?H textMine:amod ?function, ?C textMine:appos ?mutation]
Added to queryTripless!! : ?G textMine:advcl ?E. ?G textMine:nsubj ?C. ?F textMine:prep ?A. ?E textMine:rcmod ?F. ?A textMine:prep ?H. ?A textMine:amod ?positive. ?H textMine:amod ?function. ?C textMine:appos ?mutation. 
186

216 Hence, E884K in  cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone, through differential inhibition of the pro survival AKT and STAT3 signaling pathways associated with altered induction of cleaved PARP(Asp214) 
[?F textMine:partmod ?function, ?B textMine:prep ?F, ?B textMine:nsubj ?mutation, ?function textMine:prep ?E, ?E textMine:amod ?impact]
Added to queryTripless!! : ?F textMine:partmod ?function. ?B textMine:prep ?F. ?B textMine:nsubj ?mutation. ?function textMine:prep ?E. ?E textMine:amod ?unknown. 
187

217 All inhibitors reduced the relative level of Mek 1/2 phosphorylation in clones carrying the V600E mutation by more than 90% with dabrafenib showing the strongest effect 
[?A textMine:dobj ?D, ?B textMine:partmod ?A, ?G textMine:prep ?function, ?D textMine:amod ?mutation, ?impact textMine:prep ?B, ?impact textMine:dobj ?G]
Added to queryTripless!! : ?A textMine:dobj ?D. ?B textMine:partmod ?A. ?G textMine:prep ?function. ?D textMine:amod ?mutation. ?negative textMine:prep ?B. ?negative textMine:dobj ?G. 
188

218 The former is the case of the S492R mutant, which confers resistance to cetuximab since the mutation is located in its binding epitope on the EGFR external domain  ; whereas the later is the case of the T790M mutant (mutation in the kinase domain), which confers resistance to gefitinib or erlotinib in lung adenocarcinomas   by stabilizing the active tyrosine kinase conformation and enhancing aTP binding   
[?D textMine:dobj ?G, ?E textMine:prepc ?D, ?I textMine:parataxis ?F, ?I textMine:prep ?H, ?G textMine:amod ?function, ?F textMine:prep ?A, ?H textMine:nn ?mutation, ?A textMine:rcmod ?E]
Added to queryTripless!! : ?D textMine:dobj ?G. ?E textMine:prepc ?D. ?I textMine:parataxis ?F. ?I textMine:prep ?H. ?G textMine:amod ?function. ?F textMine:prep ?A. ?H textMine:nn ?mutation. ?A textMine:rcmod ?E. 
189

219 We verified that oncogenic RET M918T increases enzymatic activity and ATP affinity analogous to the T790M mutation of the EGFR ( Yun et al, 2008 ) 
[?impact textMine:nsubj ?mutation, ?impact textMine:dobj ?function]
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation, ]
Match 


220 In a dose response experiment ( Figure 3 B, left panel), the best inhibitor, D4, was effective at a concentration of 200 nM to inhibit RET C634Y  autophosphorylation up to 70% and to drastically reduce ERK phosphorylation 
[?function textMine:ccomp ?B, ?function textMine:ccomp ?impact, ?E textMine:nsubj ?mutation, ?B textMine:conj ?impact, ?B textMine:ccomp ?E]
Added to queryTripless!! : ?function textMine:ccomp ?B. ?function textMine:ccomp ?negative. ?E textMine:nsubj ?mutation. ?B textMine:conj ?negative. ?B textMine:ccomp ?E. 
190

221 The NS1 mutants D2N †  and V226I bound F2F3 FLAG with comparable affinity to HK wt NS1, but NS1 mutants V23A and R227K †  demonstrated a 2 fold increase in binding affinity (p<0 05 and p<001, two tailed student's t test) 
[?impact textMine:prep ?function, ?D textMine:dobj ?impact, ?A textMine:conj ?D, ?A textMine:nsubj ?mutation]
Added to queryTripless!! : ?positive textMine:prep ?function. ?D textMine:dobj ?positive. ?A textMine:conj ?D. ?A textMine:nsubj ?mutation. 
191

282 These data indicate that BRAF V600E  increases NFAT transcriptional activity via MEK/ERK dependent signalling ( Figure 2C ) 
[?impact textMine:nsubj ?mutation, ?impact textMine:dobj ?function]
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation, ]
Match 


223 Similarly, E884K further enhanced the sensitivity of L858R to the inhibition by the irreversible EGFR/ERBB2 inhibitor, CL 387,785 
[?B textMine:prep ?mutation, ?impact textMine:prep ?function, ?impact textMine:dobj ?B]
Added to queryTripless!! : ?B textMine:prep ?mutation. ?positive textMine:prep ?function. ?positive textMine:dobj ?B. 
192

224 Our biochemical studies here now show that E884K mutation in  cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone, through differential inhibition of the pro survival AKT and STAT3 signaling pathways associated with altered induction of cleaved PARP(Asp214) 
[?F textMine:amod ?mutation, ?function textMine:prep ?A, ?E textMine:prep ?C, ?E textMine:nsubj ?F, ?A textMine:amod ?impact, ?C textMine:partmod ?function]
Added to queryTripless!! : ?F textMine:amod ?mutation. ?function textMine:prep ?A. ?E textMine:prep ?C. ?E textMine:nsubj ?F. ?A textMine:amod ?unknown. ?C textMine:partmod ?function. 
193

225 In vitro , Y791F mutations have been shown to enhance signal transducer and activator of transcription 3 (STAT3) signaling ( 74 ) 
[?D textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:xsubj ?D]
Query : [?D textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:xsubj ?D]
Existing trips : 
?A textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:xsubj ?A. 
Similar Query!!!!


226 To understand the role of the c Met N375S sequence variant in modulating sensitivity to MET inhibitor, we measured the viability of A549 lung cancer cells transfected with the recombinant  c Met WT  and  c Met N375S  constructs after treatment with the preclinical MET inhibitor SU11274  
[?C textMine:prepc ?impact, ?E textMine:advcl ?C, ?E textMine:dep ?F, ?F textMine:nsubj ?mutation, ?impact textMine:dobj ?function]
Added to queryTripless!! : ?C textMine:prepc ?unknown. ?E textMine:advcl ?C. ?E textMine:dep ?F. ?F textMine:nsubj ?mutation. ?unknown textMine:dobj ?function. 
194

227 Although inhibition of MEK and ERK phosphorylation was achieved in BRAF V600E/K  mutant melanoma, significantly increased tumour growth was seen in BRAF wild type melanomas with upstream RAS mutations 
[?impact textMine:advcl ?B, ?C textMine:prep ?function, ?B textMine:prep ?D, ?B textMine:nsubjpass ?C, ?D textMine:nn ?mutation]
Added to queryTripless!! : ?positive textMine:advcl ?B. ?C textMine:prep ?function. ?B textMine:prep ?D. ?B textMine:nsubjpass ?C. ?D textMine:nn ?mutation. 
195

228 In comparison, the activity of some FOP mutants was generally increased to a level similar to caALK2, revealing an inherent gain of function in their catalytic domain in the absence of added BMP ligand ( Fig. 1  B )  Significantly, the signaling by R206H was increased by FK506 to a far greater extent than other GS domain mutants, such as L196P ( Fig 1  B ) 
[?B textMine:parataxis ?A, ?B textMine:parataxis ?C, ?A textMine:dobj ?D, ?D textMine:prep ?function, ?C textMine:auxpass ?mutation]
Added to queryTripless!! : ?B textMine:parataxis ?A. ?B textMine:parataxis ?C. ?A textMine:dobj ?D. ?D textMine:prep ?function. ?C textMine:auxpass ?mutation. 
196

229 Furthermore, expression of CDK1 was increased in S249C and Y375C cells, and the difference was particularly pronounced when the cells were starved in depleted medium to block stimulation by other growth factors 
[?D textMine:nn ?mutation, ?impact textMine:prep ?D, ?impact textMine:nsubjpass ?function]
[?D textMine:nn ?mutation, ?impact textMine:nsubjpass ?function, ?impact textMine:prep ?D, ]
Match 


230 The activity of DAS is maintained despite the presence of mutations that confer resistance to IM with the exception of the T315I mutation, and to a large degree, mutations affecting the residue 317 (F317L, F317V) 
[?A textMine:dep ?mutation, ?B textMine:prep ?C, ?C textMine:appos ?A, ?impact textMine:prep ?B, ?impact textMine:nsubjpass ?function]
Added to queryTripless!! : ?A textMine:dep ?mutation. ?B textMine:prep ?C. ?C textMine:appos ?A. ?neutral textMine:prep ?B. ?neutral textMine:nsubjpass ?function. 
197

231 The combination of vemurafenib and metformin tended to have stronger anti proliferative effects on BRAF V600E  mutant cell lines 
[?function textMine:amod ?impact, ?function textMine:prep ?D, ?D textMine:nn ?mutation]
Query : [?function textMine:amod ?impact, ?function textMine:prep ?D, ?D textMine:nn ?mutation]
Existing trips : 
?A textMine:nn ?mutation. ?function textMine:amod ?impact. ?function textMine:prep ?A. 
Similar Query!!!!


232 Our studies here, using COS 7 transfection model system, show that E884K works in concert with L858R in  cis , in a dominant fashion, to change downstream signaling, differentially induce MAPK ERK1/2 signaling and associated cell proliferation, and differentially alter sensitivity of EGFR phosphorylation inhibition by ERBB family inhibitors in an inhibitor specific fashion 
[?A textMine:xsubj ?mutation, ?A textMine:conj ?impact, ?impact textMine:dobj ?function]
Added to queryTripless!! : ?A textMine:xsubj ?mutation. ?A textMine:conj ?unknown. ?unknown textMine:dobj ?function. 
198

233 Expression of the p61 BRAF V600E  splice variant shows enhanced dimerization rendering a subset of melanoma patients resistant to vemurafenib  
[?G textMine:partmod ?K, ?G textMine:amod ?impact, ?C textMine:amod ?function, ?D textMine:prep ?I, ?F textMine:dobj ?G, ?F textMine:nsubj ?J, ?A textMine:nn ?mutation, ?I textMine:amod ?C, ?K textMine:dobj ?D, ?J textMine:prep ?A]
Added to queryTripless!! : ?G textMine:partmod ?K. ?G textMine:amod ?positive. ?C textMine:amod ?function. ?D textMine:prep ?I. ?F textMine:dobj ?G. ?F textMine:nsubj ?J. ?A textMine:nn ?mutation. ?I textMine:amod ?C. ?K textMine:dobj ?D. ?J textMine:prep ?A. 
199

234 This agent has demonstrated 325 fold greater activity against native BCR ABL in vitro as compared with imatinib, and is active against all imatinib resistant BCR ABL mutations with the exception of T315I   
[?E textMine:prep ?mutation, ?C textMine:conj ?function, ?C textMine:dobj ?A, ?function textMine:prep ?E, ?A textMine:amod ?impact]
Added to queryTripless!! : ?E textMine:prep ?mutation. ?C textMine:conj ?function. ?C textMine:dobj ?A. ?function textMine:prep ?E. ?A textMine:amod ?positive. 
200

235 In colorectal cancer patients, a mutation in the extracellular domain of EGFR (S492R), which abrogates cetuximab binding but retains panitumumab sensitivity, has been recently described as a mechanism of acquired resistance   (Fig  2c ) 
[?D textMine:appos ?mutation, ?E textMine:prep ?B, ?E textMine:rcmod ?impact, ?E textMine:rcmod ?A, ?H textMine:amod ?function, ?A textMine:conj ?impact, ?A textMine:dobj ?H, ?B textMine:prep ?D]
Added to queryTripless!! : ?D textMine:appos ?mutation. ?E textMine:prep ?B. ?E textMine:rcmod ?neutral. ?E textMine:rcmod ?A. ?H textMine:amod ?function. ?A textMine:conj ?neutral. ?A textMine:dobj ?H. ?B textMine:prep ?D. 
201

236 Transformation induced by each of the three oncogenes  KRAS G12V   (Caco K cells),  BRAF V600E   (Caco BR cells) and  HRAS G12V   (Caco H cells) managed to increase the ability of Caco 2 cells to migrate and invade  in vitro , independently of their proliferating ability, which has been previously analyzed in   
[?D textMine:prep ?function, ?A textMine:advmod ?D, ?impact textMine:xsubj ?mutation, ?impact textMine:xcomp ?A]
Added to queryTripless!! : ?D textMine:prep ?function. ?A textMine:advmod ?D. ?positive textMine:xsubj ?mutation. ?positive textMine:xcomp ?A. 
202

237 The increase in BIM expression and apoptosis are inhibited by the secondary resistant mutation, T790M 
[?D textMine:appos ?mutation, ?impact textMine:prep ?function, ?C textMine:prep ?D, ?C textMine:nsubj ?impact]
Added to queryTripless!! : ?D textMine:appos ?mutation. ?positive textMine:prep ?function. ?C textMine:prep ?D. ?C textMine:nsubj ?positive. 
203

238 The activity of DAS is maintained despite the presence of mutations that confer resistance to IM with the exception of the T315I mutation, and to a large degree, mutations affecting the residue 317 (F317L, F317V) 
[?A textMine:prep ?I, ?G textMine:nn ?mutation, ?B textMine:prep ?G, ?impact textMine:prep ?E, ?impact textMine:nsubjpass ?function, ?I textMine:prep ?B, ?E textMine:prep ?F, ?F textMine:rcmod ?A]
Added to queryTripless!! : ?A textMine:prep ?I. ?G textMine:nn ?mutation. ?B textMine:prep ?G. ?neutral textMine:prep ?E. ?neutral textMine:nsubjpass ?function. ?I textMine:prep ?B. ?E textMine:prep ?F. ?F textMine:rcmod ?A. 
204

239 The AKT1 (E17K) mutant can cause increases in the protein levels of Bcl 2 and the phosphorylation of the pro apoptotic protein BAD, resulting in enhanced resistance to apoptosis 
[?C textMine:prep ?function, ?C textMine:dobj ?impact, ?C textMine:nsubj ?E, ?E textMine:appos ?mutation]
Added to queryTripless!! : ?C textMine:prep ?function. ?C textMine:dobj ?positive. ?C textMine:nsubj ?E. ?E textMine:appos ?mutation. 
205

240 However, this EGFR mutant carrying D761Y or L747S was 100 fold less resistant to EGFR TKIs than the mutant carrying T790M in vitro 
[?function textMine:advmod ?impact, ?function textMine:nsubj ?mutation]
Added to queryTripless!! : ?function textMine:advmod ?negative. ?function textMine:nsubj ?mutation. 
206

241 Other possibilities are that the associated haplotype causes the JAK2  gene to be more susceptible to mutation or allows increased survival of  JAK2  V617F  alleles 
[?function textMine:amod ?impact, ?function textMine:prep ?B, ?B textMine:nn ?mutation]
Query : [?function textMine:amod ?impact, ?function textMine:prep ?B, ?B textMine:nn ?mutation]
Existing trips : 
?A textMine:nn ?mutation. ?function textMine:amod ?impact. ?function textMine:prep ?A. 
Similar Query!!!!


242 Initial data testing MEK inhibitors in melanoma cell lines suggested a high level and selective sensitivity in  BRAF   V600E   mutant melanoma cell lines, with low sensitivity in melanoma cell lines with other driver oncogenes   
[?A textMine:prep ?B, ?A textMine:amod ?impact, ?E textMine:prep ?function, ?E textMine:dobj ?A, ?B textMine:amod ?mutation]
Added to queryTripless!! : ?A textMine:prep ?B. ?A textMine:amod ?positive. ?E textMine:prep ?function. ?E textMine:dobj ?A. ?B textMine:amod ?mutation. 
207

243 Our biochemical studies here now show that E884K mutation in  cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone, through differential inhibition of the pro survival AKT and STAT3 signaling pathways associated with altered induction of cleaved PARP(Asp214) 
[?B textMine:partmod ?function, ?function textMine:prep ?A, ?A textMine:amod ?impact, ?E textMine:prep ?B, ?E textMine:pobj ?mutation]
Added to queryTripless!! : ?B textMine:partmod ?function. ?function textMine:prep ?A. ?A textMine:amod ?unknown. ?E textMine:prep ?B. ?E textMine:pobj ?mutation. 
208

244 The somatic E884K substitution appears to be relatively infrequent, and resulted in a mutant lysine residue that disrupts an ion pair with residue R958 in the EGFR kinase domain C lobe, an interaction that is highly conserved within the human kinome as demonstrated by our sequence analysis and structure analysis 
[?C textMine:prep ?G, ?impact textMine:prep ?C, ?A textMine:prep ?F, ?A textMine:nsubj ?H, ?F textMine:rcmod ?impact, ?G textMine:appos ?function, ?H textMine:nn ?mutation]
Added to queryTripless!! : ?C textMine:prep ?G. ?negative textMine:prep ?C. ?A textMine:prep ?F. ?A textMine:nsubj ?H. ?F textMine:rcmod ?negative. ?G textMine:appos ?function. ?H textMine:nn ?mutation. 
209

245 In addition, the  JAK2  V617F  mutation may increase the stability of the JAK2 protein by rendering it resistant to the effect of SOCS3 binding, as overexpression of SOCS3 results in increased SOCS3 and  JAK2  V617F  phosphorylation [ 68 ] 
[?H textMine:num ?mutation, ?A textMine:amod ?impact, ?C textMine:prep ?A, ?D textMine:conj ?H, ?D textMine:prep ?G, ?D textMine:prep ?function, ?G textMine:prep ?C]
Added to queryTripless!! : ?H textMine:num ?mutation. ?A textMine:amod ?positive. ?C textMine:prep ?A. ?D textMine:conj ?H. ?D textMine:prep ?G. ?D textMine:prep ?function. ?G textMine:prep ?C. 
210

246 It is also interesting that the apparent K  m  of L858R tEGFR for substrate peptide is ~4 fold greater than for WT and Δ746–750 tEGFRs 
[?E textMine:prep ?D, ?E textMine:amod ?mutation, ?F textMine:prep ?E, ?D textMine:amod ?function, ?impact textMine:nsubj ?F]
Added to queryTripless!! : ?E textMine:prep ?D. ?E textMine:amod ?mutation. ?F textMine:prep ?E. ?D textMine:amod ?function. ?positive textMine:nsubj ?F. 
211

247 NVP BEZ235 inhibited proliferation of both cytokine independent WT BCR ABL  and mutant  BCR ABL  (E255K and T315I) overexpressing cells, whereas parental cytokine dependent Ba/F3 cells were much less sensitive 
[?C textMine:appos ?mutation, ?function textMine:advmod ?impact, ?D textMine:prep ?C, ?F textMine:advcl ?function, ?F textMine:dobj ?D]
Added to queryTripless!! : ?C textMine:appos ?mutation. ?function textMine:advmod ?negative. ?D textMine:prep ?C. ?F textMine:advcl ?function. ?F textMine:dobj ?D. 
212

248 The extent of body weight loss in general correlated with mortality however the M106I mutant virus induced the greatest weight loss but resulted in less mortality than the two most virulent mutants, D2N †  and M106I+L98S, which both induced the next greatest statistically significant increase in body weight loss compared to rHK wt (p<0 001,
[?D textMine:nn ?mutation, ?A textMine:amod ?impact, ?A textMine:prep ?D, ?A textMine:rcmod ?function]
Added to queryTripless!! : ?D textMine:nn ?mutation. ?A textMine:amod ?negative. ?A textMine:prep ?D. ?A textMine:rcmod ?function. 
213

249 The results showed an increase in phospho FAK (S910), the ERK1/2 phosphorylation site, in YUDOSO BRAF WT  and a reduction in YULAC BRAF V600E  melanoma cells ( Figure 6B , pFAK S910) 
[?A textMine:nn ?mutation, ?C textMine:nn ?function, ?E textMine:prep ?A, ?impact textMine:conj ?E, ?impact textMine:appos ?C]
Added to queryTripless!! : ?A textMine:nn ?mutation. ?C textMine:nn ?function. ?E textMine:prep ?A. ?positive textMine:conj ?E. ?positive textMine:appos ?C. 
214

250 The putative relationships between  MLH1  expression and BRAF V600E, RET/PTC and IDH1 genetic alterations were evaluated 
[?D textMine:nn ?mutation, ?B textMine:prep ?impact, ?B textMine:prep ?D, ?B textMine:prep ?function, ?function textMine:conj ?impact, ?function textMine:conj ?D]
Added to queryTripless!! : ?D textMine:nn ?mutation. ?B textMine:prep ?unknown. ?B textMine:prep ?D. ?B textMine:prep ?function. ?function textMine:conj ?unknown. ?function textMine:conj ?D. 
215

251 We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated (native) BCR/ABL ( 15 – 17 ) 
[?C textMine:dobj ?A, ?C textMine:dobj ?function, ?C textMine:nsubj ?F, ?function textMine:conj ?A, ?A textMine:amod ?impact, ?F textMine:nn ?mutation]
Added to queryTripless!! : ?C textMine:dobj ?A. ?C textMine:dobj ?function. ?C textMine:nsubj ?F. ?function textMine:conj ?A. ?A textMine:amod ?positive. ?F textMine:nn ?mutation. 
216

252 Strongly reduced activity of the PPARγ K365R mutant contradicts the results of Pascual  et al who reported similar activation of the Aox tk  luciferase construct by wild type PPARγ and by the PPARγ K365R mutant 
[?F textMine:prep ?D, ?E textMine:ccomp ?F, ?impact textMine:dep ?E, ?impact textMine:dobj ?function, ?D textMine:nn ?mutation]
Added to queryTripless!! : ?F textMine:prep ?D. ?E textMine:ccomp ?F. ?negative textMine:dep ?E. ?negative textMine:dobj ?function. ?D textMine:nn ?mutation. 
217

253 In an  in vitro  study, these two types of EGFR mutants demonstrated an enhanced TK activity in response to EGF and increased sensitivity to inhibition by TKI, although the biological activity between tumours with L858R and those with deletions was different ( Paez  et al , 2004 ;  Pao  et al , 2004 ) 
[?E textMine:prep ?mutation, ?F textMine:prep ?E, ?D textMine:nsubj ?F, ?A textMine:advcl ?D, ?impact textMine:xcomp ?A, ?impact textMine:dobj ?function]
Added to queryTripless!! : ?E textMine:prep ?mutation. ?F textMine:prep ?E. ?D textMine:nsubj ?F. ?A textMine:advcl ?D. ?positive textMine:xcomp ?A. ?positive textMine:dobj ?function. 
218

254 This led us to question whether in solution, perturbation of the autoP trajectory by RET M918T could arise through presentation of a better intermolecular substrate by favoring an “AL out” conformer presenting Y900 or Y905 as a substrate to an active RET kinase in  trans  
[?B textMine:partmod ?A, ?H textMine:prep ?E, ?C textMine:prep ?mutation, ?E textMine:amod ?function, ?A textMine:prep ?H, ?F textMine:prep ?C, ?impact textMine:dobj ?B, ?D textMine:prepc ?impact, ?D textMine:nsubj ?F]
Added to queryTripless!! : ?B textMine:partmod ?A. ?H textMine:prep ?E. ?C textMine:prep ?mutation. ?E textMine:amod ?function. ?A textMine:prep ?H. ?F textMine:prep ?C. ?positive textMine:dobj ?B. ?D textMine:prepc ?positive. ?D textMine:nsubj ?F. 
219

255 T315I is a gate keeper mutation that abrogates inhibitor binding to the BCR ABL kinase domain 
[?C textMine:rcmod ?impact, ?C textMine:nsubj ?mutation, ?impact textMine:dobj ?D, ?D textMine:amod ?function]
Added to queryTripless!! : ?C textMine:rcmod ?negative. ?C textMine:nsubj ?mutation. ?negative textMine:dobj ?D. ?D textMine:amod ?function. 
220

256 Of note, a decreased steady state expression of the R728L variant was detected in both cell lines, and the T933M variant in hTERT RPE1 cells (  Fig S6A and B  ) 
[?function textMine:prep ?B, ?function textMine:amod ?impact, ?B textMine:nn ?mutation]
Query : [?function textMine:prep ?B, ?function textMine:amod ?impact, ?B textMine:nn ?mutation]
Existing trips : 
?A textMine:nn ?mutation. ?function textMine:amod ?impact. ?function textMine:prep ?A. 
Similar Query!!!!


257 Enforced expression of Stat3C increased miR 92a expression in H460 cells that could be inhibited by S3I 201 ( Figure 3D ) 
[?A textMine:number ?mutation, ?E textMine:rcmod ?function, ?impact textMine:dobj ?D, ?function textMine:agent ?A, ?D textMine:prep ?E]
Added to queryTripless!! : ?A textMine:number ?mutation. ?E textMine:rcmod ?function. ?positive textMine:dobj ?D. ?function textMine:agent ?A. ?D textMine:prep ?E. 
221

258 Moreover, E884K had a dominant effect over L858R, when in  cis , in these signaling modulatory effects 
[?D textMine:prep ?function, ?D textMine:dobj ?C, ?C textMine:prep ?mutation, ?C textMine:amod ?impact]
Added to queryTripless!! : ?D textMine:prep ?function. ?D textMine:dobj ?C. ?C textMine:prep ?mutation. ?C textMine:amod ?positive. 
222

259 Remarkably, abrogating MITF activity in  BRAF V600E mitf  melanoma leads to dramatic tumor regression marked by melanophage infiltration and increased apoptosis 
[?B textMine:nn ?mutation, ?function textMine:prep ?B, ?function textMine:amod ?impact]
Query : [?B textMine:nn ?mutation, ?function textMine:prep ?B, ?function textMine:amod ?impact]
Existing trips : 
?A textMine:nn ?mutation. ?function textMine:amod ?impact. ?function textMine:prep ?A. 
Similar Query!!!!


260 In addition, in PMF, JAK2 V617F positive patients, compared to their mutation negative counterparts, were more likely to display higher plasma levels of IL 1RA, IL 2R, IL 6, IL 12, hepatocyte growth factor (HGF), CXCL10 and monokine induced by interferon (IFN) γ other phenotypic correlates included increased levels of (i) IL 6 and IL 8 with constitutional symptoms, (ii) HGF with marked splenomegaly, (iii) IL 2R, IL 8, IL 10, macrophage inflammatory protein (MIP) 1α and monocyte chemotactic protein 1 with red cell transfusion dependency, (iv) IL 2R, HGF and CXCL10 with leukocytosis and (v) CXCL10 with thrombocytopenia 
[?C textMine:partmod ?function, ?A textMine:dobj ?B, ?A textMine:dobj ?D, ?A textMine:xsubj ?F, ?B textMine:conj ?C, ?D textMine:conj ?C, ?D textMine:conj ?B, ?D textMine:amod ?impact, ?F textMine:num ?mutation]
Added to queryTripless!! : ?C textMine:partmod ?function. ?A textMine:dobj ?B. ?A textMine:dobj ?D. ?A textMine:xsubj ?F. ?B textMine:conj ?C. ?D textMine:conj ?C. ?D textMine:conj ?B. ?D textMine:amod ?positive. ?F textMine:num ?mutation. 
223

261 With the aim of selecting the best assays for the tracking of MRD (% JAK2  V617F <1), in QC5, two further 'in house' assays were evaluated (Assays 8 and 9), but were eliminated because they exhibited poorer specificity when tested on serial dilutions of HEL in K562 cells 
[?impact textMine:advcl ?function, ?F textMine:nsubj ?mutation, ?I textMine:dobj ?G, ?H textMine:ccomp ?F, ?J textMine:conj ?impact, ?J textMine:prep ?C, ?A textMine:dep ?H, ?G textMine:prep ?A, ?C textMine:prepc ?I]
Added to queryTripless!! : ?negative textMine:advcl ?function. ?F textMine:nsubj ?mutation. ?I textMine:dobj ?G. ?H textMine:ccomp ?F. ?J textMine:conj ?negative. ?J textMine:prep ?C. ?A textMine:dep ?H. ?G textMine:prep ?A. ?C textMine:prepc ?I. 
224

262 The mutations F317V, Y253F, Y253H and E255K experience increased vdW interactions with residue Leu248 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ?C textMine:amod ?E, ?E textMine:dep ?mutation]
Query : [?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ?C textMine:amod ?E, ?E textMine:dep ?mutation]
Existing trips : 
?B textMine:amod ?E. ?E textMine:dep ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?B. 
Similar Query!!!!


263 Ba/F3 cells with ITD A848P FLT3 were resistant to both sunitinib and sorafenib, but maintained sensitivity to midostaurin 
[?B textMine:nn ?mutation, ?A textMine:prep ?B, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?A]
Added to queryTripless!! : ?B textMine:nn ?mutation. ?A textMine:prep ?B. ?neutral textMine:dobj ?function. ?neutral textMine:nsubj ?A. 
225

264 Hence we hypothesized that the constitutive activation of the EGFR/RAS/BRAF pathway could be responsible for the lack of sensitivity of FO 1 cells to NAC and therefore treated them with both NAC and PLX4032, a specific inhibitor of BRAF V600E 
[?A textMine:prep ?mutation, ?G textMine:conj ?D, ?G textMine:ccomp ?E, ?E textMine:nsubj ?function, ?function textMine:amod ?impact, ?D textMine:dobj ?A]
Added to queryTripless!! : ?A textMine:prep ?mutation. ?G textMine:conj ?D. ?G textMine:ccomp ?E. ?E textMine:nsubj ?function. ?function textMine:amod ?positive. ?D textMine:dobj ?A. 
226

265 JAK2 inhibitors, such as pacritinib (SB1518), an oral inhibitor currently in Phase II clinical studies, as well as other JAK2 inhibitors show significant efficacy in treating MPNs, reducing the JAK STAT (signal transducer and activator of transcription) signaling, spleen size, JAK2 V617F  mutation burden, as well as levels of certain cytokines/growth factors relevant in MPNs 
[?impact textMine:parataxis ?F, ?B textMine:appos ?A, ?A textMine:nn ?mutation, ?D textMine:dep ?impact, ?D textMine:dobj ?B, ?F textMine:dobj ?function]
Added to queryTripless!! : ?negative textMine:parataxis ?F. ?B textMine:appos ?A. ?A textMine:nn ?mutation. ?D textMine:dep ?negative. ?D textMine:dobj ?B. ?F textMine:dobj ?function. 
227

266 Specifically, BRAF V600E  alters the typical epithelial morphology of Caco 2 cells, the distribution of E cadherin and reduces its expression at the mRNA level 
[?impact textMine:nsubj ?mutation, ?impact textMine:dobj ?function]
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation, ]
Match 


267 The former is the case of the S492R mutant, which confers resistance to cetuximab since the mutation is located in its binding epitope on the EGFR external domain  ; whereas the later is the case of the T790M mutant (mutation in the kinase domain), which confers resistance to gefitinib or erlotinib in lung adenocarcinomas   by stabilizing the active tyrosine kinase conformation and enhancing aTP binding   
[?D textMine:prepc ?impact, ?B textMine:nn ?mutation, ?B textMine:rcmod ?D, ?impact textMine:acomp ?function]
Added to queryTripless!! : ?D textMine:prepc ?positive. ?B textMine:nn ?mutation. ?B textMine:rcmod ?D. ?positive textMine:acomp ?function. 
228

268 In pre clinical studies, JAK2 inhibitors reduced the proliferation of JAK2 V617F  and MPL W515L  mutant cells and attenuated disease development in murine models of MPN ( 40   43 ) 
[?function textMine:prep ?mutation, ?impact textMine:iobj ?function]
Added to queryTripless!! : ?function textMine:prep ?mutation. ?negative textMine:iobj ?function. 
229

269 This uncoupling of the LKB1 AMPK complex allows BRAF V600E  oncogene driven cancer cells to become resistant to energy stress and avoid apoptosis   
[?C textMine:partmod ?A, ?C textMine:nn ?mutation, ?A textMine:xcomp ?impact, ?A textMine:xcomp ?function, ?function textMine:conj ?impact]
Added to queryTripless!! : ?C textMine:partmod ?A. ?C textMine:nn ?mutation. ?A textMine:xcomp ?negative. ?A textMine:xcomp ?function. ?function textMine:conj ?negative. 
230

270 In vitro  studies in thyroid cells suggest that BRAF V600E induces invasion via increased expression of matrix metalloproteinases (MMP12) ( Mesa  et al , 2006 ) and that it reduces expression and membrane localisation of the Na, I symporter responsible for thyrocyte uptake of iodine ( Riesco Eizaguirre  et al , 2006 ) 
[?B textMine:nsubj ?mutation, ?B textMine:conj ?impact, ?impact textMine:dobj ?D, ?D textMine:nn ?function]
Added to queryTripless!! : ?B textMine:nsubj ?mutation. ?B textMine:conj ?negative. ?negative textMine:dobj ?D. ?D textMine:nn ?function. 
231

271 However, tyrosine phosphorylation on the EGFR mutants could be further increased by EGF stimulation ( Figure 2 B), suggesting that the mutant EGFRs exhibit both ligand independent and ligand dependent activation, similar to that observed upon EGF stimulation of the L858R mutant H3255 lung adenocarcinoma cell line   
[?B textMine:prep ?F, ?D textMine:amod ?A, ?F textMine:nn ?mutation, ?G textMine:ccomp ?J, ?E textMine:partmod ?G, ?J textMine:dobj ?D, ?J textMine:nsubj ?function, ?impact textMine:agent ?E, ?A textMine:prep ?B]
Added to queryTripless!! : ?B textMine:prep ?F. ?D textMine:amod ?A. ?F textMine:nn ?mutation. ?G textMine:ccomp ?J. ?E textMine:partmod ?G. ?J textMine:dobj ?D. ?J textMine:nsubj ?function. ?positive textMine:agent ?E. ?A textMine:prep ?B. 
232

272 Cells expressing S249C and Y375C FGFR3 displayed an increased saturation density, related to increased proliferation and viability 
[?A textMine:partmod ?F, ?E textMine:dobj ?A, ?E textMine:nsubj ?mutation, ?F textMine:prep ?function, ?function textMine:amod ?impact]
Added to queryTripless!! : ?A textMine:partmod ?F. ?E textMine:dobj ?A. ?E textMine:nsubj ?mutation. ?F textMine:prep ?function. ?function textMine:amod ?positive. 
233

273 In normal B cells, the wild type BRAF activation loop (T 599 VKS 602 ) induces kinase activity by conformational changes  [27] , whereas the V600E mutation intrinsically achieves a constitutively active conformation by mimicking the loop, leading to chronic MEK/ERK signaling and transformation  [28]  
[?function textMine:advmod ?impact, ?A textMine:amod ?function, ?D textMine:nn ?mutation, ?E textMine:nsubj ?D, ?E textMine:dobj ?A]
Added to queryTripless!! : ?function textMine:advmod ?positive. ?A textMine:amod ?function. ?D textMine:nn ?mutation. ?E textMine:nsubj ?D. ?E textMine:dobj ?A. 
234

274 Upon FGF2 stimulation, S252W fibroblasts significantly altered expression of 55 DEGs, up regulating 21 genes and down regulating 34 genes ( Table S3 ) 
[?impact textMine:prepc ?function, ?impact textMine:nsubj ?D, ?D textMine:nn ?mutation]
Added to queryTripless!! : ?unknown textMine:prepc ?function. ?unknown textMine:nsubj ?D. ?D textMine:nn ?mutation. 
235

275 BCR ABL1 ,  FLT3  D835V and  KIT  D816Y transfectants displayed an intermediate sensitivity pattern (estimated IC50s for NVP BEZ235 ~10 130 nM and ~65 180 nM for NVP BGT226) whereas  FLT3  ITD demonstrated high sensitivity for both agents with IC50s below 10 nM 
[?E textMine:dobj ?function, ?C textMine:nn ?mutation, ?B textMine:nsubj ?C, ?B textMine:advcl ?E, ?function textMine:amod ?impact]
Added to queryTripless!! : ?E textMine:dobj ?function. ?C textMine:nn ?mutation. ?B textMine:nsubj ?C. ?B textMine:advcl ?E. ?function textMine:amod ?positive. 
236

276 BRAF V600E   mutation is the most frequent genetic alteration in papillary thyroid carcinoma (PTC); its high prevalence makes this oncogene a useful marker to refine inconclusive FNC results 
[?D textMine:infmod ?B, ?impact textMine:parataxis ?E, ?impact textMine:nsubj ?A, ?A textMine:nn ?mutation, ?E textMine:dobj ?D, ?B textMine:dobj ?function]
Added to queryTripless!! : ?D textMine:infmod ?B. ?unknown textMine:parataxis ?E. ?unknown textMine:nsubj ?A. ?A textMine:nn ?mutation. ?E textMine:dobj ?D. ?B textMine:dobj ?function. 
237

277 E255K and T315I are the most predominant mutations of BCR/ABL causing imatinib resistance in patients and may increase the kinase activity or change the substrate preferences of BCR/ABL ( 15 , 18 ) 
[?E textMine:conj ?B, ?E textMine:conj ?impact, ?E textMine:nsubj ?mutation, ?B textMine:dobj ?A, ?A textMine:amod ?function, ?impact textMine:conj ?B, ?impact textMine:nsubj ?mutation]
Added to queryTripless!! : ?E textMine:conj ?B. ?E textMine:conj ?positive. ?E textMine:nsubj ?mutation. ?B textMine:dobj ?A. ?A textMine:amod ?function. ?positive textMine:conj ?B. ?positive textMine:nsubj ?mutation. 
238

278 This mutation ( E17K ) increases recruitment of AKT1 to the membrane, increases AKT1 phosphorylation and activity, transforms Rat1 fibroblasts, and induces leukaemia in transgenic mice ( Carpten  et al , 2007 ) 
[?A textMine:appos ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?A]
[?A textMine:appos ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?A, ]
Match 


279 Here we provide the first evidence that  V600E BRAF causes the upregulation of genes involved in glycolysis, whereas knock down of  V600E BRAF in melanoma cells conversely reduces the expression of these genes, lowers the rate of glycolysis and causes the reversal of the Warburg phenotype 
[?F textMine:prep ?function, ?impact textMine:nsubj ?F, ?impact textMine:advcl ?A, ?C textMine:prep ?E, ?E textMine:nn ?mutation, ?A textMine:csubj ?C]
Added to queryTripless!! : ?F textMine:prep ?function. ?negative textMine:nsubj ?F. ?negative textMine:advcl ?A. ?C textMine:prep ?E. ?E textMine:nn ?mutation. ?A textMine:csubj ?C. 
239

280 E255K and T315I are the most predominant mutations of BCR/ABL causing imatinib resistance in patients and may increase the kinase activity or change the substrate preferences of BCR/ABL ( 15 , 18 ) 
[?C textMine:conj ?impact, ?C textMine:nsubj ?mutation, ?C textMine:nsubj ?E, ?E textMine:conj ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?E]
Added to queryTripless!! : ?C textMine:conj ?positive. ?C textMine:nsubj ?mutation. ?C textMine:nsubj ?E. ?E textMine:conj ?mutation. ?positive textMine:dobj ?function. ?positive textMine:nsubj ?E. 
240

281 Another study found uncoupling in rare TnC variants identified in DCM: cTnC Y5H, M103I, and I148V either decreased or abolished the effects of PKA phosphorylation on Ca 2+  sensitivity (Pinto et al,  2011 ) 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:conj ?mutation]
Added to queryTripless!! : ?negative textMine:dobj ?function. ?negative textMine:nsubj ?B. ?B textMine:conj ?mutation. 
241

283 In fact, rare divergent results between BRAF DNA sequencing and V600E immunohistochemistry usually resolve in favor of the antibody based results 
[?impact textMine:prep ?F, ?mutation textMine:dep ?B, ?F textMine:partmod ?C, ?B textMine:prep ?impact, ?C textMine:dobj ?function]
Added to queryTripless!! : ?positive textMine:prep ?F. ?mutation textMine:dep ?B. ?F textMine:partmod ?C. ?B textMine:prep ?positive. ?C textMine:dobj ?function. 
242

284 E884K EGFR modulates inhibitor sensitivity effects in an inhibitor specific fashion
[?impact textMine:dobj ?D, ?impact textMine:nsubj ?B, ?D textMine:nn ?function, ?B textMine:nn ?mutation]
Added to queryTripless!! : ?unknown textMine:dobj ?D. ?unknown textMine:nsubj ?B. ?D textMine:nn ?function. ?B textMine:nn ?mutation. 
243

285 The classic FOP associated ACVR1 mutation R206H renders ACVR1 constitutively active and increases the phosphorylation of downstream Smad1 effector proteins 
[?impact textMine:dobj ?function, ?A textMine:nn ?mutation, ?E textMine:conj ?impact, ?E textMine:iobj ?A]
Added to queryTripless!! : ?positive textMine:dobj ?function. ?A textMine:nn ?mutation. ?E textMine:conj ?positive. ?E textMine:iobj ?A. 
244

286 Indeed, upon the addition of NN, hTMSC chemotactic migration was significantly reduced compared with the control condition as well as to N C  stimulated cells ( Fig. 3  A )  Furthermore, in NSCLC line H1975, which expresses EGFR with the double mutation L858R and T790M as well as HER2 and HER3  , NN stimulation reduced chemokinesis relative to NRG stimulated and untreated control cells ( Fig 3 ,  B  and  C ) 
[?H textMine:pobj ?G, ?G textMine:partmod ?C, ?A textMine:rcmod ?E, ?F textMine:nsubj ?impact, ?E textMine:dobj ?function, ?I textMine:xcomp ?F, ?I textMine:advcl ?H, ?C textMine:prep ?A]
Added to queryTripless!! : ?H textMine:pobj ?G. ?G textMine:partmod ?C. ?A textMine:rcmod ?E. ?F textMine:nsubj ?negative. ?E textMine:dobj ?function. ?I textMine:xcomp ?F. ?I textMine:advcl ?H. ?C textMine:prep ?A. 
245

287 Recent studies have demonstrated an approximately 10 fold higher tumor burden with Braf V600E  expression in mouse lung compared to Kras G12D , while adenocarcinoma formation was exclusively observed with Kras G12D  but not Braf V600E  expression  [56] ,  [57]  
[?F textMine:advcl ?E, ?F textMine:ccomp ?C, ?C textMine:dobj ?A, ?H textMine:nn ?function, ?H textMine:nn ?mutation, ?E textMine:prep ?H, ?A textMine:amod ?impact]
Added to queryTripless!! : ?F textMine:advcl ?E. ?F textMine:ccomp ?C. ?C textMine:dobj ?A. ?H textMine:nn ?function. ?H textMine:nn ?mutation. ?E textMine:prep ?H. ?A textMine:amod ?positive. 
246

288 Oncogenic mutations, S768I and L861Q, may alter the canonical interactions at the JM C helix interface
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ?C textMine:appos ?mutation]
Query : [?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ?C textMine:appos ?mutation]
Existing trips : 
?A textMine:appos ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?A. 
Similar Query!!!!


289 Ki67 staining showed that the proportion of proliferating cells was significantly increased within the midline mesenchyme separating premaxillary bones in  Fgfr2 +/S252W   mice compared with unaffected littermates 
[?G textMine:prep ?F, ?D textMine:partmod ?A, ?B textMine:amod ?function, ?C textMine:prep ?B, ?impact textMine:prep ?D, ?impact textMine:nsubjpass ?C, ?A textMine:dobj ?G, ?F textMine:nn ?mutation]
Added to queryTripless!! : ?G textMine:prep ?F. ?D textMine:partmod ?A. ?B textMine:amod ?function. ?C textMine:prep ?B. ?positive textMine:prep ?D. ?positive textMine:nsubjpass ?C. ?A textMine:dobj ?G. ?F textMine:nn ?mutation. 
247

290 Motesanib and imatinib have much diminished activity against the activation loop mutant (D816V) 
[?B textMine:appos ?mutation, ?F textMine:nsubj ?B, ?F textMine:dobj ?G, ?E textMine:nn ?function, ?G textMine:prep ?E, ?G textMine:amod ?impact]
Added to queryTripless!! : ?B textMine:appos ?mutation. ?F textMine:nsubj ?B. ?F textMine:dobj ?G. ?E textMine:nn ?function. ?G textMine:prep ?E. ?G textMine:amod ?negative. 
248

291 In the present study, FGFR2 S252W  mutation leads to increased proliferation, migration, and osteogenic potential of both fibroblasts and MSCs 
[?function textMine:amod ?impact, ?C textMine:prep ?function, ?C textMine:nsubj ?E, ?E textMine:nn ?mutation]
Query : [?function textMine:amod ?impact, ?C textMine:prep ?function, ?C textMine:nsubj ?E, ?E textMine:nn ?mutation]
Existing trips : 
?B textMine:nn ?mutation. ?E textMine:nsubj ?B. ?E textMine:prep ?function. ?function textMine:amod ?impact. 
Similar Query!!!!


292 FDG could furthermore be used to distinguish between  BRAF  V600E  mutant melanomas with high or low sensitivity to PLX4032 
[?function textMine:amod ?impact, ?A textMine:prep ?function, ?A textMine:prep ?B, ?B textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:amod ?positive. ?A textMine:prep ?function. ?A textMine:prep ?B. ?B textMine:nn ?mutation. 
249

293 H606Q disrupts the interactions between the residue 606 sidechain and the L604/L609 backbones, affecting the conformation of the loop (604 to 609) connecting the JH2 C helix and the β 4 sheet and thus changing the position of V617 relative to the C helix 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation]
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation, ]
Match 


294 Here, we show for the first time that activation of FGFR3 is associated with an increase in FGFR3b expression in S249C mutated tumors 
[?impact textMine:prep ?C, ?C textMine:prep ?E, ?function textMine:prep ?impact, ?E textMine:nn ?mutation]
Added to queryTripless!! : ?positive textMine:prep ?C. ?C textMine:prep ?E. ?function textMine:prep ?positive. ?E textMine:nn ?mutation. 
250

295 Since this initial report, Xing has shown that the BRAF activating mutation is the most common genetic alteration in thyroid cancer  , occurring in 18% to 87% of thyroid cancers  ; importantly, the BRAF V600E   mutation occurs in nearly 45% of sporadic cases of PTC   and 24% of cases of anaplastic carcinoma   
[?G textMine:parataxis ?A, ?G textMine:ccomp ?impact, ?E textMine:nn ?mutation, ?A textMine:nsubj ?E, ?impact textMine:nsubj ?B, ?B textMine:nn ?function]
Added to queryTripless!! : ?G textMine:parataxis ?A. ?G textMine:ccomp ?unknown. ?E textMine:nn ?mutation. ?A textMine:nsubj ?E. ?unknown textMine:nsubj ?B. ?B textMine:nn ?function. 
251

296 One important question that emerged was whether the higher aggregation propensity of the R248Q mutant was related to the negative dominance effect observed  in vivo  
[?F textMine:prep ?C, ?C textMine:nn ?mutation, ?function textMine:amod ?impact, ?E textMine:prep ?function, ?E textMine:nsubjpass ?F]
Added to queryTripless!! : ?F textMine:prep ?C. ?C textMine:nn ?mutation. ?function textMine:amod ?negative. ?E textMine:prep ?function. ?E textMine:nsubjpass ?F. 
252

297 Patients with Apert syndrome with the S252W mutation in the FGFR2  gene enhanced osteoblastic marker gene expression and ALP activity  
[?E textMine:prep ?F, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:prep ?E, ?F textMine:amod ?mutation]
Added to queryTripless!! : ?E textMine:prep ?F. ?positive textMine:dobj ?function. ?positive textMine:nsubj ?B. ?B textMine:prep ?E. ?F textMine:amod ?mutation. 
253

298 Increased activation of Akt1 by E17K, L52R, C77F, and Q79K mutants led, as expected, to increased phosphorylation of Akt target proteins including FOXO1/3 and PRAS40 
[?function textMine:amod ?impact, ?C textMine:prep ?mutation, ?E textMine:prep ?C, ?A textMine:prep ?function, ?A textMine:nsubj ?E]
Added to queryTripless!! : ?function textMine:amod ?positive. ?C textMine:prep ?mutation. ?E textMine:prep ?C. ?A textMine:prep ?function. ?A textMine:nsubj ?E. 
254

299 Furthermore, as shown in  Figure 2H , the level of ISG15 was also found induced in proliferating, undifferentiated erythroblasts expressing a constitutively activated form of STAT5 (STAT5 S710F ), an essential effector of EpoR signaling in erythroid development  
[?D textMine:amod ?function, ?D textMine:prep ?E, ?D textMine:amod ?impact, ?E textMine:appos ?mutation]
Added to queryTripless!! : ?D textMine:amod ?function. ?D textMine:prep ?E. ?D textMine:amod ?positive. ?E textMine:appos ?mutation. 
255

300 Hence, the double mutation L858R+E884K modulated downstream EGFR signaling differentially with distinctly different effects on the AKT (downregulated) and MAPK ERK1/2 phosphorylation (upregulated) 
[?D textMine:partmod ?A, ?impact textMine:dobj ?D, ?impact textMine:nsubj ?mutation, ?A textMine:prep ?function]
Added to queryTripless!! : ?D textMine:partmod ?A. ?unknown textMine:dobj ?D. ?unknown textMine:nsubj ?mutation. ?A textMine:prep ?function. 
256

301 The FGFR2 S252W  mutation has a positive effect on both proliferation and migration of fibroblasts, and a negative effect on MSC proliferation 
[?E textMine:dobj ?function, ?E textMine:nsubj ?C, ?C textMine:nn ?mutation, ?function textMine:amod ?impact]
Added to queryTripless!! : ?E textMine:dobj ?function. ?E textMine:nsubj ?C. ?C textMine:nn ?mutation. ?function textMine:amod ?negative. 
257

302 Tyrosine phosphorylation of MIG6 appears to be increased in cancer cell lines containing Δ746–750 or L858R EGFRs, suggesting that in addition to inhibiting EGFR, MIG6 may also be a direct substrate of these mutant receptor EGFRs  
[?D textMine:dep ?A, ?A textMine:num ?mutation, ?F textMine:xcomp ?E, ?F textMine:dobj ?D, ?impact textMine:xcomp ?F, ?E textMine:ccomp ?function]
Added to queryTripless!! : ?D textMine:dep ?A. ?A textMine:num ?mutation. ?F textMine:xcomp ?E. ?F textMine:dobj ?D. ?positive textMine:xcomp ?F. ?E textMine:ccomp ?function. 
258

303 The single mutants, with the exception of K112N and K118N, exhibited slightly lower thermal stability than the wild type 
[?A textMine:prep ?E, ?B textMine:dobj ?function, ?B textMine:nsubj ?A, ?E textMine:prep ?mutation]
Added to queryTripless!! : ?A textMine:prep ?E. ?B textMine:dobj ?function. ?B textMine:nsubj ?A. ?E textMine:prep ?mutation. 
259

304 The FGFR2 S252W  mutation has a positive effect on both proliferation and migration of fibroblasts, and a negative effect on MSC proliferation 
[?F textMine:dobj ?A, ?F textMine:nsubj ?C, ?C textMine:nn ?mutation, ?A textMine:prep ?function, ?A textMine:amod ?impact]
Query : [?F textMine:dobj ?A, ?F textMine:nsubj ?C, ?C textMine:nn ?mutation, ?A textMine:prep ?function, ?A textMine:amod ?impact]
Existing trips : 
?A textMine:dobj ?D. ?A textMine:nsubj ?B. ?B textMine:nn ?mutation. ?D textMine:amod ?impact. ?D textMine:prep ?function. 
Similar Query!!!!


305 Although these antagonistic roles offset in the steady state, we demonstrate that the supportive role of macrophages in RBC development is dominant in recovery from hemolytic anemia, acute blood loss, myeloablation, and also JAK2 V617F  induced polycythemia vera 
[?impact textMine:prep ?C, ?C textMine:nn ?function, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?positive textMine:prep ?C. ?C textMine:nn ?function. ?C textMine:nn ?mutation. 
260

306 This mutant form of  BRAF  V600E elicits enhanced dimerization in cells which contain low levels of active Ras, in comparison to cells containing the full length  BRAF  V600E mutation 
[?H textMine:prep ?J, ?function textMine:amod ?impact, ?I textMine:rcmod ?F, ?A textMine:prep ?I, ?A textMine:dobj ?function, ?E textMine:dobj ?G, ?F textMine:prep ?H, ?G textMine:nn ?mutation, ?J textMine:partmod ?E]
Added to queryTripless!! : ?H textMine:prep ?J. ?function textMine:amod ?positive. ?I textMine:rcmod ?F. ?A textMine:prep ?I. ?A textMine:dobj ?function. ?E textMine:dobj ?G. ?F textMine:prep ?H. ?G textMine:nn ?mutation. ?J textMine:partmod ?E. 
261

307 We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated (native) BCR/ABL ( 15 – 17 ) 
[?G textMine:prep ?function, ?B textMine:dobj ?G, ?A textMine:infmod ?B, ?A textMine:amod ?impact, ?H textMine:nn ?mutation, ?E textMine:dobj ?A, ?E textMine:nsubj ?H]
Added to queryTripless!! : ?G textMine:prep ?function. ?B textMine:dobj ?G. ?A textMine:infmod ?B. ?A textMine:amod ?positive. ?H textMine:nn ?mutation. ?E textMine:dobj ?A. ?E textMine:nsubj ?H. 
262

308 The V600E mutation confers an increase in BRAF kinase activity of approximately 480 times compared with wild type BRAF, whereas the V600D mutation increases this by approximately 700 times ( Wan  et al , 2004 ) 
[?impact textMine:nsubj ?D, ?F textMine:prep ?function, ?E textMine:advcl ?impact, ?E textMine:dobj ?F, ?D textMine:nn ?mutation]
Added to queryTripless!! : ?positive textMine:nsubj ?D. ?F textMine:prep ?function. ?E textMine:advcl ?positive. ?E textMine:dobj ?F. ?D textMine:nn ?mutation. 
263

309 In fact, it is well established that gefitinib is more active in some patient subgroups, such as Asians, females, never smokers and adenocarcinoma histotypes which have a higher probability of harbouring activating mutations in the tyrosine kinase domain, the most frequent being L858R in exon 21 and Del (746 750) in exon 19   
[?I textMine:appos ?F, ?I textMine:rcmod ?A, ?C textMine:amod ?function, ?A textMine:dobj ?D, ?F textMine:partmod ?mutation, ?G textMine:dobj ?C, ?D textMine:prepc ?G, ?D textMine:amod ?impact]
Added to queryTripless!! : ?I textMine:appos ?F. ?I textMine:rcmod ?A. ?C textMine:amod ?function. ?A textMine:dobj ?D. ?F textMine:partmod ?mutation. ?G textMine:dobj ?C. ?D textMine:prepc ?G. ?D textMine:amod ?positive. 
264

310 For example, crizotinib maintains activity against the R1275Q mutant, but drastically loses activity against F1174L, another frequently occurring mutant (Wood et al., ; Sakamoto et al , ; Schönherr et al, ) 
[?B textMine:conj ?impact, ?B textMine:prep ?A, ?impact textMine:dobj ?function, ?A textMine:nn ?mutation]
Query : [?B textMine:conj ?impact, ?B textMine:prep ?A, ?impact textMine:dobj ?function, ?A textMine:nn ?mutation]
Existing trips : 
?B textMine:nn ?mutation. ?C textMine:conj ?impact. ?C textMine:prep ?B. ?impact textMine:dobj ?function. 
Similar Query!!!!


311 F1174L may therefore stabilize an active conformation that is both more oncogenic and less favored for crizotinib binding 
[?E textMine:amod ?function, ?impact textMine:prep ?E, ?F textMine:rcmod ?impact, ?B textMine:dobj ?F, ?B textMine:nsubj ?mutation]
Added to queryTripless!! : ?E textMine:amod ?function. ?positive textMine:prep ?E. ?F textMine:rcmod ?positive. ?B textMine:dobj ?F. ?B textMine:nsubj ?mutation. 
265

312 The patient remained on this regimen for 7 mo with an excellent performance status, exceeding the expected survival of a patient expressing B RAF V600E colon cancer 
[?C textMine:dobj ?D, ?D textMine:prep ?E, ?E textMine:nn ?mutation, ?E textMine:nn ?function, ?impact textMine:xcomp ?C]
Added to queryTripless!! : ?C textMine:dobj ?D. ?D textMine:prep ?E. ?E textMine:nn ?mutation. ?E textMine:nn ?function. ?neutral textMine:xcomp ?C. 
266

313 Consistent with published studies, our findings reveal that gefitinib resistant PC9 cells acquired a T790M gate keeper mutation and gefitinib resistant HCC827 cells exhibited markedly increased MET expression levels  13 ,  14 ,  15 ,  17   ( Supplementary Figures S2 and S3 ) 
[?function textMine:nsubj ?A, ?function textMine:ccomp ?impact, ?A textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:nsubj ?A. ?function textMine:ccomp ?positive. ?A textMine:nn ?mutation. 
267

314 The mutations E255K and T315A experience increased vdW interactions with Leu354 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:nn ?mutation]
Query : [?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:nn ?mutation]
Existing trips : 
?C textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?C. 
Similar Query!!!!


315 The two substitutions (V600E and V600K) represent 95% of all BRAF mutations in melanoma, and both create a constitutively active kinase that is independent of receptor tyrosine kinase or RAS 
[?G textMine:conj ?A, ?G textMine:nsubj ?D, ?A textMine:dobj ?E, ?function textMine:advmod ?impact, ?E textMine:amod ?function, ?D textMine:appos ?mutation]
Added to queryTripless!! : ?G textMine:conj ?A. ?G textMine:nsubj ?D. ?A textMine:dobj ?E. ?function textMine:advmod ?positive. ?E textMine:amod ?function. ?D textMine:appos ?mutation. 
268

349 (A)  PRV1  expression was higher in ET JAK2 V617F positive patients than in JAK2 V617F negative patients; (B) a positive correlation between  PRV1  expression in ET leukocytes and JAK2 V617F allele burden percentage was detected 
[?D textMine:dep ?G, ?D textMine:rcmod ?impact, ?G textMine:dep ?A, ?B textMine:prep ?function, ?A textMine:nsubjpass ?B, ?function textMine:prep ?E, ?E textMine:nn ?mutation]
Added to queryTripless!! : ?D textMine:dep ?G. ?D textMine:rcmod ?positive. ?G textMine:dep ?A. ?B textMine:prep ?function. ?A textMine:nsubjpass ?B. ?function textMine:prep ?E. ?E textMine:nn ?mutation. 
269

316 We identified 25 fold increased expression of MMP 1 mRNA in melanoma cells possessing BRAF V600E  compared to wildtype while HPMs expressed similar transcript levels with BRAF wildtype melanoma cell ( Figure 2a ), suggesting that increased BRAF kinase activity may be associated with elevated MMP 1 expression in melanomas 
[?D textMine:partmod ?F, ?function textMine:amod ?impact, ?E textMine:advcl ?D, ?E textMine:dobj ?mutation, ?F textMine:dobj ?function]
Added to queryTripless!! : ?D textMine:partmod ?F. ?function textMine:amod ?positive. ?E textMine:advcl ?D. ?E textMine:dobj ?mutation. ?F textMine:dobj ?function. 
270

317 The mutations Y253F, E255V and H396P experience decreased vdW interactions with Phe382 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:amod ?D, ?D textMine:dep ?mutation]
Query : [?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:amod ?D, ?D textMine:dep ?mutation]
Existing trips : 
?B textMine:amod ?E. ?E textMine:dep ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?B. 
Similar Query!!!!


318 Our observation that NFAT activity was higher in V600D mutated WM266 4 cells compared with V600E mutated A375 cells, which correlated with the amount of BRAF kinase activity evoked by each mutant is particularly noteworthy 
[?C textMine:rcmod ?F, ?C textMine:num ?mutation, ?B textMine:pobj ?C, ?B textMine:advmod ?impact, ?G textMine:prep ?function, ?F textMine:prep ?G]
Added to queryTripless!! : ?C textMine:rcmod ?F. ?C textMine:num ?mutation. ?B textMine:pobj ?C. ?B textMine:advmod ?positive. ?G textMine:prep ?function. ?F textMine:prep ?G. 
271

319 This mutation, JAK2 V617F, is a gain of function mutation and hematopoietic progenitor cells from patients with this mutation have increased sensitivity to hematopoietic growth factors   
[?impact textMine:dobj ?function, ?A textMine:appos ?mutation, ?E textMine:advcl ?impact, ?E textMine:nsubj ?A]
Added to queryTripless!! : ?positive textMine:dobj ?function. ?A textMine:appos ?mutation. ?E textMine:advcl ?positive. ?E textMine:nsubj ?A. 
272

320 In the presence of the S252W mutation, FGFR2 shows enhanced ligand binding affinity to FGF2 and loses isoform ligand specificity for most of the other ligands   
[?D textMine:dobj ?function, ?D textMine:prep ?E, ?E textMine:prep ?F, ?function textMine:amod ?impact, ?F textMine:nn ?mutation]
Added to queryTripless!! : ?D textMine:dobj ?function. ?D textMine:prep ?E. ?E textMine:prep ?F. ?function textMine:amod ?positive. ?F textMine:nn ?mutation. 
273

321 The majority of mutations in BRAF  are accounted for by a single nucleotide transversion from thymidine to adenosine leading to a substitution of valine by glutamic acid at position 600 (termed  BRAF  V600E )  , which leads to a 500 fold increase in activity compared to the wild type protein kinase   
[?impact textMine:prep ?function, ?A textMine:prep ?impact, ?B textMine:dobj ?mutation, ?C textMine:dep ?B, ?C textMine:rcmod ?A]
Added to queryTripless!! : ?positive textMine:prep ?function. ?A textMine:prep ?positive. ?B textMine:dobj ?mutation. ?C textMine:dep ?B. ?C textMine:rcmod ?A. 
274

322 The most common mutation is V600E, which dramatically enhances BRAF enzyme activity, and thus induces tumorous transformation 
[?mutation textMine:rcmod ?function, ?mutation textMine:rcmod ?impact, ?impact textMine:conj ?function]
Added to queryTripless!! : ?mutation textMine:rcmod ?function. ?mutation textMine:rcmod ?positive. ?positive textMine:conj ?function. 
275

323 We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated (native) BCR/ABL ( 15 – 17 ) 
[?C textMine:dobj ?function, ?C textMine:nsubj ?E, ?function textMine:amod ?impact, ?E textMine:nn ?mutation]
Query : [?C textMine:dobj ?function, ?C textMine:nsubj ?E, ?function textMine:amod ?impact, ?E textMine:nn ?mutation]
Existing trips : 
?C textMine:nn ?mutation. ?E textMine:dobj ?function. ?E textMine:nsubj ?C. ?function textMine:amod ?impact. 
Similar Query!!!!


324 In this last study, the JAK2  V617F mutation was found associated with the increased platelet activation 
[?D textMine:dep ?B, ?D textMine:nsubjpass ?E, ?E textMine:nn ?mutation, ?B textMine:prep ?function, ?function textMine:amod ?impact]
Added to queryTripless!! : ?D textMine:dep ?B. ?D textMine:nsubjpass ?E. ?E textMine:nn ?mutation. ?B textMine:prep ?function. ?function textMine:amod ?positive. 
276

325 Strongly reduced activity of the PPARγ K365R mutant contradicts the results of Pascual  et al who reported similar activation of the Aox tk  luciferase construct by wild type PPARγ and by the PPARγ K365R mutant 
[?E textMine:prep ?C, ?E textMine:nsubj ?function, ?D textMine:ccomp ?E, ?impact textMine:dep ?D, ?C textMine:nn ?mutation]
[?C textMine:nn ?mutation, ?D textMine:ccomp ?E, ?E textMine:nsubj ?function, ?E textMine:prep ?C, ?impact textMine:dep ?D, ]
Match 


326 CNP and meclozine increased the Alcian blue staining of ATDC5 cells expressing FGFR3 G380R and –K650E in micromass culture 
[?B textMine:prep ?D, ?function textMine:dobj ?mutation, ?D textMine:partmod ?function, ?impact textMine:dobj ?B]
Added to queryTripless!! : ?B textMine:prep ?D. ?function textMine:dobj ?mutation. ?D textMine:partmod ?function. ?positive textMine:dobj ?B. 
277

327 Substitution of S252W and P253R alter the ligand binding specificities of FGFR2b and FGFR2c, but retain the ligand dependent activation properties  , whereas K659N causes receptor hyperactivation   
[?A textMine:nn ?function, ?C textMine:prep ?mutation, ?impact textMine:dobj ?A, ?impact textMine:nsubj ?C]
Added to queryTripless!! : ?A textMine:nn ?function. ?C textMine:prep ?mutation. ?neutral textMine:dobj ?A. ?neutral textMine:nsubj ?C. 
278

328 Intriguingly, the imatinib resistant BCR/ABL mutants E255K and T315I showed increased ability as compared with native BCR/ABL to induce tyrosine phosphorylation of PECAM 1 when expressed in the murine model hematopoietic cell line BaF3 cells or in 293T cells ( Fig 4 ) 
[?C textMine:advcl ?function, ?E textMine:infmod ?C, ?E textMine:amod ?impact, ?A textMine:dobj ?E, ?A textMine:nsubj ?mutation]
Added to queryTripless!! : ?C textMine:advcl ?function. ?E textMine:infmod ?C. ?E textMine:amod ?positive. ?A textMine:dobj ?E. ?A textMine:nsubj ?mutation. 
279

329 BRAF V600E  is a dominant activating mutation in melanoma resulting in a constitutive activation of the mitogen activated protein kinase (MAPK) pathway and uncontrolled cell growth  
[?F textMine:partmod ?G, ?D textMine:prep ?F, ?D textMine:nsubj ?mutation, ?A textMine:prep ?H, ?A textMine:amod ?impact, ?H textMine:amod ?function, ?G textMine:prep ?A]
Added to queryTripless!! : ?F textMine:partmod ?G. ?D textMine:prep ?F. ?D textMine:nsubj ?mutation. ?A textMine:prep ?H. ?A textMine:amod ?positive. ?H textMine:amod ?function. ?G textMine:prep ?A. 
280

330 Interestingly, S252W mutation had opposite effects on different cell types: S252W MSCs proliferated less than WT MSCs, while S252W fibroblasts proliferated more than WT fibroblasts 
[?A textMine:nn ?mutation, ?function textMine:nsubj ?A, ?D textMine:advcl ?function, ?D textMine:advmod ?impact]
Added to queryTripless!! : ?A textMine:nn ?mutation. ?function textMine:nsubj ?A. ?D textMine:advcl ?function. ?D textMine:advmod ?negative. 
281

331 Molecular studies on the receptors harbouring a known L858R mutation demonstrated a decreased affinity of the tyrosine kinase for ATP and an increase in the affinity for the tyrosine kinase inhibitors (TKI) 
[?J textMine:prep ?E, ?E textMine:partmod ?G, ?H textMine:nn ?mutation, ?G textMine:dobj ?H, ?I textMine:prep ?function, ?A textMine:prep ?I, ?A textMine:amod ?impact, ?B textMine:dobj ?A, ?B textMine:nsubj ?J]
Added to queryTripless!! : ?J textMine:prep ?E. ?E textMine:partmod ?G. ?H textMine:nn ?mutation. ?G textMine:dobj ?H. ?I textMine:prep ?function. ?A textMine:prep ?I. ?A textMine:amod ?negative. ?B textMine:dobj ?A. ?B textMine:nsubj ?J. 
282

332 We find that PACSIN1 shows significantly increased phosphorylation when co transfected with the P52L mutant compared to the wild type PAK6 (  Fig 2F and G  ), suggesting that the melanoma associated mutation indeed functions to increase kinase activity 
[?function textMine:xcomp ?impact, ?D textMine:prep ?F, ?B textMine:ccomp ?function, ?H textMine:partmod ?B, ?H textMine:dobj ?C, ?F textMine:nn ?mutation, ?C textMine:rcmod ?D]
Added to queryTripless!! : ?function textMine:xcomp ?positive. ?D textMine:prep ?F. ?B textMine:ccomp ?function. ?H textMine:partmod ?B. ?H textMine:dobj ?C. ?F textMine:nn ?mutation. ?C textMine:rcmod ?D. 
283

333 Substitution of S252W and P253R alter the ligand binding specificities of FGFR2b and FGFR2c, but retain the ligand dependent activation properties  , whereas K659N causes receptor hyperactivation   
[?A textMine:nn ?function, ?D textMine:prep ?mutation, ?impact textMine:dobj ?A, ?impact textMine:nsubj ?D]
Query : [?A textMine:nn ?function, ?D textMine:prep ?mutation, ?impact textMine:dobj ?A, ?impact textMine:nsubj ?D]
Existing trips : 
?A textMine:nn ?function. ?C textMine:prep ?mutation. ?impact textMine:dobj ?A. ?impact textMine:nsubj ?C. 
Similar Query!!!!


334 TBP 3868 exhibits high basal Ras activity relative to the PLX4720 sensitive line, TBP 3743 suggesting that the resistance to BRAF V600E  inhibition in TBP 3868 may be attributed to Ras dependent transactivation of RAF dimers 
[?K textMine:prep ?I, ?E textMine:prep ?function, ?G textMine:advmod ?C, ?G textMine:amod ?impact, ?A textMine:dobj ?E, ?A textMine:xsubj ?K, ?J textMine:xcomp ?A, ?J textMine:nsubjpass ?K, ?H textMine:appos ?B, ?C textMine:prep ?H, ?B textMine:partmod ?M, ?M textMine:ccomp ?J, ?I textMine:nn ?mutation]
Added to queryTripless!! : ?K textMine:prep ?I. ?E textMine:prep ?function. ?G textMine:advmod ?C. ?G textMine:amod ?positive. ?A textMine:dobj ?E. ?A textMine:xsubj ?K. ?J textMine:xcomp ?A. ?J textMine:nsubjpass ?K. ?H textMine:appos ?B. ?C textMine:prep ?H. ?B textMine:partmod ?M. ?M textMine:ccomp ?J. ?I textMine:nn ?mutation. 
284

335 Previous studies showed that Mps1 T676A  has less active kinase activity than Mps1 WT  [29] – [30]  
[?function textMine:amod ?B, ?D textMine:dobj ?function, ?D textMine:nsubj ?mutation, ?B textMine:advmod ?impact]
Added to queryTripless!! : ?function textMine:amod ?B. ?D textMine:dobj ?function. ?D textMine:nsubj ?mutation. ?B textMine:advmod ?negative. 
285

337 In vitro  studies have demonstrated that  JAK2  V617F  leads to a specific phosphorylation associated with the constitutive activation of the tyrosine kinase function  [3]  
[?B textMine:partmod ?A, ?function textMine:amod ?impact, ?D textMine:prep ?B, ?D textMine:nsubj ?mutation, ?A textMine:prep ?function]
Added to queryTripless!! : ?B textMine:partmod ?A. ?function textMine:amod ?positive. ?D textMine:prep ?B. ?D textMine:nsubj ?mutation. ?A textMine:prep ?function. 
286

338 Furthermore, from a gefitinib resistant patient carrying the activating L858R mutation, we identified a novel secondary resistant mutation, L747S in cis to the activating mutation, which attenuated the up regulation of BIM and reduced apoptosis 
[?G textMine:partmod ?C, ?C textMine:dobj ?E, ?E textMine:nn ?mutation, ?B textMine:rcmod ?impact, ?I textMine:prep ?B, ?I textMine:prep ?G, ?impact textMine:dobj ?F, ?F textMine:prep ?function]
Added to queryTripless!! : ?G textMine:partmod ?C. ?C textMine:dobj ?E. ?E textMine:nn ?mutation. ?B textMine:rcmod ?negative. ?I textMine:prep ?B. ?I textMine:prep ?G. ?negative textMine:dobj ?F. ?F textMine:prep ?function. 
287

339 In that context, we demonstrate that inhibition of SIRT1 with genetic or pharmacological approaches additively enhances the efficacy of PLX4032 of melanoma cells but more importantly that it rescues the sensitivity to PLX4032 of the resistant BRAF V600E  mutated melanoma cells 
[?impact textMine:conj ?B, ?B textMine:prep ?E, ?B textMine:dobj ?function, ?E textMine:prep ?mutation]
Added to queryTripless!! : ?positive textMine:conj ?B. ?B textMine:prep ?E. ?B textMine:dobj ?function. ?E textMine:prep ?mutation. 
288

340 NFAT transcriptional activity was approximately 10 fold higher in A375 cells and approximately 70 fold higher in WM266 4 cells compared with  BRAF  wild type CHL 1 cells ( Figure 1A ), consistent with increased B RAF activity of BRAF V600D  compared with BRAF V600E  ( Wan  et al , 2004 ) 
[?function textMine:amod ?impact, ?function textMine:prep ?D, ?D textMine:pobj ?mutation]
Added to queryTripless!! : ?function textMine:amod ?positive. ?function textMine:prep ?D. ?D textMine:pobj ?mutation. 
289

341 BRAF V600E  induced transforming properties are further enhanced through cooperation with TGFβ 1, suggesting that synergism between oncogene and growth factor is essential for induction of further migration properties in colon adenocarcinoma cells 
[?mutation textMine:partmod ?function, ?impact textMine:nsubjpass ?mutation]
Added to queryTripless!! : ?mutation textMine:partmod ?function. ?positive textMine:nsubjpass ?mutation. 
290

342 Immune complexes kinase assays showed, as expected, high BRAF activity in YULAC BRAF V600E  and YUMAC BRAF V600K  cells that was suppressed after treatment with PLX4032 for 30 min ( Figure 3A , YULAC and YUMAC) 
[?E textMine:nn ?mutation, ?function textMine:amod ?impact, ?D textMine:prep ?E, ?D textMine:prep ?function]
Query : [?E textMine:nn ?mutation, ?function textMine:amod ?impact, ?D textMine:prep ?E, ?D textMine:prep ?function]
Existing trips : 
?A textMine:prep ?B. ?A textMine:prep ?function. ?B textMine:nn ?mutation. ?function textMine:amod ?impact. 
Similar Query!!!!


343 Simultaneously, we have applied the increase of sensitivity of COLD PCR assay approach combined with HRM genotyping analysis for the NIPD of a C634Y fetal mutation using pregnant woman serum 
[?D textMine:pobj ?A, ?E textMine:pcomp ?D, ?A textMine:partmod ?H, ?impact textMine:prep ?function, ?G textMine:prep ?F, ?H textMine:prep ?G, ?B textMine:prep ?E, ?B textMine:dobj ?impact, ?F textMine:amod ?mutation]
Added to queryTripless!! : ?D textMine:pobj ?A. ?E textMine:pcomp ?D. ?A textMine:partmod ?H. ?positive textMine:prep ?function. ?G textMine:prep ?F. ?H textMine:prep ?G. ?B textMine:prep ?E. ?B textMine:dobj ?positive. ?F textMine:amod ?mutation. 
291

344 Conversely, E884K worked in concert with L858R in  cis  to further enhance the sensitivity of the mutant receptor to gefitinib inhibition ( Fig 1A, B ) 
[?impact textMine:xsubj ?mutation, ?impact textMine:dobj ?function]
Added to queryTripless!! : ?positive textMine:xsubj ?mutation. ?positive textMine:dobj ?function. 
292

345 Vemurafenib treatment results in deletion mutant p61B RAF V600E  with enhanced dimerization and activity through a similar allosteric mechanism 
[?C textMine:conj ?function, ?C textMine:amod ?impact, ?mutation textMine:prep ?function, ?mutation textMine:prep ?C]
Added to queryTripless!! : ?C textMine:conj ?function. ?C textMine:amod ?positive. ?mutation textMine:prep ?function. ?mutation textMine:prep ?C. 
293

346 Intriguingly, the imatinib resistant BCR/ABL mutants E255K and T315I showed increased ability as compared with native BCR/ABL to induce tyrosine phosphorylation of PECAM 1 when expressed in the murine model hematopoietic cell line BaF3 cells or in 293T cells ( Fig 4 ) 
[?D textMine:infmod ?function, ?D textMine:amod ?impact, ?A textMine:dobj ?D, ?A textMine:nsubj ?mutation]
Added to queryTripless!! : ?D textMine:infmod ?function. ?D textMine:amod ?positive. ?A textMine:dobj ?D. ?A textMine:nsubj ?mutation. 
294

347 Sorafenib induces inhibition of proliferation in all cell lines and induces a significant increase in apoptosis in the cell line harbouring BRAF V600E  mutation (Figure  3 ) 
[?function textMine:prepc ?A, ?function textMine:dobj ?impact, ?A textMine:dobj ?C, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:prepc ?A. ?function textMine:dobj ?positive. ?A textMine:dobj ?C. ?C textMine:nn ?mutation. 
295

348 G2385R also similarly increased NF κB activity at 100 ng and 500 ng ( Fig 6D ) 
[?impact textMine:dobj ?function, ?mutation textMine:dep ?impact]
Added to queryTripless!! : ?positive textMine:dobj ?function. ?mutation textMine:dep ?positive. 
296

350 In this critical step, BsaXI removes from the wild type PCR product a 30 bp fragment containing the V617F mutation site, which effectively eliminates the chance that the full length wild type product is re generated in the subsequent PCR 
[?D textMine:amod ?mutation, ?D textMine:rcmod ?impact, ?impact textMine:advmod ?function]
Added to queryTripless!! : ?D textMine:amod ?mutation. ?D textMine:rcmod ?negative. ?negative textMine:advmod ?function. 
297

351 We find an increased activity of SIRT1 in PLX4032 resistant BRAF V600E  mutated melanoma cells compared with their sensitive counterpart, thereby linking SIRT1 to drug resistance and poor prognosis in melanoma 
[?mutation textMine:partmod ?A, ?C textMine:dobj ?B, ?B textMine:prep ?function, ?G textMine:prep ?mutation, ?G textMine:amod ?impact, ?A textMine:partmod ?C]
Added to queryTripless!! : ?mutation textMine:partmod ?A. ?C textMine:dobj ?B. ?B textMine:prep ?function. ?G textMine:prep ?mutation. ?G textMine:amod ?positive. ?A textMine:partmod ?C. 
298

352 Previous studies in other cellular contexts have demonstrated that the S252W FGFR2 mutant receptor exhibits decreased ligand dissociation ( Anderson et al, 1998 ) 
[?impact textMine:dobj ?A, ?impact textMine:nsubj ?C, ?A textMine:amod ?function, ?C textMine:nn ?mutation]
Query : [?impact textMine:dobj ?A, ?impact textMine:nsubj ?C, ?A textMine:amod ?function, ?C textMine:nn ?mutation]
Existing trips : 
?B textMine:amod ?function. ?D textMine:nn ?mutation. ?impact textMine:dobj ?B. ?impact textMine:nsubj ?D. 
Similar Query!!!!


353 Recently, several mechanisms of EGFR TKI resistance have been identified and classified as follows: (1) alteration of the target  EGFR  gene (e.g., T790M gatekeeper mutation)  6 , 7  ; (2) activation of bypass resistance signals (e g,  Met  gene amplification,  8   hepatocyte growth factor [HGF] overexpression,  9   and activation of the nuclear factor kappa B (NFkB)pathway  10   and Gas6 AXL axis)  11  ; and (3) other mechanisms such as transformation to small cell lung cancer,  12 – 14   epithelial to mesenchymal transition,  15 – 17   alteration of microRNA,  18   and down regulation of MED12 
[?H textMine:num ?impact, ?E textMine:appos ?D, ?E textMine:conj ?F, ?I textMine:dep ?H, ?F textMine:prep ?C, ?C textMine:prep ?I, ?D textMine:dep ?G, ?G textMine:num ?mutation]
Added to queryTripless!! : ?H textMine:num ?unknown. ?E textMine:appos ?D. ?E textMine:conj ?F. ?I textMine:dep ?H. ?F textMine:prep ?C. ?C textMine:prep ?I. ?D textMine:dep ?G. ?G textMine:num ?mutation. 
299

355 Other mutations, outside the active site (secondary mutations), can increase resistance in the presence of major primary mutations like L10I/V, K20M/L/T, and I54V, as well as additional primary mutations such as M46I, and V82A/F/L/T 
[?F textMine:prep ?A, ?G textMine:prep ?D, ?D textMine:amod ?function, ?impact textMine:prep ?F, ?impact textMine:nsubj ?G, ?A textMine:nn ?mutation]
Added to queryTripless!! : ?F textMine:prep ?A. ?G textMine:prep ?D. ?D textMine:amod ?function. ?positive textMine:prep ?F. ?positive textMine:nsubj ?G. ?A textMine:nn ?mutation. 
300

356 (D) Transient re expression of KT3 tagged wild type PTP PEST cDNA, but not the C231S mutant, in PTP PEST knockdown cells suppresses enhanced tyrosine phosphorylation of p120 
[?A textMine:dep ?C, ?A textMine:dobj ?function, ?function textMine:amod ?impact, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?A textMine:dep ?C. ?A textMine:dobj ?function. ?function textMine:amod ?positive. ?C textMine:nn ?mutation. 
301

357 The T315I cells exhibit increased proliferation rate (Supporting Information Fig S8 ), elevated basal expressions of Rad51 and γ H2AX ( Fig 5A ) and display increased endogenous DNA damage response, indicated by increased Rad51 and γ H2AX foci ( Fig 5B and C ), when compared with parental cells 
[?C textMine:nn ?function, ?H textMine:ccomp ?F, ?H textMine:nsubj ?A, ?B textMine:amod ?impact, ?F textMine:prep ?B, ?F textMine:nsubj ?C, ?A textMine:nn ?mutation]
Added to queryTripless!! : ?C textMine:nn ?function. ?H textMine:ccomp ?F. ?H textMine:nsubj ?A. ?B textMine:amod ?positive. ?F textMine:prep ?B. ?F textMine:nsubj ?C. ?A textMine:nn ?mutation. 
302

358 Genetic variations that directly affect ATP sensitivity (I182V; ABCC8 ) do so by decreasing K ATP  channel affinity for ATP, which causes the K ATP  channel to remain open that translates to a reduction in insulin secretion 
[?A textMine:appos ?mutation, ?E textMine:prepc ?impact, ?E textMine:nsubj ?A, ?impact textMine:ccomp ?C, ?C textMine:advmod ?function]
Added to queryTripless!! : ?A textMine:appos ?mutation. ?E textMine:prepc ?negative. ?E textMine:nsubj ?A. ?negative textMine:ccomp ?C. ?C textMine:advmod ?function. 
303

359 In order to determine the effect of the FGFR2 S252W  mutation in periosteal cells, we first accessed whether the presence of the mutation altered the proliferation rates of S252W fibroblasts and S252W MSCs 
[?A textMine:nn ?mutation, ?impact textMine:dobj ?E, ?E textMine:prep ?A, ?E textMine:nn ?function]
Added to queryTripless!! : ?A textMine:nn ?mutation. ?unknown textMine:dobj ?E. ?E textMine:prep ?A. ?E textMine:nn ?function. 
304

360 These cases uniformly harbored a monoallelic  BRAF  V600E mutation, which associates with constitutive activation of ERK1/2 reported in HCL  [19] ,  [20]  
[?function textMine:amod ?impact, ?F textMine:rcmod ?D, ?F textMine:nn ?mutation, ?E textMine:prep ?function, ?D textMine:nsubj ?E]
Added to queryTripless!! : ?function textMine:amod ?positive. ?F textMine:rcmod ?D. ?F textMine:nn ?mutation. ?E textMine:prep ?function. ?D textMine:nsubj ?E. 
305

361 The cobas test showed a very high sensitivity (>99%) and specificity (88%) for the detection of the  BRAF  V600E mutation 
[?F textMine:prep ?E, ?F textMine:dobj ?function, ?E textMine:prep ?D, ?function textMine:amod ?impact, ?D textMine:nn ?mutation]
Query : [?F textMine:prep ?E, ?F textMine:dobj ?function, ?E textMine:prep ?D, ?function textMine:amod ?impact, ?D textMine:nn ?mutation]
Existing trips : 
?D textMine:dobj ?function. ?D textMine:prep ?E. ?E textMine:prep ?F. ?F textMine:nn ?mutation. ?function textMine:amod ?impact. 
Similar Query!!!!


362 We identified 25 fold increased expression of MMP 1 mRNA in melanoma cells possessing BRAF V600E  compared to wildtype while HPMs expressed similar transcript levels with BRAF wildtype melanoma cell ( Figure 2a ), suggesting that increased BRAF kinase activity may be associated with elevated MMP 1 expression in melanomas 
[?function textMine:amod ?impact, ?E textMine:dobj ?mutation, ?C textMine:nsubjpass ?D, ?C textMine:prep ?function, ?D textMine:partmod ?E]
Added to queryTripless!! : ?function textMine:amod ?positive. ?E textMine:dobj ?mutation. ?C textMine:nsubjpass ?D. ?C textMine:prep ?function. ?D textMine:partmod ?E. 
306

363 Immune complexes kinase assays showed, as expected, high BRAF activity in YULAC BRAF V600E  and YUMAC BRAF V600K  cells that was suppressed after treatment with PLX4032 for 30 min ( Figure 3A , YULAC and YUMAC) 
[?E textMine:nn ?mutation, ?function textMine:amod ?impact, ?D textMine:prep ?E, ?D textMine:prep ?function]
Query : [?E textMine:nn ?mutation, ?function textMine:amod ?impact, ?D textMine:prep ?E, ?D textMine:prep ?function]
Existing trips : 
?A textMine:prep ?B. ?A textMine:prep ?function. ?B textMine:nn ?mutation. ?function textMine:amod ?impact. 
Similar Query!!!!


364 We previously demonstrated a high degree of variability in the extent of GSK 3β Ser 9  phosphorylation among BRAF V600E  (+) melanoma cell lines and showed that GSK 3β activity in these cells was increased in response to the multikinase inhibitor sorafenib  , presumably through an ER stress dependent mechanism 
[?C textMine:prep ?A, ?E textMine:prep ?mutation, ?E textMine:amod ?function, ?G textMine:prep ?H, ?G textMine:amod ?impact, ?H textMine:amod ?C, ?A textMine:prep ?E]
Added to queryTripless!! : ?C textMine:prep ?A. ?E textMine:prep ?mutation. ?E textMine:amod ?function. ?G textMine:prep ?H. ?G textMine:amod ?positive. ?H textMine:amod ?C. ?A textMine:prep ?E. 
307

365 Studying how BRAF V600E  altered kinase activity in patients with PTC creates alterations in the already complex tumor cell–ECM interactions has been a logical next step for our laboratory 
[?A textMine:nsubj ?impact, ?A textMine:ccomp ?B, ?B textMine:dobj ?function, ?B textMine:nsubj ?mutation]
Added to queryTripless!! : ?A textMine:nsubj ?unknown. ?A textMine:ccomp ?B. ?B textMine:dobj ?function. ?B textMine:nsubj ?mutation. 
308

366 It was noted that PLX4720 also reduced pRB protein phosphorylation, increased p27 expression, suppressed cyclin D1 expression and induced cleavage of PARP only in melanoma cell lines harbouring the  BRAF  V600E mutation ( Figure 1D ) 
[?C textMine:nn ?mutation, ?impact textMine:ccomp ?E, ?A textMine:dobj ?C, ?F textMine:partmod ?A, ?E textMine:prep ?F, ?E textMine:nsubj ?function]
Added to queryTripless!! : ?C textMine:nn ?mutation. ?negative textMine:ccomp ?E. ?A textMine:dobj ?C. ?F textMine:partmod ?A. ?E textMine:prep ?F. ?E textMine:nsubj ?function. 
309

367 Previous studies demonstrated that expression of AKT1 E17K protein in NIH 3T3 cells increased AKT phosphorylation in those cells ( Carpten  et al , 2007 ) 
[?B textMine:prep ?A, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?A textMine:nn ?mutation]
Query : [?B textMine:prep ?A, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?A textMine:nn ?mutation]
Existing trips : 
?A textMine:prep ?B. ?B textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?A. 
Similar Query!!!!


368 These data suggest that BRAF V600E  can negatively regulate MST1 kinase through direct interaction with its C terminus 
[?function textMine:nsubj ?mutation, ?function textMine:advmod ?impact]
[?function textMine:advmod ?impact, ?function textMine:nsubj ?mutation, ]
Match 


369 In BRAF V600E  human melanoma xenograft BRAFi + MEKi showed enhanced antitumor activity, with more sustained tumor control than that seen either single agent 
[?A textMine:dobj ?function, ?A textMine:prep ?mutation, ?function textMine:amod ?impact]
Query : [?A textMine:dobj ?function, ?A textMine:prep ?mutation, ?function textMine:amod ?impact]
Existing trips : 
?B textMine:dobj ?function. ?B textMine:prep ?mutation. ?function textMine:amod ?impact. 
Similar Query!!!!


370 In summary, the BRAF V600E  inhibitor PLX4720 and the SRC inhibitor dasatinib synergize to inhibit proliferation, reduce cellular migration and induce apoptosis in a variety of BRAF V600E  positive PTC and ATC cell lines 
[?G textMine:conj ?F, ?G textMine:conj ?impact, ?D textMine:prep ?C, ?F textMine:prep ?D, ?impact textMine:dobj ?function, ?C textMine:amod ?mutation]
Added to queryTripless!! : ?G textMine:conj ?F. ?G textMine:conj ?negative. ?D textMine:prep ?C. ?F textMine:prep ?D. ?negative textMine:dobj ?function. ?C textMine:amod ?mutation. 
310

371 The JAK2 V617F mutation present in over 95% of Polycythemia Vera patients and in 50% of Essential Thrombocythemia and Primary Myelofibrosis patients renders the kinase constitutively active 
[?A textMine:nn ?mutation, ?C textMine:nsubj ?A, ?C textMine:xcomp ?function, ?function textMine:advmod ?impact]
Added to queryTripless!! : ?A textMine:nn ?mutation. ?C textMine:nsubj ?A. ?C textMine:xcomp ?function. ?function textMine:advmod ?positive. 
311

372 Hence, the double mutation L858R+E884K modulated basal and stimulated downstream EGFR signaling differentially with differential effects on the AKT (down regulated), CBL and MAPK ERK1/2 phosphorylation (up regulated) 
[?impact textMine:xcomp ?B, ?impact textMine:nsubj ?E, ?E textMine:nn ?mutation, ?B textMine:prep ?function]
Added to queryTripless!! : ?unknown textMine:xcomp ?B. ?unknown textMine:nsubj ?E. ?E textMine:nn ?mutation. ?B textMine:prep ?function. 
312

373 The mutational status of these two lines is particularly relevant to interpretation of the data, since BRAF in both A375 and LOX IMVI is constitutively activated by the V600E mutation  
[?C textMine:nn ?mutation, ?function textMine:agent ?C, ?function textMine:advmod ?impact]
Added to queryTripless!! : ?C textMine:nn ?mutation. ?function textMine:agent ?C. ?function textMine:advmod ?positive. 
313

374 These studies variably identified those patients who were JAK2 V617F positive to have a higher risk of thrombotic complications, a result that has been confirmed in a recent meta analysis 
[?C textMine:prep ?D, ?C textMine:amod ?impact, ?mutation textMine:amod ?A, ?G textMine:dobj ?C, ?D textMine:appos ?function, ?A textMine:xcomp ?G]
Added to queryTripless!! : ?C textMine:prep ?D. ?C textMine:amod ?positive. ?mutation textMine:amod ?A. ?G textMine:dobj ?C. ?D textMine:appos ?function. ?A textMine:xcomp ?G. 
314

375 However, when used in combination, NAC enhanced the inhibitory effect of PLX4032 (BRAF V600E inhibitor) and Gefitinib (EGFR inhibitor), on FO 1 and PT4 cell survival 
[?D textMine:appos ?C, ?C textMine:nn ?mutation, ?impact textMine:dobj ?function, ?function textMine:prep ?D]
Added to queryTripless!! : ?D textMine:appos ?C. ?C textMine:nn ?mutation. ?positive textMine:dobj ?function. ?function textMine:prep ?D. 
315

376 The D816V mutant destabilizes the inactivated form of Kit, in a way that the ability of the protein to adopt the "DFG out" (inactive) conformation is much reduced or even eliminated; thus, the mutation prevents both motesanib and imatinib from binding to the ATP pocket   
[?C textMine:dep ?impact, ?C textMine:dep ?B, ?B textMine:conj ?impact, ?B textMine:nsubjpass ?function, ?D textMine:prep ?C, ?D textMine:nsubj ?A, ?A textMine:nn ?mutation, ?impact textMine:nsubjpass ?function]
Added to queryTripless!! : ?C textMine:dep ?negative. ?C textMine:dep ?B. ?B textMine:conj ?negative. ?B textMine:nsubjpass ?function. ?D textMine:prep ?C. ?D textMine:nsubj ?A. ?A textMine:nn ?mutation. ?negative textMine:nsubjpass ?function. 
316

377 The data demonstrated that while E cadherin was well expressed in normal thyroid tissue, its expression was markedly decreased and vimentin expression up regulated in the thyroid carcinomas from the transgenic mice over expressing BRAF V600E  ( 25 ) 
[?impact textMine:conj ?C, ?D textMine:prepc ?function, ?C textMine:prep ?D, ?function textMine:dobj ?mutation]
Added to queryTripless!! : ?negative textMine:conj ?C. ?D textMine:prepc ?function. ?C textMine:prep ?D. ?function textMine:dobj ?mutation. 
317

378 In case of occurrence of both L858R and T790M mutations, the concentration of erlotinib should be three times higher in order to achieve a therapeutic effect 
[?B textMine:dobj ?function, ?C textMine:nn ?mutation, ?E textMine:prep ?C, ?impact textMine:ccomp ?B, ?impact textMine:prep ?E]
Added to queryTripless!! : ?B textMine:dobj ?function. ?C textMine:nn ?mutation. ?E textMine:prep ?C. ?positive textMine:ccomp ?B. ?positive textMine:prep ?E. 
318

379 The T790M EGFR mutant has increased affinity for ATP, which is the primary mechanism responsible for the development of resistance to small molecule tyrosine kinase inhibitors (TKIs), such as gefitinib and erlotinib  [36]  
[?impact textMine:advmod ?function, ?impact textMine:nsubj ?C, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?positive textMine:advmod ?function. ?positive textMine:nsubj ?C. ?C textMine:nn ?mutation. 
319

380 The V617F mutation disrupts the inhibitory activity of the JAK2 pseudokinase domain, leading to constitutive JAK2 kinase activity and hyperactivation of multiple downstream targets ( James et al, 2005 ) 
[?G textMine:partmod ?F, ?A textMine:nn ?mutation, ?impact textMine:dobj ?G, ?impact textMine:nsubj ?A, ?E textMine:dobj ?function, ?F textMine:xcomp ?E]
Added to queryTripless!! : ?G textMine:partmod ?F. ?A textMine:nn ?mutation. ?negative textMine:dobj ?G. ?negative textMine:nsubj ?A. ?E textMine:dobj ?function. ?F textMine:xcomp ?E. 
320

381 It may be that there is preferential MAPK pathway addiction in sensitive cell lines, and cells with lower sensitivity are less dependent on the  BRAF  V600E  oncogenic signaling, relying on the co activation of other signaling pathways including the PI3K/Akt pathway 
[?D textMine:nn ?mutation, ?E textMine:prep ?D, ?E textMine:nsubj ?B, ?B textMine:prep ?function, ?function textMine:amod ?impact]
Added to queryTripless!! : ?D textMine:nn ?mutation. ?E textMine:prep ?D. ?E textMine:nsubj ?B. ?B textMine:prep ?function. ?function textMine:amod ?negative. 
321

382 MST1 expression significantly increased apoptosis, which is reduced by expression of BRAF V600E  
[?E textMine:agent ?B, ?B textMine:prep ?mutation, ?function textMine:rcmod ?E, ?impact textMine:nsubj ?function]
Added to queryTripless!! : ?E textMine:agent ?B. ?B textMine:prep ?mutation. ?function textMine:rcmod ?E. ?positive textMine:nsubj ?function. 
322

383 Conversely, E884K worked in concert with L858R in  cis  to further enhance the sensitivity of the mutant receptor to gefitinib inhibition ( Fig 1A, B ) 
[?impact textMine:prep ?function, ?impact textMine:xsubj ?mutation]
[?impact textMine:prep ?function, ?impact textMine:xsubj ?mutation, ]
Match 


384 Two sensitive transfectants (harboring a  FLT3  D835V or  KIT  D816Y mutation) were immunoblotted – and showed higher elevated threonine 308 phosphorylation levels compared to  FLT3  ITD or  BCR ABL1  transfected cells 
[?G textMine:nn ?function, ?G textMine:amod ?impact, ?C textMine:dep ?F, ?B textMine:dobj ?G, ?B textMine:nsubjpass ?C, ?F textMine:dobj ?mutation]
Added to queryTripless!! : ?G textMine:nn ?function. ?G textMine:amod ?positive. ?C textMine:dep ?F. ?B textMine:dobj ?G. ?B textMine:nsubjpass ?C. ?F textMine:dobj ?mutation. 
323

385 The mutations G250E, Y253H and T315I experience decreased vdW interactions with Phe359 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ?C textMine:amod ?E, ?E textMine:dep ?mutation]
Query : [?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ?C textMine:amod ?E, ?E textMine:dep ?mutation]
Existing trips : 
?B textMine:amod ?E. ?E textMine:dep ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?B. 
Similar Query!!!!


386 These are autoinhibitory phosphorylation sites, and the V617F mutation has been proposed to promote Jak2 activation in part by abrogating pseudokinase catalytic activity and therefore phosphorylation of these sites  15 , 20   
[?B textMine:nn ?mutation, ?A textMine:prepc ?impact, ?A textMine:xsubj ?B, ?impact textMine:dobj ?function]
Added to queryTripless!! : ?B textMine:nn ?mutation. ?A textMine:prepc ?negative. ?A textMine:xsubj ?B. ?negative textMine:dobj ?function. 
324

387 Moreover, E884K had a dominant effect over L858R, when in  cis , in these signaling modulatory effects 
[?D textMine:prep ?function, ?D textMine:dobj ?C, ?D textMine:nsubj ?mutation, ?C textMine:amod ?impact]
Added to queryTripless!! : ?D textMine:prep ?function. ?D textMine:dobj ?C. ?D textMine:nsubj ?mutation. ?C textMine:amod ?positive. 
325

388 The EphA3 G518L mutation found in lung cancer increases the affinity of the lateral interaction between EphA3 and ephrin A3 
[?D textMine:prep ?function, ?impact textMine:dobj ?D, ?impact textMine:nsubj ?A, ?A textMine:nn ?mutation]
Added to queryTripless!! : ?D textMine:prep ?function. ?positive textMine:dobj ?D. ?positive textMine:nsubj ?A. ?A textMine:nn ?mutation. 
326

389 Most recently, MITF dependent BCL2A1 was identified as an oncogene restricted to melanoma  versus  normal tissues, and the co treatment of  V600E BRAF melanomas with BRAF inhibitors and obatoclax, an inhibitor of BCL2A1, reduced the resistance to BRAF inhibitors in  BCL2A1  amplified melanoma cells  in vitro  and  in vivo  [55]  
[?B textMine:nsubj ?E, ?D textMine:nn ?mutation, ?impact textMine:dobj ?function, ?A textMine:conj ?impact, ?A textMine:conj ?B, ?E textMine:prep ?D]
Added to queryTripless!! : ?B textMine:nsubj ?E. ?D textMine:nn ?mutation. ?negative textMine:dobj ?function. ?A textMine:conj ?negative. ?A textMine:conj ?B. ?E textMine:prep ?D. 
327

390 Surprisingly we found that, expression of each activated KRAS ED  lead to a substantial decrease in Braf V600E  induced tumors relative to the EGFP control suggesting the existence of a KRAS activated negative regulator of tumorigenesis 
[?G textMine:advmod ?D, ?mutation textMine:partmod ?G, ?E textMine:partmod ?H, ?H textMine:dobj ?A, ?D textMine:prep ?E, ?function textMine:amod ?impact, ?A textMine:prep ?function]
Added to queryTripless!! : ?G textMine:advmod ?D. ?mutation textMine:partmod ?G. ?E textMine:partmod ?H. ?H textMine:dobj ?A. ?D textMine:prep ?E. ?function textMine:amod ?negative. ?A textMine:prep ?function. 
328

391 PDGFRA  exon 18 mutations (D842V), which affect the activation loop of the PDGFRα kinase, are biochemically less sensitive to imatinib than the more common KIT exon 11 mutations 
[?function textMine:advmod ?impact, ?function textMine:nsubj ?D, ?D textMine:appos ?mutation]
Added to queryTripless!! : ?function textMine:advmod ?negative. ?function textMine:nsubj ?D. ?D textMine:appos ?mutation. 
329

392 The results showed increased phosphorylation of Erk1/2 and p38 in  Fgfr2 +/S252W   mice BMSCs, which indicated that Erk1/2 and p38 signaling may participate in the regulation of endochondral bone formation by FGFR2 
[?G textMine:prep ?D, ?G textMine:amod ?impact, ?A textMine:prep ?function, ?D textMine:rcmod ?C, ?D textMine:nn ?mutation, ?C textMine:ccomp ?A]
Added to queryTripless!! : ?G textMine:prep ?D. ?G textMine:amod ?positive. ?A textMine:prep ?function. ?D textMine:rcmod ?C. ?D textMine:nn ?mutation. ?C textMine:ccomp ?A. 
330

393 This V600E BRAF variant possesses a markedly higher dimerization property irrespective of RAS status and strongly activates MEK and ERK1/2 in the presence of vemurafenib 
[?A textMine:dobj ?D, ?A textMine:nsubj ?E, ?E textMine:nn ?mutation, ?D textMine:nn ?function, ?D textMine:amod ?impact]
Added to queryTripless!! : ?A textMine:dobj ?D. ?A textMine:nsubj ?E. ?E textMine:nn ?mutation. ?D textMine:nn ?function. ?D textMine:amod ?positive. 
331

394 This mutation ( E17K ) increases recruitment of AKT1 to the membrane, increases AKT1 phosphorylation and activity, transforms Rat1 fibroblasts, and induces leukaemia in transgenic mice ( Carpten  et al , 2007 ) 
[?A textMine:appos ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?A]
[?A textMine:appos ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?A, ]
Match 


395 (A, B and C) pro apoptotic genes  BAX, BIK  and  BAD  showed lower expression in ET JAK2 V617F positive patients compared to negative patients; (D, E and F)  BAX, BIK  and  BAD  expression in ET leukocytes also negatively correlated with the patients' JAK2 V617F allele burden 
[?D textMine:dobj ?E, ?D textMine:nsubj ?A, ?D textMine:parataxis ?function, ?A textMine:num ?mutation, ?E textMine:amod ?impact]
Added to queryTripless!! : ?D textMine:dobj ?E. ?D textMine:nsubj ?A. ?D textMine:parataxis ?function. ?A textMine:num ?mutation. ?E textMine:amod ?negative. 
332

396 Although B RAF appears to be a plausible target in N RAS mutated melanoma, preclinical studies have consistently shown that selective B RAF V600E  inhibitors can actually stimulate cell growth and have detrimental effects in N RAS mutated melanoma   
[?B textMine:nn ?mutation, ?C textMine:dobj ?function, ?C textMine:nsubj ?B, ?function textMine:amod ?impact]
Query : [?B textMine:nn ?mutation, ?C textMine:dobj ?function, ?C textMine:nsubj ?B, ?function textMine:amod ?impact]
Existing trips : 
?C textMine:nn ?mutation. ?E textMine:dobj ?function. ?E textMine:nsubj ?C. ?function textMine:amod ?impact. 
Similar Query!!!!


397 These results suggest that acquired resistance to adjuvant imatinib was infrequent, especially since both arms included patients with mutations known to be less sensitive or resistant to imatinib (e g, platelet derived growth factor receptor alpha [PDGFRA] D842V)   
[?function textMine:advmod ?impact, ?function textMine:dep ?D, ?D textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:advmod ?negative. ?function textMine:dep ?D. ?D textMine:nn ?mutation. 
333

398 The other possibility is that the presence of the EGFR T790M mutation could increase the affinity of the EGFR L858R for ATP and thus reduce the potency of an ATP competitive kinase inhibitor   
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?A, ?A textMine:prep ?E, ?E textMine:nn ?mutation]
Query : [?impact textMine:dobj ?function, ?impact textMine:nsubj ?A, ?A textMine:prep ?E, ?E textMine:nn ?mutation]
Existing trips : 
?A textMine:prep ?B. ?B textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?A. 
Similar Query!!!!


399 Furthermore, high levels of CXCR4 expression were found in  BRAF  V600E  positive PTCs, and CXCR4 expression was associated with thyroid capsule infiltration and extrathyroidal extension (Torregrossa et al,  2011 ) 
[?A textMine:conj ?B, ?A textMine:prep ?C, ?A textMine:nsubjpass ?F, ?F textMine:amod ?impact, ?C textMine:nn ?mutation, ?B textMine:nsubjpass ?function]
Added to queryTripless!! : ?A textMine:conj ?B. ?A textMine:prep ?C. ?A textMine:nsubjpass ?F. ?F textMine:amod ?positive. ?C textMine:nn ?mutation. ?B textMine:nsubjpass ?function. 
334

400 On the contrary, when F595 was replaced by an aromatic residue (Tyr or Trp) in the context of V617F, the constitutive activity was maintained 
[?F textMine:prep ?A, ?A textMine:prep ?mutation, ?B textMine:agent ?F, ?impact textMine:nsubjpass ?function, ?impact textMine:advcl ?B]
Added to queryTripless!! : ?F textMine:prep ?A. ?A textMine:prep ?mutation. ?B textMine:agent ?F. ?neutral textMine:nsubjpass ?function. ?neutral textMine:advcl ?B. 
335

401 (A)  L858R mutation in EGFR kinase (the circled R) causes non small cell lung cancer (NSCLC) by constitutively activating its kinase domain [ 175 ] 
[?A textMine:nsubj ?B, ?B textMine:amod ?mutation, ?E textMine:prepc ?function, ?E textMine:dep ?A, ?function textMine:advmod ?impact]
Added to queryTripless!! : ?A textMine:nsubj ?B. ?B textMine:amod ?mutation. ?E textMine:prepc ?function. ?E textMine:dep ?A. ?function textMine:advmod ?positive. 
336

402 The two major classes of EGFR  mutations are an L858R point mutation and small, in frame deletions in exon 19; both types of mutation enhance the activity and oncogenicity of EGFR compared to the wild type protein   
[?impact textMine:dobj ?function, ?B textMine:parataxis ?impact, ?B textMine:amod ?mutation]
Added to queryTripless!! : ?positive textMine:dobj ?function. ?B textMine:parataxis ?positive. ?B textMine:amod ?mutation. 
337

403 However, an active form of  β  catenin increases the penetrance and incidence of melanoma in mice expressing oncogenic NRAS Q61K  or BRAF V600E  specifically in melanocytes [ 131 ,  216 ] 
[?impact textMine:dobj ?G, ?impact textMine:nsubj ?A, ?D textMine:prep ?E, ?E textMine:partmod ?C, ?A textMine:amod ?function, ?G textMine:prep ?D, ?C textMine:dobj ?mutation]
Added to queryTripless!! : ?positive textMine:dobj ?G. ?positive textMine:nsubj ?A. ?D textMine:prep ?E. ?E textMine:partmod ?C. ?A textMine:amod ?function. ?G textMine:prep ?D. ?C textMine:dobj ?mutation. 
338

404 In comparison to the S252W mutation that enhances signaling with a limited subset of Fgfs, the P253R mutation enhances signaling with many Fgfs and one hypothesis is that the P253R mutation may respond to many more signals that can have overlapping, redundant, and/or counteracting effects, resulting in a more moderate increase of MI 
[?F textMine:dobj ?function, ?K textMine:prep ?C, ?A textMine:dobj ?B, ?impact textMine:ccomp ?G, ?impact textMine:prep ?E, ?C textMine:rcmod ?A, ?E textMine:prep ?I, ?B textMine:dep ?F, ?G textMine:ccomp ?K, ?I textMine:amod ?mutation]
Added to queryTripless!! : ?F textMine:dobj ?function. ?K textMine:prep ?C. ?A textMine:dobj ?B. ?positive textMine:ccomp ?G. ?positive textMine:prep ?E. ?C textMine:rcmod ?A. ?E textMine:prep ?I. ?B textMine:dep ?F. ?G textMine:ccomp ?K. ?I textMine:amod ?mutation. 
339

405 As expected  , single agent vemurafenib induced significant levels of apoptosis in all the BRAF V600E  mutant cell lines that are sensitive to this agent, with a much less effect in the resistant ones (Figure  3b ) 
[?C textMine:prep ?E, ?C textMine:rcmod ?D, ?F textMine:nn ?mutation, ?D textMine:prep ?function, ?E textMine:prep ?F, ?function textMine:amod ?impact]
Added to queryTripless!! : ?C textMine:prep ?E. ?C textMine:rcmod ?D. ?F textMine:nn ?mutation. ?D textMine:prep ?function. ?E textMine:prep ?F. ?function textMine:amod ?negative. 
340

406 Hence, the double mutation L858R+E884K modulated basal and stimulated downstream EGFR signaling differentially with differential effects on the AKT (down regulated), CBL and MAPK ERK1/2 phosphorylation (up regulated) 
[?A textMine:appos ?function, ?impact textMine:xcomp ?B, ?impact textMine:nsubj ?mutation, ?B textMine:prep ?A]
Added to queryTripless!! : ?A textMine:appos ?function. ?unknown textMine:xcomp ?B. ?unknown textMine:nsubj ?mutation. ?B textMine:prep ?A. 
341

407 The high potency of afatinib to inhibit the tyrosine kinase activity of wild type EGFR was fully maintained on EGFR with the activating L858R mutation (Solca et al  ; Sos et al ) 
[?E textMine:infmod ?function, ?impact textMine:prep ?C, ?impact textMine:nsubjpass ?D, ?D textMine:prep ?E, ?C textMine:amod ?mutation]
Added to queryTripless!! : ?E textMine:infmod ?function. ?neutral textMine:prep ?C. ?neutral textMine:nsubjpass ?D. ?D textMine:prep ?E. ?C textMine:amod ?mutation. 
342

408 Furthermore, in wild type cells, overexpression of BRAF V600E  increased NFAT activity, which was blocked by the MEK inhibitor PD98059 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?A, ?A textMine:prep ?mutation]
Added to queryTripless!! : ?positive textMine:dobj ?function. ?positive textMine:nsubj ?A. ?A textMine:prep ?mutation. 
343

409 Actually, our  in vitro  kinase assay clearly showed that MST1 kinase activity on histone H2B was markedly decreased by BRAF V600E  
[?impact textMine:prep ?mutation, ?impact textMine:nsubj ?function]
Added to queryTripless!! : ?negative textMine:prep ?mutation. ?negative textMine:nsubj ?function. 
344

410 Based on these results, and on a molecular model of FGFR3 TM domain created with the program CHI , it has been proposed that the G380R mutation introduces a structural change in the unliganded FGFR3 dimers, thus altering their phosphorylation efficiencies and ultimately increasing FGFR3 phosphorylation in the absence of ligand 
[?E textMine:dep ?D, ?E textMine:nsubj ?B, ?E textMine:dep ?impact, ?impact textMine:conj ?D, ?B textMine:nn ?mutation, ?D textMine:dobj ?function]
Added to queryTripless!! : ?E textMine:dep ?D. ?E textMine:nsubj ?B. ?E textMine:dep ?unknown. ?unknown textMine:conj ?D. ?B textMine:nn ?mutation. ?D textMine:dobj ?function. 
345

411 The role of  BRAF  and  KRAS  oncogenes in altering cytoskeletal properties was further emphasized following depletion of BRAF V600E  by shRNA in HT29 cells, where migration ability of HT ShBR3 cells, with downregulated expression of mt BRAF  gene, was significantly impaired as compared to the empty vector control HT ps cells 
[?A textMine:prep ?D, ?mutation textMine:prep ?A, ?D textMine:rcmod ?impact, ?impact textMine:prep ?function]
Added to queryTripless!! : ?A textMine:prep ?D. ?mutation textMine:prep ?A. ?D textMine:rcmod ?negative. ?negative textMine:prep ?function. 
346

412 In agreement with the effects on EGFR phosphorylation and AKT/ERK signaling, cells expressing the T790M form of L858R EGFR had less apoptosis when exposed to dasatinib ( Figure 5C ) 
[?E textMine:partmod ?A, ?A textMine:dobj ?C, ?C textMine:amod ?mutation, ?function textMine:amod ?impact, ?D textMine:dobj ?function, ?D textMine:nsubj ?E]
Added to queryTripless!! : ?E textMine:partmod ?A. ?A textMine:dobj ?C. ?C textMine:amod ?mutation. ?function textMine:amod ?negative. ?D textMine:dobj ?function. ?D textMine:nsubj ?E. 
347

475 Solid double headed arrow placed near the R683G mutation suggests increased flexibility induced by this JH2 hinge mutant 
[?G textMine:nn ?mutation, ?E textMine:dobj ?C, ?E textMine:nsubj ?D, ?C textMine:partmod ?function, ?C textMine:amod ?impact, ?D textMine:partmod ?B, ?B textMine:prep ?G]
Added to queryTripless!! : ?G textMine:nn ?mutation. ?E textMine:dobj ?C. ?E textMine:nsubj ?D. ?C textMine:partmod ?function. ?C textMine:amod ?positive. ?D textMine:partmod ?B. ?B textMine:prep ?G. 
348

413 9   Preclinical studies have shown superior activity of afatinib over first generation TKIs, mainly due to (1) irreversible binding, which confers stronger binding affinity and potency, (2) ability to circumvent first generation TKI resistance mechanism T790M mutation in exon 20, and (3) effectiveness against multiple HER endothelial growth factor receptors   10  
[?A textMine:dobj ?D, ?A textMine:dep ?G, ?C textMine:amod ?impact, ?E textMine:rcmod ?H, ?H textMine:dobj ?C, ?D textMine:nn ?mutation, ?D textMine:nn ?function, ?G textMine:prep ?E]
Added to queryTripless!! : ?A textMine:dobj ?D. ?A textMine:dep ?G. ?C textMine:amod ?positive. ?E textMine:rcmod ?H. ?H textMine:dobj ?C. ?D textMine:nn ?mutation. ?D textMine:nn ?function. ?G textMine:prep ?E. 
349

414 However, imatinib is less effective against the D816V KIT mutation in vitro    and in the clinic   
[?function textMine:prep ?C, ?function textMine:advmod ?impact, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:prep ?C. ?function textMine:advmod ?negative. ?C textMine:nn ?mutation. 
350

415 Regarding the interference with the ERK signaling, cell lines with BRAF V600D/R  mutations presented a faster and stronger inhibition of phosphorylated ERK as compared to control cells with a wild type  BRAF  (Figure  1 C) 
[?C textMine:nsubj ?function, ?C textMine:prep ?E, ?function textMine:amod ?impact, ?E textMine:prep ?D, ?B textMine:prep ?A, ?A textMine:nn ?mutation, ?D textMine:appos ?B]
[?A textMine:nn ?mutation, ?B textMine:prep ?A, ?C textMine:nsubj ?function, ?C textMine:prep ?E, ?D textMine:appos ?B, ?E textMine:prep ?D, ?function textMine:amod ?impact, ]
Match 


416 Our lab previously demonstrated that the inhibition of oncogenic BRAF results in dramatic tumor reduction in a model of human ATC and several other groups have shown that dasatinib treatment effectively reduces tumor growth in mice implanted with human BRAF V600E  positive thyroid cancer cells [ 6 ,  8 ,  23 ,  31 ] 
[?E textMine:partmod ?B, ?B textMine:prep ?F, ?F textMine:nn ?mutation, ?impact textMine:prep ?E, ?impact textMine:advmod ?function]
Added to queryTripless!! : ?E textMine:partmod ?B. ?B textMine:prep ?F. ?F textMine:nn ?mutation. ?negative textMine:prep ?E. ?negative textMine:advmod ?function. 
351

417 The BRAF  mutations found in CFC can confer either weakly elevated kinase activity (mutations of Q257R, S467A, L485F, K499E) or impaired kinase activity versus wild type  BRAF  (E501G and G596V)     
[?E textMine:dep ?D, ?D textMine:nn ?mutation, ?F textMine:conj ?function, ?F textMine:appos ?E, ?F textMine:amod ?impact]
Added to queryTripless!! : ?E textMine:dep ?D. ?D textMine:nn ?mutation. ?F textMine:conj ?function. ?F textMine:appos ?E. ?F textMine:amod ?positive. 
352

418 Sumimoto et al ( 15 ) have shown that BRAF V600E  knock down decreased phospho ERK1/2 protein levels and inhibited invasion of melanoma cells accompanied by a decrease of matrix metalloproteinase activity and ITGβ1 expression 
[?D textMine:partmod ?A, ?C textMine:prep ?D, ?A textMine:agent ?impact, ?F textMine:dobj ?C, ?F textMine:nsubj ?mutation, ?impact textMine:prep ?function]
Query : [?D textMine:partmod ?A, ?C textMine:prep ?D, ?A textMine:agent ?impact, ?F textMine:dobj ?C, ?F textMine:nsubj ?mutation, ?impact textMine:prep ?function]
Existing trips : 
?A textMine:agent ?impact. ?D textMine:prep ?E. ?E textMine:partmod ?A. ?F textMine:dobj ?D. ?F textMine:nsubj ?mutation. ?impact textMine:prep ?function. 
Similar Query!!!!


419 9   Preclinical studies have shown superior activity of afatinib over first generation TKIs, mainly due to (1) irreversible binding, which confers stronger binding affinity and potency, (2) ability to circumvent first generation TKI resistance mechanism T790M mutation in exon 20, and (3) effectiveness against multiple HER endothelial growth factor receptors   10  
[?A textMine:dobj ?E, ?A textMine:dep ?H, ?D textMine:amod ?function, ?D textMine:amod ?impact, ?F textMine:rcmod ?I, ?I textMine:dobj ?D, ?E textMine:nn ?mutation, ?H textMine:prep ?F]
Added to queryTripless!! : ?A textMine:dobj ?E. ?A textMine:dep ?H. ?D textMine:amod ?function. ?D textMine:amod ?positive. ?F textMine:rcmod ?I. ?I textMine:dobj ?D. ?E textMine:nn ?mutation. ?H textMine:prep ?F. 
353

420 Results:  There was decreased expression of thyroid specific genes such as Tg and NIS and increased expression of stemness markers, such as Oct4, Rex1, CD15, and Sox2 in the thyroid carcinoma tissue from 6 week old BRAF V600E  mice indicating the dedifferentiated status of the cells and the fact that stemness was derived in this model from differentiated thyroid cells 
[?A textMine:prep ?E, ?E textMine:nn ?mutation, ?impact textMine:prep ?A, ?impact textMine:nsubjpass ?C, ?C textMine:prep ?function]
Added to queryTripless!! : ?A textMine:prep ?E. ?E textMine:nn ?mutation. ?negative textMine:prep ?A. ?negative textMine:nsubjpass ?C. ?C textMine:prep ?function. 
354

421 On the other hand, YFP EGFR ICD proteins bearing the uncommon exon 21 mutation P848L and A859T showed markedly lower autophosphorylation levels than YFP EGFR ICD L858R (Figure  4C ) 
[?F textMine:nn ?function, ?F textMine:amod ?impact, ?D textMine:dobj ?F, ?D textMine:nsubj ?E, ?E textMine:partmod ?A, ?A textMine:dobj ?mutation]
Added to queryTripless!! : ?F textMine:nn ?function. ?F textMine:amod ?negative. ?D textMine:dobj ?F. ?D textMine:nsubj ?E. ?E textMine:partmod ?A. ?A textMine:dobj ?mutation. 
355

422 PACSIN1 shows significantly increased phosphorylation when co transfected with the P52L mutant compared to the wild type PAK6 (* indicates p<005; ** indicates p<0 01;
[?impact textMine:advcl ?A, ?impact textMine:dobj ?function, ?C textMine:nn ?mutation, ?E textMine:partmod ?B, ?A textMine:nsubj ?E, ?B textMine:prep ?C]
Added to queryTripless!! : ?positive textMine:advcl ?A. ?positive textMine:dobj ?function. ?C textMine:nn ?mutation. ?E textMine:partmod ?B. ?A textMine:nsubj ?E. ?B textMine:prep ?C. 
356

423 Our results reveal that SIRT1 activity is higher in PLX4032 resistant BRAF V600E  mutated melanoma cells compared with their sensitive counterpart 
[?mutation textMine:partmod ?E, ?E textMine:pobj ?D, ?impact textMine:prep ?mutation, ?D textMine:amod ?function]
Added to queryTripless!! : ?mutation textMine:partmod ?E. ?E textMine:pobj ?D. ?positive textMine:prep ?mutation. ?D textMine:amod ?function. 
357

424 It is also possible that binding of the drug to one p61B RAF V600E  monomer inhibits drug binding to the other, resulting in one active monomer per dimer and abolishing drug resistance 
[?G textMine:ccomp ?impact, ?G textMine:nsubj ?C, ?D textMine:prep ?A, ?A textMine:nn ?mutation, ?impact textMine:dobj ?function, ?C textMine:prep ?D]
Added to queryTripless!! : ?G textMine:ccomp ?negative. ?G textMine:nsubj ?C. ?D textMine:prep ?A. ?A textMine:nn ?mutation. ?negative textMine:dobj ?function. ?C textMine:prep ?D. 
358

425 As a whole, these findings show that SkE also exhibited high activity against the B Raf V600E mutation 
[?B textMine:prep ?A, ?B textMine:dobj ?function, ?A textMine:nn ?mutation, ?function textMine:amod ?impact]
Added to queryTripless!! : ?B textMine:prep ?A. ?B textMine:dobj ?function. ?A textMine:nn ?mutation. ?function textMine:amod ?positive. 
359

426 Moreover, PHA 739358 reportedly has a higher affinity for the T315I form (5 nM) than the Abl wild type (21 nM)  , which may prove advantageous for clinical treatment 
[?C textMine:amod ?mutation, ?function textMine:prep ?C, ?function textMine:amod ?impact]
Added to queryTripless!! : ?C textMine:amod ?mutation. ?function textMine:prep ?C. ?function textMine:amod ?positive. 
360

427 This stepwise enhancement of PtdIns binding is confirmed by the estimated free energies of binding predicted by AutoDock, which suggest that docking to the E416A mutant (open) PH domain is more favorable than docking to the wild type (open), which in turn is an improvement over the wild type (closed) PH domain 
[?I textMine:nn ?mutation, ?K textMine:csubj ?J, ?K textMine:nsubj ?C, ?J textMine:prep ?G, ?H textMine:prep ?function, ?E textMine:prep ?C, ?E textMine:dep ?F, ?G textMine:nn ?I, ?F textMine:agent ?H, ?F textMine:nsubjpass ?impact]
Added to queryTripless!! : ?I textMine:nn ?mutation. ?K textMine:csubj ?J. ?K textMine:nsubj ?C. ?J textMine:prep ?G. ?H textMine:prep ?function. ?E textMine:prep ?C. ?E textMine:dep ?F. ?G textMine:nn ?I. ?F textMine:agent ?H. ?F textMine:nsubjpass ?positive. 
361

428 The calculated free energies correlate with experimentally measured IC50 values and comparably ponatinib has better binding towards the mutation T315A (−10 44 kcal/mol) than T315I (−1035 kcal/mol) 
[?function textMine:advmod ?impact]
Added to queryTripless!! : ?function textMine:advmod ?positive. 
362

429 It is certainly possible that our  BRAF   V600E   mutant cutaneous melanoma panel is skewed for cell lines with natural resistance to inhibition of the MAPK pathway, since we have previously reported a similar greater than expected frequency of cutaneous cell lines resistant to the type I BRAF inhibitor vemurafenib   
[?C textMine:amod ?function, ?E textMine:nn ?mutation, ?F textMine:amod ?impact, ?D textMine:prep ?C, ?H textMine:dobj ?F, ?impact textMine:prep ?D, ?I textMine:advcl ?H, ?I textMine:nsubj ?E]
Added to queryTripless!! : ?C textMine:amod ?function. ?E textMine:nn ?mutation. ?F textMine:amod ?positive. ?D textMine:prep ?C. ?H textMine:dobj ?F. ?positive textMine:prep ?D. ?I textMine:advcl ?H. ?I textMine:nsubj ?E. 
363

430 Furthermore, from a gefitinib resistant patient carrying the activating L858R mutation, we identified a novel secondary resistant mutation, L747S in cis to the activating mutation, which attenuated the up regulation of BIM and reduced apoptosis 
[?E textMine:appos ?mutation, ?A textMine:rcmod ?impact, ?A textMine:amod ?function, ?F textMine:prep ?A, ?F textMine:dobj ?E]
Added to queryTripless!! : ?E textMine:appos ?mutation. ?A textMine:rcmod ?negative. ?A textMine:amod ?function. ?F textMine:prep ?A. ?F textMine:dobj ?E. 
364

431 Notably, melanomas that have the V600E  BRAF  mutation exhibit increased HIF 1α expression 
[?F textMine:dobj ?D, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:rcmod ?F, ?D textMine:nn ?mutation]
Added to queryTripless!! : ?F textMine:dobj ?D. ?positive textMine:dobj ?function. ?positive textMine:nsubj ?B. ?B textMine:rcmod ?F. ?D textMine:nn ?mutation. 
365

432 We find that PACSIN1 shows significantly increased phosphorylation when co transfected with the P52L mutant compared to the wild type PAK6 (  Fig 2F and G  ), suggesting that the melanoma associated mutation indeed functions to increase kinase activity 
[?E textMine:xcomp ?impact, ?D textMine:prep ?F, ?B textMine:ccomp ?E, ?H textMine:partmod ?B, ?H textMine:dobj ?function, ?F textMine:nn ?mutation, ?function textMine:rcmod ?D]
Added to queryTripless!! : ?E textMine:xcomp ?positive. ?D textMine:prep ?F. ?B textMine:ccomp ?E. ?H textMine:partmod ?B. ?H textMine:dobj ?function. ?F textMine:nn ?mutation. ?function textMine:rcmod ?D. 
366

433 NSCLCs harboring a small insertion or duplication in exon 20 observed in ~5% of NSCLCs are less sensitive to EGFR TKIs compared to the exon 19 deletion mutants and L858R mutants in vitro  , as well as in patients   
[?C textMine:pobj ?D, ?function textMine:prep ?C, ?function textMine:advmod ?impact, ?D textMine:num ?mutation]
Added to queryTripless!! : ?C textMine:pobj ?D. ?function textMine:prep ?C. ?function textMine:advmod ?negative. ?D textMine:num ?mutation. 
367

434 Although the frequency of HGF expression among cases of acquired resistance is unclear because of scarcity of reports, the frequency of coexistence of HGF expression with T790M mutations could possibly be high   
[?E textMine:prep ?H, ?B textMine:prep ?G, ?F textMine:nsubj ?D, ?D textMine:prep ?E, ?J textMine:num ?mutation, ?impact textMine:nsubj ?K, ?impact textMine:advcl ?F, ?G textMine:prep ?J, ?H textMine:prep ?function, ?K textMine:prep ?B]
Added to queryTripless!! : ?E textMine:prep ?H. ?B textMine:prep ?G. ?F textMine:nsubj ?D. ?D textMine:prep ?E. ?J textMine:num ?mutation. ?positive textMine:nsubj ?K. ?positive textMine:advcl ?F. ?G textMine:prep ?J. ?H textMine:prep ?function. ?K textMine:prep ?B. 
368

435 Furthermore, from a gefitinib resistant patient carrying the activating L858R mutation, we identified a novel secondary resistant mutation, L747S in cis to the activating mutation, which attenuated the up regulation of BIM and reduced apoptosis 
[?D textMine:appos ?mutation, ?A textMine:rcmod ?impact, ?G textMine:prep ?A, ?G textMine:dobj ?D, ?impact textMine:dobj ?E, ?E textMine:prep ?function]
Added to queryTripless!! : ?D textMine:appos ?mutation. ?A textMine:rcmod ?negative. ?G textMine:prep ?A. ?G textMine:dobj ?D. ?negative textMine:dobj ?E. ?E textMine:prep ?function. 
369

436 Immuno precipitation data showed that curcumin induced EGFR protein degradation by accelerating ubiquitin proteasome ability in wide type EGFR (CL1 5 and A549) and also in the mutated EGFR with T790M (H1975) 
[?function textMine:dobj ?impact, ?function textMine:conj ?B, ?B textMine:prep ?A, ?A textMine:prep ?mutation]
Added to queryTripless!! : ?function textMine:dobj ?negative. ?function textMine:conj ?B. ?B textMine:prep ?A. ?A textMine:prep ?mutation. 
370

437 In comparison to the S252W mutation that enhances signaling with a limited subset of Fgfs, the P253R mutation enhances signaling with many Fgfs and one hypothesis is that the P253R mutation may respond to many more signals that can have overlapping, redundant, and/or counteracting effects, resulting in a more moderate increase of MI 
[?E textMine:dobj ?function, ?J textMine:prep ?C, ?J textMine:nsubj ?F, ?F textMine:nn ?mutation, ?A textMine:dobj ?B, ?impact textMine:ccomp ?G, ?C textMine:rcmod ?A, ?G textMine:ccomp ?J, ?B textMine:dep ?E]
Added to queryTripless!! : ?E textMine:dobj ?function. ?J textMine:prep ?C. ?J textMine:nsubj ?F. ?F textMine:nn ?mutation. ?A textMine:dobj ?B. ?positive textMine:ccomp ?G. ?C textMine:rcmod ?A. ?G textMine:ccomp ?J. ?B textMine:dep ?E. 
371

438 FP 1039 is currently in a Phase II trial for endometrial cancers with the S252W FGFR2  mutation which confers increased affinity and altered specificity of FGF binding   
[?function textMine:amod ?impact, ?A textMine:rcmod ?C, ?A textMine:nn ?mutation, ?C textMine:dobj ?function]
Added to queryTripless!! : ?function textMine:amod ?positive. ?A textMine:rcmod ?C. ?A textMine:nn ?mutation. ?C textMine:dobj ?function. 
372

439 Gain in   V600E B RAF  copy number was reflected in corresponding increased gene expression at the protein level ( Fig 1b ) 
[?B textMine:prep ?A, ?D textMine:prep ?function, ?D textMine:nsubjpass ?B, ?A textMine:nn ?mutation, ?function textMine:amod ?impact]
Added to queryTripless!! : ?B textMine:prep ?A. ?D textMine:prep ?function. ?D textMine:nsubjpass ?B. ?A textMine:nn ?mutation. ?function textMine:amod ?positive. 
373

440 In vitro  studies in thyroid cells suggest that BRAF V600E induces invasion via increased expression of matrix metalloproteinases (MMP12) ( Mesa  et al , 2006 ) and that it reduces expression and membrane localisation of the Na, I symporter responsible for thyrocyte uptake of iodine ( Riesco Eizaguirre  et al , 2006 ) 
[?G textMine:nn ?function, ?B textMine:prep ?F, ?D textMine:dobj ?G, ?F textMine:amod ?impact, ?C textMine:conj ?D, ?C textMine:dobj ?B, ?C textMine:nsubj ?mutation]
Added to queryTripless!! : ?G textMine:nn ?function. ?B textMine:prep ?F. ?D textMine:dobj ?G. ?F textMine:amod ?positive. ?C textMine:conj ?D. ?C textMine:dobj ?B. ?C textMine:nsubj ?mutation. 
374

441 Further elevated CDK4 levels in the embryonic pancreas, through the CDK4 R24C  mutant, showed increased proliferation of early mesenchymal endocrine precursors   
[?function textMine:amod ?impact, ?D textMine:dobj ?function, ?D textMine:prep ?A, ?A textMine:nn ?mutation]
Query : [?function textMine:amod ?impact, ?D textMine:dobj ?function, ?D textMine:prep ?A, ?A textMine:nn ?mutation]
Existing trips : 
?A textMine:nn ?mutation. ?B textMine:dobj ?function. ?B textMine:prep ?A. ?function textMine:amod ?impact. 
Similar Query!!!!


442 In numerous studies, the  JAK2  V617F allele has been variably associated with higher indices of erythropoiesis, unchanged or decreased platelet counts, greater occurrence of thrombosis, increased BM fibrosis or cytoreductive treatments, older age, longer disease duration, or poorer survival in MPN   
[?function textMine:advmod ?impact, ?function textMine:nsubjpass ?C, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:advmod ?neutral. ?function textMine:nsubjpass ?C. ?C textMine:nn ?mutation. 
375

443 The Ba/F3 EpoR cells expressing JAK2 V617F previously selected for autonomous growth show a typical increase in STAT5 transcriptional activity both in the presence and absence of Epo 
[?D textMine:partmod ?E, ?impact textMine:prep ?function, ?C textMine:dobj ?impact, ?C textMine:nsubj ?D, ?E textMine:dobj ?mutation]
Added to queryTripless!! : ?D textMine:partmod ?E. ?positive textMine:prep ?function. ?C textMine:dobj ?positive. ?C textMine:nsubj ?D. ?E textMine:dobj ?mutation. 
376

444 On the other hand, YFP EGFR ICD proteins bearing the uncommon exon 21 mutation P848L and A859T showed markedly lower autophosphorylation levels than YFP EGFR ICD L858R (Figure  4C ) 
[?F textMine:nn ?function, ?F textMine:amod ?impact, ?D textMine:dobj ?F, ?D textMine:nsubj ?E, ?E textMine:partmod ?A, ?A textMine:dobj ?mutation]
[?A textMine:dobj ?mutation, ?D textMine:dobj ?F, ?D textMine:nsubj ?E, ?E textMine:partmod ?A, ?F textMine:amod ?impact, ?F textMine:nn ?function, ]
Match 


445 As shown in  Figure 3a–b , the kinase activities of L858R/V948R tEGFR in its EGF– and Cetuximab–bound forms were reduced substantially compared to that of L858R tEGFR, indicating that mutation of either the N lobe or C lobe face of the dimer interface of L858R results in a 10  to 30 fold decrease in catalytic rate 
[?C textMine:dep ?function, ?B textMine:prep ?K, ?A textMine:num ?mutation, ?K textMine:partmod ?M, ?function textMine:prep ?B, ?J textMine:parataxis ?D, ?J textMine:prep ?C, ?D textMine:ccomp ?G, ?G textMine:dobj ?I, ?M textMine:ccomp ?impact, ?H textMine:prep ?A, ?I textMine:prep ?H]
Added to queryTripless!! : ?C textMine:dep ?function. ?B textMine:prep ?K. ?A textMine:num ?mutation. ?K textMine:partmod ?M. ?function textMine:prep ?B. ?J textMine:parataxis ?D. ?J textMine:prep ?C. ?D textMine:ccomp ?G. ?G textMine:dobj ?I. ?M textMine:ccomp ?negative. ?H textMine:prep ?A. ?I textMine:prep ?H. 
377

446 These studies demonstrate that by targeting the switch pocket, this class of KIT inhibitors possesses a novel mechanism of inhibition whose dual suppression of KIT D816V neoplastic proliferation and SCF enhanced mast cell activation advocate future clinical development 
[?D textMine:prep ?mutation, ?D textMine:poss ?B, ?B textMine:rcmod ?impact, ?B textMine:prep ?function, ?impact textMine:dobj ?D]
Added to queryTripless!! : ?D textMine:prep ?mutation. ?D textMine:poss ?B. ?B textMine:rcmod ?positive. ?B textMine:prep ?function. ?positive textMine:dobj ?D. 
378

447 BCR ABL mutations respond differently to three tyrosine kinase inhibitors approved for first line treatment of CML, e g, Y253F and G250E mutations resistant to imatinib can respond to nilotinib or/and dasatinib, T315A shows better response to imatinib though resistant to Dasatinib and Nilotinib, while some mutations are less sensitive to nilotinib (E255K/V and F359V/C) or dasatinib (F317L and V299L)  
[?B textMine:cop ?impact, ?B textMine:advmod ?function]
[?B textMine:advmod ?function, ?B textMine:cop ?impact, ]
Match 


448 R958D mutation, when in  cis  with L858R, decreased the sensitivity of the mutant receptor to erlotinib inhibition, while increasing the sensitivity to gefitinib in a dominant fashion ( Figure 5A, B ) 
[?A textMine:prep ?mutation, ?B textMine:rcmod ?A, ?impact textMine:prep ?function, ?impact textMine:nsubj ?B]
Added to queryTripless!! : ?A textMine:prep ?mutation. ?B textMine:rcmod ?A. ?negative textMine:prep ?function. ?negative textMine:nsubj ?B. 
379

449 Our data suggest that exon 20 insertions may disrupt these interactions to a greater extent than the T790M point mutation 
[?B textMine:nn ?mutation, ?D textMine:prep ?B, ?impact textMine:prep ?D, ?impact textMine:dobj ?function]
Query : [?B textMine:nn ?mutation, ?D textMine:prep ?B, ?impact textMine:prep ?D, ?impact textMine:dobj ?function]
Existing trips : 
?A textMine:nn ?mutation. ?E textMine:prep ?A. ?impact textMine:dobj ?function. ?impact textMine:prep ?E. 
Similar Query!!!!


450 The S252W mutation increased cell proliferation in fibroblasts at all times of culture (24 h:  p  < 0 001,
[?B textMine:nn ?mutation, ?impact textMine:ccomp ?C, ?impact textMine:nsubj ?B, ?C textMine:nsubj ?function]
Added to queryTripless!! : ?B textMine:nn ?mutation. ?positive textMine:ccomp ?C. ?positive textMine:nsubj ?B. ?C textMine:nsubj ?function. 
380

451 Finally, the specific silencing or inhibition of BRAF V600E  expression in the NM176 and ME1042 melanoma cells decreased Tbx3 protein expression and this correlated with the concomitant increased E cadherin ( Figure 2c ) 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ?B textMine:nn ?mutation, ?C textMine:prep ?B]
Query : [?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ?B textMine:nn ?mutation, ?C textMine:prep ?B]
Existing trips : 
?A textMine:prep ?B. ?B textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?A. 
Similar Query!!!!


452 The mutation Y253F (−0.22 kcal/mol) experiences increased electrostatic interactions, Y253H experiences increased electrostatic interactions (−0 3 kcal/mol) and decreased vdW (−131 kcal/mol) when binding to ponatinib 
[?C textMine:nn ?mutation, ?impact textMine:nsubj ?C, ?impact textMine:dobj ?function]
[?C textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ]
Match 


453 In this work we explore the role of the pseudokinase domain helix C in the constitutive activation of JAK2 V617F by focusing on residue F595, predicted to be located in the middle of the helix 
[?function textMine:prep ?mutation, ?function textMine:amod ?impact]
[?function textMine:amod ?impact, ?function textMine:prep ?mutation, ]
Match 


454 Hence, the main objective behind applying a one plus one template reference strategy is to reduce the inevitable biases associated with assessing  JAK2  V617F  AB to approximately 50%, considering that this value is of major clinical significance 
[?impact textMine:dobj ?A, ?C textMine:nn ?mutation, ?B textMine:dobj ?C, ?A textMine:partmod ?function, ?function textMine:prepc ?B]
Added to queryTripless!! : ?negative textMine:dobj ?A. ?C textMine:nn ?mutation. ?B textMine:dobj ?C. ?A textMine:partmod ?function. ?function textMine:prepc ?B. 
381

455 Intriguingly, tyrosine phosphorylation of PECAM 1 as well as its physical association with SHP2 was enhanced by the imatinib resistance E255K or T315I mutation 
[?impact textMine:agent ?D, ?impact textMine:nsubjpass ?E, ?E textMine:prep ?function, ?D textMine:nn ?mutation]
Added to queryTripless!! : ?positive textMine:agent ?D. ?positive textMine:nsubjpass ?E. ?E textMine:prep ?function. ?D textMine:nn ?mutation. 
382

456 As expected based on prior data  , MEK inhibition resulted in increase of pMEK in non  BRAF   V600E   mutant cell lines (Figure  3 ) 
[?function textMine:prep ?A, ?function textMine:prep ?impact, ?A textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:prep ?A. ?function textMine:prep ?positive. ?A textMine:nn ?mutation. 
383

457 Furthermore, they demonstrated an enhanced anti tumor effect against a subcutaneously implanted, mouse derived V600E BRAF melanoma line using vemurafenib in combination with adoptively transferred splenocytes designed to target the melanocyte marker gp100 
[?B textMine:appos ?F, ?function textMine:prep ?B, ?function textMine:amod ?impact, ?F textMine:partmod ?D, ?D textMine:dobj ?E, ?E textMine:nn ?mutation]
Added to queryTripless!! : ?B textMine:appos ?F. ?function textMine:prep ?B. ?function textMine:amod ?positive. ?F textMine:partmod ?D. ?D textMine:dobj ?E. ?E textMine:nn ?mutation. 
384

458 The T790M mutation affects the gatekeeper residue in the catalytic kinase domain and confers drug resistance by increasing EGFR's affinity for ATP – thus reducing the potency of the ATP competitive kinase inhibitors [ 39 ] 
[?impact textMine:dobj ?function, ?A textMine:nn ?mutation, ?E textMine:prepc ?impact, ?E textMine:nsubj ?A]
Added to queryTripless!! : ?positive textMine:dobj ?function. ?A textMine:nn ?mutation. ?E textMine:prepc ?positive. ?E textMine:nsubj ?A. 
385

459 The mutations E255K, F317L and F317V experience increased electrostatic interactions with Tyr253 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:amod ?D, ?D textMine:dep ?mutation]
Query : [?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:amod ?D, ?D textMine:dep ?mutation]
Existing trips : 
?B textMine:amod ?E. ?E textMine:dep ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?B. 
Similar Query!!!!


460 This group recently published that human naevi (benign tumors of melanocytic origin that can remain in unaltered state for decades and often express BRAF V600E ) display senescence like growth arrest   
[?impact textMine:conj ?function, ?function textMine:dobj ?mutation]
Added to queryTripless!! : ?neutral textMine:conj ?function. ?function textMine:dobj ?mutation. 
386

461 TBP 3868 exhibits high basal Ras activity relative to the PLX4720 sensitive line, TBP 3743 suggesting that the resistance to BRAF V600E  inhibition in TBP 3868 may be attributed to Ras dependent transactivation of RAF dimers 
[?D textMine:prep ?function, ?I textMine:advmod ?E, ?I textMine:amod ?impact, ?B textMine:nsubjpass ?D, ?J textMine:appos ?C, ?E textMine:prep ?J, ?C textMine:partmod ?H, ?H textMine:ccomp ?B, ?function textMine:nn ?mutation]
Added to queryTripless!! : ?D textMine:prep ?function. ?I textMine:advmod ?E. ?I textMine:amod ?positive. ?B textMine:nsubjpass ?D. ?J textMine:appos ?C. ?E textMine:prep ?J. ?C textMine:partmod ?H. ?H textMine:ccomp ?B. ?function textMine:nn ?mutation. 
387

462 The counterselection necessary to avoid selecting for aptamers that nonspecifically recognized the cell surface included a first step against parental PC12 cells in order to eliminate nonspecific binders of the PC12 cell surface, followed by a second counterselection step against PC12/MEN2B cells that expressed an allele of RET (RET M918T ) mutated in the intracellular tyrosine kinase domain 
[?K textMine:ccomp ?A, ?D textMine:appos ?mutation, ?E textMine:prep ?D, ?impact textMine:xcomp ?I, ?C textMine:rcmod ?K, ?function textMine:dobj ?E, ?I textMine:prep ?C, ?J textMine:rcmod ?function, ?A textMine:pobj ?F, ?F textMine:prep ?J]
Added to queryTripless!! : ?K textMine:ccomp ?A. ?D textMine:appos ?mutation. ?E textMine:prep ?D. ?negative textMine:xcomp ?I. ?C textMine:rcmod ?K. ?function textMine:dobj ?E. ?I textMine:prep ?C. ?J textMine:rcmod ?function. ?A textMine:pobj ?F. ?F textMine:prep ?J. 
388

463 Therefore, the modulation of feed back loops and alteration of Raf dimerization upon treatment with Raf inhibitors may also have a role in the differential sensitivity to PLX4032 in BRAF  V600E  mutant cell lines 
[?E textMine:prep ?G, ?impact textMine:prep ?E, ?B textMine:prep ?D, ?B textMine:nsubj ?impact, ?D textMine:prep ?A, ?G textMine:partmod ?function, ?A textMine:nn ?mutation]
Added to queryTripless!! : ?E textMine:prep ?G. ?unknown textMine:prep ?E. ?B textMine:prep ?D. ?B textMine:nsubj ?unknown. ?D textMine:prep ?A. ?G textMine:partmod ?function. ?A textMine:nn ?mutation. 
389

464 Now, recent work from the Rosen lab at Memorial Sloan Kettering Cancer Center has uncovered data that vemurafenib reduces feedback inhibition in BRAF V600E  expressing cells such that these cells become sensitized to extracellular growth factors like hepatocyte and epidermal growth factors 
[?impact textMine:dobj ?function, ?impact textMine:prep ?mutation]
[?impact textMine:dobj ?function, ?impact textMine:prep ?mutation, ]
Match 


465 Similar to E884K, R958D modulated the sensitizing effect of L858R differentially to reversible EGFR inhibitors when in  cis  (with L858R) 
[?C textMine:amod ?function, ?impact textMine:prep ?E, ?impact textMine:dobj ?C, ?E textMine:prep ?mutation]
Added to queryTripless!! : ?C textMine:amod ?function. ?unknown textMine:prep ?E. ?unknown textMine:dobj ?C. ?E textMine:prep ?mutation. 
390

466 The enhanced tyrosine phosphorylation of PECAM 1 by the E255K and T315I mutants may be at least partly due to their enhanced activities ( 15 – 17 ) 
[?D textMine:nn ?mutation, ?A textMine:prep ?function, ?A textMine:nsubj ?F, ?F textMine:prep ?D, ?function textMine:amod ?impact]
[?A textMine:nsubj ?F, ?A textMine:prep ?function, ?D textMine:nn ?mutation, ?F textMine:prep ?D, ?function textMine:amod ?impact, ]
Match 


467 Hence, E884K in  cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone, through differential inhibition of the pro survival AKT and STAT3 signaling pathways associated with altered induction of cleaved PARP(Asp214) 
[?F textMine:partmod ?function, ?B textMine:prep ?F, ?B textMine:nsubj ?mutation, ?function textMine:prep ?E, ?E textMine:amod ?impact]
[?B textMine:nsubj ?mutation, ?B textMine:prep ?F, ?E textMine:amod ?impact, ?F textMine:partmod ?function, ?function textMine:prep ?E, ]
Match 


468 The mutation F359V experiences decreased vdW (−2.13 kcal/mol) and electrostatic interactions (−0.16 kcal/mol), while decreased electrostatic interactions are experienced due to mutations E255K (0 35 kcal/mol) and E255V (−009 kcal/mol) 
[?E textMine:nsubjpass ?function, ?function textMine:amod ?impact, ?D textMine:advcl ?E, ?D textMine:nsubj ?mutation]
Added to queryTripless!! : ?E textMine:nsubjpass ?function. ?function textMine:amod ?negative. ?D textMine:advcl ?E. ?D textMine:nsubj ?mutation. 
391

469 This test was reported to have a very high sensitivity when the V600E mutant allele content was greater than 10%  
[?function textMine:amod ?impact, ?B textMine:nsubj ?C, ?C textMine:amod ?mutation, ?F textMine:advcl ?B, ?F textMine:dobj ?function]
Added to queryTripless!! : ?function textMine:amod ?positive. ?B textMine:nsubj ?C. ?C textMine:amod ?mutation. ?F textMine:advcl ?B. ?F textMine:dobj ?function. 
392

470 Another genetic aberration in BRAF in addition to BRAF V600E point mutations that leads to increased kinase activity in low  and high grade pediatric brain tumors is a fusion protein of KIAA1549:BRAF that is found in the majority of pilocytic astrocytomas 
[?function textMine:amod ?impact, ?B textMine:prep ?A, ?B textMine:rcmod ?E, ?A textMine:nn ?mutation, ?E textMine:prep ?function]
Added to queryTripless!! : ?function textMine:amod ?positive. ?B textMine:prep ?A. ?B textMine:rcmod ?E. ?A textMine:nn ?mutation. ?E textMine:prep ?function. 
393

471 The  BRAF V600E  mutation, in particular, impairs the therapeutic effects of cetuximab and panitumumab 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?A, ?A textMine:nn ?mutation]
Query : [?impact textMine:dobj ?function, ?impact textMine:nsubj ?A, ?A textMine:nn ?mutation]
Existing trips : 
?C textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?C. 
Similar Query!!!!


472 This mutation ( E17K ) increases recruitment of AKT1 to the membrane, increases AKT1 phosphorylation and activity, transforms Rat1 fibroblasts, and induces leukaemia in transgenic mice ( Carpten  et al , 2007 ) 
[?A textMine:appos ?mutation, ?E textMine:conj ?function, ?E textMine:conj ?impact, ?E textMine:nsubj ?A, ?function textMine:nsubj ?A, ?impact textMine:nsubj ?A]
Added to queryTripless!! : ?A textMine:appos ?mutation. ?E textMine:conj ?function. ?E textMine:conj ?positive. ?E textMine:nsubj ?A. ?function textMine:nsubj ?A. ?positive textMine:nsubj ?A. 
394

474 In case of occurrence of both L858R and T790M mutations, the concentration of erlotinib should be three times higher in order to achieve a therapeutic effect 
[?B textMine:dobj ?function, ?C textMine:nn ?mutation, ?E textMine:prep ?C, ?impact textMine:ccomp ?B, ?impact textMine:prep ?E]
[?B textMine:dobj ?function, ?C textMine:nn ?mutation, ?E textMine:prep ?C, ?impact textMine:ccomp ?B, ?impact textMine:prep ?E, ]
Match 


476 V600E was distributed equally between tumors that lost vs retained expression of HLA class I in the sporadic MSI H cases 
[?A textMine:ccomp ?impact, ?A textMine:nsubjpass ?mutation, ?impact textMine:dobj ?function]
Added to queryTripless!! : ?A textMine:ccomp ?neutral. ?A textMine:nsubjpass ?mutation. ?neutral textMine:dobj ?function. 
395

477 We employed the human mast cell leukemia cell line  1 (HMC 1) model, which harbors KIT D816V and V560G mutations, and depends on signaling from these constitutively active KIT receptors for growth and survival [ 4 ] 
[?E textMine:conj ?D, ?E textMine:dobj ?mutation, ?function textMine:advmod ?impact, ?A textMine:prep ?B, ?D textMine:prepc ?A, ?B textMine:amod ?function]
Added to queryTripless!! : ?E textMine:conj ?D. ?E textMine:dobj ?mutation. ?function textMine:advmod ?positive. ?A textMine:prep ?B. ?D textMine:prepc ?A. ?B textMine:amod ?function. 
396

478 We now show in an animal that a low level of wild type MITF activity is oncogenic with BRAF V600E  and that abrogating MITF activity in melanoma leads to tumor regression 
[?A textMine:nsubj ?function, ?D textMine:prep ?mutation, ?D textMine:conj ?A, ?function textMine:amod ?impact]
Added to queryTripless!! : ?A textMine:nsubj ?function. ?D textMine:prep ?mutation. ?D textMine:conj ?A. ?function textMine:amod ?negative. 
397

479 Oncogenic mutations, S768I and L861Q, may alter the canonical interactions at the JM C helix interface
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ?C textMine:appos ?mutation]
Query : [?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ?C textMine:appos ?mutation]
Existing trips : 
?A textMine:appos ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?A. 
Similar Query!!!!


480 Hence, the double mutation L858R+E884K modulated basal and stimulated downstream EGFR signaling differentially with differential effects on the AKT (down regulated), CBL and MAPK ERK1/2 phosphorylation (up regulated) 
[?A textMine:appos ?function, ?impact textMine:xcomp ?B, ?impact textMine:nsubj ?F, ?F textMine:nn ?mutation, ?B textMine:prep ?A]
Added to queryTripless!! : ?A textMine:appos ?function. ?unknown textMine:xcomp ?B. ?unknown textMine:nsubj ?F. ?F textMine:nn ?mutation. ?B textMine:prep ?A. 
398

481 Our biochemical studies here now show that E884K mutation in  cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone, through differential inhibition of the pro survival AKT and STAT3 signaling pathways associated with altered induction of cleaved PARP(Asp214) 
[?G textMine:amod ?mutation, ?B textMine:prep ?A, ?E textMine:prep ?C, ?E textMine:dobj ?function, ?E textMine:nsubj ?G, ?A textMine:amod ?impact, ?C textMine:partmod ?B]
Added to queryTripless!! : ?G textMine:amod ?mutation. ?B textMine:prep ?A. ?E textMine:prep ?C. ?E textMine:dobj ?function. ?E textMine:nsubj ?G. ?A textMine:amod ?unknown. ?C textMine:partmod ?B. 
399

482 Vikis et al reported that standalone T790M mutations exhibit increased kinase activity 
[?A textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?A]
Query : [?A textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?A]
Existing trips : 
?C textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?C. 
Similar Query!!!!


483 FLT3  D835V and  KIT  D816Y) retained some level of sensitivity with regard to induction of apoptosis 
[?impact textMine:prep ?C, ?impact textMine:nsubj ?mutation, ?C textMine:prep ?function]
Added to queryTripless!! : ?neutral textMine:prep ?C. ?neutral textMine:nsubj ?mutation. ?C textMine:prep ?function. 
400

484 Some mutations (P112Q, R895C, E897K) enhance angiotensin II receptor mediated activation of TRPC6 when expressed in HEK293 cells, while neither the S270T nor the N143S missense mutations, nor a 57 amino acid truncation mutation (K874X), altered the channel activity   
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ?E textMine:advcl ?D, ?C textMine:partmod ?E, ?D textMine:advcl ?G, ?G textMine:nsubj ?mutation]
Added to queryTripless!! : ?unknown textMine:dobj ?function. ?unknown textMine:nsubj ?C. ?E textMine:advcl ?D. ?C textMine:partmod ?E. ?D textMine:advcl ?G. ?G textMine:nsubj ?mutation. 
401

485 Among the investigated melanoma cell lines, three display constitutive activation of the Ras/Raf/MEK/ERK pathway through activating V600E BRAF mutation or NRAS mutations: Colo 679 (BRAF V600E mut; Nras wt), IGR 39 (BRAF V600E mut; Nras wt), IPC298 (Braf wt; Nras Q61K mut)  
[?E textMine:appos ?B, ?function textMine:dobj ?C, ?impact textMine:prepc ?function, ?F textMine:nn ?mutation, ?C textMine:dep ?E, ?B textMine:appos ?F]
Added to queryTripless!! : ?E textMine:appos ?B. ?function textMine:dobj ?C. ?positive textMine:prepc ?function. ?F textMine:nn ?mutation. ?C textMine:dep ?E. ?B textMine:appos ?F. 
402

486 Transformation induced by each of the three oncogenes  KRAS G12V   (Caco K cells),  BRAF V600E   (Caco BR cells) and  HRAS G12V   (Caco H cells) managed to increase the ability of Caco 2 cells to migrate and invade  in vitro , independently of their proliferating ability, which has been previously analyzed in   
[?impact textMine:xsubj ?mutation, ?D textMine:dep ?function, ?mutation textMine:amod ?D]
Added to queryTripless!! : ?positive textMine:xsubj ?mutation. ?D textMine:dep ?function. ?mutation textMine:amod ?D. 
403

487 Our data support the potential role of dual TKI combinatorial inhibition using EGFR inhibitors to enhance MET inhibition in T790M EGFR mediated therapy resistance 
[?function textMine:prep ?B, ?impact textMine:dobj ?function, ?B textMine:nn ?mutation]
Query : [?function textMine:prep ?B, ?impact textMine:dobj ?function, ?B textMine:nn ?mutation]
Existing trips : 
?D textMine:nn ?mutation. ?function textMine:prep ?D. ?impact textMine:dobj ?function. 
Similar Query!!!!


488 In the analyses of clinical specimens obtained from patients who acquired resistance to EGFR TKIs, high expression of HGF was identified in 61% patients, overlapping with T790M mutation and MET amplification 
[?D textMine:prep ?J, ?K textMine:prep ?H, ?L textMine:prep ?I, ?E textMine:prep ?G, ?I textMine:rcmod ?D, ?G textMine:partmod ?L, ?J textMine:appos ?function, ?B textMine:appos ?K, ?A textMine:nsubjpass ?B, ?A textMine:prep ?E, ?function textMine:amod ?impact, ?H textMine:amod ?mutation]
Added to queryTripless!! : ?D textMine:prep ?J. ?K textMine:prep ?H. ?L textMine:prep ?I. ?E textMine:prep ?G. ?I textMine:rcmod ?D. ?G textMine:partmod ?L. ?J textMine:appos ?function. ?B textMine:appos ?K. ?A textMine:nsubjpass ?B. ?A textMine:prep ?E. ?function textMine:amod ?positive. ?H textMine:amod ?mutation. 
404

489 BCR ABL mutations respond differently to three tyrosine kinase inhibitors approved for first line treatment of CML, e g, Y253F and G250E mutations resistant to imatinib can respond to nilotinib or/and dasatinib, T315A shows better response to imatinib though resistant to Dasatinib and Nilotinib, while some mutations are less sensitive to nilotinib (E255K/V and F359V/C) or dasatinib (F317L and V299L)  
[?B textMine:cop ?impact, ?B textMine:advmod ?function]
[?B textMine:advmod ?function, ?B textMine:cop ?impact, ]
Match 


490 Our results reveal that SIRT1 activity is higher in PLX4032 resistant BRAF V600E  mutated melanoma cells compared with their sensitive counterpart 
[?impact textMine:nsubj ?function, ?impact textMine:prep ?mutation]
[?impact textMine:nsubj ?function, ?impact textMine:prep ?mutation, ]
Match 


491 Signaling studies show again that cells expressing the L858R allele have reduced EGFR, AKT, and ERK phosphorylation in response to increasing concentrations of dasatinib ( Figure 5B ) 
[?F textMine:dobj ?B, ?B textMine:amod ?mutation, ?D textMine:partmod ?F, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?D]
Added to queryTripless!! : ?F textMine:dobj ?B. ?B textMine:amod ?mutation. ?D textMine:partmod ?F. ?negative textMine:dobj ?function. ?negative textMine:nsubj ?D. 
405

492 The mutation of arginine at position 24 into cysteine (CDK4 R24C ) or histidine (CDK4 R24C ) renders the protein insensitive to regulation by p16 INK4a  but preserves interaction between CDK4 and cyclin D1 leading to constitutive activation of the complex and aberrant proliferation, through retinoblastoma protein inactivation and E2F activation 
[?G textMine:prep ?L, ?L textMine:prep ?A, ?H textMine:dobj ?E, ?B textMine:prep ?G, ?I textMine:xcomp ?H, ?J textMine:partmod ?I, ?A textMine:appos ?mutation, ?C textMine:prep ?J, ?impact textMine:dobj ?C, ?impact textMine:nsubj ?B, ?E textMine:prep ?function]
Added to queryTripless!! : ?G textMine:prep ?L. ?L textMine:prep ?A. ?H textMine:dobj ?E. ?B textMine:prep ?G. ?I textMine:xcomp ?H. ?J textMine:partmod ?I. ?A textMine:appos ?mutation. ?C textMine:prep ?J. ?neutral textMine:dobj ?C. ?neutral textMine:nsubj ?B. ?E textMine:prep ?function. 
406

493 In addition, the  JAK2  V617F  mutation may increase the stability of the JAK2 protein by rendering it resistant to the effect of SOCS3 binding, as overexpression of SOCS3 results in increased SOCS3 and  JAK2  V617F  phosphorylation [ 68 ] 
[?function textMine:num ?mutation, ?A textMine:amod ?impact, ?B textMine:prep ?A, ?C textMine:conj ?function, ?C textMine:prep ?F, ?F textMine:prep ?B]
Added to queryTripless!! : ?function textMine:num ?mutation. ?A textMine:amod ?positive. ?B textMine:prep ?A. ?C textMine:conj ?function. ?C textMine:prep ?F. ?F textMine:prep ?B. 
407

494 The mutations F317V, Y253F, Y253H and E255K experience increased vdW interactions with residue Leu248 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ?C textMine:amod ?E, ?E textMine:dep ?mutation]
Query : [?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ?C textMine:amod ?E, ?E textMine:dep ?mutation]
Existing trips : 
?B textMine:amod ?E. ?E textMine:dep ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?B. 
Similar Query!!!!


495 Additional genetic alterations within the target oncogene itself, which prevent drug binding and lead to kinase activation even in the presence of the inhibitor, are a common mechanism of both primary and acquired resistance in cancer; a paradigmatic example is provided by the T790M “gatekeeper” secondary mutation in the  EGFR  gene, which installs resistance to reversible EGFR inhibitors in  EGFR  mutant NSCLC   
[?impact textMine:rcmod ?H, ?C textMine:nn ?mutation, ?E textMine:parataxis ?F, ?E textMine:nsubj ?impact, ?H textMine:dobj ?A, ?A textMine:amod ?function, ?F textMine:agent ?C]
Added to queryTripless!! : ?unknown textMine:rcmod ?H. ?C textMine:nn ?mutation. ?E textMine:parataxis ?F. ?E textMine:nsubj ?unknown. ?H textMine:dobj ?A. ?A textMine:amod ?function. ?F textMine:agent ?C. 
408

496 These two mutations, resulting in L1198F and G1201E amino acid changes, respectively, both reside within the ALK tyrosine kinase domain where they dramatically increased tyrosine kinase activities 
[?impact textMine:dobj ?function, ?A textMine:nn ?mutation, ?D textMine:advcl ?impact, ?D textMine:partmod ?F, ?F textMine:prep ?A]
[?A textMine:nn ?mutation, ?D textMine:advcl ?impact, ?D textMine:partmod ?F, ?F textMine:prep ?A, ?impact textMine:dobj ?function, ]
Match 


497 An acquired T790M mutation was found in a NSLCL patient resistant to the drug Gefitnib by increasing the affinity to ATP   
[?B textMine:nn ?mutation, ?D textMine:amod ?A, ?A textMine:prepc ?impact, ?G textMine:prep ?D, ?G textMine:nsubjpass ?B, ?impact textMine:dobj ?function]
Added to queryTripless!! : ?B textMine:nn ?mutation. ?D textMine:amod ?A. ?A textMine:prepc ?positive. ?G textMine:prep ?D. ?G textMine:nsubjpass ?B. ?positive textMine:dobj ?function. 
409

498 This suggests that MAPK pathway activation by BRAF V600E  (as in A375) and by NRAS Q61K  (as in Mel Juso) is important in maintaining FOSL1 expression 
[?E textMine:conj ?D, ?E textMine:prep ?mutation, ?impact textMine:dobj ?function, ?D textMine:prepc ?impact]
Added to queryTripless!! : ?E textMine:conj ?D. ?E textMine:prep ?mutation. ?neutral textMine:dobj ?function. ?D textMine:prepc ?neutral. 
410

499 Further, crystallographic data showed that E542K disrupts the inhibitory interaction of p110α with the amino terminal SH2 domain of p85, thus enhancing its catalytic activity   
[?impact textMine:dobj ?function, ?A textMine:partmod ?impact, ?A textMine:nsubj ?mutation]
Added to queryTripless!! : ?positive textMine:dobj ?function. ?A textMine:partmod ?positive. ?A textMine:nsubj ?mutation. 
411

500 Hence, the E884K mutation, when in  cis  with L858R, modulates the sensitivity of the mutant receptor towards ERBB family kinase inhibitors in an inhibitor specific fashion 
[?B textMine:prep ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ?C textMine:rcmod ?B]
Added to queryTripless!! : ?B textMine:prep ?mutation. ?unknown textMine:dobj ?function. ?unknown textMine:nsubj ?C. ?C textMine:rcmod ?B. 
412

501 Under chondrocyte induction conditions, the already reduced gene expression in  Fgfr2 +/S252W   mice was recovered after inhibition of p38 signaling 
[?function textMine:prep ?B, ?function textMine:amod ?impact, ?B textMine:nn ?mutation]
Query : [?function textMine:prep ?B, ?function textMine:amod ?impact, ?B textMine:nn ?mutation]
Existing trips : 
?A textMine:nn ?mutation. ?function textMine:amod ?impact. ?function textMine:prep ?A. 
Similar Query!!!!


502 Two of these missense mutants, V689M and L703F are constitutively active, possibly because they stabilize acceptor/donor interactions   
[?A textMine:prep ?mutation, ?C textMine:advcl ?function, ?C textMine:nsubj ?A]
Added to queryTripless!! : ?A textMine:prep ?mutation. ?C textMine:advcl ?function. ?C textMine:nsubj ?A. 
413

503 In conclusion, our study indicates that the antiproliferative and apoptotic effects of these three xanthones on human melanoma SK MEL 28 cell line are via modulation of the genes involved in the cell cycle and apoptosis pathway, together with downregulation of the mRNA expression of Akt1, NF κ B, and BRAF V600E 
[?B textMine:prep ?E, ?D textMine:partmod ?B, ?E textMine:nn ?function, ?G textMine:prep ?I, ?G textMine:prep ?impact, ?I textMine:prep ?C, ?impact textMine:prep ?D, ?C textMine:prep ?mutation]
Added to queryTripless!! : ?B textMine:prep ?E. ?D textMine:partmod ?B. ?E textMine:nn ?function. ?G textMine:prep ?I. ?G textMine:prep ?unknown. ?I textMine:prep ?C. ?unknown textMine:prep ?D. ?C textMine:prep ?mutation. 
414

504 Recently WZ4002, a new inhibitor specifically targeting T790M gatekeeper mutation was developed and found to induce greater growth inhibition in vitro and in vivo against T790M than against wild type EGFR   ( Figure 1 ) 
[?function textMine:amod ?impact, ?F textMine:dobj ?function, ?F textMine:xsubj ?A, ?E textMine:prep ?mutation, ?E textMine:nsubjpass ?A]
Added to queryTripless!! : ?function textMine:amod ?positive. ?F textMine:dobj ?function. ?F textMine:xsubj ?A. ?E textMine:prep ?mutation. ?E textMine:nsubjpass ?A. 
415

505 Both mutations lead to ALK constitutive activation by autophosphorylation, although ALK F1174L displays a higher degree of phosphorylation, and an increased tumorigenic potential compared to other ALK mutations [ 10 ,  13 ,  20   22 ,  26 ] 
[?function textMine:amod ?impact, ?C textMine:nsubj ?mutation, ?A textMine:advcl ?C, ?A textMine:dobj ?function]
Added to queryTripless!! : ?function textMine:amod ?positive. ?C textMine:nsubj ?mutation. ?A textMine:advcl ?C. ?A textMine:dobj ?function. 
416

506 This discrepancy might be a result of modulation of other genes besides JAK2 V617F  and FLT3 ITD by HDAC inhibition 
[?function textMine:prep ?impact, ?C textMine:prep ?mutation, ?impact textMine:prep ?C]
Added to queryTripless!! : ?function textMine:prep ?unknown. ?C textMine:prep ?mutation. ?unknown textMine:prep ?C. 
417

507 The activity of DAS is maintained despite the presence of mutations that confer resistance to IM with the exception of the T315I mutation, and to a large degree, mutations affecting the residue 317 (F317L, F317V) 
[?A textMine:dobj ?function, ?impact textMine:prep ?E, ?E textMine:prep ?F, ?F textMine:appos ?C, ?F textMine:rcmod ?A, ?C textMine:dep ?mutation]
Added to queryTripless!! : ?A textMine:dobj ?function. ?neutral textMine:prep ?E. ?E textMine:prep ?F. ?F textMine:appos ?C. ?F textMine:rcmod ?A. ?C textMine:dep ?mutation. 
418

508 The most frequent somatic alteration in  BRAF  is a point mutation (T1799A encoding BRAF V600E ), which results in a several hundred fold increased activity of the protein’s kinase domain 
[?B textMine:appos ?mutation, ?B textMine:rcmod ?E, ?function textMine:amod ?impact, ?E textMine:dobj ?function]
Added to queryTripless!! : ?B textMine:appos ?mutation. ?B textMine:rcmod ?E. ?function textMine:amod ?positive. ?E textMine:dobj ?function. 
419

509 Stimulation of GTL16 L858R cells with a physiological concentration of EGF (1 ng/ml) resulted in further increase of anchorage independent growth, only in the absence of MET signaling 
[?C textMine:prep ?A, ?function textMine:prep ?impact, ?function textMine:nsubj ?C, ?A textMine:num ?mutation]
Added to queryTripless!! : ?C textMine:prep ?A. ?function textMine:prep ?positive. ?function textMine:nsubj ?C. ?A textMine:num ?mutation. 
420

510 BRAF inhibition by RNAi strongly reduces ERK activation in the cell line harbouring the BRAF V600E  mutation, is also effective in the cell line with RAS G13R , but has no effect in ERK activation in the cell line with RET/PTC rearrangement 
[?impact textMine:conj ?A, ?impact textMine:xcomp ?G, ?D textMine:nn ?mutation, ?G textMine:dobj ?D, ?E textMine:prep ?function, ?A textMine:dobj ?E]
Added to queryTripless!! : ?negative textMine:conj ?A. ?negative textMine:xcomp ?G. ?D textMine:nn ?mutation. ?G textMine:dobj ?D. ?E textMine:prep ?function. ?A textMine:dobj ?E. 
421

511 Consistent with this differential signaling effect, the L858R+E884K COS 7 cells had a significantly higher cell proliferation rate than that of the L858R COS 7 cells in the MTS cell proliferation assay for 5 days ( Figure 3B ) 
[?L textMine:appos ?G, ?B textMine:prep ?C, ?D textMine:dobj ?L, ?H textMine:partmod ?D, ?C textMine:nn ?function, ?K textMine:dobj ?E, ?E textMine:amod ?impact, ?G textMine:nn ?mutation, ?A textMine:nsubj ?B, ?A textMine:dep ?K, ?A textMine:prep ?H]
Added to queryTripless!! : ?L textMine:appos ?G. ?B textMine:prep ?C. ?D textMine:dobj ?L. ?H textMine:partmod ?D. ?C textMine:nn ?function. ?K textMine:dobj ?E. ?E textMine:amod ?positive. ?G textMine:nn ?mutation. ?A textMine:nsubj ?B. ?A textMine:dep ?K. ?A textMine:prep ?H. 
422

512 We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated (native) BCR/ABL ( 15 – 17 ) 
[?D textMine:dobj ?A, ?D textMine:nsubj ?F, ?A textMine:infmod ?function, ?A textMine:amod ?impact, ?F textMine:nn ?mutation]
Added to queryTripless!! : ?D textMine:dobj ?A. ?D textMine:nsubj ?F. ?A textMine:infmod ?function. ?A textMine:amod ?positive. ?F textMine:nn ?mutation. 
423

513 Another possibility is that PLX4032 resistant  BRAF  V600E  mutants have alternative signaling at the level of Raf, as has been described for cell lines with acquired resistance to a different Raf inhibitor, AZ628, which show increased signaling through C Raf   
[?D textMine:nn ?mutation, ?B textMine:advcl ?E, ?B textMine:nsubj ?D, ?G textMine:ccomp ?B, ?impact textMine:dep ?G, ?E textMine:prep ?function]
Added to queryTripless!! : ?D textMine:nn ?mutation. ?B textMine:advcl ?E. ?B textMine:nsubj ?D. ?G textMine:ccomp ?B. ?positive textMine:dep ?G. ?E textMine:prep ?function. 
424

514 In summary, our data demonstrate that MEK inhibition of BRAF V600E  positive melanoma cells can lead to AKT dependent enhanced apoptosis resistance towards genotoxic stress, implying a careful choice of pathway inhibitors in combination therapies 
[?function textMine:amod ?impact, ?E textMine:nn ?mutation, ?C textMine:prep ?E, ?A textMine:prep ?function, ?A textMine:nsubj ?C]
Added to queryTripless!! : ?function textMine:amod ?positive. ?E textMine:nn ?mutation. ?C textMine:prep ?E. ?A textMine:prep ?function. ?A textMine:nsubj ?C. 
425

515 In the two cell lines with exon 19 deletion (15 bp) (H1650 and PC9), expression of EGFR (D38B1) protein and EGFR E746 A750 deletion specific (6B6) was positive (score 3) (100%) and expression of EGFR L858R mutant specific (43B2) was negative (score 0) 
[?function textMine:prep ?A, ?impact textMine:nsubj ?B, ?B textMine:prep ?function, ?A textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:prep ?A. ?negative textMine:nsubj ?B. ?B textMine:prep ?function. ?A textMine:nn ?mutation. 
426

516 Likewise, the T790M specific siRNA could knock down T790M mRNA, and also suppress cell proliferation and enhance cell caspase activity in H1975 cells containing the T790M mutation 
[?function textMine:prep ?D, ?impact textMine:dobj ?function, ?F textMine:dobj ?B, ?D textMine:partmod ?F, ?B textMine:amod ?mutation]
Added to queryTripless!! : ?function textMine:prep ?D. ?positive textMine:dobj ?function. ?F textMine:dobj ?B. ?D textMine:partmod ?F. ?B textMine:amod ?mutation. 
427

517 An accumulation of alternative mutations, including a T790M insensitive mutation, in addition to the primary activating mutation could modulate the sensitivity to EGFR TKI 
[?C textMine:nn ?mutation, ?F textMine:prep ?E, ?E textMine:prep ?C, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?F]
Added to queryTripless!! : ?C textMine:nn ?mutation. ?F textMine:prep ?E. ?E textMine:prep ?C. ?unknown textMine:dobj ?function. ?unknown textMine:nsubj ?F. 
428

518 The increase in BIM expression and apoptosis are inhibited by the secondary resistant mutation, T790M 
[?D textMine:appos ?mutation, ?impact textMine:prep ?function, ?C textMine:prep ?D, ?C textMine:nsubj ?impact]
[?C textMine:nsubj ?impact, ?C textMine:prep ?D, ?D textMine:appos ?mutation, ?impact textMine:prep ?function, ]
Match 


519 Indeed, we found that TAK1 was tyrosine phosphorylated in HEK293 cells transiently expressing constitutively active FGFR3 (K650E), but not the kinase dead receptor (K508M), indicating that activated FGFR3 can either directly or indirectly tyrosine phosphorylate TAK1 ( Figure 2A ) 
[?A textMine:dobj ?E, ?C textMine:nn ?function, ?I textMine:partmod ?J, ?F textMine:nsubj ?C, ?G textMine:advmod ?impact, ?K textMine:conj ?I, ?K textMine:partmod ?A, ?E textMine:appos ?mutation, ?E textMine:amod ?G, ?J textMine:ccomp ?F]
Added to queryTripless!! : ?A textMine:dobj ?E. ?C textMine:nn ?function. ?I textMine:partmod ?J. ?F textMine:nsubj ?C. ?G textMine:advmod ?positive. ?K textMine:conj ?I. ?K textMine:partmod ?A. ?E textMine:appos ?mutation. ?E textMine:amod ?G. ?J textMine:ccomp ?F. 
429

520 BCR ABL mutations respond differently to three tyrosine kinase inhibitors approved for first line treatment of CML, e g, Y253F and G250E mutations resistant to imatinib can respond to nilotinib or/and dasatinib, T315A shows better response to imatinib though resistant to Dasatinib and Nilotinib, while some mutations are less sensitive to nilotinib (E255K/V and F359V/C) or dasatinib (F317L and V299L)  
[?B textMine:cop ?impact, ?B textMine:advmod ?function]
[?B textMine:advmod ?function, ?B textMine:cop ?impact, ]
Match 


521 TRAIL dependence on the constitutive activation of BRAF V600E  is emphasised through the overexpression of BRAF V600E  in the permissive genetic background of colon adenocarcinoma Caco 2 cells 
[?C textMine:prep ?A, ?C textMine:nsubjpass ?B, ?A textMine:prep ?mutation, ?function textMine:amod ?impact, ?B textMine:prep ?function]
Added to queryTripless!! : ?C textMine:prep ?A. ?C textMine:nsubjpass ?B. ?A textMine:prep ?mutation. ?function textMine:amod ?positive. ?B textMine:prep ?function. 
430

522 Ki67 labeling revealed an enhanced proliferation index in JoMa1 ALK F1174L derived tumors (48%) compared to JoMa1 ALK R1275Q  (40%), and JoMa1 ALK wt derived tumors (38%) (Figure  3b ), suggesting that the accelerated tumor growth of JoMa1 ALK F1174L tumors may partly result from their increased proliferation capacity 
[?A textMine:prep ?C, ?A textMine:nsubj ?B, ?B textMine:prep ?F, ?F textMine:nn ?mutation, ?C textMine:nn ?function, ?C textMine:amod ?impact]
Added to queryTripless!! : ?A textMine:prep ?C. ?A textMine:nsubj ?B. ?B textMine:prep ?F. ?F textMine:nn ?mutation. ?C textMine:nn ?function. ?C textMine:amod ?positive. 
431

523 Previous studies in other cellular contexts have demonstrated that the S252W FGFR2 mutant receptor exhibits decreased ligand dissociation ( Anderson et al, 1998 ) 
[?impact textMine:nsubj ?function, ?function textMine:nn ?mutation]
Added to queryTripless!! : ?negative textMine:nsubj ?function. ?function textMine:nn ?mutation. 
432

524 Indeed, dual blockade of MEK/BRAF V600E  (with PD184352, PLX4720 or vemurafenib) and MET (with crizotinib, SU11274 or MET specific siRNA) resulted in reversal of drug resistance and reduced the proliferation of melanoma cell lines, which was restored by exogenous HGF ( 29 , 109 ) 
[?impact textMine:nsubj ?C, ?impact textMine:dobj ?function, ?C textMine:prep ?mutation]
Query : [?impact textMine:nsubj ?C, ?impact textMine:dobj ?function, ?C textMine:prep ?mutation]
Existing trips : 
?A textMine:prep ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?A. 
Similar Query!!!!


526 The most characterized resistance mutation is the T790M point mutation in exon 20, which increases the affinity of the EGFR for ATP, thus reducing the binding of EGFR TKIs to the ATP pocket 
[?impact textMine:dobj ?function, ?D textMine:prep ?E, ?D textMine:amod ?mutation, ?E textMine:rcmod ?impact]
Added to queryTripless!! : ?positive textMine:dobj ?function. ?D textMine:prep ?E. ?D textMine:amod ?mutation. ?E textMine:rcmod ?positive. 
433

527 BRAF V600E   enhances the migrating and invasive capacity of colon adenocarcinoma cells through RhoA activation  
[?impact textMine:nsubj ?mutation, ?impact textMine:prep ?function]
Added to queryTripless!! : ?positive textMine:nsubj ?mutation. ?positive textMine:prep ?function. 
434

528 Notably, inhibition of phosphorylation of the D816V mutation was significantly reduced compared to the D816Y and D816F isoforms 
[?C textMine:prep ?function, ?impact textMine:pobj ?B, ?impact textMine:nsubjpass ?C, ?B textMine:nn ?mutation]
Added to queryTripless!! : ?C textMine:prep ?function. ?negative textMine:pobj ?B. ?negative textMine:nsubjpass ?C. ?B textMine:nn ?mutation. 
435

529 To ascertain whether E SLAM HSCs from JAK2 V617F  mice were less functional than normal controls, 10 donor E SLAM HSCs were transplanted alongside competitor BM cells and secondary transplantations were performed using BM from all the primary recipients showing even trace amounts of donor derived repopulation 
[?B textMine:prep ?E, ?E textMine:nn ?mutation, ?function textMine:advmod ?impact, ?function textMine:nsubj ?B]
Added to queryTripless!! : ?B textMine:prep ?E. ?E textMine:nn ?mutation. ?function textMine:advmod ?negative. ?function textMine:nsubj ?B. 
436

530 Similar to oncogenic Ras, the BRAF V600E  mutant induces an increase in the number of senescent cells in melanoma  (92)  
[?function textMine:dobj ?impact, ?function textMine:nsubj ?C, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:dobj ?positive. ?function textMine:nsubj ?C. ?C textMine:nn ?mutation. 
437

531 Thus, in in vitro  assays carried out using metformin, MPP + , or TEA as prototypical substrates, a reduced or even abolished OCT1 mediated transport activity was observed for R61C, C88R, S189L, G220V, P341L, G401S, M420del, G465R, P283L, R287G, P117L, Q97K, R206C, R61S fs∗10, and C88A fs∗16 ( Table 4 ) 
[?C textMine:prep ?B, ?C textMine:nsubjpass ?function, ?B textMine:appos ?mutation, ?E textMine:conj ?A, ?E textMine:amod ?impact, ?A textMine:amod ?G, ?G textMine:ccomp ?C]
Added to queryTripless!! : ?C textMine:prep ?B. ?C textMine:nsubjpass ?function. ?B textMine:appos ?mutation. ?E textMine:conj ?A. ?E textMine:amod ?negative. ?A textMine:amod ?G. ?G textMine:ccomp ?C. 
438

532 Intriguingly, the imatinib resistant BCR/ABL mutants E255K and T315I showed increased ability as compared with native BCR/ABL to induce tyrosine phosphorylation of PECAM 1 when expressed in the murine model hematopoietic cell line BaF3 cells or in 293T cells ( Fig 4 ) 
[?B textMine:dobj ?function, ?E textMine:infmod ?B, ?E textMine:amod ?impact, ?A textMine:dobj ?E, ?A textMine:nsubj ?mutation]
Added to queryTripless!! : ?B textMine:dobj ?function. ?E textMine:infmod ?B. ?E textMine:amod ?positive. ?A textMine:dobj ?E. ?A textMine:nsubj ?mutation. 
439

533 When we first verified the expression level of genes up regulated by FGFR2 +/S252W , similar significant alterations in these genes in FGF2 induced control fibroblasts was only observed after 24 h    
[?G textMine:partmod ?E, ?D textMine:nsubjpass ?impact, ?D textMine:advcl ?F, ?impact textMine:prep ?H, ?E textMine:agent ?mutation, ?J textMine:nn ?function, ?H textMine:prep ?J, ?F textMine:dobj ?B, ?B textMine:prep ?G]
Added to queryTripless!! : ?G textMine:partmod ?E. ?D textMine:nsubjpass ?unknown. ?D textMine:advcl ?F. ?unknown textMine:prep ?H. ?E textMine:agent ?mutation. ?J textMine:nn ?function. ?H textMine:prep ?J. ?F textMine:dobj ?B. ?B textMine:prep ?G. 
440

534 These cells express an FGFR3 mutant, K650E, which has significantly enhanced tyrosine kinase activity   
[?impact textMine:dobj ?function, ?C textMine:appos ?mutation, ?C textMine:rcmod ?impact]
Added to queryTripless!! : ?positive textMine:dobj ?function. ?C textMine:appos ?mutation. ?C textMine:rcmod ?positive. 
441

535 BRAF V600E   mutations are found in 60% of benign nevi and are thought to result in the initial increase in proliferation of melanocytic cells followed by induction of cell cycle arrest and senescence   
[?B textMine:prep ?impact, ?B textMine:xsubj ?D, ?D textMine:nn ?mutation, ?impact textMine:prep ?function]
Added to queryTripless!! : ?B textMine:prep ?positive. ?B textMine:xsubj ?D. ?D textMine:nn ?mutation. ?positive textMine:prep ?function. 
442

536 Depletion of PKN1 increases apoptosis initiated by a BRAF V600E inhibitor 
[?impact textMine:dobj ?function, ?function textMine:partmod ?A, ?B textMine:nn ?mutation, ?A textMine:agent ?B]
Added to queryTripless!! : ?positive textMine:dobj ?function. ?function textMine:partmod ?A. ?B textMine:nn ?mutation. ?A textMine:agent ?B. 
443

537 In vitro, both S249C and K652E or K653M mutations are shown to constitutively increase the FGFR3 kinase activity, albeit with different mechanisms ( Naski et al , 1996 ;  d’Avis et al, 1998 ) 
[?impact textMine:xsubj ?mutation, ?impact textMine:dobj ?function]
[?impact textMine:dobj ?function, ?impact textMine:xsubj ?mutation, ]
Match 


567 These studies demonstrate that by targeting the switch pocket, this class of KIT inhibitors possesses a novel mechanism of inhibition whose dual suppression of KIT D816V neoplastic proliferation and SCF enhanced mast cell activation advocate future clinical development 
[?E textMine:prep ?mutation, ?D textMine:nsubj ?function, ?impact textMine:dobj ?E, ?impact textMine:ccomp ?D]
Added to queryTripless!! : ?E textMine:prep ?mutation. ?D textMine:nsubj ?function. ?positive textMine:dobj ?E. ?positive textMine:ccomp ?D. 
444

538 NFAT transcriptional activity was approximately 10 fold higher in A375 cells and approximately 70 fold higher in WM266 4 cells compared with  BRAF  wild type CHL 1 cells ( Figure 1A ), consistent with increased B RAF activity of BRAF V600D  compared with BRAF V600E  ( Wan  et al , 2004 ) 
[?A textMine:amod ?D, ?G textMine:pobj ?mutation, ?C textMine:nsubj ?A, ?C textMine:ccomp ?impact, ?function textMine:prep ?G, ?D textMine:prep ?function]
[?A textMine:amod ?D, ?C textMine:ccomp ?impact, ?C textMine:nsubj ?A, ?D textMine:prep ?function, ?G textMine:pobj ?mutation, ?function textMine:prep ?G, ]
Match 


539 The mutation F359V experiences decreased vdW (−2.13 kcal/mol) and electrostatic interactions (−0.16 kcal/mol), while decreased electrostatic interactions are experienced due to mutations E255K (0 35 kcal/mol) and E255V (−009 kcal/mol) 
[?function textMine:amod ?impact]
Added to queryTripless!! : ?function textMine:amod ?negative. 
445

540 BRAF V600E  is the most prevalent genetic alteration implicated in the initiation and progression of PTC, especially in aggressive subtypes such as the tall cell variant of PTC and in those with extra thyroidal extension and lymph node or distant metastases 
[?impact textMine:nsubj ?mutation, ?impact textMine:partmod ?function]
Added to queryTripless!! : ?unknown textMine:nsubj ?mutation. ?unknown textMine:partmod ?function. 
446

541 Our observation that NFAT activity was higher in V600D mutated WM266 4 cells compared with V600E mutated A375 cells, which correlated with the amount of BRAF kinase activity evoked by each mutant is particularly noteworthy 
[?C textMine:rcmod ?F, ?C textMine:num ?mutation, ?B textMine:pobj ?C, ?B textMine:advmod ?impact, ?G textMine:prep ?function, ?F textMine:prep ?G]
[?B textMine:advmod ?impact, ?B textMine:pobj ?C, ?C textMine:num ?mutation, ?C textMine:rcmod ?F, ?F textMine:prep ?G, ?G textMine:prep ?function, ]
Match 


542 Indeed, upon the addition of NN, hTMSC chemotactic migration was significantly reduced compared with the control condition as well as to N C  stimulated cells ( Fig. 3  A )  Furthermore, in NSCLC line H1975, which expresses EGFR with the double mutation L858R and T790M as well as HER2 and HER3  , NN stimulation reduced chemokinesis relative to NRG stimulated and untreated control cells ( Fig 3 ,  B  and  C ) 
[?D textMine:appos ?function, ?F textMine:nsubjpass ?E, ?C textMine:nsubj ?impact, ?E textMine:prep ?D, ?G textMine:advcl ?F, ?G textMine:xcomp ?C]
Added to queryTripless!! : ?D textMine:appos ?function. ?F textMine:nsubjpass ?E. ?C textMine:nsubj ?negative. ?E textMine:prep ?D. ?G textMine:advcl ?F. ?G textMine:xcomp ?C. 
447

543 Residue Leu573 forms hydrophobic interactions that appear to stabilize the helical segment of the SH2 PK linker, and mutation of the corresponding residue in Jak2 from methionine to alanine (M535A) also reversed V617F driven proliferation 
[?function textMine:xsubj ?E, ?A textMine:dobj ?E, ?A textMine:conj ?B, ?B textMine:dobj ?mutation]
Added to queryTripless!! : ?function textMine:xsubj ?E. ?A textMine:dobj ?E. ?A textMine:conj ?B. ?B textMine:dobj ?mutation. 
448

544 In addition, the  JAK2  V617F  mutation may increase the stability of the JAK2 protein by rendering it resistant to the effect of SOCS3 binding, as overexpression of SOCS3 results in increased SOCS3 and  JAK2  V617F  phosphorylation [ 68 ] 
[?G textMine:num ?mutation, ?A textMine:amod ?impact, ?function textMine:prep ?A, ?C textMine:conj ?G, ?C textMine:prep ?F, ?F textMine:prep ?function]
Added to queryTripless!! : ?G textMine:num ?mutation. ?A textMine:amod ?positive. ?function textMine:prep ?A. ?C textMine:conj ?G. ?C textMine:prep ?F. ?F textMine:prep ?function. 
449

545 The EGFR  T790M variant changes the structural conformation of the ATP binding site, thereby increasing the affinity of ATP to EGFR, while the affinity of gefitinib to ATP is unchanged 
[?A textMine:nsubj ?function, ?impact textMine:advcl ?A, ?E textMine:dobj ?C, ?E textMine:nsubj ?G, ?C textMine:prep ?F, ?F textMine:partmod ?impact, ?G textMine:nn ?mutation]
Added to queryTripless!! : ?A textMine:nsubj ?function. ?positive textMine:advcl ?A. ?E textMine:dobj ?C. ?E textMine:nsubj ?G. ?C textMine:prep ?F. ?F textMine:partmod ?positive. ?G textMine:nn ?mutation. 
450

546 We found that the suppressor of cytokine signaling 3 ( SOCS3 ) expression was significantly elevated in MPN patients with a  JAK2  V617F mutation, suggesting that  SOCS3  mRNA in peripheral blood can be used as a biomarker for diagnosis and assessment of MPN patients 
[?C textMine:partmod ?B, ?impact textMine:prep ?E, ?impact textMine:nsubj ?D, ?B textMine:dobj ?A, ?D textMine:prep ?C, ?H textMine:nsubj ?function, ?A textMine:rcmod ?H, ?E textMine:nn ?mutation]
Added to queryTripless!! : ?C textMine:partmod ?B. ?positive textMine:prep ?E. ?positive textMine:nsubj ?D. ?B textMine:dobj ?A. ?D textMine:prep ?C. ?H textMine:nsubj ?function. ?A textMine:rcmod ?H. ?E textMine:nn ?mutation. 
451

547 The effect on the downstream signal mediators p AKT [S473] and p STAT3 [Y705] correlated well with the inhibition of EGFR phosphorylation ( Figure 1A ); E884K in  cis  with L858R decreased erlotinib inhibition of AKT and STAT3 phosphorylation but increased inhibition by gefitinib 
[?impact textMine:conj ?D, ?impact textMine:nsubj ?mutation, ?D textMine:dobj ?function, ?D textMine:nsubj ?mutation]
Added to queryTripless!! : ?negative textMine:conj ?D. ?negative textMine:nsubj ?mutation. ?D textMine:dobj ?function. ?D textMine:nsubj ?mutation. 
452

548 Taken together these data suggest that BRAF V600E  is able to relax cell cell junctions by reducing E cadherin expression and may drive colon epithelial cells to a more aggressive phenotype, while KRAS G12V  reserves their epithelial characteristics 
[?A textMine:xsubj ?mutation, ?A textMine:prepc ?impact, ?impact textMine:dobj ?function]
Added to queryTripless!! : ?A textMine:xsubj ?mutation. ?A textMine:prepc ?negative. ?negative textMine:dobj ?function. 
453

549 Our studies here, using COS 7 transfection model system, show that E884K works in concert with L858R in  cis , in a dominant fashion, to change downstream signaling, differentially induce MAPK ERK1/2 signaling and associated cell proliferation, and differentially alter sensitivity of EGFR phosphorylation inhibition by ERBB family inhibitors in an inhibitor specific fashion 
[?A textMine:xsubj ?mutation, ?A textMine:conj ?impact, ?impact textMine:dobj ?function]
[?A textMine:conj ?impact, ?A textMine:xsubj ?mutation, ?impact textMine:dobj ?function, ]
Match 


550 Structurally, this residue lies in the substrate binding pocket of the kinase, and the M918T mutation appears to increase RET–ATP binding affinity and the stability of the active ATP bound form, effectively making RET more active, more of the time ( 48 )–( 51 ) 
[?C textMine:dep ?function, ?impact textMine:dobj ?C, ?impact textMine:xsubj ?B, ?B textMine:nn ?mutation]
Added to queryTripless!! : ?C textMine:dep ?function. ?positive textMine:dobj ?C. ?positive textMine:xsubj ?B. ?B textMine:nn ?mutation. 
454

552 Correcting the results for the variables that could have influence on BT,  JAK2 V617F wt and homozygous genotypes remained independently associated with BT 
[?function textMine:aux ?impact, ?function textMine:nsubj ?B, ?B textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:aux ?neutral. ?function textMine:nsubj ?B. ?B textMine:nn ?mutation. 
455

553 The sensitivity and accuracy of the PNAcqPCR method were both higher than those of DS for the detection of the  BRAF  V600E  mutation 
[?B textMine:nn ?mutation, ?A textMine:prep ?B, ?impact textMine:prep ?A, ?impact textMine:nsubj ?function]
Added to queryTripless!! : ?B textMine:nn ?mutation. ?A textMine:prep ?B. ?positive textMine:prep ?A. ?positive textMine:nsubj ?function. 
456

554 The other possibility is that the presence of the EGFR T790M mutation could increase the affinity of the EGFR L858R for ATP and thus reduce the potency of an ATP competitive kinase inhibitor   
[?impact textMine:dobj ?function, ?function textMine:prep ?mutation]
Added to queryTripless!! : ?positive textMine:dobj ?function. ?function textMine:prep ?mutation. 
457

555 Upon FGF2 stimulation, S252W fibroblasts significantly altered expression of 55 DEGs, up regulating 21 genes and down regulating 34 genes ( Table S3 ) 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?D, ?D textMine:nn ?mutation]
Query : [?impact textMine:dobj ?function, ?impact textMine:nsubj ?D, ?D textMine:nn ?mutation]
Existing trips : 
?C textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?C. 
Similar Query!!!!


556 Potentially, the increased TGFβ2 expression resulting from SF 1 knockdown could pose a problem for such a therapy if childhood tumors have dysregulated TGFβ signaling like the NCI H295R cells, and this needs to be explored further 
[?function textMine:amod ?impact, ?C textMine:xcomp ?A, ?G textMine:advcl ?C, ?G textMine:nsubj ?function, ?F textMine:nn ?mutation, ?A textMine:prep ?F]
Added to queryTripless!! : ?function textMine:amod ?positive. ?C textMine:xcomp ?A. ?G textMine:advcl ?C. ?G textMine:nsubj ?function. ?F textMine:nn ?mutation. ?A textMine:prep ?F. 
458

557 Mcl 1 depletion in JAK2 V617F  mutant SET 2 cells increases apoptosis and sensitizes the cells to NVP BSK805 induced cell death  
[?mutation textMine:rcmod ?function, ?mutation textMine:rcmod ?D, ?function textMine:nsubj ?impact, ?D textMine:conj ?function, ?D textMine:nsubj ?impact]
Added to queryTripless!! : ?mutation textMine:rcmod ?function. ?mutation textMine:rcmod ?D. ?function textMine:nsubj ?positive. ?D textMine:conj ?function. ?D textMine:nsubj ?positive. 
459

558 In summary, we have demonstrated that targeting the switch pocket of KIT offers a novel and selective method to effectively suppress KIT D816V neoplastic proliferation and SCF enhanced mast cell activation 
[?function textMine:amod ?impact, ?D textMine:nn ?mutation, ?D textMine:conj ?function]
Added to queryTripless!! : ?function textMine:amod ?positive. ?D textMine:nn ?mutation. ?D textMine:conj ?function. 
460

559 F1174L may therefore stabilize an active conformation that is both more oncogenic and less favored for crizotinib binding 
[?D textMine:amod ?function, ?A textMine:dobj ?D, ?A textMine:nsubj ?mutation]
Added to queryTripless!! : ?D textMine:amod ?function. ?A textMine:dobj ?D. ?A textMine:nsubj ?mutation. 
461

560 The pan BCR ABL kinase inhibitor ponatinib exhibits potent activity against native, T315I, and all other clinically relevant mutants, and showed better inhibition than the previously known inhibitors 
[?function textMine:amod ?impact, ?B textMine:dobj ?function, ?E textMine:conj ?B, ?E textMine:prep ?mutation]
Added to queryTripless!! : ?function textMine:amod ?positive. ?B textMine:dobj ?function. ?E textMine:conj ?B. ?E textMine:prep ?mutation. 
462

561 To test whether functional interactions between NF1 and ALK exist in human cells, we used the SK SY5Y and Kelly neuroblastoma cells, both of which harbor constitutively active F1174L  ALK  alleles, and both of which are highly sensitive to pharmacological ALK inhibition  
[?B textMine:nsubj ?D, ?D textMine:nn ?mutation, ?function textMine:advmod ?impact, ?function textMine:ccomp ?B]
Added to queryTripless!! : ?B textMine:nsubj ?D. ?D textMine:nn ?mutation. ?function textMine:advmod ?positive. ?function textMine:ccomp ?B. 
463

562 (A) JAK2 K539L, T875N and R683G all induce constitutive activation of JAK2, however all three mutants display a marked decrease in STAT5 transcriptional activity in γ 2A cells when the F595A mutation is also introduced 
[?D textMine:dep ?B, ?D textMine:dobj ?E, ?D textMine:nsubj ?mutation, ?F textMine:prep ?function, ?E textMine:amod ?impact, ?B textMine:dobj ?F]
Added to queryTripless!! : ?D textMine:dep ?B. ?D textMine:dobj ?E. ?D textMine:nsubj ?mutation. ?F textMine:prep ?function. ?E textMine:amod ?positive. ?B textMine:dobj ?F. 
464

563 The expression levels of Runx2 were similar in  Fgfr2 +/S252W   mice and unaffected littermates, with high expression in osteoblasts and low expression in the intervening mesenchyme, but this mesenchyme was more extensive in the mutant suture 
[?C textMine:nn ?F, ?A textMine:prep ?B, ?A textMine:prep ?C, ?F textMine:amod ?mutation, ?B textMine:prep ?function, ?B textMine:amod ?impact]
Added to queryTripless!! : ?C textMine:nn ?F. ?A textMine:prep ?B. ?A textMine:prep ?C. ?F textMine:amod ?mutation. ?B textMine:prep ?function. ?B textMine:amod ?positive. 
465

564 Intriguingly, the imatinib resistant BCR/ABL mutants E255K and T315I showed increased ability as compared with native BCR/ABL to induce tyrosine phosphorylation of PECAM 1 when expressed in the murine model hematopoietic cell line BaF3 cells or in 293T cells ( Fig 4 ) 
[?function textMine:amod ?impact, ?A textMine:dobj ?function, ?A textMine:nsubj ?mutation]
Query : [?function textMine:amod ?impact, ?A textMine:dobj ?function, ?A textMine:nsubj ?mutation]
Existing trips : 
?D textMine:dobj ?function. ?D textMine:nsubj ?mutation. ?function textMine:amod ?impact. 
Similar Query!!!!


565 We found that tumors expressing Braf V600E  and either KRAS V12  or KRAS V12/C40  were significantly larger than those expressing Braf V600E  alone or Braf V600E  and the other KRAS ED  mutants 
[?A textMine:partmod ?function, ?A textMine:conj ?mutation, ?impact textMine:prep ?mutation, ?impact textMine:prep ?A]
Added to queryTripless!! : ?A textMine:partmod ?function. ?A textMine:conj ?mutation. ?positive textMine:prep ?mutation. ?positive textMine:prep ?A. 
466

566 Some of these mutations alter specifically the configuration of the ATP binding kinase pocket (V654A and T670I), inhibiting imatinib binding 
[?C textMine:amod ?function, ?D textMine:prep ?B, ?impact textMine:dobj ?D, ?B textMine:appos ?C, ?B textMine:appos ?mutation]
Added to queryTripless!! : ?C textMine:amod ?function. ?D textMine:prep ?B. ?unknown textMine:dobj ?D. ?B textMine:appos ?C. ?B textMine:appos ?mutation. 
467

568 We find an increased activity of SIRT1 in PLX4032 resistant BRAF V600E  mutated melanoma cells compared with their sensitive counterpart, thereby linking SIRT1 to drug resistance and poor prognosis in melanoma 
[?mutation textMine:partmod ?A, ?E textMine:prep ?mutation, ?E textMine:amod ?impact, ?A textMine:dobj ?C, ?C textMine:pobj ?G, ?G textMine:amod ?function]
Added to queryTripless!! : ?mutation textMine:partmod ?A. ?E textMine:prep ?mutation. ?E textMine:amod ?positive. ?A textMine:dobj ?C. ?C textMine:pobj ?G. ?G textMine:amod ?function. 
468

569 These domains interact when the enzyme is in the inactive conformation, and the V600E mutation shifts the kinase into the active conformation, suggesting that disrupting this interaction is a primary mechanism for activating the  BRAF  oncogenes 
[?impact textMine:dobj ?function, ?G textMine:ccomp ?F, ?F textMine:csubj ?impact, ?A textMine:partmod ?G, ?A textMine:nsubj ?C, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?negative textMine:dobj ?function. ?G textMine:ccomp ?F. ?F textMine:csubj ?negative. ?A textMine:partmod ?G. ?A textMine:nsubj ?C. ?C textMine:nn ?mutation. 
469

570 Cells expressing the L747_E749del A750P and D770_N771insNPG  EGFR  mutants also exhibited a greater degree of loss of contact inhibition than was observed in cells expressing the L858R or G719S EGFR mutants in a primary focus formation assay (unpublished data) 
[?A textMine:dobj ?mutation, ?B textMine:prep ?G, ?G textMine:partmod ?A, ?C textMine:prep ?H, ?C textMine:amod ?impact, ?H textMine:prep ?function, ?D textMine:advcl ?B, ?D textMine:dobj ?C]
Added to queryTripless!! : ?A textMine:dobj ?mutation. ?B textMine:prep ?G. ?G textMine:partmod ?A. ?C textMine:prep ?H. ?C textMine:amod ?positive. ?H textMine:prep ?function. ?D textMine:advcl ?B. ?D textMine:dobj ?C. 
470

571 This study finds that the two most common EGFR mutations in non small cell lung cancer (L858R and Δ746–750) result in EGF–independent tEGFR activities comparable to, or greater than, the activity of EGF–stimulated WT EGFR, and that tEGFR activation resulting from these mutations remains strongly coupled to asymmetric kinase dimer formation ( Fig 3d ) 
[?B textMine:dep ?mutation, ?impact textMine:nsubj ?D, ?D textMine:partmod ?function, ?C textMine:conj ?impact, ?C textMine:nsubj ?B]
Added to queryTripless!! : ?B textMine:dep ?mutation. ?neutral textMine:nsubj ?D. ?D textMine:partmod ?function. ?C textMine:conj ?neutral. ?C textMine:nsubj ?B. 
471

572 As previously reported  , levels of phosphorylated RET and ERK were constitutively high in untreated PC12/MEN2A cells due to the presence of the active RET C634Y  allele 
[?A textMine:prep ?D, ?D textMine:nn ?mutation, ?C textMine:amod ?function, ?impact textMine:prep ?B, ?impact textMine:nsubj ?H, ?H textMine:prep ?C, ?B textMine:prep ?A]
Added to queryTripless!! : ?A textMine:prep ?D. ?D textMine:nn ?mutation. ?C textMine:amod ?function. ?positive textMine:prep ?B. ?positive textMine:nsubj ?H. ?H textMine:prep ?C. ?B textMine:prep ?A. 
472

573 These data suggest that binding to PtsInsP species is enhanced by the E416A mutation, in agreement with the MD results reported above 
[?C textMine:nn ?mutation, ?impact textMine:agent ?C, ?impact textMine:nsubjpass ?E, ?E textMine:amod ?function]
Added to queryTripless!! : ?C textMine:nn ?mutation. ?positive textMine:agent ?C. ?positive textMine:nsubjpass ?E. ?E textMine:amod ?function. 
473

574 These differences in MITF activity may reflect distinct subtypes of melanoma; however, another possibility is that MITF amplification indicates the need for melanoma cells to maintain sufficient MITF activity for survival in the context of high BRAF V600E  signaling   
[?D textMine:nn ?mutation, ?A textMine:prep ?D, ?impact textMine:dobj ?function, ?impact textMine:prep ?A]
Query : [?D textMine:nn ?mutation, ?A textMine:prep ?D, ?impact textMine:dobj ?function, ?impact textMine:prep ?A]
Existing trips : 
?A textMine:nn ?mutation. ?E textMine:prep ?A. ?impact textMine:dobj ?function. ?impact textMine:prep ?E. 
Similar Query!!!!


575 Mutations to this protein such as G469A, E586K, V600E, and K601E can increase BRAF catalytic activity  
[?C textMine:prep ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?D, ?D textMine:prep ?C]
Added to queryTripless!! : ?C textMine:prep ?mutation. ?positive textMine:dobj ?function. ?positive textMine:nsubj ?D. ?D textMine:prep ?C. 
474

576 Treatment with UO126, at the most optimal treatment condition (Additional Figure 3 ), resulted in the decreased activation of RhoA illustrating that mutant BRAF V600E  utilises the MAPK pathway to activate RhoA (Figure  5E , upper panel) 
[?F textMine:prep ?C, ?F textMine:amod ?impact, ?C textMine:partmod ?H, ?H textMine:ccomp ?E, ?A textMine:nn ?function, ?E textMine:prep ?A, ?E textMine:nsubj ?mutation]
Added to queryTripless!! : ?F textMine:prep ?C. ?F textMine:amod ?negative. ?C textMine:partmod ?H. ?H textMine:ccomp ?E. ?A textMine:nn ?function. ?E textMine:prep ?A. ?E textMine:nsubj ?mutation. 
475

578 The EphA3 G518L mutation found in lung cancer increases the affinity of the lateral interaction between EphA3 and ephrin A3 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?A, ?A textMine:nn ?mutation]
Query : [?impact textMine:dobj ?function, ?impact textMine:nsubj ?A, ?A textMine:nn ?mutation]
Existing trips : 
?C textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?C. 
Similar Query!!!!


579 Hence, the E884K mutation, when in  cis  with L858R, modulates the sensitivity of the mutant receptor towards ERBB family kinase inhibitors in an inhibitor specific fashion 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?A, ?A textMine:amod ?mutation]
[?A textMine:amod ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?A, ]
Match 


580 Research into the molecular mechanisms of BRAF V600E  positive tumors has revealed that the missense valine to glutamic acid mutation increases kinase activity, promoting the constitutive activation of MEK ERK signaling and enhancing ERK dependent transcriptional output  
[?D textMine:prep ?G, ?I textMine:dobj ?function, ?E textMine:ccomp ?B, ?E textMine:nsubj ?D, ?G textMine:prep ?H, ?H textMine:nn ?mutation, ?B textMine:partmod ?I, ?function textMine:amod ?impact]
Added to queryTripless!! : ?D textMine:prep ?G. ?I textMine:dobj ?function. ?E textMine:ccomp ?B. ?E textMine:nsubj ?D. ?G textMine:prep ?H. ?H textMine:nn ?mutation. ?B textMine:partmod ?I. ?function textMine:amod ?positive. 
476

581 In a dose response experiment ( Figure 3 B, left panel), the best inhibitor, D4, was effective at a concentration of 200 nM to inhibit RET C634Y  autophosphorylation up to 70% and to drastically reduce ERK phosphorylation 
[?impact textMine:dobj ?function, ?E textMine:nsubj ?mutation, ?B textMine:conj ?impact, ?B textMine:ccomp ?E]
Added to queryTripless!! : ?negative textMine:dobj ?function. ?E textMine:nsubj ?mutation. ?B textMine:conj ?negative. ?B textMine:ccomp ?E. 
477

582 A change at residue 600 in the BRAF gene (V600E) leads to 500 fold increased activation of BRAF V600E  MEK ERK signaling in tumor cells, a signaling pathway that is frequently mutated in melanoma (Cantwell Dorris et al,  2011 ) 
[?function textMine:prep ?C, ?function textMine:amod ?impact, ?C textMine:nn ?mutation]
Query : [?function textMine:prep ?C, ?function textMine:amod ?impact, ?C textMine:nn ?mutation]
Existing trips : 
?A textMine:nn ?mutation. ?function textMine:amod ?impact. ?function textMine:prep ?A. 
Similar Query!!!!


583 Recent studies show that EGFR expression occurs in a significant percentage of BRAF resistant melanomas, and receptor activation, though disadvantageous under normal conditions, becomes beneficial when the MAPK pathway is blocked in BRAF V600E  positive melanomas [ 40 ] 
[?impact textMine:advcl ?C, ?impact textMine:nsubj ?function, ?E textMine:nn ?mutation, ?C textMine:prep ?E]
Added to queryTripless!! : ?positive textMine:advcl ?C. ?positive textMine:nsubj ?function. ?E textMine:nn ?mutation. ?C textMine:prep ?E. 
478

584 Intriguingly, the imatinib resistant BCR/ABL mutants E255K and T315I showed increased ability as compared with native BCR/ABL to induce tyrosine phosphorylation of PECAM 1 when expressed in the murine model hematopoietic cell line BaF3 cells or in 293T cells ( Fig 4 ) 
[?function textMine:amod ?impact, ?A textMine:dobj ?function, ?A textMine:nsubj ?mutation]
Query : [?function textMine:amod ?impact, ?A textMine:dobj ?function, ?A textMine:nsubj ?mutation]
Existing trips : 
?D textMine:dobj ?function. ?D textMine:nsubj ?mutation. ?function textMine:amod ?impact. 
Similar Query!!!!


585 Instead, the T790M mutation induces resistance by increasing the binding affinity of ATP by one order of magnitude, which is near the affinity for wild type  EGFR , thus enabling ATP to compete effectively with the kinase inhibitors   
[?A textMine:nn ?mutation, ?function textMine:prepc ?impact, ?function textMine:nsubj ?A]
Added to queryTripless!! : ?A textMine:nn ?mutation. ?function textMine:prepc ?positive. ?function textMine:nsubj ?A. 
479

586 Non hotspot AKT1 PH domain mutants L52R, C77F, and Q79K increase Akt1 activation and downstream signaling
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation]
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation, ]
Match 


587 In colon cancer suppression of BRAF in cell lines with BRAF V600E  showed significant decreased proliferation through cyclin D1 and p27 Kip1  and induces apoptosis by a significant decrease in the levels of anti apoptotic protein Bcl 2   
[?function textMine:nsubj ?mutation, ?function textMine:prep ?impact]
Added to queryTripless!! : ?function textMine:nsubj ?mutation. ?function textMine:prep ?negative. 
480

588 Moreover, treatment of mice carrying BRAF V600E  PTC with BRAF inhibitors reduced tumor proliferative index and partially restored thyroid specific gene expression (Chakravarty et al,  2011 ) 
[?H textMine:nn ?mutation, ?F textMine:dobj ?function, ?F textMine:nsubj ?D, ?G textMine:dobj ?H, ?C textMine:partmod ?G, ?D textMine:prep ?C, ?impact textMine:conj ?F, ?impact textMine:nsubj ?D]
Added to queryTripless!! : ?H textMine:nn ?mutation. ?F textMine:dobj ?function. ?F textMine:nsubj ?D. ?G textMine:dobj ?H. ?C textMine:partmod ?G. ?D textMine:prep ?C. ?negative textMine:conj ?F. ?negative textMine:nsubj ?D. 
481

589 Previous  in vivo  analyses of the Fgfr2 P253R/+  and Fgfr2 S252W/+  mouse models of Apert syndrome revealed increased osteoblastic gene expression around the coronal suture   
[?A textMine:dobj ?function, ?A textMine:nsubj ?C, ?function textMine:amod ?impact, ?C textMine:prep ?B, ?B textMine:nn ?mutation]
Query : [?A textMine:dobj ?function, ?A textMine:nsubj ?C, ?function textMine:amod ?impact, ?C textMine:prep ?B, ?B textMine:nn ?mutation]
Existing trips : 
?A textMine:nn ?mutation. ?D textMine:dobj ?function. ?D textMine:nsubj ?E. ?E textMine:prep ?A. ?function textMine:amod ?impact. 
Similar Query!!!!


590 Taken together, these data provide support that cooperative enhanced inhibition using dual TKIs against MET and EGFR pathways may be an effective treatment strategy to inhibit lung cancer with intrinsic or acquired T790M EGFR mediated TKI resistance 
[?A textMine:nsubj ?G, ?H textMine:ccomp ?A, ?I textMine:amod ?impact, ?function textMine:xsubj ?I, ?C textMine:xcomp ?function, ?C textMine:nsubj ?I, ?E textMine:conj ?H, ?E textMine:ccomp ?C, ?G textMine:nn ?mutation]
Added to queryTripless!! : ?A textMine:nsubj ?G. ?H textMine:ccomp ?A. ?I textMine:amod ?positive. ?function textMine:xsubj ?I. ?C textMine:xcomp ?function. ?C textMine:nsubj ?I. ?E textMine:conj ?H. ?E textMine:ccomp ?C. ?G textMine:nn ?mutation. 
482

591 One Akt mutant (E17K), found in a subset of human cancers, displays higher PIP3 binding, membrane localization, and activation (Brazil et al , ; Varnai et al, ) 
[?E textMine:conj ?function, ?E textMine:amod ?impact, ?C textMine:appos ?mutation, ?D textMine:dobj ?function, ?D textMine:dobj ?E, ?D textMine:nsubj ?C]
Added to queryTripless!! : ?E textMine:conj ?function. ?E textMine:amod ?positive. ?C textMine:appos ?mutation. ?D textMine:dobj ?function. ?D textMine:dobj ?E. ?D textMine:nsubj ?C. 
483

592 Immunoblot analysis revealed that this inhibition was caused by reduced phosphorylation of BCR ABL and Crk L and increased activation of PARP in Ba/F3 BCR ABL T315I cells after treatment with ponatinib ( Figure 1D ) 
[?B textMine:nn ?mutation, ?D textMine:prep ?B, ?function textMine:amod ?impact, ?function textMine:conj ?D]
Added to queryTripless!! : ?B textMine:nn ?mutation. ?D textMine:prep ?B. ?function textMine:amod ?negative. ?function textMine:conj ?D. 
484

593 Another study found uncoupling in rare TnC variants identified in DCM: cTnC Y5H, M103I, and I148V either decreased or abolished the effects of PKA phosphorylation on Ca 2+  sensitivity (Pinto et al,  2011 ) 
[?D textMine:prep ?function, ?impact textMine:dobj ?D, ?impact textMine:nsubj ?B, ?B textMine:conj ?mutation]
Added to queryTripless!! : ?D textMine:prep ?function. ?negative textMine:dobj ?D. ?negative textMine:nsubj ?B. ?B textMine:conj ?mutation. 
485

594 Selumetinib induces an increase in ADC in BRAF V600E  Colo205 colon tumour xenografts concomitant with inhibition of ERK1/2 signalling and tumour growth
[?function textMine:dobj ?impact, ?impact textMine:prep ?E, ?D textMine:nn ?mutation, ?E textMine:prep ?D]
Added to queryTripless!! : ?function textMine:dobj ?positive. ?positive textMine:prep ?E. ?D textMine:nn ?mutation. ?E textMine:prep ?D. 
486

595 Therefore,  BRAF  V600E increases the kinase activity that provides cancer cells with both proliferation and survival signals and promotes them to become tumors in the model system 
[?B textMine:nn ?function, ?C textMine:prep ?B, ?A textMine:rcmod ?C, ?impact textMine:dobj ?A, ?impact textMine:nsubj ?mutation]
Added to queryTripless!! : ?B textMine:nn ?function. ?C textMine:prep ?B. ?A textMine:rcmod ?C. ?positive textMine:dobj ?A. ?positive textMine:nsubj ?mutation. 
487

596 Two sensitive transfectants (harboring a  FLT3  D835V or  KIT  D816Y mutation) were immunoblotted – and showed higher elevated threonine 308 phosphorylation levels compared to  FLT3  ITD or  BCR ABL1  transfected cells 
[?G textMine:nn ?function, ?G textMine:amod ?impact, ?F textMine:dobj ?C, ?C textMine:nn ?mutation, ?B textMine:dobj ?G, ?B textMine:nsubjpass ?D, ?D textMine:dep ?F]
Added to queryTripless!! : ?G textMine:nn ?function. ?G textMine:amod ?positive. ?F textMine:dobj ?C. ?C textMine:nn ?mutation. ?B textMine:dobj ?G. ?B textMine:nsubjpass ?D. ?D textMine:dep ?F. 
488

597 Although not significant, our data showed a decrease in  MLH1  expression in samples harbouring BRAF V600E mutations (Figure  1 A), RET/PTC rearrangements (Figure  1 B), or transitions (Figure  1 C) 
[?impact textMine:prep ?function, ?F textMine:nn ?mutation, ?E textMine:dobj ?F, ?function textMine:prep ?A, ?A textMine:partmod ?E]
Added to queryTripless!! : ?negative textMine:prep ?function. ?F textMine:nn ?mutation. ?E textMine:dobj ?F. ?function textMine:prep ?A. ?A textMine:partmod ?E. 
489

598 Notably, inhibition of phosphorylation of the D816V mutation was significantly reduced compared to the D816Y and D816F isoforms 
[?impact textMine:nsubjpass ?function, ?impact textMine:pobj ?B, ?B textMine:nn ?mutation]
Added to queryTripless!! : ?negative textMine:nsubjpass ?function. ?negative textMine:pobj ?B. ?B textMine:nn ?mutation. 
490

599 In numerous studies, the  JAK2  V617F allele has been variably associated with higher indices of erythropoiesis, unchanged or decreased platelet counts, greater occurrence of thrombosis, increased BM fibrosis or cytoreductive treatments, older age, longer disease duration, or poorer survival in MPN   
[?B textMine:ccomp ?impact, ?B textMine:nsubjpass ?D, ?D textMine:nn ?mutation, ?impact textMine:dobj ?function]
Added to queryTripless!! : ?B textMine:ccomp ?positive. ?B textMine:nsubjpass ?D. ?D textMine:nn ?mutation. ?positive textMine:dobj ?function. 
491

600 Our data support the potential role of dual TKI combinatorial inhibition using EGFR inhibitors to enhance MET inhibition in T790M EGFR mediated therapy resistance 
[?A textMine:prep ?function, ?impact textMine:dobj ?A, ?function textMine:nn ?mutation]
Added to queryTripless!! : ?A textMine:prep ?function. ?positive textMine:dobj ?A. ?function textMine:nn ?mutation. 
492

601 Wnt5a  methylation also remained strongly associated with  BRAF  V600E before (OR=25 9,
[?function textMine:aux ?impact, ?function textMine:prep ?mutation]
Added to queryTripless!! : ?function textMine:aux ?neutral. ?function textMine:prep ?mutation. 
493

602 Partial degradation of mutant BRAF and insufficient MAPK pathway inhibition in Caco BR cells overexpressing mutant BRAF V600E , appear to preclude cell sensitivity to 17 AAG ( Figure S10 ), regardless of the interaction between mutant BRAF and Hsp90 in the Caco BR cells ( Figure 8B ) 
[?impact textMine:prep ?function, ?B textMine:partmod ?C, ?function textMine:prep ?B, ?C textMine:dobj ?mutation]
Added to queryTripless!! : ?negative textMine:prep ?function. ?B textMine:partmod ?C. ?function textMine:prep ?B. ?C textMine:dobj ?mutation. 
494

603 Our studies here, using COS 7 transfection model system, show that E884K works in concert with L858R in  cis , in a dominant fashion, to change downstream signaling, differentially induce MAPK ERK1/2 signaling and associated cell proliferation, and differentially alter sensitivity of EGFR phosphorylation inhibition by ERBB family inhibitors in an inhibitor specific fashion 
[?impact textMine:dobj ?function, ?B textMine:prep ?mutation, ?B textMine:xcomp ?impact]
Added to queryTripless!! : ?unknown textMine:dobj ?function. ?B textMine:prep ?mutation. ?B textMine:xcomp ?unknown. 
495

604 Furthermore, in some leukemias and myeloproliferative neoplasms, constitutive JAK2 activation (V617F mutation) drives malignant transformation [ 27 ] and this prompted a significant effort in targeting JAK2 inhibition as a potential therapeutic strategy 
[?function textMine:appos ?B, ?function textMine:amod ?impact, ?B textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:appos ?B. ?function textMine:amod ?positive. ?B textMine:nn ?mutation. 
496

605 In addition, the T1799A alteration can rather be associated with a second nucleotide mutation (G1798A) and leads to a V600K mutation in an additional ~6% to 29% of patients with a BRAF mutation   
[?function textMine:conj ?D, ?function textMine:nsubjpass ?impact, ?D textMine:prep ?C, ?D textMine:nsubj ?impact, ?C textMine:amod ?mutation]
Added to queryTripless!! : ?function textMine:conj ?D. ?function textMine:nsubjpass ?unknown. ?D textMine:prep ?C. ?D textMine:nsubj ?unknown. ?C textMine:amod ?mutation. 
497

606 Furthermore, constitutive activity of a JAK1 mutant homologous to JAK2 V617F (JAK1 V658F) was also inhibited by the homologous JAK1 F595 mutation (F636A), suggesting that our results in JAK2 might be relevant for activation of JAK1 mutants recently identified in T ALL     
[?A textMine:xcomp ?B, ?A textMine:nsubj ?F, ?F textMine:prep ?H, ?F textMine:amod ?impact, ?I textMine:appos ?mutation, ?B textMine:ccomp ?G, ?G textMine:prep ?function, ?H textMine:prep ?I]
Added to queryTripless!! : ?A textMine:xcomp ?B. ?A textMine:nsubj ?F. ?F textMine:prep ?H. ?F textMine:amod ?positive. ?I textMine:appos ?mutation. ?B textMine:ccomp ?G. ?G textMine:prep ?function. ?H textMine:prep ?I. 
498

607 Previously, we reported that constitutive activation of STAT5 induced by JAK2 (V617F) conferred growth factor independence on Ba/F3 cells and assumed that a wide range of genes induced by STAT5 activation seems to play important roles in cellular transformation induced by JAK2 (V617F); therefore, by performing DNA array analysis, the alteration of the gene expression was examined between cells expressing wild type JAK2 with EpoR (WT/EpoR cells) and cells expressing JAK2 (V617F) with EpoR (VF/EpoR cells) 
[?J textMine:partmod ?K, ?K textMine:agent ?function, ?H textMine:ccomp ?B, ?H textMine:nsubj ?M, ?E textMine:dobj ?mutation, ?D textMine:prep ?J, ?B textMine:nsubj ?D, ?M textMine:amod ?impact, ?L textMine:parataxis ?C, ?L textMine:ccomp ?H, ?C textMine:prep ?I, ?I textMine:dep ?E]
Added to queryTripless!! : ?J textMine:partmod ?K. ?K textMine:agent ?function. ?H textMine:ccomp ?B. ?H textMine:nsubj ?M. ?E textMine:dobj ?mutation. ?D textMine:prep ?J. ?B textMine:nsubj ?D. ?M textMine:amod ?positive. ?L textMine:parataxis ?C. ?L textMine:ccomp ?H. ?C textMine:prep ?I. ?I textMine:dep ?E. 
499

608 Jak2 V617F is constitutively activated without cytokine stimulation and stimulates the various downstream signaling pathways that are normally activated by cytokine stimulated Jak2, such as the STAT5, MEK/Erk and PI3K/Akt pathways, thus leading to cytokine independent cell survival and proliferation when expressed in cytokine dependent hematopoietic cell lines  
[?G textMine:dep ?A, ?G textMine:nsubj ?mutation, ?A textMine:dobj ?F, ?C textMine:conj ?G, ?C textMine:advmod ?impact, ?C textMine:nsubjpass ?mutation, ?F textMine:rcmod ?function]
Added to queryTripless!! : ?G textMine:dep ?A. ?G textMine:nsubj ?mutation. ?A textMine:dobj ?F. ?C textMine:conj ?G. ?C textMine:advmod ?positive. ?C textMine:nsubjpass ?mutation. ?F textMine:rcmod ?function. 
500

609 9   Preclinical studies have shown superior activity of afatinib over first generation TKIs, mainly due to (1) irreversible binding, which confers stronger binding affinity and potency, (2) ability to circumvent first generation TKI resistance mechanism T790M mutation in exon 20, and (3) effectiveness against multiple HER endothelial growth factor receptors   10  
[?A textMine:dobj ?function, ?A textMine:dobj ?E, ?A textMine:dep ?H, ?C textMine:amod ?impact, ?F textMine:rcmod ?I, ?I textMine:dobj ?C, ?E textMine:conj ?function, ?E textMine:nn ?mutation, ?H textMine:prep ?F]
Added to queryTripless!! : ?A textMine:dobj ?function. ?A textMine:dobj ?E. ?A textMine:dep ?H. ?C textMine:amod ?positive. ?F textMine:rcmod ?I. ?I textMine:dobj ?C. ?E textMine:conj ?function. ?E textMine:nn ?mutation. ?H textMine:prep ?F. 
501

610 One Akt mutant (E17K), found in a subset of human cancers, displays higher PIP3 binding, membrane localization, and activation (Brazil et al , ; Varnai et al, ) 
[?function textMine:amod ?impact, ?B textMine:appos ?mutation, ?C textMine:dobj ?function, ?C textMine:nsubj ?B]
[?B textMine:appos ?mutation, ?C textMine:dobj ?function, ?C textMine:nsubj ?B, ?function textMine:amod ?impact, ]
Match 


611 Briefly, wild type or constitutively active (K650E) sequences of the human FGFR3 cytoplasmic domain amino acids 399–806) were fused to the LexA DNA binding domain in the pBTM116 plasmid and used to screen a human chondrocyte library encoding fusion proteins with the Gal4 activation domain (BD Biosciences Clontech, Palo Alto, CA) in the L40 strain of Saccharomyces cerevisiae  
[?E textMine:nn ?function, ?G textMine:prep ?E, ?B textMine:xcomp ?G, ?B textMine:xsubj ?A, ?I textMine:amod ?F, ?A textMine:conj ?I, ?F textMine:dep ?mutation, ?F textMine:advmod ?impact]
Added to queryTripless!! : ?E textMine:nn ?function. ?G textMine:prep ?E. ?B textMine:xcomp ?G. ?B textMine:xsubj ?A. ?I textMine:amod ?F. ?A textMine:conj ?I. ?F textMine:dep ?mutation. ?F textMine:advmod ?positive. 
502

612 Although the tumors are heterogeneous, the low expression of differentiation genes ( tyr  and  dct ) coupled with high  c met  gene expression pattern suggests that hypomorphic MITF activity may maintain melanocytes in a less differentiated state that is more susceptible to BRAF V600E  transformation 
[?D textMine:rcmod ?C, ?A textMine:nn ?mutation, ?impact textMine:prep ?D, ?impact textMine:nsubj ?function, ?C textMine:prep ?A]
Added to queryTripless!! : ?D textMine:rcmod ?C. ?A textMine:nn ?mutation. ?neutral textMine:prep ?D. ?neutral textMine:nsubj ?function. ?C textMine:prep ?A. 
503

613 Mutations to this protein such as G469A, E586K, V600E, and K601E can increase BRAF catalytic activity  
[?C textMine:prep ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?E, ?E textMine:prep ?C]
Query : [?C textMine:prep ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?E, ?E textMine:prep ?C]
Existing trips : 
?C textMine:prep ?mutation. ?D textMine:prep ?C. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?D. 
Similar Query!!!!


614 A mutated BRAF gene with a single amino acid substitution (BRAF V600E) results in higher kinase activity 
[?function textMine:amod ?impact, ?D textMine:appos ?mutation, ?F textMine:prep ?function, ?E textMine:dep ?F, ?E textMine:prep ?D]
Added to queryTripless!! : ?function textMine:amod ?positive. ?D textMine:appos ?mutation. ?F textMine:prep ?function. ?E textMine:dep ?F. ?E textMine:prep ?D. 
504

615 Interestingly, in our hands the cells carrying the G250E mutation seems less sensitive to the effect of ponatinib that the one carrying the T315I mutation 
[?A textMine:dobj ?B, ?B textMine:amod ?mutation, ?function textMine:ccomp ?A, ?function textMine:advmod ?impact]
Added to queryTripless!! : ?A textMine:dobj ?B. ?B textMine:amod ?mutation. ?function textMine:ccomp ?A. ?function textMine:advmod ?negative. 
505

616 Here, we present evidence that BRAF V600E  enhances migration and invasion properties in colon carcinoma cells through RhoA activation, while KRAS G12V  induces these properties less efficiently as compared to BRAF V600E , albeit through Cdc42 activation and filopodia formation 
[?impact textMine:advcl ?D, ?E textMine:prep ?function, ?A textMine:advmod ?E, ?A textMine:ccomp ?impact, ?D textMine:pobj ?mutation]
Added to queryTripless!! : ?positive textMine:advcl ?D. ?E textMine:prep ?function. ?A textMine:advmod ?E. ?A textMine:ccomp ?positive. ?D textMine:pobj ?mutation. 
506

617 Contrarily, mutation of F595 to Tyr or Trp, supported a level of constitutive activity of V617F similar to non mutated F595, indicating the presence of an aromatic residue at position 595 is required to maintain the constitutive activity of JAK2 V617F ( Figure 2A ) 
[?function textMine:prep ?mutation, ?function textMine:amod ?impact]
[?function textMine:amod ?impact, ?function textMine:prep ?mutation, ]
Match 


618 To confirm DUB regulation through BRAF activation, mutant BRAF (V600E) was expressed in HEK293T cells and DUB activity assessments were used to demonstrate increased Usp5 activity in cells expressing BRAF V600E  (Fig  1F ) 
[?A textMine:prep ?C, ?A textMine:amod ?impact, ?function textMine:dobj ?mutation, ?C textMine:partmod ?function]
Added to queryTripless!! : ?A textMine:prep ?C. ?A textMine:amod ?positive. ?function textMine:dobj ?mutation. ?C textMine:partmod ?function. 
507

619 We note that M918T also has increased activity toward exogenous substrates and is itself phosphorylated to a greater degree by exogenous kinases such as FAK ( Figure S7 ) 
[?function textMine:amod ?impact, ?D textMine:dobj ?function, ?D textMine:nsubj ?mutation]
[?D textMine:dobj ?function, ?D textMine:nsubj ?mutation, ?function textMine:amod ?impact, ]
Match 


620 Hence, E884K in  cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone, through differential inhibition of the pro survival AKT and STAT3 signaling pathways associated with altered induction of cleaved PARP(Asp214) 
[?G textMine:partmod ?E, ?C textMine:prep ?G, ?C textMine:pobj ?mutation, ?C textMine:dobj ?function, ?E textMine:prep ?F, ?F textMine:amod ?impact]
Query : [?G textMine:partmod ?E, ?C textMine:prep ?G, ?C textMine:pobj ?mutation, ?C textMine:dobj ?function, ?E textMine:prep ?F, ?F textMine:amod ?impact]
Existing trips : 
?A textMine:amod ?impact. ?B textMine:partmod ?C. ?C textMine:prep ?A. ?E textMine:dobj ?function. ?E textMine:pobj ?mutation. ?E textMine:prep ?B. 
Similar Query!!!!


621 In the context of wildtype RAF (BRAF or CRAF)  and  high Ras activity, BRAF V600E  inhibition may “paradoxically” enhance MAPK activity [ 60 ,  61 ] 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:nn ?mutation]
Query : [?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:nn ?mutation]
Existing trips : 
?C textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?C. 
Similar Query!!!!


622 This study finds that the two most common EGFR mutations in non small cell lung cancer (L858R and Δ746–750) result in EGF–independent tEGFR activities comparable to, or greater than, the activity of EGF–stimulated WT EGFR, and that tEGFR activation resulting from these mutations remains strongly coupled to asymmetric kinase dimer formation ( Fig 3d ) 
[?B textMine:dep ?mutation, ?impact textMine:nsubj ?D, ?D textMine:partmod ?function, ?C textMine:conj ?impact, ?C textMine:nsubj ?B]
[?B textMine:dep ?mutation, ?C textMine:conj ?impact, ?C textMine:nsubj ?B, ?D textMine:partmod ?function, ?impact textMine:nsubj ?D, ]
Match 


623 Therefore,  BRAF  V600E increases the kinase activity that provides cancer cells with both proliferation and survival signals and promotes them to become tumors in the model system 
[?B textMine:nn ?function, ?C textMine:prep ?B, ?A textMine:rcmod ?C, ?impact textMine:dobj ?A, ?impact textMine:nsubj ?mutation]
[?A textMine:rcmod ?C, ?B textMine:nn ?function, ?C textMine:prep ?B, ?impact textMine:dobj ?A, ?impact textMine:nsubj ?mutation, ]
Match 


624 Increased activation of Akt1 by E17K, L52R, C77F, and Q79K mutants led, as expected, to increased phosphorylation of Akt target proteins including FOXO1/3 and PRAS40 
[?D textMine:amod ?impact, ?C textMine:prep ?mutation, ?function textMine:prep ?C, ?A textMine:prep ?D, ?A textMine:nsubj ?function]
Added to queryTripless!! : ?D textMine:amod ?positive. ?C textMine:prep ?mutation. ?function textMine:prep ?C. ?A textMine:prep ?D. ?A textMine:nsubj ?function. 
508

625 In western blot experiments, we observed that IM was unable to decrease the expression of the mature form of T670I c Kit mutant, while the  wt  form of the receptor decreased in UT 7/Epo or in  wt  c Kit BaF3 cells ( Figure 7B ) 
[?D textMine:nn ?mutation, ?C textMine:advcl ?impact, ?C textMine:dobj ?function, ?B textMine:prep ?D, ?function textMine:prep ?B]
Added to queryTripless!! : ?D textMine:nn ?mutation. ?C textMine:advcl ?negative. ?C textMine:dobj ?function. ?B textMine:prep ?D. ?function textMine:prep ?B. 
509

626 The most characterized resistance mutation is the T790M point mutation in exon 20, which increases the affinity of the EGFR for ATP, thus reducing the binding of EGFR TKIs to the ATP pocket 
[?E textMine:amod ?function, ?impact textMine:partmod ?C, ?C textMine:dobj ?E, ?F textMine:prep ?G, ?F textMine:amod ?mutation, ?G textMine:rcmod ?impact]
Added to queryTripless!! : ?E textMine:amod ?function. ?positive textMine:partmod ?C. ?C textMine:dobj ?E. ?F textMine:prep ?G. ?F textMine:amod ?mutation. ?G textMine:rcmod ?positive. 
510

627 MST1 expression significantly increased apoptosis, which is reduced by expression of BRAF V600E  
[?E textMine:agent ?function, ?function textMine:prep ?mutation, ?D textMine:rcmod ?E, ?impact textMine:nsubj ?D]
Added to queryTripless!! : ?E textMine:agent ?function. ?function textMine:prep ?mutation. ?D textMine:rcmod ?E. ?positive textMine:nsubj ?D. 
511

659 Consistent with this, we observed a substantially higher ALK phosphorylation in Karpas299 cells carrying I1171T and F1174C mutations 
[?function textMine:amod ?impact, ?A textMine:prep ?D, ?A textMine:dobj ?function, ?D textMine:partmod ?C, ?C textMine:dobj ?G, ?G textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:amod ?positive. ?A textMine:prep ?D. ?A textMine:dobj ?function. ?D textMine:partmod ?C. ?C textMine:dobj ?G. ?G textMine:nn ?mutation. 
512

628 Approximately 90% of all identified BRAF mutations that occur in human cancer are a T1799A transversion mutation in exon 15, which results in a V600E amino acid substitution   T1799A alteration (V600E mutation) accounts for 70 to 90% of BRAF mutant melanoma patients   
[?B textMine:nn ?mutation, ?function textMine:prep ?impact, ?impact textMine:appos ?B]
Added to queryTripless!! : ?B textMine:nn ?mutation. ?function textMine:prep ?unknown. ?unknown textMine:appos ?B. 
513

629 They demonstrated that panobinostat treatment depletes the auto phosphorylation, expression, and downstream signaling of JAK2 V617F and disrupted the chaperone association of JAK2 V617F with heat shock protein 90, thus promoting proteasomal degradation of JAK2 V617F 
[?impact textMine:dep ?A, ?impact textMine:dobj ?function, ?B textMine:prep ?mutation, ?A textMine:dobj ?B]
Added to queryTripless!! : ?negative textMine:dep ?A. ?negative textMine:dobj ?function. ?B textMine:prep ?mutation. ?A textMine:dobj ?B. 
514

630 The prevalent  BRAF  c.1799 T > A (V600E) mutation, characterizing 4.7% to 8.7% of CRC, demonstrated a negative prognostic effect compared to  BRAF  wild type pts in MCRC pts treated with doublet chemotherapy alone or added to cetuximab, BEV and cetuximab plus BEV, with a median PFS of 5.6 to 8 months and median OS of 10 3 to 159 months   
[?A textMine:appos ?mutation, ?E textMine:nsubj ?A, ?E textMine:dobj ?function, ?function textMine:amod ?impact]
Query : [?A textMine:appos ?mutation, ?E textMine:nsubj ?A, ?E textMine:dobj ?function, ?function textMine:amod ?impact]
Existing trips : 
?B textMine:appos ?mutation. ?C textMine:dobj ?function. ?C textMine:nsubj ?B. ?function textMine:amod ?impact. 
Similar Query!!!!


631 This is consistent with data indicating that high levels of ERK activation causes cell cycle arrest and senescence  , and that oncogene induced senescence is potently induced by V600E BRAF   
[?B textMine:nn ?mutation, ?G textMine:conj ?D, ?G textMine:nsubj ?C, ?D textMine:agent ?B, ?C textMine:prep ?function, ?C textMine:amod ?impact]
Added to queryTripless!! : ?B textMine:nn ?mutation. ?G textMine:conj ?D. ?G textMine:nsubj ?C. ?D textMine:agent ?B. ?C textMine:prep ?function. ?C textMine:amod ?positive. 
515

632 Importantly, Mcl 1 depletion increased apoptosis in JAK2 V617F  mutant SET 2 cells and sensitized the cells to NVP BSK805 induced cell death as assessed by Western blot analysis and measuring the sub G1 cell fraction by flow cytometry (Figure  7B  and  7C ) 
[?impact textMine:prep ?B, ?impact textMine:dobj ?function, ?B textMine:nn ?mutation]
Added to queryTripless!! : ?positive textMine:prep ?B. ?positive textMine:dobj ?function. ?B textMine:nn ?mutation. 
516

633 The V600E mutation confers an increase in BRAF kinase activity of approximately 480 times compared with wild type BRAF, whereas the V600D mutation increases this by approximately 700 times ( Wan  et al , 2004 ) 
[?impact textMine:nsubj ?D, ?F textMine:prep ?function, ?E textMine:advcl ?impact, ?E textMine:dobj ?F, ?D textMine:nn ?mutation]
[?D textMine:nn ?mutation, ?E textMine:advcl ?impact, ?E textMine:dobj ?F, ?F textMine:prep ?function, ?impact textMine:nsubj ?D, ]
Match 


634 In addition, MITF mutations have been identified in BRAF V600E  melanomas including somatic mutations with either hypomorphic or increased activity  , and a germline SUMOylation E318K mutation that is a melanoma risk factor and confers differential gene expression of MITF target genes   
[?function textMine:amod ?impact, ?D textMine:prep ?C, ?D textMine:nn ?mutation, ?C textMine:prep ?function]
Query : [?function textMine:amod ?impact, ?D textMine:prep ?C, ?D textMine:nn ?mutation, ?C textMine:prep ?function]
Existing trips : 
?A textMine:prep ?B. ?A textMine:prep ?function. ?B textMine:nn ?mutation. ?function textMine:amod ?impact. 
Similar Query!!!!


635 It has been shown that the A391E mutation increases FGFR3 dimerization , unlike the G380R and G375C mutations 
[?impact textMine:dobj ?function, ?impact textMine:prep ?D, ?D textMine:nn ?mutation]
Added to queryTripless!! : ?positive textMine:dobj ?function. ?positive textMine:prep ?D. ?D textMine:nn ?mutation. 
517

636 However, this resistance to EGFR TKI has been many times lower than the resistance in cells harbouring both the L858R and T790M mutations 
[?impact textMine:prep ?function, ?B textMine:partmod ?D, ?function textMine:prep ?B, ?D textMine:dobj ?mutation]
Added to queryTripless!! : ?negative textMine:prep ?function. ?B textMine:partmod ?D. ?function textMine:prep ?B. ?D textMine:dobj ?mutation. 
518

637 Even the few LT sensitive human tumor cells having the BRAF V600E mutation, such as melanoma SK MEL 28, HT29 and colon carcinoma Colo205, are less sensitive to LT than to PA/FP59 ( Figure 1 ) 
[?E textMine:dobj ?D, ?D textMine:nn ?mutation, ?function textMine:advmod ?impact, ?function textMine:nsubj ?B, ?B textMine:partmod ?E]
Added to queryTripless!! : ?E textMine:dobj ?D. ?D textMine:nn ?mutation. ?function textMine:advmod ?negative. ?function textMine:nsubj ?B. ?B textMine:partmod ?E. 
519

638 We have previously shown that the JAK2 V617F homologous mutation in JAK1, V658F, induces constitutive activation of JAK1  
[?function textMine:amod ?impact, ?C textMine:prep ?mutation, ?A textMine:dobj ?function, ?A textMine:nsubj ?C]
Added to queryTripless!! : ?function textMine:amod ?positive. ?C textMine:prep ?mutation. ?A textMine:dobj ?function. ?A textMine:nsubj ?C. 
520

639 However, the overall lower IC50 and preserved activity against a wide spectrum of BCR–ABL1 mutations, including T315I, can be appreciated  
[?function textMine:prep ?mutation, ?function textMine:nn ?impact]
Added to queryTripless!! : ?function textMine:prep ?mutation. ?function textMine:nn ?neutral. 
521

640 Moreover,  Fgfr2 +/S252W   BMSCs developed fewer mineralized colonies and exhibited reduced alizarin red staining ( Fig 5 B ) 
[?D textMine:nn ?mutation, ?C textMine:dobj ?E, ?C textMine:nsubj ?D, ?E textMine:amod ?impact, ?E textMine:amod ?function]
Added to queryTripless!! : ?D textMine:nn ?mutation. ?C textMine:dobj ?E. ?C textMine:nsubj ?D. ?E textMine:amod ?negative. ?E textMine:amod ?function. 
522

641 Notably, melanomas that have the V600E  BRAF  mutation exhibit increased HIF 1α expression 
[?E textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:rcmod ?E, ?function textMine:nn ?mutation]
Added to queryTripless!! : ?E textMine:dobj ?function. ?positive textMine:nsubj ?B. ?B textMine:rcmod ?E. ?function textMine:nn ?mutation. 
523

642 Overall, SP inhibitors represent an innovative mechanism of KIT inhibition whose dual suppression of KIT D816V neoplastic mast cell proliferation and SCF enhanced mast cell activation may provide significant therapeutic benefits 
[?E textMine:prep ?mutation, ?B textMine:nsubj ?function, ?impact textMine:dobj ?E, ?impact textMine:ccomp ?B]
Query : [?E textMine:prep ?mutation, ?B textMine:nsubj ?function, ?impact textMine:dobj ?E, ?impact textMine:ccomp ?B]
Existing trips : 
?D textMine:nsubj ?function. ?E textMine:prep ?mutation. ?impact textMine:ccomp ?D. ?impact textMine:dobj ?E. 
Similar Query!!!!


643 For 4557W (reversible dual TKI of EGFR/ERBB2), the E884K mutation modulated the L858R mutation in  cis , again in a dominant fashion, rendering the double mutant receptor more sensitive to the dual inhibitor ( Figure 2 ) 
[?E textMine:xcomp ?function, ?impact textMine:partmod ?E, ?impact textMine:nsubj ?D, ?D textMine:nn ?mutation]
Added to queryTripless!! : ?E textMine:xcomp ?function. ?unknown textMine:partmod ?E. ?unknown textMine:nsubj ?D. ?D textMine:nn ?mutation. 
524

644 Thus, certain P loop mutations (Y253F, E255K) and the T315I mutation display a high oncogenic potential, which is consistent with the clinical observation of a poor outcome concerning overall and progression free survival   
[?D textMine:xcomp ?E, ?E textMine:dobj ?function, ?G textMine:rcmod ?D, ?G textMine:amod ?impact, ?A textMine:amod ?mutation, ?B textMine:dobj ?G, ?B textMine:nsubj ?A]
Added to queryTripless!! : ?D textMine:xcomp ?E. ?E textMine:dobj ?function. ?G textMine:rcmod ?D. ?G textMine:amod ?positive. ?A textMine:amod ?mutation. ?B textMine:dobj ?G. ?B textMine:nsubj ?A. 
525

645 Over time, however, the WT GARS  and Empt expressing mice exhibited significantly improved PWT compared with the G240R  and L129P expressing mice and the allodynia behavior in G240R  and L129P expressing mice was unchanged for 7 days after adenovirus infection ( Fig 3C ) 
[?G textMine:xcomp ?E, ?G textMine:prep ?mutation, ?D textMine:partmod ?G, ?B textMine:pobj ?D, ?function textMine:dobj ?B, ?E textMine:ccomp ?impact]
Added to queryTripless!! : ?G textMine:xcomp ?E. ?G textMine:prep ?mutation. ?D textMine:partmod ?G. ?B textMine:pobj ?D. ?function textMine:dobj ?B. ?E textMine:ccomp ?neutral. 
526

646 However, an active form of  β  catenin increases the penetrance and incidence of melanoma in mice expressing oncogenic NRAS Q61K  or BRAF V600E  specifically in melanocytes [ 131 ,  216 ] 
[?impact textMine:dobj ?F, ?C textMine:prep ?D, ?D textMine:partmod ?function, ?F textMine:prep ?C, ?function textMine:dobj ?mutation]
Added to queryTripless!! : ?positive textMine:dobj ?F. ?C textMine:prep ?D. ?D textMine:partmod ?function. ?F textMine:prep ?C. ?function textMine:dobj ?mutation. 
527

647 Research into the molecular mechanisms of BRAF V600E  positive tumors has revealed that the missense valine to glutamic acid mutation increases kinase activity, promoting the constitutive activation of MEK ERK signaling and enhancing ERK dependent transcriptional output  
[?D textMine:prep ?F, ?H textMine:dobj ?function, ?E textMine:ccomp ?impact, ?E textMine:nsubj ?D, ?F textMine:prep ?G, ?G textMine:nn ?mutation, ?impact textMine:partmod ?H]
Added to queryTripless!! : ?D textMine:prep ?F. ?H textMine:dobj ?function. ?E textMine:ccomp ?positive. ?E textMine:nsubj ?D. ?F textMine:prep ?G. ?G textMine:nn ?mutation. ?positive textMine:partmod ?H. 
528

648 Cells expressing S249C and Y375C FGFR3 displayed an increased saturation density, related to increased proliferation and viability 
[?function textMine:amod ?impact, ?B textMine:nn ?mutation, ?G textMine:prep ?function, ?E textMine:dobj ?A, ?E textMine:nsubj ?B, ?A textMine:partmod ?G]
Added to queryTripless!! : ?function textMine:amod ?positive. ?B textMine:nn ?mutation. ?G textMine:prep ?function. ?E textMine:dobj ?A. ?E textMine:nsubj ?B. ?A textMine:partmod ?G. 
529

649 Firstly, exon 19 deletions might be more efficiently inhibited by EGFR TKIs than exon 21 L858R mutations [8] Mutant forms of exon 19 deletion and L858R mutation had a reduced affinity for its natural substrate, ATP, but equivalent or increased affinity for reversible EGFR TKIs, which explained why tumors with these EGFR mutations had higher sensitivity to TKIs  [30] ,  [31]  
[?A textMine:prep ?function, ?A textMine:amod ?impact, ?E textMine:dobj ?A, ?E textMine:nsubj ?F, ?F textMine:prep ?G, ?G textMine:nn ?mutation]
Added to queryTripless!! : ?A textMine:prep ?function. ?A textMine:amod ?negative. ?E textMine:dobj ?A. ?E textMine:nsubj ?F. ?F textMine:prep ?G. ?G textMine:nn ?mutation. 
530

650 Our biochemical studies here now show that E884K mutation in  cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone, through differential inhibition of the pro survival AKT and STAT3 signaling pathways associated with altered induction of cleaved PARP(Asp214) 
[?G textMine:amod ?mutation, ?B textMine:prep ?A, ?E textMine:prep ?C, ?E textMine:dobj ?function, ?E textMine:nsubj ?G, ?A textMine:amod ?impact, ?C textMine:partmod ?B]
[?A textMine:amod ?impact, ?B textMine:prep ?A, ?C textMine:partmod ?B, ?E textMine:dobj ?function, ?E textMine:nsubj ?G, ?E textMine:prep ?C, ?G textMine:amod ?mutation, ]
Match 


651 The up regulation of BIM was also attenuated in a similar dose–response manner as seen in the apoptosis assay ( Figure 6 A, bottom), with L858R T790M completely abrogating the induction of BIM and L858R L747S attenuating both the up regulation of BIM and apoptosis 
[?impact textMine:dep ?A, ?impact textMine:prep ?C, ?A textMine:nn ?mutation, ?C textMine:prep ?function]
Added to queryTripless!! : ?negative textMine:dep ?A. ?negative textMine:prep ?C. ?A textMine:nn ?mutation. ?C textMine:prep ?function. 
531

652 By far the most numerous BRAF alteration is a single point mutation resulting in an amino acid exchange in position 600 dubbed V600E 
[?function textMine:prep ?E, ?E textMine:prep ?G, ?D textMine:partmod ?function, ?G textMine:partmod ?C, ?impact textMine:rcmod ?D, ?C textMine:dobj ?mutation]
Added to queryTripless!! : ?function textMine:prep ?E. ?E textMine:prep ?G. ?D textMine:partmod ?function. ?G textMine:partmod ?C. ?unknown textMine:rcmod ?D. ?C textMine:dobj ?mutation. 
532

653 We previously demonstrated a high degree of variability in the extent of GSK 3β Ser 9  phosphorylation among BRAF V600E  (+) melanoma cell lines and showed that GSK 3β activity in these cells was increased in response to the multikinase inhibitor sorafenib  , presumably through an ER stress dependent mechanism 
[?D textMine:prep ?A, ?G textMine:prep ?mutation, ?I textMine:prep ?J, ?C textMine:conj ?F, ?C textMine:dobj ?I, ?J textMine:amod ?D, ?A textMine:prep ?G, ?impact textMine:nsubjpass ?function, ?F textMine:ccomp ?impact]
Added to queryTripless!! : ?D textMine:prep ?A. ?G textMine:prep ?mutation. ?I textMine:prep ?J. ?C textMine:conj ?F. ?C textMine:dobj ?I. ?J textMine:amod ?D. ?A textMine:prep ?G. ?positive textMine:nsubjpass ?function. ?F textMine:ccomp ?positive. 
533

654 Cells expressing the L747_E749del A750P and D770_N771insNPG  EGFR  mutants also exhibited a greater degree of loss of contact inhibition than was observed in cells expressing the L858R or G719S EGFR mutants in a primary focus formation assay (unpublished data) 
[?A textMine:dobj ?G, ?B textMine:prep ?F, ?F textMine:partmod ?A, ?C textMine:prep ?H, ?C textMine:amod ?impact, ?H textMine:prep ?function, ?D textMine:advcl ?B, ?D textMine:dobj ?C, ?G textMine:nn ?mutation]
Added to queryTripless!! : ?A textMine:dobj ?G. ?B textMine:prep ?F. ?F textMine:partmod ?A. ?C textMine:prep ?H. ?C textMine:amod ?positive. ?H textMine:prep ?function. ?D textMine:advcl ?B. ?D textMine:dobj ?C. ?G textMine:nn ?mutation. 
534

655 We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated (native) BCR/ABL ( 15 – 17 ) 
[?C textMine:dobj ?A, ?C textMine:dobj ?function, ?C textMine:nsubj ?F, ?function textMine:conj ?A, ?A textMine:amod ?impact, ?F textMine:nn ?mutation]
[?A textMine:amod ?impact, ?C textMine:dobj ?A, ?C textMine:dobj ?function, ?C textMine:nsubj ?F, ?F textMine:nn ?mutation, ?function textMine:conj ?A, ]
Match 


656 CL 387,785 had an even greater effect on colony formation by cells expressing L858R  EGFR,  completely inhibiting transformation at 0003 μM (unpublished data) 
[?function textMine:amod ?impact, ?F textMine:dobj ?D, ?C textMine:prep ?G, ?C textMine:dobj ?function, ?G textMine:partmod ?F, ?D textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:amod ?positive. ?F textMine:dobj ?D. ?C textMine:prep ?G. ?C textMine:dobj ?function. ?G textMine:partmod ?F. ?D textMine:nn ?mutation. 
535

657 In an effort to enhance the efficacy of BRAF V600E  inhibition in thyroid cancer, we chose to target additional signaling pathways, chiefly SRC signaling 
[?impact textMine:dobj ?A, ?A textMine:prep ?mutation, ?mutation textMine:partmod ?function]
Added to queryTripless!! : ?positive textMine:dobj ?A. ?A textMine:prep ?mutation. ?mutation textMine:partmod ?function. 
536

658 BA/F3 cells expressing empty vector (control), BCR/ABL wild type or imatinib resistant mutations (BCR/ABL E255K and T315I) were a kind gift of Dr Brian Druker (Oregon Health Science University, Portland, OR, USA) and maintained as described 
[?function textMine:dobj ?A, ?A textMine:dep ?mutation, ?impact textMine:nsubj ?E, ?E textMine:partmod ?function]
Query : [?function textMine:dobj ?A, ?A textMine:dep ?mutation, ?impact textMine:nsubj ?E, ?E textMine:partmod ?function]
Existing trips : 
?A textMine:dep ?mutation. ?D textMine:partmod ?function. ?function textMine:dobj ?A. ?impact textMine:nsubj ?D. 
Similar Query!!!!


660 However, in the scratch assays performed to determine whether YAP1 affected the migration ability of  BRAF   V600E   activated 8505C cells, shYAP1 8505C showed a remarkably lower migration rate compared with shCTL 8505C (46.2±7 4% vs 229±3 9%,
[?A textMine:xcomp ?B, ?I textMine:prep ?mutation, ?B textMine:ccomp ?D, ?H textMine:nn ?function, ?H textMine:amod ?impact, ?C textMine:dobj ?H, ?C textMine:prep ?E, ?D textMine:dobj ?I, ?E textMine:partmod ?A]
Added to queryTripless!! : ?A textMine:xcomp ?B. ?I textMine:prep ?mutation. ?B textMine:ccomp ?D. ?H textMine:nn ?function. ?H textMine:amod ?negative. ?C textMine:dobj ?H. ?C textMine:prep ?E. ?D textMine:dobj ?I. ?E textMine:partmod ?A. 
537

661 The level of activation of the K652E receptor was higher than the S249C and Y375C mutants ( Figure 3a ,  Supplementary Figure 4a ) 
[?E textMine:prep ?function, ?B textMine:nn ?mutation, ?impact textMine:prep ?B, ?impact textMine:nsubj ?E]
Added to queryTripless!! : ?E textMine:prep ?function. ?B textMine:nn ?mutation. ?positive textMine:prep ?B. ?positive textMine:nsubj ?E. 
538

662 These features stem from elevated activation of JAK2 downstream of EPOR (arising from the  JAK2 V617F   mutation in Polycythemia vera or elevated EPO levels in β thalassemia) and can be limited by the administration of JAK2 inhibitors  39 , 40 , 42 – 45   
[?E textMine:prep ?F, ?E textMine:prep ?D, ?function textMine:prep ?A, ?A textMine:dep ?E, ?F textMine:amod ?impact, ?D textMine:conj ?F, ?D textMine:nn ?mutation]
Added to queryTripless!! : ?E textMine:prep ?F. ?E textMine:prep ?D. ?function textMine:prep ?A. ?A textMine:dep ?E. ?F textMine:amod ?positive. ?D textMine:conj ?F. ?D textMine:nn ?mutation. 
539

664 In conclusion, the auto inhibitory activity of JAK2 was disrupted by the presence of this V617F mutation 
[?impact textMine:agent ?D, ?impact textMine:nsubjpass ?function, ?D textMine:prep ?B, ?B textMine:nn ?mutation]
Added to queryTripless!! : ?negative textMine:agent ?D. ?negative textMine:nsubjpass ?function. ?D textMine:prep ?B. ?B textMine:nn ?mutation. 
540

665 Finally, the specific silencing or inhibition of BRAF V600E  expression in the NM176 and ME1042 melanoma cells decreased Tbx3 protein expression and this correlated with the concomitant increased E cadherin ( Figure 2c ) 
[?impact textMine:nsubj ?function, ?impact textMine:nsubj ?C, ?B textMine:nn ?mutation, ?C textMine:prep ?B, ?C textMine:conj ?function]
Added to queryTripless!! : ?negative textMine:nsubj ?function. ?negative textMine:nsubj ?C. ?B textMine:nn ?mutation. ?C textMine:prep ?B. ?C textMine:conj ?function. 
541

666 In that case, it may well be that DAX 1 is independent of SF 1 in the state represented by the NCI H295R cells or that compensatory mechanisms step in when SF 1 expression is diminished 
[?B textMine:agent ?E, ?F textMine:prepc ?impact, ?E textMine:nn ?mutation, ?H textMine:partmod ?B, ?impact textMine:nsubjpass ?function, ?A textMine:conj ?F, ?A textMine:prep ?H]
Added to queryTripless!! : ?B textMine:agent ?E. ?F textMine:prepc ?negative. ?E textMine:nn ?mutation. ?H textMine:partmod ?B. ?negative textMine:nsubjpass ?function. ?A textMine:conj ?F. ?A textMine:prep ?H. 
542

667 The G380R mutation has been shown to increase FGFR3 phosphorylation and thus shorten the proliferative phase in chondrocyte development, but the cause for the increased receptor phosphorylation is under debate 
[?A textMine:prep ?function, ?G textMine:conj ?F, ?G textMine:nsubjpass ?B, ?F textMine:nsubj ?A, ?function textMine:amod ?impact, ?B textMine:nn ?mutation]
[?A textMine:prep ?function, ?B textMine:nn ?mutation, ?F textMine:nsubj ?A, ?G textMine:conj ?F, ?G textMine:nsubjpass ?B, ?function textMine:amod ?impact, ]
Match 


668 Interestingly, SIRT1 level and activity are enhanced in the PLX4032 resistant BRAF V600E  mutated melanoma cells compared with their sensitive counterpart 
[?E textMine:pobj ?D, ?D textMine:amod ?function, ?mutation textMine:partmod ?E, ?impact textMine:prep ?mutation]
[?D textMine:amod ?function, ?E textMine:pobj ?D, ?impact textMine:prep ?mutation, ?mutation textMine:partmod ?E, ]
Match 


669 (A) E SLAM HSCs were increased in frequency in wild type (∼2 fold, see  Figure 1E ) but not JAK2 V617F  marrow in 18–24 mo old mice ( n  = 10) compared to 6–10 mo old mice resulting in a 3 fold overall reduction in E SLAM HSCs compared to wild type ( p  = 0002) in three independent experiments 
[?G textMine:dep ?B, ?impact textMine:prep ?G, ?C textMine:nn ?mutation, ?C textMine:dep ?D, ?D textMine:partmod ?function, ?B textMine:npadvmod ?C]
Added to queryTripless!! : ?G textMine:dep ?B. ?positive textMine:prep ?G. ?C textMine:nn ?mutation. ?C textMine:dep ?D. ?D textMine:partmod ?function. ?B textMine:npadvmod ?C. 
543

670 Our study revealed that the BRAF V600E  mutation was significantly associated with several molecular alterations 
[?C textMine:nn ?mutation, ?function textMine:prep ?impact, ?function textMine:nsubjpass ?C]
Added to queryTripless!! : ?C textMine:nn ?mutation. ?function textMine:prep ?unknown. ?function textMine:nsubjpass ?C. 
544

671 Dasatinib is a dual BCR ABL and Src kinase inhibitor with approximately 325 fold greater activity than IM against BCR ABL, and with activity against most mutations resistant to IM, with the exception of T315I, but to date, it is still unknown whether dasatinib therapy is superior to IM in terms of preventing relapse or inducing longer EFS 
[?G textMine:rcmod ?J, ?B textMine:prep ?function, ?J textMine:dobj ?C, ?C textMine:amod ?impact, ?function textMine:amod ?H, ?H textMine:prep ?E, ?E textMine:prep ?mutation, ?A textMine:conj ?B, ?A textMine:prep ?G]
Added to queryTripless!! : ?G textMine:rcmod ?J. ?B textMine:prep ?function. ?J textMine:dobj ?C. ?C textMine:amod ?positive. ?function textMine:amod ?H. ?H textMine:prep ?E. ?E textMine:prep ?mutation. ?A textMine:conj ?B. ?A textMine:prep ?G. 
545

672 Introduction  of a melanoma associated mutation, P52L, into this peptide reduces pseudosubstrate autoinhibition of PAK6, and increases phosphorylation of its substrate PACSIN1 (Syndapin I) in cells 
[?B textMine:partmod ?F, ?C textMine:prep ?B, ?impact textMine:dobj ?D, ?impact textMine:nsubj ?C, ?F textMine:dobj ?I, ?D textMine:prep ?G, ?G textMine:amod ?function, ?I textMine:appos ?mutation]
Added to queryTripless!! : ?B textMine:partmod ?F. ?C textMine:prep ?B. ?positive textMine:dobj ?D. ?positive textMine:nsubj ?C. ?F textMine:dobj ?I. ?D textMine:prep ?G. ?G textMine:amod ?function. ?I textMine:appos ?mutation. 
546

673 We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated (native) BCR/ABL ( 15 – 17 ) 
[?D textMine:dobj ?A, ?D textMine:nsubj ?G, ?A textMine:infmod ?B, ?A textMine:amod ?impact, ?G textMine:nn ?mutation, ?B textMine:dobj ?function]
Added to queryTripless!! : ?D textMine:dobj ?A. ?D textMine:nsubj ?G. ?A textMine:infmod ?B. ?A textMine:amod ?positive. ?G textMine:nn ?mutation. ?B textMine:dobj ?function. 
547

674 Expression of BRAF V600E  in BRAF mutant naïve cells resulted in increased expression and activation of Usp5, suggesting that pathway activation or phospho regulation underlie Usp5 activation 
[?E textMine:dobj ?function, ?C textMine:xcomp ?B, ?C textMine:prep ?D, ?C textMine:nsubj ?F, ?B textMine:ccomp ?E, ?D textMine:amod ?impact, ?F textMine:prep ?mutation]
Added to queryTripless!! : ?E textMine:dobj ?function. ?C textMine:xcomp ?B. ?C textMine:prep ?D. ?C textMine:nsubj ?F. ?B textMine:ccomp ?E. ?D textMine:amod ?positive. ?F textMine:prep ?mutation. 
548

675 There was approximately fourfold increase in YUDOSO BRAF WT  migrating cells compared with control, whereas the number of migrating YULAC BRAF V600E  melanoma cells was reduced by 30% ( Figure 6D(b) ) 
[?A textMine:prep ?B, ?impact textMine:nsubjpass ?A, ?B textMine:nn ?mutation, ?B textMine:amod ?function]
Added to queryTripless!! : ?A textMine:prep ?B. ?negative textMine:nsubjpass ?A. ?B textMine:nn ?mutation. ?B textMine:amod ?function. 
549

676 41   The presence of the JAK2 V617F mutation was shown to be prognostically unfavorable in a few cases of t(8;21) leukemia affecting their disease free survival rate 
[?F textMine:prep ?H, ?impact textMine:partmod ?D, ?B textMine:nsubj ?impact, ?B textMine:dobj ?F, ?E textMine:dobj ?C, ?C textMine:nn ?function, ?H textMine:nn ?mutation, ?D textMine:xcomp ?E]
Added to queryTripless!! : ?F textMine:prep ?H. ?negative textMine:partmod ?D. ?B textMine:nsubj ?negative. ?B textMine:dobj ?F. ?E textMine:dobj ?C. ?C textMine:nn ?function. ?H textMine:nn ?mutation. ?D textMine:xcomp ?E. 
550

677 Based on these results, and on a molecular model of FGFR3 TM domain created with the program CHI , it has been proposed that the G380R mutation introduces a structural change in the unliganded FGFR3 dimers, thus altering their phosphorylation efficiencies and ultimately increasing FGFR3 phosphorylation in the absence of ligand 
[?D textMine:dep ?impact, ?D textMine:nsubj ?B, ?B textMine:nn ?mutation, ?impact textMine:dobj ?function]
Added to queryTripless!! : ?D textMine:dep ?positive. ?D textMine:nsubj ?B. ?B textMine:nn ?mutation. ?positive textMine:dobj ?function. 
551

678 It has been shown that the A391E mutation increases FGFR3 dimerization , unlike the G380R and G375C mutations 
[?D textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?D]
Query : [?D textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?D]
Existing trips : 
?C textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?C. 
Similar Query!!!!


679 There is also evidence that siRNA knockdown of AKT3 and  BRAF  V600E leads to the enhanced inhibition of melanoma xenograft growth in nude mice ( Cheung  et al , 2008 ;  Tran  et al , 2008 ) 
[?E textMine:prep ?function, ?E textMine:nsubj ?C, ?function textMine:amod ?impact, ?C textMine:prep ?mutation]
Added to queryTripless!! : ?E textMine:prep ?function. ?E textMine:nsubj ?C. ?function textMine:amod ?positive. ?C textMine:prep ?mutation. 
552

680 This study also showed that endogenous expression or ectopic induction of p61B Raf (V600E) induced ERK signaling resistant to vemurafenib, where disruption of p61B Raf (V600E) dimerization by site directed mutation restored its sensitivity to vemurafenib 
[?impact textMine:prep ?B, ?B textMine:appos ?mutation, ?B textMine:partmod ?function]
Added to queryTripless!! : ?negative textMine:prep ?B. ?B textMine:appos ?mutation. ?B textMine:partmod ?function. 
553

681 In contrast to these compounds, the B Raf V600E  inhibitor dabrafenib selectively decreased proliferation of  BRAF  mutant cell clones (Figure  4 D) 
[?A textMine:nn ?mutation, ?E textMine:prep ?B, ?B textMine:appos ?A, ?impact textMine:dobj ?function, ?impact textMine:prep ?E]
Added to queryTripless!! : ?A textMine:nn ?mutation. ?E textMine:prep ?B. ?B textMine:appos ?A. ?negative textMine:dobj ?function. ?negative textMine:prep ?E. 
554

682 In agreement with the effects on EGFR phosphorylation and AKT/ERK signaling, cells expressing the T790M form of L858R EGFR had less apoptosis when exposed to dasatinib ( Figure 5C ) 
[?E textMine:partmod ?A, ?A textMine:dobj ?C, ?C textMine:prep ?B, ?function textMine:amod ?impact, ?D textMine:dobj ?function, ?D textMine:nsubj ?E, ?B textMine:nn ?mutation]
Added to queryTripless!! : ?E textMine:partmod ?A. ?A textMine:dobj ?C. ?C textMine:prep ?B. ?function textMine:amod ?negative. ?D textMine:dobj ?function. ?D textMine:nsubj ?E. ?B textMine:nn ?mutation. 
555

683 The JAK2 V617F mutation can induce constitutive activation regardless of the dimeric conformation of the receptor it is bound to, while JAK2 wild type requires a ligand activated EpoR dimer in order to signal 
[?B textMine:nn ?mutation, ?G textMine:advcl ?A, ?J textMine:amod ?impact, ?A textMine:dobj ?C, ?I textMine:prep ?F, ?I textMine:dobj ?J, ?I textMine:nsubj ?B, ?K textMine:rcmod ?G, ?C textMine:amod ?function, ?F textMine:prep ?K]
Added to queryTripless!! : ?B textMine:nn ?mutation. ?G textMine:advcl ?A. ?J textMine:amod ?positive. ?A textMine:dobj ?C. ?I textMine:prep ?F. ?I textMine:dobj ?J. ?I textMine:nsubj ?B. ?K textMine:rcmod ?G. ?C textMine:amod ?function. ?F textMine:prep ?K. 
556

684 We show that B RAF induces the transcriptional repressor Tbx3, which results in diminished E cadherin expression in human melanocytes and increased invasiveness of B RAF V600E  mutant melanoma cells 
[?function textMine:conj ?A, ?function textMine:amod ?impact, ?D textMine:nn ?mutation, ?A textMine:prep ?D]
Query : [?function textMine:conj ?A, ?function textMine:amod ?impact, ?D textMine:nn ?mutation, ?A textMine:prep ?D]
Existing trips : 
?B textMine:nn ?mutation. ?D textMine:prep ?B. ?function textMine:amod ?impact. ?function textMine:conj ?D. 
Similar Query!!!!


685 In vitro studies show that T790M confers resistance to gefitinib, possibly by increasing EGFR’s affinity for ATP, thus decreasing the binding of the ATP competitive TKI 
[?impact textMine:dobj ?function, ?D textMine:prepc ?impact, ?D textMine:nsubj ?mutation]
Added to queryTripless!! : ?positive textMine:dobj ?function. ?D textMine:prepc ?positive. ?D textMine:nsubj ?mutation. 
557

686 Finally, we observed that expression of the murine  Mycn  gene was significantly higher in  MYCN / Alk  tumors compared with  MYCN  tumors, as previously described in transgenic  ALK   F1174L   mice [ 22 ] 
[?E textMine:nn ?mutation, ?B textMine:prep ?E, ?impact textMine:nsubj ?function, ?impact textMine:advcl ?B]
Query : [?E textMine:nn ?mutation, ?B textMine:prep ?E, ?impact textMine:nsubj ?function, ?impact textMine:advcl ?B]
Existing trips : 
?C textMine:prep ?E. ?E textMine:nn ?mutation. ?impact textMine:advcl ?C. ?impact textMine:nsubj ?function. 
Similar Query!!!!


687 The R611Q, R611W, A614D, C696Y and V769E substitutions   disrupted the tuberin–hamartin interaction, and prevented the phosphorylation of tuberin by PKB , the inhibition of S6 and S6K phosphorylation, and the stimulation of Rheb GTPase activity, cause TSC because they result in major conformational changes to tuberin 
[?impact textMine:dobj ?function, ?mutation textMine:rcmod ?impact]
[?impact textMine:dobj ?function, ?mutation textMine:rcmod ?impact, ]
Match 


688 We have evaluated the role of mutant BRAF (V600E) in human melanoma cells by using mutant BRAF (V600E) specific lentiviral shRNAs, and found that BRAF mutation was involved in enhanced cell proliferation and invasion (Sumimoto et al, ) 
[?C textMine:rcmod ?D, ?C textMine:appos ?mutation, ?A textMine:prep ?function, ?D textMine:ccomp ?A, ?function textMine:amod ?impact]
Added to queryTripless!! : ?C textMine:rcmod ?D. ?C textMine:appos ?mutation. ?A textMine:prep ?function. ?D textMine:ccomp ?A. ?function textMine:amod ?positive. 
558

689 Tumor responses were dependent on the presence of the BRAF   V600E   oncogene and efficient inhibition of the MAPK pathway as detected by decreased phosphorylation of ERK   
[?G textMine:advcl ?D, ?G textMine:prep ?A, ?B textMine:nn ?mutation, ?A textMine:prep ?B, ?D textMine:prep ?function, ?function textMine:amod ?impact]
Added to queryTripless!! : ?G textMine:advcl ?D. ?G textMine:prep ?A. ?B textMine:nn ?mutation. ?A textMine:prep ?B. ?D textMine:prep ?function. ?function textMine:amod ?negative. 
559

690 Among the genetic alterations known in thyroid cancer,  BRAF V600E   is the most useful to this purpose, because of its high sensitivity and its absolute specificity 
[?A textMine:prep ?function, ?A textMine:nsubj ?mutation, ?function textMine:amod ?impact]
Added to queryTripless!! : ?A textMine:prep ?function. ?A textMine:nsubj ?mutation. ?function textMine:amod ?positive. 
560

691 Second, the constitutive activation of ERK by BRAF V600E  could inhibit FoxO3 activation via the ubiquitin proteasome pathway  
[?A textMine:dobj ?function, ?A textMine:nsubj ?F, ?D textMine:prep ?mutation, ?F textMine:prep ?D, ?F textMine:amod ?impact]
Added to queryTripless!! : ?A textMine:dobj ?function. ?A textMine:nsubj ?F. ?D textMine:prep ?mutation. ?F textMine:prep ?D. ?F textMine:amod ?positive. 
561

692 This series represents preliminary results from our population and indicates a higher  JAK2  V617F  allele burden and RNA expression in patients with PMF than in those with PV or ET 
[?function textMine:amod ?impact, ?function textMine:nn ?A, ?A textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:amod ?positive. ?function textMine:nn ?A. ?A textMine:nn ?mutation. 
562

693 Graph shows that the common L858R mutation confers higher autophosphorylation levels to YFP EGFR ICD than P848L and A859T 
[?C textMine:nn ?function, ?C textMine:amod ?impact, ?D textMine:dobj ?C, ?D textMine:nsubj ?E, ?E textMine:nn ?mutation]
Query : [?C textMine:nn ?function, ?C textMine:amod ?impact, ?D textMine:dobj ?C, ?D textMine:nsubj ?E, ?E textMine:nn ?mutation]
Existing trips : 
?A textMine:dobj ?D. ?A textMine:nsubj ?E. ?D textMine:amod ?impact. ?D textMine:nn ?function. ?E textMine:nn ?mutation. 
Similar Query!!!!


694 Interestingly, further  V600E B RAF over expression at a much greater level, as in the case of M395 R relative to M395 P (increase in RNA/cDNA level shown in  Supplementary Fig. S3c and S5 ; increase in protein level shown in  Fig  2c ) conferred enhanced drug resistance mainly at 1 μM vemurafenib but not 10 μM vemurafenib ( Fig 2d ) 
[?B textMine:nsubj ?A, ?B textMine:dobj ?function, ?function textMine:amod ?impact, ?A textMine:nn ?mutation]
Query : [?B textMine:nsubj ?A, ?B textMine:dobj ?function, ?function textMine:amod ?impact, ?A textMine:nn ?mutation]
Existing trips : 
?C textMine:nn ?mutation. ?E textMine:dobj ?function. ?E textMine:nsubj ?C. ?function textMine:amod ?impact. 
Similar Query!!!!


695 The data suggest that low BRCA1 level may neutralize the negative effects of the EGFR T790M mutation on erlotinib sensitivity and that high BRCA1 expression may lead to de novo EGFR TKI resistance potentially through increased DNA damage repair capacity   
[?B textMine:nn ?mutation, ?function textMine:amod ?impact, ?A textMine:nsubj ?function, ?F textMine:prep ?B, ?C textMine:conj ?A, ?C textMine:dobj ?F]
Added to queryTripless!! : ?B textMine:nn ?mutation. ?function textMine:amod ?positive. ?A textMine:nsubj ?function. ?F textMine:prep ?B. ?C textMine:conj ?A. ?C textMine:dobj ?F. 
563

696 In comparison, the activity of some FOP mutants was generally increased to a level similar to caALK2, revealing an inherent gain of function in their catalytic domain in the absence of added BMP ligand ( Fig. 1  B )  Significantly, the signaling by R206H was increased by FK506 to a far greater extent than other GS domain mutants, such as L196P ( Fig 1  B ) 
[?D textMine:parataxis ?E, ?D textMine:parataxis ?C, ?E textMine:auxpass ?mutation, ?F textMine:prep ?B, ?B textMine:partmod ?function, ?C textMine:prep ?F]
Added to queryTripless!! : ?D textMine:parataxis ?E. ?D textMine:parataxis ?C. ?E textMine:auxpass ?mutation. ?F textMine:prep ?B. ?B textMine:partmod ?function. ?C textMine:prep ?F. 
564

697 Graph shows that autophosphorylation levels are lower for T790M (white diamonds) than for S768I (white squares) or Ins770SVD (black triangles) 
[?impact textMine:prep ?mutation, ?impact textMine:nsubj ?D, ?D textMine:nn ?function]
Added to queryTripless!! : ?negative textMine:prep ?mutation. ?negative textMine:nsubj ?D. ?D textMine:nn ?function. 
565

698 These differences in MITF activity may reflect distinct subtypes of melanoma; however, another possibility is that MITF amplification indicates the need for melanoma cells to maintain sufficient MITF activity for survival in the context of high BRAF V600E  signaling   
[?D textMine:nn ?mutation, ?A textMine:prep ?D, ?B textMine:prep ?function, ?impact textMine:dobj ?B, ?impact textMine:prep ?A]
Added to queryTripless!! : ?D textMine:nn ?mutation. ?A textMine:prep ?D. ?B textMine:prep ?function. ?neutral textMine:dobj ?B. ?neutral textMine:prep ?A. 
566

699 Thus, although dasatinib failed to affect activation specific phosphorylation of STAT5, a well established substrate of Jak2, it is possible that Lyn may modulate the activity of Jak2 V617F in PVTL 1 cells, which needs to be addressed in future studies 
[?impact textMine:dobj ?function, ?function textMine:prep ?mutation]
[?function textMine:prep ?mutation, ?impact textMine:dobj ?function, ]
Match 


700 NFAT transcriptional activity was approximately 10 fold higher in A375 cells and approximately 70 fold higher in WM266 4 cells compared with  BRAF  wild type CHL 1 cells ( Figure 1A ), consistent with increased B RAF activity of BRAF V600D  compared with BRAF V600E  ( Wan  et al , 2004 ) 
[?function textMine:amod ?impact, ?function textMine:prep ?D, ?D textMine:pobj ?mutation]
[?D textMine:pobj ?mutation, ?function textMine:amod ?impact, ?function textMine:prep ?D, ]
Match 


701 (A) JAK2 K539L, T875N and R683G all induce constitutive activation of JAK2, however all three mutants display a marked decrease in STAT5 transcriptional activity in γ 2A cells when the F595A mutation is also introduced 
[?C textMine:dep ?A, ?C textMine:dobj ?D, ?C textMine:nsubj ?mutation, ?E textMine:prep ?function, ?D textMine:amod ?impact, ?A textMine:dobj ?E]
Query : [?C textMine:dep ?A, ?C textMine:dobj ?D, ?C textMine:nsubj ?mutation, ?E textMine:prep ?function, ?D textMine:amod ?impact, ?A textMine:dobj ?E]
Existing trips : 
?B textMine:dobj ?F. ?D textMine:dep ?B. ?D textMine:dobj ?E. ?D textMine:nsubj ?mutation. ?E textMine:amod ?impact. ?F textMine:prep ?function. 
Similar Query!!!!


702 Whether resistance to BRAF V600E inhibitors also arises in gliomas, where EGFR and PI3K/mTOR pathways are often over activated, remains to be seen in neuro oncology patients treated with BRAF V600E inhibitors 
[?B textMine:partmod ?G, ?G textMine:prep ?H, ?impact textMine:xcomp ?C, ?impact textMine:ccomp ?A, ?C textMine:prep ?B, ?A textMine:nsubj ?function, ?H textMine:nn ?mutation]
Added to queryTripless!! : ?B textMine:partmod ?G. ?G textMine:prep ?H. ?neutral textMine:xcomp ?C. ?neutral textMine:ccomp ?A. ?C textMine:prep ?B. ?A textMine:nsubj ?function. ?H textMine:nn ?mutation. 
567

703 In the current study, Liu and colleagues show that mutant V600E BRAF enhances STAT3 phosphorylation and increases PAX3 expression in melanocytes 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ?C textMine:nn ?mutation]
[?C textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ]
Match 


704 E884K is activating, and can work cooperatively with L858R to differentially modulate downstream signal transduction
[?function textMine:amod ?impact, ?B textMine:prep ?function, ?B textMine:nsubj ?mutation]
Query : [?function textMine:amod ?impact, ?B textMine:prep ?function, ?B textMine:nsubj ?mutation]
Existing trips : 
?A textMine:nsubj ?mutation. ?A textMine:prep ?function. ?function textMine:amod ?impact. 
Similar Query!!!!


705 Although T315I BCR ABL is sufficient to confer resistance to TKIs in CML cells, surprisingly we found that multiple drug resistance pathways were activated in KCL 22M cells along with reduced expression of a set of myeloid differentiation genes 
[?B textMine:nn ?mutation, ?function textMine:amod ?impact, ?E textMine:ccomp ?F, ?E textMine:advcl ?D, ?F textMine:prep ?function, ?D textMine:nsubj ?B]
Added to queryTripless!! : ?B textMine:nn ?mutation. ?function textMine:amod ?negative. ?E textMine:ccomp ?F. ?E textMine:advcl ?D. ?F textMine:prep ?function. ?D textMine:nsubj ?B. 
568

706 The data they collected using cell lines of colon adenocarcinoma shows that  BRAF  V600E induces migration and enhances the invasive potential of these cells 
[?function textMine:conj ?impact, ?function textMine:nsubj ?mutation, ?impact textMine:nsubj ?mutation]
Added to queryTripless!! : ?function textMine:conj ?positive. ?function textMine:nsubj ?mutation. ?positive textMine:nsubj ?mutation. 
569

707 Clinical results from phase I, II, and III trials showed that vemurafenib treatment caused complete or partial tumor regression in 80% of patients carrying BRAF V600E  tumors as well as an increased progression free survival rate   
[?C textMine:nn ?mutation, ?C textMine:conj ?A, ?A textMine:nn ?function, ?A textMine:amod ?impact]
Added to queryTripless!! : ?C textMine:nn ?mutation. ?C textMine:conj ?A. ?A textMine:nn ?function. ?A textMine:amod ?positive. 
570

708 We identified 25 fold increased expression of MMP 1 mRNA in melanoma cells possessing BRAF V600E  compared to wildtype while HPMs expressed similar transcript levels with BRAF wildtype melanoma cell ( Figure 2a ), suggesting that increased BRAF kinase activity may be associated with elevated MMP 1 expression in melanomas 
[?D textMine:partmod ?G, ?C textMine:prep ?function, ?C textMine:nsubjpass ?D, ?G textMine:advcl ?F, ?G textMine:dobj ?mutation, ?F textMine:partmod ?I, ?I textMine:dobj ?B, ?B textMine:amod ?impact]
Added to queryTripless!! : ?D textMine:partmod ?G. ?C textMine:prep ?function. ?C textMine:nsubjpass ?D. ?G textMine:advcl ?F. ?G textMine:dobj ?mutation. ?F textMine:partmod ?I. ?I textMine:dobj ?B. ?B textMine:amod ?positive. 
571

709 The effect on the downstream signal mediators p AKT [S473] and p STAT3 [Y705] correlated well with the inhibition of EGFR phosphorylation ( Figure 1A ); E884K in  cis  with L858R decreased erlotinib inhibition of AKT and STAT3 phosphorylation but increased inhibition by gefitinib 
[?impact textMine:conj ?D, ?impact textMine:nsubj ?mutation, ?D textMine:dobj ?function, ?D textMine:nsubj ?mutation]
[?D textMine:dobj ?function, ?D textMine:nsubj ?mutation, ?impact textMine:conj ?D, ?impact textMine:nsubj ?mutation, ]
Match 


710 The T315I mutation experiences increased (−4.11 kcal/mol) and T315A mutation experiences decreased electrostatic interactions (−2 05 kcal/mol), and the mutation G250E contributes increased electrostatic interaction (−032 kcal/mol) while binding to ponatinib 
[?impact textMine:dobj ?F, ?B textMine:nn ?mutation, ?G textMine:conj ?impact, ?G textMine:conj ?E, ?E textMine:nsubj ?B, ?F textMine:amod ?function]
Added to queryTripless!! : ?positive textMine:dobj ?F. ?B textMine:nn ?mutation. ?G textMine:conj ?positive. ?G textMine:conj ?E. ?E textMine:nsubj ?B. ?F textMine:amod ?function. 
572

711 Moreover, coexpression of a dominant negative SENP 1(C630S) mutant significantly enhanced FOXM1 SUMOylation, suggesting that modified FOXM1 is a substrate for endogenous SENP 1 ( Figure 1f ) 
[?C textMine:ccomp ?function, ?impact textMine:xcomp ?C, ?E textMine:partmod ?impact, ?E textMine:nn ?mutation]
Added to queryTripless!! : ?C textMine:ccomp ?function. ?positive textMine:xcomp ?C. ?E textMine:partmod ?positive. ?E textMine:nn ?mutation. 
573

712 Furthermore, although the gold standard for detection of BRAF V600E mutation is PCR, a recently developed monoclonal antibody VE1 shows high sensitivity and specificity for this mutation, and has been widely used in replace of PCR for research purpose 
[?E textMine:nn ?mutation, ?F textMine:prep ?D, ?D textMine:prep ?E, ?G textMine:nsubj ?F, ?function textMine:amod ?impact, ?C textMine:dobj ?function, ?C textMine:advcl ?G]
Added to queryTripless!! : ?E textMine:nn ?mutation. ?F textMine:prep ?D. ?D textMine:prep ?E. ?G textMine:nsubj ?F. ?function textMine:amod ?positive. ?C textMine:dobj ?function. ?C textMine:advcl ?G. 
574

713 The T790M mutation may result in an alteration of EGFR topology that precludes the binding of reversible EGFR TKIs through steric hindrance, or T790M may increase the affinity of the kinase domain for ATP  
[?function textMine:conj ?A, ?function textMine:prep ?impact, ?A textMine:nsubj ?mutation]
Added to queryTripless!! : ?function textMine:conj ?A. ?function textMine:prep ?unknown. ?A textMine:nsubj ?mutation. 
575

714 The G370C and S371C mutants produced higher levels of constitutive activation of MAPK in L8 cells and c  fos  transcription in RCJ cells than the G375C mutant, consistent with the fact that TD1 is much more severe than ACH 
[?A textMine:prep ?function, ?A textMine:amod ?impact, ?C textMine:nn ?mutation, ?F textMine:prep ?C, ?F textMine:dobj ?A]
Added to queryTripless!! : ?A textMine:prep ?function. ?A textMine:amod ?positive. ?C textMine:nn ?mutation. ?F textMine:prep ?C. ?F textMine:dobj ?A. 
576

715 The most characterized resistance mutation is the T790M point mutation in exon 20, which increases the affinity of the EGFR for ATP, thus reducing the binding of EGFR TKIs to the ATP pocket 
[?E textMine:amod ?function, ?B textMine:partmod ?impact, ?impact textMine:dobj ?E, ?F textMine:prep ?G, ?F textMine:amod ?mutation, ?G textMine:rcmod ?B]
Added to queryTripless!! : ?E textMine:amod ?function. ?B textMine:partmod ?negative. ?negative textMine:dobj ?E. ?F textMine:prep ?G. ?F textMine:amod ?mutation. ?G textMine:rcmod ?B. 
577

716 RO5424802 treatment inhibited the growth of cells expressing the native, and L1196M and C1156Y EML ALK mutants and inhibited ALK and STAT3 phosphorylation, and lowered the levels of the STAT3 regulated proteins BCL3 and NNMT [ 142 , 143 ] 
[?impact textMine:nsubj ?B, ?function textMine:nsubj ?B, ?A textMine:conj ?impact, ?A textMine:conj ?function, ?A textMine:nsubj ?B, ?B textMine:nn ?mutation]
Added to queryTripless!! : ?negative textMine:nsubj ?B. ?function textMine:nsubj ?B. ?A textMine:conj ?negative. ?A textMine:conj ?function. ?A textMine:nsubj ?B. ?B textMine:nn ?mutation. 
578

717 Given that all cases with  BRAF   V600E   positive were histologically diagnosed as malignant thyroid neoplasm after thyroidectomy, in order to further increase diagnostic sensitivity, the cut off values for each gene were calculated using ROC curves to distinguish the cases with  BRAF   V600E   negative from benign nodules (Figure  2 ) 
[?I textMine:prep ?mutation, ?E textMine:advcl ?C, ?E textMine:dep ?H, ?D textMine:advcl ?impact, ?impact textMine:dobj ?function, ?C textMine:xcomp ?B, ?H textMine:pcomp ?D, ?B textMine:xcomp ?I]
Added to queryTripless!! : ?I textMine:prep ?mutation. ?E textMine:advcl ?C. ?E textMine:dep ?H. ?D textMine:advcl ?positive. ?positive textMine:dobj ?function. ?C textMine:xcomp ?B. ?H textMine:pcomp ?D. ?B textMine:xcomp ?I. 
579

718 V617F) that lead to constitutive kinase activation  
[?mutation textMine:prep ?function, ?function textMine:amod ?impact]
Added to queryTripless!! : ?mutation textMine:prep ?function. ?function textMine:amod ?positive. 
580

719 S252W mutation alters the gene expression in response to FGFR2 activation
[?impact textMine:dep ?D, ?impact textMine:amod ?mutation, ?E textMine:prep ?function, ?D textMine:prep ?E]
Added to queryTripless!! : ?unknown textMine:dep ?D. ?unknown textMine:amod ?mutation. ?E textMine:prep ?function. ?D textMine:prep ?E. 
581

720 For 4557W (reversible dual TKI of EGFR/ERBB2), the E884K mutation modulated the L858R mutation in  cis , again in a dominant fashion, rendering the double mutant receptor more sensitive to the dual inhibitor ( Figure 2 ) 
[?E textMine:xcomp ?function, ?impact textMine:partmod ?E, ?impact textMine:nsubj ?D, ?D textMine:nn ?mutation]
[?D textMine:nn ?mutation, ?E textMine:xcomp ?function, ?impact textMine:nsubj ?D, ?impact textMine:partmod ?E, ]
Match 


721 BRAF V600E  is a constitutively active onco kinase and is the most common genetic alteration in papillary thyroid carcinoma (PTC), and in anaplastic thyroid carcinoma as well, albeit at a lower frequency 
[?C textMine:amod ?function, ?C textMine:nsubj ?mutation, ?function textMine:advmod ?impact]
Added to queryTripless!! : ?C textMine:amod ?function. ?C textMine:nsubj ?mutation. ?function textMine:advmod ?positive. 
582

722 Enforced expression of Stat3C increased miR 92a expression in H460 cells that could be inhibited by S3I 201 ( Figure 3D ) 
[?A textMine:number ?mutation, ?E textMine:rcmod ?C, ?impact textMine:dobj ?function, ?C textMine:agent ?A, ?function textMine:prep ?E]
Added to queryTripless!! : ?A textMine:number ?mutation. ?E textMine:rcmod ?C. ?positive textMine:dobj ?function. ?C textMine:agent ?A. ?function textMine:prep ?E. 
583

723 The presence of R164Q in cluster 2, rather than in cluster 1 with wt  K Ras  was therefore initially surprising, but suggests that the R164Q mutation also has an 'activating' phenotype, albeit attenuated relative to the other mutations studied 
[?impact textMine:nsubj ?B, ?impact textMine:dobj ?function, ?B textMine:nn ?mutation]
Query : [?impact textMine:nsubj ?B, ?impact textMine:dobj ?function, ?B textMine:nn ?mutation]
Existing trips : 
?C textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?C. 
Similar Query!!!!


724 The two substitutions (V600E and V600K) represent 95% of all BRAF mutations in melanoma, and both create a constitutively active kinase that is independent of receptor tyrosine kinase or RAS 
[?G textMine:conj ?A, ?G textMine:nsubj ?D, ?A textMine:dobj ?E, ?function textMine:advmod ?impact, ?E textMine:amod ?function, ?D textMine:appos ?mutation]
[?A textMine:dobj ?E, ?D textMine:appos ?mutation, ?E textMine:amod ?function, ?G textMine:conj ?A, ?G textMine:nsubj ?D, ?function textMine:advmod ?impact, ]
Match 


725 (A) AUC for the logistic regression model based on L858R Q score and total EGFR expression Q score was higher than that for L858R intensity only (0.891 vs. 0 853;  p  = 0036) 
[?B textMine:prep ?A, ?C textMine:prep ?H, ?H textMine:num ?mutation, ?E textMine:prep ?F, ?A textMine:nn ?function, ?F textMine:partmod ?B, ?impact textMine:prep ?C, ?impact textMine:nsubj ?E]
Added to queryTripless!! : ?B textMine:prep ?A. ?C textMine:prep ?H. ?H textMine:num ?mutation. ?E textMine:prep ?F. ?A textMine:nn ?function. ?F textMine:partmod ?B. ?positive textMine:prep ?C. ?positive textMine:nsubj ?E. 
584

726 The single mutants, with the exception of K112N and K118N, exhibited slightly lower thermal stability than the wild type 
[?B textMine:prep ?F, ?C textMine:dobj ?function, ?C textMine:nsubj ?B, ?function textMine:amod ?impact, ?F textMine:prep ?mutation]
Added to queryTripless!! : ?B textMine:prep ?F. ?C textMine:dobj ?function. ?C textMine:nsubj ?B. ?function textMine:amod ?negative. ?F textMine:prep ?mutation. 
585

727 Combined BRAF V600E   and SRC inhibition induces apoptosis, evokes an immune response and reduces tumor growth in an immunocompetent orthotopic mouse model of anaplastic thyroid cancer
[?impact textMine:nsubj ?mutation, ?function textMine:conj ?impact, ?function textMine:nsubj ?mutation]
[?function textMine:conj ?impact, ?function textMine:nsubj ?mutation, ?impact textMine:nsubj ?mutation, ]
Match 


728 Indeed, as shown in Figure 3a , Tbx3 was significantly upregulated (~10 fold) in melanocytes with B RAF V600E  signaling, while no other known E cadherin regulator in our Illumina dataset was significantly altered 
[?impact textMine:nsubjpass ?function, ?A textMine:advcl ?impact, ?A textMine:prep ?mutation]
Added to queryTripless!! : ?unknown textMine:nsubjpass ?function. ?A textMine:advcl ?unknown. ?A textMine:prep ?mutation. 
586

729 Similar to E884K, R958D modulated the sensitizing effect of L858R differentially to reversible EGFR inhibitors when in  cis  (with L858R) 
[?A textMine:nn ?mutation, ?B textMine:prep ?A, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?B]
Query : [?A textMine:nn ?mutation, ?B textMine:prep ?A, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?B]
Existing trips : 
?A textMine:prep ?B. ?B textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?A. 
Similar Query!!!!


730 All inhibitors reduced the relative level of Mek 1/2 phosphorylation in clones carrying the V600E mutation by more than 90% with dabrafenib showing the strongest effect 
[?A textMine:agent ?D, ?A textMine:dobj ?E, ?B textMine:partmod ?A, ?D textMine:dobj ?function, ?E textMine:amod ?mutation, ?impact textMine:prep ?B]
Added to queryTripless!! : ?A textMine:agent ?D. ?A textMine:dobj ?E. ?B textMine:partmod ?A. ?D textMine:dobj ?function. ?E textMine:amod ?mutation. ?negative textMine:prep ?B. 
587

732 Immunoblot analysis revealed that this inhibition was caused by reduced phosphorylation of BCR ABL and Crk L and increased activation of PARP in Ba/F3 BCR ABL T315I cells after treatment with ponatinib ( Figure 1D ) 
[?A textMine:nn ?mutation, ?function textMine:amod ?impact, ?function textMine:prep ?A]
[?A textMine:nn ?mutation, ?function textMine:amod ?impact, ?function textMine:prep ?A, ]
Match 


733 Cell proliferation (Ki67 labelling) was significantly reduced in melanocytes transfected with   V600E   BRAF  but not   WT   BRAF  ( Figure 5B ) 
[?D textMine:nn ?mutation, ?impact textMine:prep ?C, ?impact textMine:nsubjpass ?function, ?B textMine:prep ?D, ?C textMine:partmod ?B]
Added to queryTripless!! : ?D textMine:nn ?mutation. ?negative textMine:prep ?C. ?negative textMine:nsubjpass ?function. ?B textMine:prep ?D. ?C textMine:partmod ?B. 
588

734 The activity of DAS is maintained despite the presence of mutations that confer resistance to IM with the exception of the T315I mutation, and to a large degree, mutations affecting the residue 317 (F317L, F317V) 
[?A textMine:dep ?mutation, ?B textMine:prep ?C, ?C textMine:appos ?A, ?impact textMine:prep ?B, ?impact textMine:nsubjpass ?function]
[?A textMine:dep ?mutation, ?B textMine:prep ?C, ?C textMine:appos ?A, ?impact textMine:nsubjpass ?function, ?impact textMine:prep ?B, ]
Match 


735 Interestingly, we found that the ability of mutant FGFR3 expressing cells to reach a higher saturation density was partially dependent on PLCγ1 phosphorylation, as this was reduced in cells expressing S249C FGFR3 with a mutation disrupting the PLCγ1 binding site 
[?impact textMine:prep ?C, ?A textMine:nn ?mutation, ?C textMine:partmod ?function, ?function textMine:dobj ?A]
Added to queryTripless!! : ?negative textMine:prep ?C. ?A textMine:nn ?mutation. ?C textMine:partmod ?function. ?function textMine:dobj ?A. 
589

736 The phosphorylation of Akt induced by S768I was abrogated by 100 nM erlotinib, and fibril formation was noted upon treatment with 1 μM or higher concentration of the drug 
[?function textMine:prep ?D, ?D textMine:partmod ?B, ?B textMine:agent ?mutation, ?impact textMine:nsubjpass ?function]
Added to queryTripless!! : ?function textMine:prep ?D. ?D textMine:partmod ?B. ?B textMine:agent ?mutation. ?negative textMine:nsubjpass ?function. 
590

737 Surprisingly we found that, expression of each activated KRAS ED  lead to a substantial decrease in Braf V600E  induced tumors relative to the EGFP control suggesting the existence of a KRAS activated negative regulator of tumorigenesis 
[?G textMine:advmod ?E, ?mutation textMine:partmod ?G, ?F textMine:partmod ?H, ?H textMine:dobj ?A, ?impact textMine:prep ?mutation, ?E textMine:prep ?F, ?B textMine:nn ?function, ?A textMine:prep ?B]
Added to queryTripless!! : ?G textMine:advmod ?E. ?mutation textMine:partmod ?G. ?F textMine:partmod ?H. ?H textMine:dobj ?A. ?negative textMine:prep ?mutation. ?E textMine:prep ?F. ?B textMine:nn ?function. ?A textMine:prep ?B. 
591

738 In a dose response experiment ( Figure 3 B, left panel), the best inhibitor, D4, was effective at a concentration of 200 nM to inhibit RET C634Y  autophosphorylation up to 70% and to drastically reduce ERK phosphorylation 
[?D textMine:nsubj ?mutation, ?function textMine:conj ?impact, ?function textMine:ccomp ?D]
Added to queryTripless!! : ?D textMine:nsubj ?mutation. ?function textMine:conj ?negative. ?function textMine:ccomp ?D. 
592

739 When using a higher sensitive approach (the ARMS assay, which may detect this allele variant with a sensitivity close to 3%) persistent cells harbouring KIT M541L  allele variant occurred only in one patient (#4), (Fig  1B ) 
[?I textMine:nsubj ?H, ?E textMine:nn ?function, ?B textMine:rcmod ?A, ?F textMine:dobj ?mutation, ?H textMine:partmod ?F, ?C textMine:dep ?B, ?C textMine:rcmod ?I, ?C textMine:amod ?impact, ?A textMine:prep ?E]
Added to queryTripless!! : ?I textMine:nsubj ?H. ?E textMine:nn ?function. ?B textMine:rcmod ?A. ?F textMine:dobj ?mutation. ?H textMine:partmod ?F. ?C textMine:dep ?B. ?C textMine:rcmod ?I. ?C textMine:amod ?positive. ?A textMine:prep ?E. 
593

740 Indeed, dual blockade of MEK/BRAF V600E  (with PD184352, PLX4720 or vemurafenib) and MET (with crizotinib, SU11274 or MET specific siRNA) resulted in reversal of drug resistance and reduced the proliferation of melanoma cell lines, which was restored by exogenous HGF ( 29 , 109 ) 
[?impact textMine:nsubj ?C, ?C textMine:prep ?mutation, ?function textMine:conj ?impact, ?function textMine:nsubj ?C]
Added to queryTripless!! : ?negative textMine:nsubj ?C. ?C textMine:prep ?mutation. ?function textMine:conj ?negative. ?function textMine:nsubj ?C. 
594

741 Ki67 labeling revealed an enhanced proliferation index in JoMa1 ALK F1174L derived tumors (48%) compared to JoMa1 ALK R1275Q  (40%), and JoMa1 ALK wt derived tumors (38%) (Figure  3b ), suggesting that the accelerated tumor growth of JoMa1 ALK F1174L tumors may partly result from their increased proliferation capacity 
[?D textMine:amod ?impact, ?E textMine:partmod ?G, ?F textMine:nn ?function, ?G textMine:pobj ?mutation, ?J textMine:conj ?I, ?J textMine:prep ?E, ?J textMine:dobj ?D, ?I textMine:partmod ?K, ?B textMine:prep ?F, ?K textMine:ccomp ?B]
Added to queryTripless!! : ?D textMine:amod ?positive. ?E textMine:partmod ?G. ?F textMine:nn ?function. ?G textMine:pobj ?mutation. ?J textMine:conj ?I. ?J textMine:prep ?E. ?J textMine:dobj ?D. ?I textMine:partmod ?K. ?B textMine:prep ?F. ?K textMine:ccomp ?B. 
595

742 The role of  BRAF  and  KRAS  oncogenes in altering cytoskeletal properties was further emphasized following depletion of BRAF V600E  by shRNA in HT29 cells, where migration ability of HT ShBR3 cells, with downregulated expression of mt BRAF  gene, was significantly impaired as compared to the empty vector control HT ps cells 
[?A textMine:prep ?D, ?mutation textMine:prep ?A, ?D textMine:rcmod ?impact, ?impact textMine:nsubj ?function]
Added to queryTripless!! : ?A textMine:prep ?D. ?mutation textMine:prep ?A. ?D textMine:rcmod ?negative. ?negative textMine:nsubj ?function. 
596

743 Activation by the Gal4 PPARγ LBD K365R mutant, however, was much lower in the absence and presence of ligands ( Figure 5B ) 
[?E textMine:nn ?mutation, ?impact textMine:nsubj ?function, ?impact textMine:dep ?C, ?C textMine:prep ?E]
Added to queryTripless!! : ?E textMine:nn ?mutation. ?negative textMine:nsubj ?function. ?negative textMine:dep ?C. ?C textMine:prep ?E. 
597

744 In support, western blotting of FLT 3 autophosphorylation of these mutants, F691L and D835F/Y, from the untreated total cell extracts showed reduced autophosphorylation of FLT3 in comparison with FLT3 ITD ( Figure 1c ), thus supporting the notion that these mutations confer resistance by destabilizing the active state rather than direct steric hindrance to the drug 
[?D textMine:prep ?E, ?G textMine:appos ?mutation, ?E textMine:prep ?G, ?C textMine:dobj ?function, ?C textMine:nsubj ?D, ?function textMine:amod ?impact]
Added to queryTripless!! : ?D textMine:prep ?E. ?G textMine:appos ?mutation. ?E textMine:prep ?G. ?C textMine:dobj ?function. ?C textMine:nsubj ?D. ?function textMine:amod ?negative. 
598

745 Hence, E884K in  cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone, through differential inhibition of the pro survival AKT and STAT3 signaling pathways associated with altered induction of cleaved PARP(Asp214) 
[?F textMine:partmod ?function, ?B textMine:prep ?F, ?B textMine:pobj ?mutation, ?function textMine:prep ?E, ?E textMine:amod ?impact]
Query : [?F textMine:partmod ?function, ?B textMine:prep ?F, ?B textMine:pobj ?mutation, ?function textMine:prep ?E, ?E textMine:amod ?impact]
Existing trips : 
?A textMine:amod ?impact. ?B textMine:partmod ?function. ?E textMine:pobj ?mutation. ?E textMine:prep ?B. ?function textMine:prep ?A. 
Similar Query!!!!


746 This is proposed to drop anti apoptotic activity in JAK2 V617F  mutant cells below a critical threshold, unleashing Bak and Bax to drive mitochondrial cell death 
[?function textMine:prep ?B, ?impact textMine:dobj ?function, ?B textMine:num ?mutation]
Added to queryTripless!! : ?function textMine:prep ?B. ?negative textMine:dobj ?function. ?B textMine:num ?mutation. 
599

747 Despite the decreased expression observed, BRAF V600E mutated samples had a hypomethylated pattern ( p  = 0048) 
[?C textMine:nsubj ?A, ?C textMine:prep ?function, ?A textMine:nn ?mutation, ?function textMine:amod ?impact]
Query : [?C textMine:nsubj ?A, ?C textMine:prep ?function, ?A textMine:nn ?mutation, ?function textMine:amod ?impact]
Existing trips : 
?B textMine:nn ?mutation. ?E textMine:nsubj ?B. ?E textMine:prep ?function. ?function textMine:amod ?impact. 
Similar Query!!!!


748 TBP 3868 exhibits high basal Ras activity relative to the PLX4720 sensitive line, TBP 3743 suggesting that the resistance to BRAF V600E  inhibition in TBP 3868 may be attributed to Ras dependent transactivation of RAF dimers 
[?function textMine:prep ?A, ?I textMine:advmod ?E, ?I textMine:amod ?impact, ?B textMine:nsubjpass ?function, ?J textMine:appos ?C, ?E textMine:prep ?J, ?C textMine:partmod ?H, ?H textMine:ccomp ?B, ?A textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:prep ?A. ?I textMine:advmod ?E. ?I textMine:amod ?positive. ?B textMine:nsubjpass ?function. ?J textMine:appos ?C. ?E textMine:prep ?J. ?C textMine:partmod ?H. ?H textMine:ccomp ?B. ?A textMine:nn ?mutation. 
600

749 Similarly, E884K further enhanced the sensitivity of L858R to the inhibition by the irreversible EGFR/ERBB2 inhibitor, CL 387,785 
[?impact textMine:nsubj ?mutation, ?impact textMine:prep ?function]
[?impact textMine:nsubj ?mutation, ?impact textMine:prep ?function, ]
Match 


750 The somatic E884K substitution appears to be relatively infrequent, and resulted in a mutant lysine residue that disrupts an ion pair with residue R958 in the EGFR kinase domain C lobe, an interaction that is highly conserved within the human kinome as demonstrated by our sequence analysis and structure analysis 
[?C textMine:prep ?G, ?impact textMine:prep ?C, ?A textMine:prep ?F, ?A textMine:nsubj ?H, ?F textMine:rcmod ?impact, ?G textMine:appos ?function, ?H textMine:nn ?mutation]
[?A textMine:nsubj ?H, ?A textMine:prep ?F, ?C textMine:prep ?G, ?F textMine:rcmod ?impact, ?G textMine:appos ?function, ?H textMine:nn ?mutation, ?impact textMine:prep ?C, ]
Match 


751 For instance, the A391E mutation in FGFR3 increases FGFR3 phosphorylation at low ligand concentration, similarly to the G380R and G375C ACH mutations studied here  
[?impact textMine:prep ?C, ?B textMine:amod ?E, ?C textMine:appos ?B, ?C textMine:amod ?function, ?G textMine:nn ?mutation, ?E textMine:prep ?G]
Added to queryTripless!! : ?positive textMine:prep ?C. ?B textMine:amod ?E. ?C textMine:appos ?B. ?C textMine:amod ?function. ?G textMine:nn ?mutation. ?E textMine:prep ?G. 
601

752 Signaling studies show again that cells expressing the L858R allele have reduced EGFR, AKT, and ERK phosphorylation in response to increasing concentrations of dasatinib ( Figure 5B ) 
[?function textMine:dobj ?B, ?B textMine:amod ?mutation, ?C textMine:partmod ?function, ?impact textMine:nsubj ?C]
Added to queryTripless!! : ?function textMine:dobj ?B. ?B textMine:amod ?mutation. ?C textMine:partmod ?function. ?negative textMine:nsubj ?C. 
602

753 Hence, the double mutation L858R+E884K modulated downstream EGFR signaling differentially with distinctly different effects on the AKT (downregulated) and MAPK ERK1/2 phosphorylation (upregulated) 
[?D textMine:partmod ?A, ?impact textMine:dobj ?D, ?impact textMine:nsubj ?mutation, ?A textMine:prep ?function]
[?A textMine:prep ?function, ?D textMine:partmod ?A, ?impact textMine:dobj ?D, ?impact textMine:nsubj ?mutation, ]
Match 


848 The striking stability of our gene expression results on  PDGFRA  mutated tumors could be explained by the D842V mutation found on 4/5 samples 
[?E textMine:agent ?A, ?E textMine:nsubjpass ?B, ?A textMine:amod ?mutation, ?B textMine:prep ?function]
Added to queryTripless!! : ?E textMine:agent ?A. ?E textMine:nsubjpass ?B. ?A textMine:amod ?mutation. ?B textMine:prep ?function. 
603

754 It is striking that several of the variants with reduced activity had altered evolutionarily conserved glycine residues; that is, G220V, G401S, and G465R, suggesting that these residues may be particularly important for OCT1 function   
[?A textMine:prep ?function, ?function textMine:amod ?impact, ?C textMine:rcmod ?mutation, ?E textMine:dobj ?C, ?E textMine:nsubj ?G, ?G textMine:prep ?A]
Added to queryTripless!! : ?A textMine:prep ?function. ?function textMine:amod ?negative. ?C textMine:rcmod ?mutation. ?E textMine:dobj ?C. ?E textMine:nsubj ?G. ?G textMine:prep ?A. 
604

755 Notably, inhibition of phosphorylation of the D816V mutation was significantly reduced compared to the D816Y and D816F isoforms 
[?C textMine:prep ?function, ?impact textMine:pobj ?B, ?impact textMine:nsubjpass ?C, ?B textMine:nn ?mutation]
[?B textMine:nn ?mutation, ?C textMine:prep ?function, ?impact textMine:nsubjpass ?C, ?impact textMine:pobj ?B, ]
Match 


756 We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated (native) BCR/ABL ( 15 – 17 ) 
[?C textMine:dobj ?function, ?C textMine:nsubj ?E, ?function textMine:amod ?impact, ?E textMine:nn ?mutation]
Query : [?C textMine:dobj ?function, ?C textMine:nsubj ?E, ?function textMine:amod ?impact, ?E textMine:nn ?mutation]
Existing trips : 
?C textMine:nn ?mutation. ?E textMine:dobj ?function. ?E textMine:nsubj ?C. ?function textMine:amod ?impact. 
Similar Query!!!!


757 Surprisingly we found that, expression of each activated KRAS ED  lead to a substantial decrease in Braf V600E  induced tumors relative to the EGFP control suggesting the existence of a KRAS activated negative regulator of tumorigenesis 
[?mutation textMine:partmod ?function, ?impact textMine:prep ?mutation]
Added to queryTripless!! : ?mutation textMine:partmod ?function. ?negative textMine:prep ?mutation. 
605

758 Tyrosine phosphorylation of STAT5 was also enhanced, though not as significantly as that of PECAM 1, in cells expressing the E255K or T315I mutant ( Fig 4C ) 
[?impact textMine:prep ?D, ?function textMine:dobj ?B, ?D textMine:partmod ?function, ?B textMine:nn ?mutation]
Query : [?impact textMine:prep ?D, ?function textMine:dobj ?B, ?D textMine:partmod ?function, ?B textMine:nn ?mutation]
Existing trips : 
?A textMine:nn ?mutation. ?C textMine:partmod ?function. ?function textMine:dobj ?A. ?impact textMine:prep ?C. 
Similar Query!!!!


759 One Akt mutant (E17K), found in a subset of human cancers, displays higher PIP3 binding, membrane localization, and activation (Brazil et al , ; Varnai et al, ) 
[?E textMine:conj ?function, ?E textMine:amod ?impact, ?C textMine:appos ?mutation, ?D textMine:dobj ?function, ?D textMine:dobj ?E, ?D textMine:nsubj ?C]
[?C textMine:appos ?mutation, ?D textMine:dobj ?E, ?D textMine:dobj ?function, ?D textMine:nsubj ?C, ?E textMine:amod ?impact, ?E textMine:conj ?function, ]
Match 


760 In terms of EGFR TKI sensitivity, Kancha et al have identified 4 sets of mutations based on their drug sensitivity profiles: (a) mutations that are very sensitive to all 3 drugs tested with IC50 values in the low nanomolar range (L858R and Del 747 753insS), (b) mutations that are less sensitive to gefitinib (IC50 >100 nmol/l) but sensitive to both erlotinib and AEE788 (G719S, V742A, and R776C; IC50 < 100 nmol/l), (c) mutations that are less sensitive to both gefitinib and erlotinib but sensitive to AEE788 (D761N, S768I, S784F, L838V, and L861Q), and (d) mutations that are resistant to all three drugs tested (N826S and T790M)   
[?A textMine:conj ?C, ?A textMine:xcomp ?function, ?A textMine:advmod ?impact, ?C textMine:dep ?mutation]
Query : [?A textMine:conj ?C, ?A textMine:xcomp ?function, ?A textMine:advmod ?impact, ?C textMine:dep ?mutation]
Existing trips : 
?A textMine:advmod ?impact. ?A textMine:conj ?D. ?A textMine:xcomp ?function. ?D textMine:dep ?mutation. 
Similar Query!!!!


761 In our recent studies on the effects of PLX4032, we demonstrated that the high enzymatic activity of both V600E and V600K BRAF mutants in melanoma cells is suppressed by treatment with PLX4032   
[?function textMine:amod ?impact, ?function textMine:prep ?D, ?D textMine:nn ?mutation]
Query : [?function textMine:amod ?impact, ?function textMine:prep ?D, ?D textMine:nn ?mutation]
Existing trips : 
?A textMine:nn ?mutation. ?function textMine:amod ?impact. ?function textMine:prep ?A. 
Similar Query!!!!


762 In BRAF V600E  mutated cells inhibition of BRAF pathway lead to a decrease in ERK1/2 phosphorylation and cyclin D1 levels and an increase in p27 Kip1  
[?impact textMine:prep ?function, ?mutation textMine:partmod ?B, ?B textMine:prep ?impact]
Added to queryTripless!! : ?negative textMine:prep ?function. ?mutation textMine:partmod ?B. ?B textMine:prep ?negative. 
606

763 The most marked effect was with  γ  mangostin, which induced a 6 8 fold decrease of the mRNA level of BRAF V600E relative to the untreated control ( P  < 001) 
[?A textMine:prep ?B, ?A textMine:amod ?impact, ?function textMine:dobj ?A, ?D textMine:nn ?mutation, ?B textMine:prep ?D]
Added to queryTripless!! : ?A textMine:prep ?B. ?A textMine:amod ?negative. ?function textMine:dobj ?A. ?D textMine:nn ?mutation. ?B textMine:prep ?D. 
607

764 62  Mutated ALK at F1174L led to increased proliferation and decreased apoptosis of neuroblastoma cell lines 
[?A textMine:prep ?mutation, ?B textMine:prep ?function, ?B textMine:nsubj ?A, ?function textMine:amod ?impact]
Added to queryTripless!! : ?A textMine:prep ?mutation. ?B textMine:prep ?function. ?B textMine:nsubj ?A. ?function textMine:amod ?negative. 
608

765 E884K is activating, and can work cooperatively with L858R to differentially modulate downstream signal transduction
[?function textMine:amod ?impact, ?B textMine:prep ?function, ?B textMine:nsubj ?mutation]
Query : [?function textMine:amod ?impact, ?B textMine:prep ?function, ?B textMine:nsubj ?mutation]
Existing trips : 
?A textMine:nsubj ?mutation. ?A textMine:prep ?function. ?function textMine:amod ?impact. 
Similar Query!!!!


766 This analysis revealed that the GST–JNK2 mutants D162N or D326N, residing within the ED and CD domains respectively, had reduced association with Myc 1018 C ( Figure 6 B, lanes 3–5) 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation]
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation, ]
Match 


767 Simultaneously, we have applied the increase of sensitivity of COLD PCR assay approach combined with HRM analysis for the non invasive prenatal diagnosis of C634Y fetal mutations using pregnant women serum 
[?B textMine:num ?mutation, ?E textMine:pobj ?A, ?F textMine:pcomp ?E, ?impact textMine:prep ?function, ?A textMine:prep ?I, ?C textMine:prep ?F, ?C textMine:dobj ?impact, ?I textMine:prep ?B]
Added to queryTripless!! : ?B textMine:num ?mutation. ?E textMine:pobj ?A. ?F textMine:pcomp ?E. ?positive textMine:prep ?function. ?A textMine:prep ?I. ?C textMine:prep ?F. ?C textMine:dobj ?positive. ?I textMine:prep ?B. 
609

768 Conversely, E884K worked in concert with L858R in  cis  to further enhance the sensitivity of the mutant receptor to gefitinib inhibition ( Fig 1A, B ) 
[?B textMine:prep ?mutation, ?B textMine:xcomp ?impact, ?impact textMine:prep ?function]
Added to queryTripless!! : ?B textMine:prep ?mutation. ?B textMine:xcomp ?positive. ?positive textMine:prep ?function. 
610

769 Our studies here, using COS 7 transfection model system, show that E884K works in concert with L858R in  cis , in a dominant fashion, to change downstream signaling, differentially induce MAPK ERK1/2 signaling and associated cell proliferation, and differentially alter sensitivity of EGFR phosphorylation inhibition by ERBB family inhibitors in an inhibitor specific fashion 
[?A textMine:prep ?function, ?impact textMine:dobj ?A, ?B textMine:prep ?mutation, ?B textMine:xcomp ?impact]
Added to queryTripless!! : ?A textMine:prep ?function. ?unknown textMine:dobj ?A. ?B textMine:prep ?mutation. ?B textMine:xcomp ?unknown. 
611

770 In addition, the  JAK2  V617F  mutation may increase the stability of the JAK2 protein by rendering it resistant to the effect of SOCS3 binding, as overexpression of SOCS3 results in increased SOCS3 and  JAK2  V617F  phosphorylation [ 68 ] 
[?I textMine:num ?mutation, ?E textMine:prepc ?D, ?E textMine:dobj ?function, ?A textMine:amod ?impact, ?B textMine:prep ?A, ?C textMine:conj ?I, ?C textMine:prep ?H, ?H textMine:prep ?B, ?D textMine:xcomp ?I, ?D textMine:xcomp ?C]
Added to queryTripless!! : ?I textMine:num ?mutation. ?E textMine:prepc ?D. ?E textMine:dobj ?function. ?A textMine:amod ?positive. ?B textMine:prep ?A. ?C textMine:conj ?I. ?C textMine:prep ?H. ?H textMine:prep ?B. ?D textMine:xcomp ?I. ?D textMine:xcomp ?C. 
612

771 Several resistance mechanisms, such as EGFR T790M secondary mutation that leads to a higher ATP binding capacity, and MET amplification resulting in an aberrantly activated alternative pathway that bypasses the inhibited EGF receptors, had been discovered 
[?E textMine:prep ?F, ?F textMine:amod ?function, ?F textMine:amod ?impact, ?D textMine:rcmod ?E, ?D textMine:nn ?mutation]
Added to queryTripless!! : ?E textMine:prep ?F. ?F textMine:amod ?function. ?F textMine:amod ?positive. ?D textMine:rcmod ?E. ?D textMine:nn ?mutation. 
613

772 In the second case, the patient was treated with KW 2449, a T315I specific inhibitor, after losing the CCyR induced by 800 mg per day imatinib 
[?C textMine:prepc ?impact, ?C textMine:prep ?G, ?G textMine:appos ?B, ?B textMine:amod ?mutation, ?impact textMine:dobj ?F, ?F textMine:partmod ?function]
Added to queryTripless!! : ?C textMine:prepc ?negative. ?C textMine:prep ?G. ?G textMine:appos ?B. ?B textMine:amod ?mutation. ?negative textMine:dobj ?F. ?F textMine:partmod ?function. 
614

773 The Y931C mutation might disrupt the π–π interaction between tyrosine ring and the inhibitor ring structure, thus weakening the inhibitor binding and resulting in easy expulsion from the pocket 
[?F textMine:ccomp ?E, ?B textMine:nn ?mutation, ?E textMine:xcomp ?function, ?impact textMine:parataxis ?F, ?impact textMine:nsubj ?B]
Added to queryTripless!! : ?F textMine:ccomp ?E. ?B textMine:nn ?mutation. ?E textMine:xcomp ?function. ?negative textMine:parataxis ?F. ?negative textMine:nsubj ?B. 
615

774 Therefore, in this study we explored the retained antitumor activity of gefitinib in resistant HCC827 GR5 and NCI H1975 NSCLC cells, carrying  MET  amplification and T790M mutation, respectively 
[?function textMine:amod ?impact, ?E textMine:dobj ?function, ?B textMine:dobj ?C, ?B textMine:prep ?D, ?D textMine:rcmod ?E, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:amod ?neutral. ?E textMine:dobj ?function. ?B textMine:dobj ?C. ?B textMine:prep ?D. ?D textMine:rcmod ?E. ?C textMine:nn ?mutation. 
616

775 The activity against the resistance mutation T790M and cell lines with downstream resistance mechanisms was, however, only slightly better than the reversible TKIs 
[?function textMine:prep ?mutation, ?impact textMine:nsubj ?function]
Added to queryTripless!! : ?function textMine:prep ?mutation. ?positive textMine:nsubj ?function. 
617

776 EGFR mutation positive NSCLCs which also test positive for mutations associated with primary or, most frequently, secondary resistance to first generation TKIs (first of all the T790M substitution) may respond better to newer agents like afatinib, and dacomitinib, which have demonstrated a greater effectiveness in these clinical situations, but more clinical data are required      
[?C textMine:prep ?D, ?H textMine:dobj ?function, ?I textMine:acomp ?impact, ?I textMine:dep ?C, ?A textMine:dep ?I, ?A textMine:rcmod ?H, ?J textMine:prep ?B, ?B textMine:amod ?mutation, ?D textMine:dep ?J]
Added to queryTripless!! : ?C textMine:prep ?D. ?H textMine:dobj ?function. ?I textMine:acomp ?positive. ?I textMine:dep ?C. ?A textMine:dep ?I. ?A textMine:rcmod ?H. ?J textMine:prep ?B. ?B textMine:amod ?mutation. ?D textMine:dep ?J. 
618

777 S252W mutation alters the gene expression in response to FGFR2 activation
[?impact textMine:dep ?function, ?impact textMine:amod ?mutation]
Added to queryTripless!! : ?unknown textMine:dep ?function. ?unknown textMine:amod ?mutation. 
619

778 In a study of four categories of imatinib  and dasatinib treated patients (imatinib resistant/dasatinib responsive; dasatinib resistant; blast crisis or CML progression and T315I or F317L mutated patient receiving omacetaxine treatment)  , transcriptional and translational levels of HCK, LYN and another SFK related gene BTK were elevated in more than 50% of resistant CML patients 
[?A textMine:nn ?function, ?C textMine:nn ?mutation, ?B textMine:prep ?I, ?G textMine:prep ?A, ?E textMine:prep ?B, ?impact textMine:prep ?G, ?impact textMine:prep ?E, ?I textMine:dep ?C]
Added to queryTripless!! : ?A textMine:nn ?function. ?C textMine:nn ?mutation. ?B textMine:prep ?I. ?G textMine:prep ?A. ?E textMine:prep ?B. ?positive textMine:prep ?G. ?positive textMine:prep ?E. ?I textMine:dep ?C. 
620

779 The V600E mutation is an acquired activating mutation that results in constitutively active  BRAF  kinase activity leading to activation of the  MAPK  pathway 
[?D textMine:prep ?function, ?D textMine:amod ?F, ?A textMine:prep ?D, ?F textMine:advmod ?impact, ?B textMine:nn ?mutation, ?H textMine:rcmod ?A, ?H textMine:nsubj ?B]
Added to queryTripless!! : ?D textMine:prep ?function. ?D textMine:amod ?F. ?A textMine:prep ?D. ?F textMine:advmod ?positive. ?B textMine:nn ?mutation. ?H textMine:rcmod ?A. ?H textMine:nsubj ?B. 
621

780 Interestingly, expression of p16 was significantly elevated in cultures transfected with   V600E   BRAF  but not   WT   BRAF , especially in individual cells expressing   V600E  BRAF relative to those expressing   WT  BRAF ( Figure 5A–C ), whereas p21 expression was no higher with   V600E  BRAF than   WT  BRAF or the empty vector ( Figure 5A ) 
[?D textMine:advcl ?F, ?A textMine:partmod ?D, ?G textMine:nn ?mutation, ?impact textMine:prep ?A, ?F textMine:prep ?G, ?F textMine:nsubj ?function]
Added to queryTripless!! : ?D textMine:advcl ?F. ?A textMine:partmod ?D. ?G textMine:nn ?mutation. ?positive textMine:prep ?A. ?F textMine:prep ?G. ?F textMine:nsubj ?function. 
622

781 The high potency of afatinib to inhibit the tyrosine kinase activity of wild type EGFR was fully maintained on EGFR with the activating L858R mutation (Solca et al  ; Sos et al ) 
[?impact textMine:prep ?B, ?B textMine:amod ?function, ?B textMine:amod ?mutation]
Added to queryTripless!! : ?neutral textMine:prep ?B. ?B textMine:amod ?function. ?B textMine:amod ?mutation. 
623

782 R958D mutation, when in  cis  with L858R, decreased the sensitivity of the mutant receptor to erlotinib inhibition, while increasing the sensitivity to gefitinib in a dominant fashion ( Figure 5A, B ) 
[?A textMine:prep ?mutation, ?B textMine:rcmod ?A, ?F textMine:dobj ?function, ?impact textMine:prepc ?F, ?impact textMine:nsubj ?B]
Added to queryTripless!! : ?A textMine:prep ?mutation. ?B textMine:rcmod ?A. ?F textMine:dobj ?function. ?negative textMine:prepc ?F. ?negative textMine:nsubj ?B. 
624

783 Moreover, E cadherin protein levels were significantly diminished in B RAF V600E  transduced normal melanocytes derived from three individuals ( Figure 2b ) and E cadherin protein levels increased when B RAF V600E  was specifically silenced by shRNA or inhibited using the targeted B RAF inhibitor Vemurafenib (PLX4032) in two B RAF V600E  positive melanoma cell lines (NM176 and ME1042) ( Figure 2c ) 
[?B textMine:prep ?C, ?impact textMine:conj ?function, ?C textMine:nn ?mutation, ?function textMine:xcomp ?E, ?E textMine:dobj ?B]
Added to queryTripless!! : ?B textMine:prep ?C. ?positive textMine:conj ?function. ?C textMine:nn ?mutation. ?function textMine:xcomp ?E. ?E textMine:dobj ?B. 
625

784 Furthermore, constitutive activity of a JAK1 mutant homologous to JAK2 V617F (JAK1 V658F) was also inhibited by the homologous JAK1 F595 mutation (F636A), suggesting that our results in JAK2 might be relevant for activation of JAK1 mutants recently identified in T ALL     
[?A textMine:xcomp ?B, ?A textMine:nsubj ?E, ?E textMine:prep ?G, ?E textMine:amod ?impact, ?B textMine:ccomp ?F, ?F textMine:prep ?function, ?G textMine:prep ?mutation]
Added to queryTripless!! : ?A textMine:xcomp ?B. ?A textMine:nsubj ?E. ?E textMine:prep ?G. ?E textMine:amod ?positive. ?B textMine:ccomp ?F. ?F textMine:prep ?function. ?G textMine:prep ?mutation. 
626

785 The Y931C mutation might disrupt the π–π interaction between tyrosine ring and the inhibitor ring structure, thus weakening the inhibitor binding and resulting in easy expulsion from the pocket 
[?A textMine:nn ?mutation, ?impact textMine:parataxis ?function, ?impact textMine:nsubj ?A]
Added to queryTripless!! : ?A textMine:nn ?mutation. ?negative textMine:parataxis ?function. ?negative textMine:nsubj ?A. 
627

786 ( H ) Mock and mscv puro STAT5 S710F  transduced p53  /   erythroid cell line maintained under proliferation conditions were lyzed and analyzed for ISG15 expression using anti ISG15 antibody on a 10% acrylamide gel (Top panel) 
[?H textMine:ccomp ?B, ?C textMine:ccomp ?H, ?C textMine:nsubj ?mutation, ?G textMine:partmod ?impact, ?E textMine:nn ?function, ?impact textMine:prep ?E, ?B textMine:nsubjpass ?G]
Added to queryTripless!! : ?H textMine:ccomp ?B. ?C textMine:ccomp ?H. ?C textMine:nsubj ?mutation. ?G textMine:partmod ?neutral. ?E textMine:nn ?function. ?neutral textMine:prep ?E. ?B textMine:nsubjpass ?G. 
628

787 The addition of c MET siRNA to either EGFR wild type or T790M specific siRNAs, resulted in an increased effect on cell growth inhibition and caspase−3/7 activity induction 
[?F textMine:prep ?function, ?F textMine:ccomp ?D, ?D textMine:prep ?E, ?function textMine:amod ?impact, ?E textMine:num ?mutation]
Added to queryTripless!! : ?F textMine:prep ?function. ?F textMine:ccomp ?D. ?D textMine:prep ?E. ?function textMine:amod ?positive. ?E textMine:num ?mutation. 
629

788 In MPN, it has been shown that the JAK2 V617F mutation induces an increase in spontaneous homologous recombination leading to a hyperrecombination state 
[?function textMine:dobj ?impact, ?function textMine:nsubj ?D, ?D textMine:nn ?mutation]
Query : [?function textMine:dobj ?impact, ?function textMine:nsubj ?D, ?D textMine:nn ?mutation]
Existing trips : 
?C textMine:nn ?mutation. ?function textMine:dobj ?impact. ?function textMine:nsubj ?C. 
Similar Query!!!!


789 R958D mutation, when in  cis  with L858R, decreased the sensitivity of the mutant receptor to erlotinib inhibition, while increasing the sensitivity to gefitinib in a dominant fashion ( Figure 5A, B ) 
[?A textMine:prep ?mutation, ?B textMine:rcmod ?A, ?impact textMine:dobj ?function, ?D textMine:prepc ?impact, ?D textMine:nsubj ?B]
Added to queryTripless!! : ?A textMine:prep ?mutation. ?B textMine:rcmod ?A. ?positive textMine:dobj ?function. ?D textMine:prepc ?positive. ?D textMine:nsubj ?B. 
630

790 The mutations F317V, Y253F, Y253H and E255K experience increased vdW interactions with residue Leu248 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?D, ?C textMine:num ?mutation, ?D textMine:amod ?F, ?F textMine:dep ?C]
Added to queryTripless!! : ?positive textMine:dobj ?function. ?positive textMine:nsubj ?D. ?C textMine:num ?mutation. ?D textMine:amod ?F. ?F textMine:dep ?C. 
631

791 At a later time point in pancreas development, S33Y mutant β cat expression enhanced islet cell proliferation and increased the size of pancreas [ 49 ] 
[?impact textMine:nsubj ?function, ?function textMine:num ?mutation]
Added to queryTripless!! : ?positive textMine:nsubj ?function. ?function textMine:num ?mutation. 
632

792 When using a higher sensitive approach (the ARMS assay, which may detect this allele variant with a sensitivity close to 3%) persistent cells harbouring KIT M541L  allele variant occurred only in one patient (#4), (Fig  1B ) 
[?I textMine:nsubj ?H, ?E textMine:nn ?function, ?B textMine:rcmod ?A, ?F textMine:dobj ?mutation, ?H textMine:partmod ?F, ?C textMine:dep ?B, ?C textMine:rcmod ?I, ?C textMine:amod ?impact, ?A textMine:prep ?E]
[?A textMine:prep ?E, ?B textMine:rcmod ?A, ?C textMine:amod ?impact, ?C textMine:dep ?B, ?C textMine:rcmod ?I, ?E textMine:nn ?function, ?F textMine:dobj ?mutation, ?H textMine:partmod ?F, ?I textMine:nsubj ?H, ]
Match 


793 The specific type of mutation may hold predictive relevance in that some mutations confer higher affinity for certain EGFR TKIs and some confer resistance to certain EGFR TKIs, for example, mutations in exon 20 and the T790M mutation 
[?function textMine:amod ?impact, ?A textMine:dobj ?function, ?A textMine:prep ?E, ?E textMine:amod ?mutation]
Added to queryTripless!! : ?function textMine:amod ?positive. ?A textMine:dobj ?function. ?A textMine:prep ?E. ?E textMine:amod ?mutation. 
633

794 Interestingly, the proliferation of BMSCs of Fgfr2+/S252W mice was decreased in the early days of culturing (P4–P8) 
[?function textMine:prep ?A, ?impact textMine:nsubjpass ?function, ?A textMine:prep ?E, ?E textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:prep ?A. ?negative textMine:nsubjpass ?function. ?A textMine:prep ?E. ?E textMine:nn ?mutation. 
634

795 The  JAK2  V617F allele burden has been associated with disease duration in PV patients, such that the allele burden was significantly elevated in patients examined more than 5 years after their initial diagnosis   
[?function textMine:ccomp ?impact, ?function textMine:nsubjpass ?B, ?B textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:ccomp ?positive. ?function textMine:nsubjpass ?B. ?B textMine:nn ?mutation. 
635

796 In some cases, AKT itself is constitutively active because of a mutation in the PH domain (E17K)   or, as in the case of the v AKT of murine thymoma virus, fusion to viral Gag sequences that mediate membrane attachment   
[?B textMine:prep ?E, ?E textMine:appos ?mutation, ?function textMine:prep ?B, ?function textMine:advmod ?impact]
Added to queryTripless!! : ?B textMine:prep ?E. ?E textMine:appos ?mutation. ?function textMine:prep ?B. ?function textMine:advmod ?positive. 
636

797 Compared to L858R alone, the L858R+E884K dual mutant was less sensitive to erlotinib in the inhibition of tyrosine phosphorylation of EGFR 
[?B textMine:nn ?mutation, ?function textMine:advmod ?impact, ?function textMine:nsubj ?B]
[?B textMine:nn ?mutation, ?function textMine:advmod ?impact, ?function textMine:nsubj ?B, ]
Match 


798 For example, crizotinib maintains activity against the R1275Q mutant, but drastically loses activity against F1174L, another frequently occurring mutant (Wood et al., ; Sakamoto et al , ; Schönherr et al, ) 
[?impact textMine:conj ?D, ?D textMine:prep ?mutation, ?D textMine:dobj ?function]
Added to queryTripless!! : ?neutral textMine:conj ?D. ?D textMine:prep ?mutation. ?D textMine:dobj ?function. 
637

799 E884K and L858R+E884K mutants remained sensitive to EGF and were activated by the ligand to a level comparable to L858R ( Figure 3A ) 
[?A textMine:nn ?mutation, ?function textMine:cop ?impact, ?function textMine:nsubj ?A]
Added to queryTripless!! : ?A textMine:nn ?mutation. ?function textMine:cop ?neutral. ?function textMine:nsubj ?A. 
638

800 FLT3  D835V and  KIT  D816Y) retained some level of sensitivity with regard to induction of apoptosis 
[?impact textMine:prep ?C, ?impact textMine:nsubj ?mutation, ?C textMine:prep ?function]
[?C textMine:prep ?function, ?impact textMine:nsubj ?mutation, ?impact textMine:prep ?C, ]
Match 


801 E884K and L858R+E884K mutants remained sensitive to EGF and were activated by the ligand to a level comparable to L858R ( Figure 3A ) 
[?A textMine:nn ?mutation, ?function textMine:cop ?impact, ?function textMine:nsubj ?A]
[?A textMine:nn ?mutation, ?function textMine:cop ?impact, ?function textMine:nsubj ?A, ]
Match 


802 We also find that a melanoma associated mutation within the pseudosubstrate sequence, P52L, disrupts PAK6 autoinhibition enhancing its kinase activity, potentially correlating with increased expression of PAK6 in prostate cancer, and implied alterations in kinase activity  
[?C textMine:prep ?function, ?A textMine:conj ?C, ?A textMine:amod ?impact, ?A textMine:appos ?mutation]
Added to queryTripless!! : ?C textMine:prep ?function. ?A textMine:conj ?C. ?A textMine:amod ?negative. ?A textMine:appos ?mutation. 
639

803 Overall, SP inhibitors represent an innovative mechanism of KIT inhibition whose dual suppression of KIT D816V neoplastic mast cell proliferation and SCF enhanced mast cell activation may provide significant therapeutic benefits 
[?D textMine:prep ?mutation, ?impact textMine:dobj ?D, ?impact textMine:nsubj ?function]
Added to queryTripless!! : ?D textMine:prep ?mutation. ?positive textMine:dobj ?D. ?positive textMine:nsubj ?function. 
640

804 Molecular studies on the receptors harbouring a known L858R mutation demonstrated a decreased affinity of the tyrosine kinase for ATP and an increase in the affinity for the tyrosine kinase inhibitors (TKI) 
[?I textMine:prep ?D, ?D textMine:partmod ?F, ?G textMine:nn ?mutation, ?F textMine:dobj ?G, ?impact textMine:prep ?function, ?A textMine:prep ?impact, ?B textMine:dobj ?A, ?B textMine:nsubj ?I]
Added to queryTripless!! : ?I textMine:prep ?D. ?D textMine:partmod ?F. ?G textMine:nn ?mutation. ?F textMine:dobj ?G. ?positive textMine:prep ?function. ?A textMine:prep ?positive. ?B textMine:dobj ?A. ?B textMine:nsubj ?I. 
641

805 BRAF V600E results in elevated kinase activity compared with BRAF wild type and stimulated phosphorylation of downstream endogenous ERK   
[?B textMine:prep ?function, ?B textMine:nsubj ?mutation, ?function textMine:amod ?impact]
Query : [?B textMine:prep ?function, ?B textMine:nsubj ?mutation, ?function textMine:amod ?impact]
Existing trips : 
?A textMine:nsubj ?mutation. ?A textMine:prep ?function. ?function textMine:amod ?impact. 
Similar Query!!!!


806 The mutations E255K and T315A experience increased vdW interactions with Leu354 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation]
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation, ]
Match 


807 In human thyroid cancers, it has recently been reported that BRAF V600E is highly associated with (1) overexpression of VEGF and that overexpression of VEGF was highly associated with increasing tumour stage and invasion ( Jo  et al , 2006 ) and (2) reduced membrane expression of NIS ( Riesco Eizaguirre  et al , 2006 ) 
[?impact textMine:dobj ?function, ?D textMine:prepc ?impact, ?A textMine:nsubjpass ?mutation, ?A textMine:prep ?D]
Added to queryTripless!! : ?positive textMine:dobj ?function. ?D textMine:prepc ?positive. ?A textMine:nsubjpass ?mutation. ?A textMine:prep ?D. 
642

808 The T315I cells exhibit increased proliferation rate (Supporting Information Fig S8 ), elevated basal expressions of Rad51 and γ H2AX ( Fig 5A ) and display increased endogenous DNA damage response, indicated by increased Rad51 and γ H2AX foci ( Fig 5B and C ), when compared with parental cells 
[?C textMine:appos ?function, ?H textMine:ccomp ?E, ?H textMine:nsubj ?A, ?B textMine:amod ?impact, ?E textMine:prep ?B, ?E textMine:nsubj ?C, ?A textMine:nn ?mutation]
Added to queryTripless!! : ?C textMine:appos ?function. ?H textMine:ccomp ?E. ?H textMine:nsubj ?A. ?B textMine:amod ?positive. ?E textMine:prep ?B. ?E textMine:nsubj ?C. ?A textMine:nn ?mutation. 
643

809 Although the Y253H mutation was less sensitive to nilotinib in an  in vitro  cell viability assay (IC 50  > 150 nM)  , the level of BCR ABL1  transcripts in the Y253H patient in our trial decreased from 8 06% to 030% 
[?A textMine:prep ?E, ?E textMine:prep ?C, ?impact textMine:nsubj ?A, ?impact textMine:advcl ?function, ?C textMine:amod ?mutation]
Added to queryTripless!! : ?A textMine:prep ?E. ?E textMine:prep ?C. ?negative textMine:nsubj ?A. ?negative textMine:advcl ?function. ?C textMine:amod ?mutation. 
644

810 Previous  in vivo  analyses of the Fgfr2 P253R/+  and Fgfr2 S252W/+  mouse models of Apert syndrome revealed increased osteoblastic gene expression around the coronal suture   
[?function textMine:amod ?impact, ?A textMine:dobj ?function, ?A textMine:nsubj ?B, ?B textMine:prep ?F, ?F textMine:prep ?D, ?D textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:amod ?positive. ?A textMine:dobj ?function. ?A textMine:nsubj ?B. ?B textMine:prep ?F. ?F textMine:prep ?D. ?D textMine:nn ?mutation. 
645

811 We have previously shown that BRAF V600E  plays an important role in the aggressive behavior of thyroid cancer cells  in vitro  and that treatment with the selective BRAF V600E  inhibitor PLX4720 results in impressive decreases in tumor volume and metastasis in an orthotopic mouse model of ATC [ 5   8 ,  10 ] 
[?H textMine:nn ?mutation, ?function textMine:amod ?G, ?D textMine:prep ?impact, ?D textMine:dobj ?B, ?F textMine:prep ?function, ?G textMine:prep ?H, ?I textMine:prep ?F, ?B textMine:prep ?I]
Added to queryTripless!! : ?H textMine:nn ?mutation. ?function textMine:amod ?G. ?D textMine:prep ?negative. ?D textMine:dobj ?B. ?F textMine:prep ?function. ?G textMine:prep ?H. ?I textMine:prep ?F. ?B textMine:prep ?I. 
646

812 With molecular testing as a standard, the delE746–A750 mutation specific antibody (6B6) could detect 69 of the 86 cases with an E746–A750 deletion mutation (40 with score 2+ and 29 with score 3+) whereas it was negative in the remaining 17 cases (4 with score 0 and 14 with score 1+) (κ = 0.584, sensitivity: 80.23%, specificity: 85.3%, PPV: 60%, NPV: 94.01%); the L858R mutation specific antibody (43B2) could identify 53 of 70 cases with a L858R point mutation (31 with score 2+ and 22 with 3+), whereas it was negative in the remaining 17 cases (7 with score 0 and 10 with score 1+) (κ = 0.639, sensitivity: 75.71%, specificity: 91.79%, PPV: 66 25%, NPV: 9467%) 
[?H textMine:dep ?impact, ?B textMine:nsubj ?H, ?B textMine:prep ?E, ?A textMine:appos ?function, ?impact textMine:prep ?D, ?E textMine:nn ?mutation, ?D textMine:dep ?I, ?I textMine:dobj ?A]
Added to queryTripless!! : ?H textMine:dep ?negative. ?B textMine:nsubj ?H. ?B textMine:prep ?E. ?A textMine:appos ?function. ?negative textMine:prep ?D. ?E textMine:nn ?mutation. ?D textMine:dep ?I. ?I textMine:dobj ?A. 
647

813 We have previously shown that the JAK2 V617F homologous mutation in JAK1, V658F, induces constitutive activation of JAK1  
[?function textMine:amod ?impact, ?C textMine:nn ?mutation, ?A textMine:dobj ?function, ?A textMine:nsubj ?C]
Query : [?function textMine:amod ?impact, ?C textMine:nn ?mutation, ?A textMine:dobj ?function, ?A textMine:nsubj ?C]
Existing trips : 
?C textMine:nn ?mutation. ?E textMine:dobj ?function. ?E textMine:nsubj ?C. ?function textMine:amod ?impact. 
Similar Query!!!!


814 We hypothesised that patients with low or heterogeneous expression of mutant BRAF V600E  protein would have a poor response to treatment with BRAF inhibitors and reduced survival, compared with patients with high and homogeneous expression 
[?D textMine:prep ?G, ?G textMine:nn ?mutation, ?function textMine:amod ?impact, ?C textMine:prep ?function, ?A textMine:prep ?D, ?F textMine:pobj ?C, ?F textMine:nsubj ?A]
Added to queryTripless!! : ?D textMine:prep ?G. ?G textMine:nn ?mutation. ?function textMine:amod ?positive. ?C textMine:prep ?function. ?A textMine:prep ?D. ?F textMine:pobj ?C. ?F textMine:nsubj ?A. 
648

815 Hence, the double mutation L858R+E884K modulated downstream EGFR signaling differentially with distinctly different effects on the AKT (downregulated) and MAPK ERK1/2 phosphorylation (upregulated) 
[?D textMine:partmod ?A, ?impact textMine:dobj ?D, ?impact textMine:nsubj ?mutation, ?A textMine:prep ?function]
[?A textMine:prep ?function, ?D textMine:partmod ?A, ?impact textMine:dobj ?D, ?impact textMine:nsubj ?mutation, ]
Match 


816 The imatinib resistant cell line DA1 3b/M1 (referred to as 'M1' hereafter), which was derived from M0 cells after prolonged selection with imatinib and carries an E255K BCR ABL mutation, and the DA1 3b/d365 cell line (referred to as 'd365' hereafter), which was derived from M0 cells injected in mice and isolated after 1 year of tumor dormancy and harbors partial resistance to imatinib, also exhibited decreased GILZ expression ( Figure 1a )   
[?G textMine:rcmod ?C, ?H textMine:dobj ?F, ?A textMine:rcmod ?H, ?F textMine:nn ?mutation, ?impact textMine:nsubj ?G, ?impact textMine:dobj ?function, ?C textMine:nsubj ?A]
Added to queryTripless!! : ?G textMine:rcmod ?C. ?H textMine:dobj ?F. ?A textMine:rcmod ?H. ?F textMine:nn ?mutation. ?negative textMine:nsubj ?G. ?negative textMine:dobj ?function. ?C textMine:nsubj ?A. 
649

817 Previous studies demonstrated that expression of AKT1 E17K protein in NIH 3T3 cells increased AKT phosphorylation in those cells ( Carpten  et al , 2007 ) 
[?function textMine:prep ?A, ?impact textMine:nsubj ?function, ?A textMine:nn ?mutation]
Query : [?function textMine:prep ?A, ?impact textMine:nsubj ?function, ?A textMine:nn ?mutation]
Existing trips : 
?B textMine:nn ?mutation. ?function textMine:prep ?B. ?impact textMine:nsubj ?function. 
Similar Query!!!!


818 Intriguingly, tyrosine phosphorylation of PECAM 1 as well as its physical association with SHP2 was enhanced by the imatinib resistance E255K or T315I mutation 
[?impact textMine:nsubjpass ?function, ?impact textMine:agent ?C, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?positive textMine:nsubjpass ?function. ?positive textMine:agent ?C. ?C textMine:nn ?mutation. 
650

819 62  Mutated ALK at F1174L led to increased proliferation and decreased apoptosis of neuroblastoma cell lines 
[?function textMine:amod ?impact, ?A textMine:prep ?mutation, ?B textMine:prep ?function, ?B textMine:nsubj ?A]
[?A textMine:prep ?mutation, ?B textMine:nsubj ?A, ?B textMine:prep ?function, ?function textMine:amod ?impact, ]
Match 


820 Four cases with increased  JAK2  V617F  RNA expression levels (outliers) are indicated 
[?A textMine:nn ?function, ?A textMine:nn ?mutation, ?A textMine:amod ?impact]
Added to queryTripless!! : ?A textMine:nn ?function. ?A textMine:nn ?mutation. ?A textMine:amod ?positive. 
651

821 The mutations G250E, Y253H and T315I experience decreased vdW interactions with Phe359 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ?C textMine:amod ?E, ?E textMine:dep ?mutation]
Query : [?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ?C textMine:amod ?E, ?E textMine:dep ?mutation]
Existing trips : 
?B textMine:amod ?E. ?E textMine:dep ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?B. 
Similar Query!!!!


822 In TERT NHUC, abolishing PLCγ1 phosphorylation significantly reduced the increase in saturation density associated with S249C FGFR3 (13% vs  24%, p=005) ( Figure 6a ), suggesting that PLCγ1 signaling contributes to this phenotype 
[?C textMine:partmod ?B, ?impact textMine:prep ?C, ?impact textMine:nsubj ?function, ?B textMine:prep ?F, ?F textMine:nn ?mutation]
Added to queryTripless!! : ?C textMine:partmod ?B. ?negative textMine:prep ?C. ?negative textMine:nsubj ?function. ?B textMine:prep ?F. ?F textMine:nn ?mutation. 
652

823 Immunoblotting for phospho AKT was performed after successful transfection and weaning of IL3 dependent growth (true autoactivating TK mutations result in IL3 independent growth) and found that AKT activation increases after transfection of plasmid vectors encoding for a  FLT3  ITD,  FLT3  D835V,  KIT  D816Y or  BCR ABL1  isoform 
[?B textMine:prep ?mutation, ?F textMine:partmod ?B, ?C textMine:prep ?F, ?impact textMine:nsubj ?function, ?impact textMine:prep ?C]
Added to queryTripless!! : ?B textMine:prep ?mutation. ?F textMine:partmod ?B. ?C textMine:prep ?F. ?positive textMine:nsubj ?function. ?positive textMine:prep ?C. 
653

824 Tyrosine phosphorylation of STAT5 was also enhanced, though not as significantly as that of PECAM 1, in cells expressing the E255K or T315I mutant ( Fig 4C ) 
[?impact textMine:prep ?E, ?impact textMine:nsubjpass ?function, ?F textMine:dobj ?D, ?E textMine:partmod ?F, ?D textMine:nn ?mutation]
Query : [?impact textMine:prep ?E, ?impact textMine:nsubjpass ?function, ?F textMine:dobj ?D, ?E textMine:partmod ?F, ?D textMine:nn ?mutation]
Existing trips : 
?C textMine:nn ?mutation. ?E textMine:partmod ?F. ?F textMine:dobj ?C. ?impact textMine:nsubjpass ?function. ?impact textMine:prep ?E. 
Similar Query!!!!


825 PLX4720 is a potent inhibitor of migration, significantly decreasing cellular migration and invasion of human BRAF V600E  positive thyroid cancer lines  in vitro  [ 6 ] 
[?B textMine:nn ?mutation, ?impact textMine:dobj ?function, ?function textMine:prep ?B]
Query : [?B textMine:nn ?mutation, ?impact textMine:dobj ?function, ?function textMine:prep ?B]
Existing trips : 
?D textMine:nn ?mutation. ?function textMine:prep ?D. ?impact textMine:dobj ?function. 
Similar Query!!!!


826 As a whole, these data indicate that blocking mTOR signalling pathway is effective in reducing proliferation and clonogenic potential of cells expressing the  JAK2 V617F mutation; however, mTOR inhibitors appeared to exert mainly a cytostatic rather than an apoptotic effect when compared with JAK2 inhibitors 
[?F textMine:partmod ?G, ?G textMine:dobj ?A, ?D textMine:prep ?F, ?D textMine:nn ?function, ?A textMine:nn ?mutation, ?impact textMine:dobj ?D]
Added to queryTripless!! : ?F textMine:partmod ?G. ?G textMine:dobj ?A. ?D textMine:prep ?F. ?D textMine:nn ?function. ?A textMine:nn ?mutation. ?negative textMine:dobj ?D. 
654

827 The mutations E255K, F317L and F317V experience increased electrostatic interactions with Tyr253 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:amod ?D, ?D textMine:dep ?mutation]
Query : [?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:amod ?D, ?D textMine:dep ?mutation]
Existing trips : 
?B textMine:amod ?E. ?E textMine:dep ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?B. 
Similar Query!!!!


828 Interestingly, all LRRK2 mutants (R1441C, G2019S, G2385R, and D1994A) significantly increased NF κB activity, indicating that the increase was independent of mutations in ROC, kinase, and WD domains ( Fig 6C ) 
[?A textMine:nsubj ?impact, ?H textMine:ccomp ?A, ?B textMine:dep ?mutation, ?G textMine:partmod ?H, ?G textMine:dobj ?function, ?G textMine:advmod ?E, ?E textMine:pobj ?B]
Added to queryTripless!! : ?A textMine:nsubj ?positive. ?H textMine:ccomp ?A. ?B textMine:dep ?mutation. ?G textMine:partmod ?H. ?G textMine:dobj ?function. ?G textMine:advmod ?E. ?E textMine:pobj ?B. 
655

829 7  Death receptor stimulated apoptotic pathways also appear disrupted in JAK2 V617F PV derived erythroblasts with deregulated expression of the short isoform of c FLIP  21  which fundamentally plays an essential role in the normal homeostatic apoptotic cascade 
[?B textMine:prep ?function, ?impact textMine:prep ?A, ?A textMine:partmod ?B, ?A textMine:nn ?mutation]
Added to queryTripless!! : ?B textMine:prep ?function. ?negative textMine:prep ?A. ?A textMine:partmod ?B. ?A textMine:nn ?mutation. 
656

830 In H3255 cells (EGFR L858R ), which display impaired EGF mediated SHP2 phosphorylation relative to cells expressing wild type EGFR (  7  ;  Supplementary Figure S2 ), SHP2 knockdown had no substantial effect on ERK phosphorylation at any concentration of gefitinib 
[?C textMine:partmod ?function, ?I textMine:nn ?impact, ?B textMine:ccomp ?E, ?E textMine:advmod ?A, ?E textMine:nsubj ?I, ?A textMine:prep ?C, ?G textMine:appos ?mutation, ?G textMine:rcmod ?B]
Added to queryTripless!! : ?C textMine:partmod ?function. ?I textMine:nn ?negative. ?B textMine:ccomp ?E. ?E textMine:advmod ?A. ?E textMine:nsubj ?I. ?A textMine:prep ?C. ?G textMine:appos ?mutation. ?G textMine:rcmod ?B. 
657

831 However, a comparison of expression arrays from human BRAF V600E  (+) PTC and ATC identified 1943 genes that were differentially regulated in the ATC compared to PTC, which included increased expression of TGFβI and decreased expression of Smad6, a negative regulator of TGFβ signaling 
[?function textMine:amod ?impact, ?mutation textMine:conj ?function]
Added to queryTripless!! : ?function textMine:amod ?negative. ?mutation textMine:conj ?function. 
658

832 Structurally, this residue lies in the substrate binding pocket of the kinase, and the M918T mutation appears to increase RET–ATP binding affinity and the stability of the active ATP bound form, effectively making RET more active, more of the time ( 48 )–( 51 ) 
[?B textMine:partmod ?D, ?impact textMine:xsubj ?A, ?impact textMine:dobj ?B, ?D textMine:advmod ?function, ?A textMine:nn ?mutation]
Added to queryTripless!! : ?B textMine:partmod ?D. ?positive textMine:xsubj ?A. ?positive textMine:dobj ?B. ?D textMine:advmod ?function. ?A textMine:nn ?mutation. 
659

833 In the 29 patients with exon 19 deletions, high expression of EGFR E746 A750 deletion specific (6B6) protein (score 2 or 3) was observed in 17/17 cases (100%) with 15 bp deletion (16 with ELREA and 1 with ELREA + T751I) 
[?function textMine:amod ?impact, ?G textMine:prep ?A, ?A textMine:dep ?E, ?E textMine:prep ?mutation, ?D textMine:prep ?G, ?D textMine:nsubjpass ?function]
Added to queryTripless!! : ?function textMine:amod ?positive. ?G textMine:prep ?A. ?A textMine:dep ?E. ?E textMine:prep ?mutation. ?D textMine:prep ?G. ?D textMine:nsubjpass ?function. 
660

834 In vivo , the efficacy of ruxolitinib in a murine  JAK2  V617F  driven malignancy model was demonstrated by the fact that it significantly reduced splenomegaly, decreased elevated levels of circulating IL 6 and tumor necrosis factor (TNF) α to normal, and increased survival, without causing anemia or lymphopenia [ 98 ] 
[?E textMine:prepc ?F, ?E textMine:amod ?impact, ?D textMine:prep ?A, ?C textMine:dobj ?E, ?C textMine:ccomp ?G, ?G textMine:nsubjpass ?D, ?A textMine:prep ?B, ?B textMine:nn ?mutation, ?F textMine:dobj ?function]
Added to queryTripless!! : ?E textMine:prepc ?F. ?E textMine:amod ?positive. ?D textMine:prep ?A. ?C textMine:dobj ?E. ?C textMine:ccomp ?G. ?G textMine:nsubjpass ?D. ?A textMine:prep ?B. ?B textMine:nn ?mutation. ?F textMine:dobj ?function. 
661

835 JAK2 F595A/V617F and F595V/V617F have lost the ability to signal constitutively from active and inactive dimeric conformations, suggesting that F595 may play a role in the constitutive activity of JAK2 V617F 
[?function textMine:amod ?impact, ?function textMine:prep ?mutation]
[?function textMine:amod ?impact, ?function textMine:prep ?mutation, ]
Match 


836 Notably, inhibition of phosphorylation of the D816V mutation was significantly reduced compared to the D816Y and D816F isoforms 
[?C textMine:prep ?function, ?impact textMine:pobj ?B, ?impact textMine:nsubjpass ?C, ?B textMine:nn ?mutation]
[?B textMine:nn ?mutation, ?C textMine:prep ?function, ?impact textMine:nsubjpass ?C, ?impact textMine:pobj ?B, ]
Match 


837 CCT137690 inhibits FLT3 D835Y kinase with similar potency to FLT3 ITD kinase, but MLN518 is much less active against FLT3 D835Y in biochemical assays (IC 50  18 μM) 
[?function textMine:advmod ?impact, ?function textMine:prep ?mutation]
Added to queryTripless!! : ?function textMine:advmod ?negative. ?function textMine:prep ?mutation. 
662

838 33 , 34  Overall, dabrafenib has markedly higher response rates and progression free survival along with a well tolerated toxicity profile compared with dacarbazine in patients with  V600E BRAF  mutated metastatic melanoma 
[?I textMine:conj ?B, ?I textMine:dobj ?F, ?G textMine:prep ?C, ?A textMine:prep ?G, ?C textMine:nn ?mutation, ?F textMine:amod ?impact, ?B textMine:pobj ?A, ?B textMine:dobj ?function]
Added to queryTripless!! : ?I textMine:conj ?B. ?I textMine:dobj ?F. ?G textMine:prep ?C. ?A textMine:prep ?G. ?C textMine:nn ?mutation. ?F textMine:amod ?positive. ?B textMine:pobj ?A. ?B textMine:dobj ?function. 
663

839 It is noteworthy that the Tbx3 primers used in these experiments amplified both splice variants of Tbx3   and expression of both variants was elevated by B RAF V600E  ( Figure 3c ) 
[?C textMine:prep ?function, ?A textMine:prep ?G, ?H textMine:dobj ?C, ?F textMine:partmod ?A, ?G textMine:partmod ?H, ?impact textMine:agent ?mutation, ?impact textMine:nsubjpass ?F]
Added to queryTripless!! : ?C textMine:prep ?function. ?A textMine:prep ?G. ?H textMine:dobj ?C. ?F textMine:partmod ?A. ?G textMine:partmod ?H. ?positive textMine:agent ?mutation. ?positive textMine:nsubjpass ?F. 
664

840 Somatic mutations of the JAK2 gene at V617F, which leads to constitutive JAK2 phosphorylation and kinase activation, occurs in almost all cases of polycythemia vera and approximately 50% of cases of chronic idiopathic myelofibrosis  
[?B textMine:prep ?mutation, ?impact textMine:dobj ?function, ?impact textMine:xsubj ?D, ?D textMine:prep ?B]
Added to queryTripless!! : ?B textMine:prep ?mutation. ?positive textMine:dobj ?function. ?positive textMine:xsubj ?D. ?D textMine:prep ?B. 
665

841 Here, we test the hypothesis that E1271K mutation of MET, analogous to E884K EGFR, can also differentially alter inhibitory sensitivity towards selective MET inhibitors ( Figure 6 ) 
[?A textMine:prep ?E, ?F textMine:amod ?A, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?F, ?E textMine:nn ?mutation]
[?A textMine:prep ?E, ?E textMine:nn ?mutation, ?F textMine:amod ?A, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?F, ]
Match 


842 The addition of EGFR siRNA (whether wild type or T790M specific)to c MET siRNAs enhanced growth inhibition in H358 and H1650 cells compared to EGFR siRNA alone, but much less so in H1975 cells ( Figure 2A ) 
[?A textMine:amod ?mutation, ?function textMine:amod ?impact, ?C textMine:dobj ?function, ?B textMine:rcmod ?C, ?B textMine:dep ?A]
Added to queryTripless!! : ?A textMine:amod ?mutation. ?function textMine:amod ?positive. ?C textMine:dobj ?function. ?B textMine:rcmod ?C. ?B textMine:dep ?A. 
666

843 This mutation ( E17K ) increases recruitment of AKT1 to the membrane, increases AKT1 phosphorylation and activity, transforms Rat1 fibroblasts, and induces leukaemia in transgenic mice ( Carpten  et al , 2007 ) 
[?A textMine:appos ?mutation, ?E textMine:conj ?function, ?E textMine:conj ?impact, ?E textMine:nsubj ?A, ?function textMine:nsubj ?A, ?impact textMine:nsubj ?A]
[?A textMine:appos ?mutation, ?E textMine:conj ?function, ?E textMine:conj ?impact, ?E textMine:nsubj ?A, ?function textMine:nsubj ?A, ?impact textMine:nsubj ?A, ]
Match 


844 Previous studies demonstrated that expression of AKT1 E17K protein in NIH 3T3 cells increased AKT phosphorylation in those cells ( Carpten  et al , 2007 ) 
[?B textMine:prep ?A, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?A textMine:nn ?mutation]
Query : [?B textMine:prep ?A, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?A textMine:nn ?mutation]
Existing trips : 
?A textMine:prep ?B. ?B textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?A. 
Similar Query!!!!


845 Regarding the interference with the ERK signaling, cell lines with BRAF V600D/R  mutations presented a faster and stronger inhibition of phosphorylated ERK as compared to control cells with a wild type  BRAF  (Figure  1 C) 
[?C textMine:nsubj ?function, ?C textMine:prep ?E, ?function textMine:amod ?impact, ?E textMine:prep ?D, ?B textMine:prep ?A, ?A textMine:nn ?mutation, ?D textMine:appos ?B]
[?A textMine:nn ?mutation, ?B textMine:prep ?A, ?C textMine:nsubj ?function, ?C textMine:prep ?E, ?D textMine:appos ?B, ?E textMine:prep ?D, ?function textMine:amod ?impact, ]
Match 


846 In numerous studies, the  JAK2  V617F allele has been variably associated with higher indices of erythropoiesis, unchanged or decreased platelet counts, greater occurrence of thrombosis, increased BM fibrosis or cytoreductive treatments, older age, longer disease duration, or poorer survival in MPN   
[?impact textMine:ccomp ?A, ?impact textMine:nsubjpass ?D, ?D textMine:nn ?mutation, ?A textMine:dobj ?function]
Added to queryTripless!! : ?negative textMine:ccomp ?A. ?negative textMine:nsubjpass ?D. ?D textMine:nn ?mutation. ?A textMine:dobj ?function. 
667

847 Consistent with that result, BRAF CT V600E and K601E induced a stronger ERK activation compared with BRAF CT wild type 
[?function textMine:amod ?impact, ?B textMine:nsubj ?function, ?B textMine:prep ?mutation]
Added to queryTripless!! : ?function textMine:amod ?positive. ?B textMine:nsubj ?function. ?B textMine:prep ?mutation. 
668

849 It was noted that PLX4720 also reduced pRB protein phosphorylation, increased p27 expression, suppressed cyclin D1 expression and induced cleavage of PARP only in melanoma cell lines harbouring the  BRAF  V600E mutation ( Figure 1D ) 
[?B textMine:nn ?mutation, ?impact textMine:ccomp ?D, ?A textMine:dobj ?B, ?E textMine:partmod ?A, ?D textMine:prep ?E, ?D textMine:dobj ?function]
Added to queryTripless!! : ?B textMine:nn ?mutation. ?negative textMine:ccomp ?D. ?A textMine:dobj ?B. ?E textMine:partmod ?A. ?D textMine:prep ?E. ?D textMine:dobj ?function. 
669

850 In human thyroid cancers, it has recently been reported that BRAF V600E is highly associated with (1) overexpression of VEGF and that overexpression of VEGF was highly associated with increasing tumour stage and invasion ( Jo  et al , 2006 ) and (2) reduced membrane expression of NIS ( Riesco Eizaguirre  et al , 2006 ) 
[?E textMine:dobj ?function, ?D textMine:prepc ?E, ?A textMine:nsubjpass ?mutation, ?A textMine:prep ?D, ?function textMine:amod ?impact]
Added to queryTripless!! : ?E textMine:dobj ?function. ?D textMine:prepc ?E. ?A textMine:nsubjpass ?mutation. ?A textMine:prep ?D. ?function textMine:amod ?negative. 
670

851 Concurrently, in a recent study published in the New England Journal of Medicine, Flaherty and colleagues provide promising data from an open label trial   involving over 400 patients that a combination of the BRAF V600E  inhibitor, dabrafenib, and a MEK inhibitor trametinib (GlaxoSmithKline), which is near approval  , significantly increased progression free survival when compared to monotherapy 
[?B textMine:nn ?mutation, ?impact textMine:nsubj ?D, ?impact textMine:dobj ?function, ?D textMine:prep ?B]
Query : [?B textMine:nn ?mutation, ?impact textMine:nsubj ?D, ?impact textMine:dobj ?function, ?D textMine:prep ?B]
Existing trips : 
?A textMine:prep ?B. ?B textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?A. 
Similar Query!!!!


852 The effects of ruxolitinib were attenuated when cells expressing JAK2 V617F  were cocultured with primary or immortalized human bone marrow mesenchymal stromal cells, probably owing to paracrine activity of the mesenchymal stromal cells 
[?impact textMine:advcl ?F, ?impact textMine:nsubjpass ?function, ?F textMine:nsubjpass ?A, ?D textMine:dobj ?mutation, ?A textMine:partmod ?D]
Added to queryTripless!! : ?negative textMine:advcl ?F. ?negative textMine:nsubjpass ?function. ?F textMine:nsubjpass ?A. ?D textMine:dobj ?mutation. ?A textMine:partmod ?D. 
671

854 To further delineate whether these gene expression circuitry modifications were consequence of altered ligand binding affinity of FGFR2 or of constitutively active intracellular signaling by the receptor, we sought for BAT3, BDP1, CYP51A1, TCF19 and RFC3 (DEGs in S252W fibroblasts treated with FGF2) expression levels in a C342Y fibroblast through qRT PCR 
[?C textMine:prep ?function, ?A textMine:num ?mutation, ?function textMine:amod ?impact, ?G textMine:prep ?A, ?H textMine:dep ?G, ?H textMine:ccomp ?B, ?B textMine:dep ?C]
Added to queryTripless!! : ?C textMine:prep ?function. ?A textMine:num ?mutation. ?function textMine:amod ?unknown. ?G textMine:prep ?A. ?H textMine:dep ?G. ?H textMine:ccomp ?B. ?B textMine:dep ?C. 
672

855 The presence of R164Q in cluster 2, rather than in cluster 1 with wt  K Ras  was therefore initially surprising, but suggests that the R164Q mutation also has an 'activating' phenotype, albeit attenuated relative to the other mutations studied 
[?impact textMine:nsubj ?B, ?impact textMine:dobj ?D, ?B textMine:nn ?mutation, ?D textMine:nn ?function]
[?B textMine:nn ?mutation, ?D textMine:nn ?function, ?impact textMine:dobj ?D, ?impact textMine:nsubj ?B, ]
Match 


856 Graph shows that the common L858R mutation confers higher autophosphorylation levels to YFP EGFR ICD than P848L and A859T 
[?D textMine:nn ?function, ?D textMine:amod ?impact, ?E textMine:prep ?C, ?E textMine:dobj ?D, ?C textMine:prep ?mutation]
Added to queryTripless!! : ?D textMine:nn ?function. ?D textMine:amod ?positive. ?E textMine:prep ?C. ?E textMine:dobj ?D. ?C textMine:prep ?mutation. 
673

857 NVP BEZ235 inhibited proliferation of both cytokine independent WT BCR ABL  and mutant  BCR ABL  (E255K and T315I) overexpressing cells, whereas parental cytokine dependent Ba/F3 cells were much less sensitive 
[?C textMine:appos ?mutation, ?function textMine:advmod ?impact, ?D textMine:prep ?C, ?F textMine:advcl ?function, ?F textMine:dobj ?D]
[?C textMine:appos ?mutation, ?D textMine:prep ?C, ?F textMine:advcl ?function, ?F textMine:dobj ?D, ?function textMine:advmod ?impact, ]
Match 


858 Notably, melanomas that have the V600E  BRAF  mutation exhibit increased HIF 1α expression 
[?E textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:rcmod ?E, ?function textMine:nn ?mutation]
[?B textMine:rcmod ?E, ?E textMine:dobj ?function, ?function textMine:nn ?mutation, ?impact textMine:nsubj ?B, ]
Match 


859 BRAF  V600E has been associated with more aggressive tumors and lower rates of patient survival   
[?C textMine:prep ?B, ?C textMine:nsubjpass ?mutation, ?B textMine:prep ?function, ?B textMine:amod ?impact]
Added to queryTripless!! : ?C textMine:prep ?B. ?C textMine:nsubjpass ?mutation. ?B textMine:prep ?function. ?B textMine:amod ?negative. 
674

860 We first reported that response rate of gefitinib is higher for patients with deletional  EGFR  mutations than for those with other types of mutations, predominantly L858R ( Mitsudomi  et al , 2005 ) and others extended this observation by demonstrating survival difference between them ( Jackman  et al , 2006 ;  Riely  et al , 2006 ) 
[?A textMine:nsubj ?mutation, ?A textMine:prepc ?F, ?E textMine:nn ?function, ?F textMine:dobj ?E, ?impact textMine:advcl ?A]
Added to queryTripless!! : ?A textMine:nsubj ?mutation. ?A textMine:prepc ?F. ?E textMine:nn ?function. ?F textMine:dobj ?E. ?positive textMine:advcl ?A. 
675

861 Our biochemical studies here now show that E884K mutation in  cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone, through differential inhibition of the pro survival AKT and STAT3 signaling pathways associated with altered induction of cleaved PARP(Asp214) 
[?F textMine:amod ?mutation, ?B textMine:prep ?A, ?E textMine:prep ?function, ?E textMine:nsubj ?F, ?A textMine:amod ?impact, ?function textMine:partmod ?B]
[?A textMine:amod ?impact, ?B textMine:prep ?A, ?E textMine:nsubj ?F, ?E textMine:prep ?function, ?F textMine:amod ?mutation, ?function textMine:partmod ?B, ]
Match 


862 JAK2 K539L, T875N and R683G were shown to exhibit constitutive STAT5 activation and to transform Ba/F3 cells expressing the EpoR to cytokine independence     
[?D textMine:dobj ?function, ?E textMine:ccomp ?D, ?E textMine:nsubjpass ?mutation, ?function textMine:amod ?impact]
[?D textMine:dobj ?function, ?E textMine:ccomp ?D, ?E textMine:nsubjpass ?mutation, ?function textMine:amod ?impact, ]
Match 


863 19 ] In addition, vemurafenib, a v raf murine sarcoma viral oncogene homolog B (BRAF) kinase inhibitor, significantly increased rates of survival over dacarbazine in patients with previously untreated BRAF V600E mutated metastatic melanoma (40 60% of melanomas) [
[?C textMine:prep ?B, ?F textMine:nn ?mutation, ?B textMine:prep ?F, ?G textMine:amod ?C, ?E textMine:prep ?G, ?E textMine:prep ?function, ?E textMine:amod ?impact]
Added to queryTripless!! : ?C textMine:prep ?B. ?F textMine:nn ?mutation. ?B textMine:prep ?F. ?G textMine:amod ?C. ?E textMine:prep ?G. ?E textMine:prep ?function. ?E textMine:amod ?positive. 
676

864 Time activity studies showed that the treatment of PC12/MEN2A cells at 200 nM for 1 h was sufficient to significantly inhibit RET C634Y  autophosphorylation and to drastically reduce ERK phosphorylation ( Figure 3 B, right panel) 
[?function textMine:conj ?impact, ?function textMine:xcomp ?A, ?A textMine:nsubj ?mutation]
Added to queryTripless!! : ?function textMine:conj ?negative. ?function textMine:xcomp ?A. ?A textMine:nsubj ?mutation. 
677

865 The T315I cells exhibit increased proliferation rate (Supporting Information Fig S8 ), elevated basal expressions of Rad51 and γ H2AX ( Fig 5A ) and display increased endogenous DNA damage response, indicated by increased Rad51 and γ H2AX foci ( Fig 5B and C ), when compared with parental cells 
[?B textMine:appos ?function, ?G textMine:ccomp ?C, ?G textMine:nsubj ?A, ?C textMine:nsubj ?B, ?A textMine:nn ?mutation, ?function textMine:amod ?impact]
Added to queryTripless!! : ?B textMine:appos ?function. ?G textMine:ccomp ?C. ?G textMine:nsubj ?A. ?C textMine:nsubj ?B. ?A textMine:nn ?mutation. ?function textMine:amod ?positive. 
678

866 Hence, the double mutation L858R+E884K modulated downstream EGFR signaling differentially with distinctly different effects on the AKT (downregulated) and MAPK ERK1/2 phosphorylation (upregulated) 
[?E textMine:partmod ?A, ?impact textMine:dobj ?E, ?impact textMine:nsubj ?D, ?D textMine:nn ?mutation, ?A textMine:prep ?function]
[?A textMine:prep ?function, ?D textMine:nn ?mutation, ?E textMine:partmod ?A, ?impact textMine:dobj ?E, ?impact textMine:nsubj ?D, ]
Match 


867 Co expression of Braf V600E  and activated KRAS significantly reduced tumor formation, with this very low tumor burden precluding our ability to observe progression to the adenocarcinoma stage as would be predicted 
[?C textMine:partmod ?E, ?E textMine:dobj ?function, ?F textMine:prep ?mutation, ?B textMine:prep ?C, ?impact textMine:dobj ?B, ?impact textMine:nsubj ?F]
Added to queryTripless!! : ?C textMine:partmod ?E. ?E textMine:dobj ?function. ?F textMine:prep ?mutation. ?B textMine:prep ?C. ?negative textMine:dobj ?B. ?negative textMine:nsubj ?F. 
679

868 Strikingly, we also observed that the number of EPO independent endogenous erythroid colonies, a clinical criterion of JAK2 V617F  induced PV  29  , was markedly reduced after macrophage depletion ( Fig  6j  and  Supplementary Fig 12g ) 
[?A textMine:prep ?B, ?B textMine:nn ?function, ?B textMine:nn ?mutation, ?impact textMine:nsubj ?F, ?F textMine:appos ?A]
Added to queryTripless!! : ?A textMine:prep ?B. ?B textMine:nn ?function. ?B textMine:nn ?mutation. ?negative textMine:nsubj ?F. ?F textMine:appos ?A. 
680

869 Dasatinib synergizes with PLX4720 to reduce proliferation in PTC and ATC BRAF V600E  cell lines
[?D textMine:nn ?mutation, ?impact textMine:prep ?D, ?impact textMine:dobj ?function]
[?D textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:prep ?D, ]
Match 


870 Furthermore, the nuclear activation of YAP1 was maintained in 8505C and K1 cells, and resistant to RAF, BRAF V600E  and MEK inhibitors 
[?impact textMine:prep ?A, ?A textMine:amod ?function, ?function textMine:prep ?mutation]
Added to queryTripless!! : ?neutral textMine:prep ?A. ?A textMine:amod ?function. ?function textMine:prep ?mutation. 
681

871 Phe636 in the C helix forms the platform for the observed rearrangement, and we found that mutation of the corresponding residue in Jak2 (Phe595) to alanine also abrogated the transforming effect of V617F ( Fig 2c ), as previously observed  17 , 18   
[?impact textMine:dobj ?function, ?function textMine:prep ?mutation]
[?function textMine:prep ?mutation, ?impact textMine:dobj ?function, ]
Match 


872 For example, prolonged treatment of BRAF V600E  expressing melanoma cells with the BRAF inhibitor AZ628, leads to the development of clones that maintain high levels of phosphorylated ERK, which continue to proliferate in the presence of drug ( Montagut  et al , 2008 ) 
[?G textMine:amod ?function, ?A textMine:rcmod ?impact, ?impact textMine:dobj ?F, ?F textMine:prep ?G, ?C textMine:prep ?H, ?C textMine:nsubj ?I, ?H textMine:prep ?A, ?I textMine:prep ?mutation]
Added to queryTripless!! : ?G textMine:amod ?function. ?A textMine:rcmod ?neutral. ?neutral textMine:dobj ?F. ?F textMine:prep ?G. ?C textMine:prep ?H. ?C textMine:nsubj ?I. ?H textMine:prep ?A. ?I textMine:prep ?mutation. 
682

873 MEK inhibition resulted in increase in pMEK more prominently in  NRAS   Q61L   mutant and  GNAQ  mutant cell lines than in  BRAF   V600E   mutant cell lines 
[?function textMine:prep ?impact, ?function textMine:prep ?B, ?B textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:prep ?positive. ?function textMine:prep ?B. ?B textMine:nn ?mutation. 
683

874 In the cases of mutation M918T, constitutive RET activation probably results from disruption of an auto inhibited head to tail RET tyrosine kinase homodimer   
[?function textMine:prep ?impact, ?function textMine:prep ?A, ?A textMine:prep ?mutation]
Added to queryTripless!! : ?function textMine:prep ?negative. ?function textMine:prep ?A. ?A textMine:prep ?mutation. 
684

875 Another study showed that germline polymorphism of fibroblast growth factor receptor 4 (FGFR4) at residue 388 (G388R) correlates with enhancement of LPA 1  expression and more aggressive migratory and invasive responses to LPA in tumors carrying R388 FGFR4   
[?A textMine:prep ?G, ?B textMine:prep ?A, ?impact textMine:prep ?function, ?G textMine:appos ?mutation, ?C textMine:prep ?impact, ?C textMine:nsubj ?B]
Added to queryTripless!! : ?A textMine:prep ?G. ?B textMine:prep ?A. ?positive textMine:prep ?function. ?G textMine:appos ?mutation. ?C textMine:prep ?positive. ?C textMine:nsubj ?B. 
685

876 Indeed, Shi et al   demonstrated that 20% of melanoma patients treated with BRAF inhibitors (Vemurafenib and Dabrafenib) showed an increase in genomic copy number of BRAF V600E  and BRAF V600E  amplification resulted in BRAF V600E  overexpression in tumors of melanoma patients whose cancer had progressed after initial response 
[?function textMine:nsubj ?impact, ?function textMine:prep ?C, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:nsubj ?positive. ?function textMine:prep ?C. ?C textMine:nn ?mutation. 
686

877 Here we applied a genome wide expression profiling approach to identify downstream B RAF V600E  signaling changes that modulate melanocyte morphology and migration 
[?C textMine:rcmod ?impact, ?mutation textMine:partmod ?D, ?D textMine:dobj ?C, ?impact textMine:dobj ?function]
Added to queryTripless!! : ?C textMine:rcmod ?unknown. ?mutation textMine:partmod ?D. ?D textMine:dobj ?C. ?unknown textMine:dobj ?function. 
687

878 Restoration of PP2A activity inhibits BCR ABL expression and activity, hence impairing wild type and T315I BCR ABL  leukemogenesis 
[?impact textMine:dobj ?E, ?A textMine:partmod ?impact, ?function textMine:dobj ?A, ?E textMine:num ?mutation]
Added to queryTripless!! : ?negative textMine:dobj ?E. ?A textMine:partmod ?negative. ?function textMine:dobj ?A. ?E textMine:num ?mutation. 
688

879 For 4557W (reversible dual TKI of EGFR/ERBB2), the E884K mutation modulated the L858R mutation in  cis , again in a dominant fashion, rendering the double mutant receptor more sensitive to the dual inhibitor ( Figure 2 ) 
[?B textMine:amod ?mutation, ?E textMine:xcomp ?function, ?impact textMine:dobj ?B, ?impact textMine:partmod ?E]
Added to queryTripless!! : ?B textMine:amod ?mutation. ?E textMine:xcomp ?function. ?unknown textMine:dobj ?B. ?unknown textMine:partmod ?E. 
689

880 The H878Y missense mutation occurring in the activation domain of  ERBB2  alters a basic hydrophilic residue to an acidic hydrophilic residue, and so is predicted to affect function 
[?B textMine:prep ?C, ?C textMine:nn ?function, ?impact textMine:nsubj ?A, ?A textMine:partmod ?B, ?A textMine:amod ?mutation]
Added to queryTripless!! : ?B textMine:prep ?C. ?C textMine:nn ?function. ?unknown textMine:nsubj ?A. ?A textMine:partmod ?B. ?A textMine:amod ?mutation. 
690

881 E884K and L858R+E884K mutants remained sensitive to EGF and were activated by the ligand to a level comparable to L858R ( Figure 3A ) 
[?E textMine:prep ?mutation, ?C textMine:prep ?B, ?B textMine:amod ?E, ?function textMine:conj ?C, ?function textMine:cop ?impact]
Added to queryTripless!! : ?E textMine:prep ?mutation. ?C textMine:prep ?B. ?B textMine:amod ?E. ?function textMine:conj ?C. ?function textMine:cop ?neutral. 
691

882 The BRAF  mutations found in CFC can confer either weakly elevated kinase activity (mutations of Q257R, S467A, L485F, K499E) or impaired kinase activity versus wild type  BRAF  (E501G and G596V)     
[?function textMine:amod ?impact, ?E textMine:dep ?D, ?D textMine:nn ?mutation, ?F textMine:conj ?function, ?F textMine:appos ?E]
Added to queryTripless!! : ?function textMine:amod ?negative. ?E textMine:dep ?D. ?D textMine:nn ?mutation. ?F textMine:conj ?function. ?F textMine:appos ?E. 
692

883 To confirm the FGFR3 TAK1 interaction in mammalian cells and, specifically, FGFR3 associated cancer cell lines, human FGFR3 constructs, including wild type, kinase dead and constitutively active (K650E) sequences, were transiently expressed in HeLa cells 
[?function textMine:advmod ?impact, ?B textMine:amod ?function, ?B textMine:appos ?mutation]
Added to queryTripless!! : ?function textMine:advmod ?positive. ?B textMine:amod ?function. ?B textMine:appos ?mutation. 
693

884 However, when cells expressing that mutant were exposed to ox stress (GO) the affinity of the L858R EGFR for the α4 2 Ab was reduced ∼70% in comparison to the untreated or EGF treated cells ( Fig 6D–E ) 
[?function textMine:ccomp ?A, ?C textMine:prep ?G, ?B textMine:partmod ?function, ?impact textMine:nsubjpass ?B, ?G textMine:nn ?mutation, ?A textMine:dobj ?C]
Added to queryTripless!! : ?function textMine:ccomp ?A. ?C textMine:prep ?G. ?B textMine:partmod ?function. ?negative textMine:nsubjpass ?B. ?G textMine:nn ?mutation. ?A textMine:dobj ?C. 
694

885 Such an approach has been undertaken whereby inhibitors are selected for potent inhibition of MEK–ERK activation in a BRAF V600E  cell line but decreased potency in the induction of MEK–ERK activation in BRAF wild type cells   
[?D textMine:conj ?impact, ?D textMine:prep ?F, ?F textMine:nn ?mutation, ?B textMine:dep ?function, ?impact textMine:prep ?B]
Added to queryTripless!! : ?D textMine:conj ?negative. ?D textMine:prep ?F. ?F textMine:nn ?mutation. ?B textMine:dep ?function. ?negative textMine:prep ?B. 
695

886 How M918T mutation perturbs the GRL  cis  inhibition in solution and increases ATP affinity is unclear from the DFG in conformer crystal structure 
[?E textMine:advmod ?function, ?C textMine:nn ?mutation, ?impact textMine:ccomp ?E, ?impact textMine:nsubj ?C]
Added to queryTripless!! : ?E textMine:advmod ?function. ?C textMine:nn ?mutation. ?positive textMine:ccomp ?E. ?positive textMine:nsubj ?C. 
696

887 This mutation ( E17K ) increases recruitment of AKT1 to the membrane, increases AKT1 phosphorylation and activity, transforms Rat1 fibroblasts, and induces leukaemia in transgenic mice ( Carpten  et al , 2007 ) 
[?A textMine:appos ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?A]
[?A textMine:appos ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?A, ]
Match 


888 Surprisingly we found that, expression of each activated KRAS ED  lead to a substantial decrease in Braf V600E  induced tumors relative to the EGFP control suggesting the existence of a KRAS activated negative regulator of tumorigenesis 
[?G textMine:advmod ?E, ?mutation textMine:partmod ?G, ?F textMine:partmod ?H, ?H textMine:dobj ?A, ?impact textMine:prep ?mutation, ?E textMine:prep ?F, ?A textMine:prep ?function]
Added to queryTripless!! : ?G textMine:advmod ?E. ?mutation textMine:partmod ?G. ?F textMine:partmod ?H. ?H textMine:dobj ?A. ?negative textMine:prep ?mutation. ?E textMine:prep ?F. ?A textMine:prep ?function. 
697

889 Intriguingly, the imatinib resistant BCR/ABL mutants E255K and T315I showed increased ability as compared with native BCR/ABL to induce tyrosine phosphorylation of PECAM 1 when expressed in the murine model hematopoietic cell line BaF3 cells or in 293T cells ( Fig 4 ) 
[?C textMine:advcl ?function, ?E textMine:infmod ?C, ?E textMine:amod ?impact, ?A textMine:dobj ?E, ?A textMine:nsubj ?mutation]
[?A textMine:dobj ?E, ?A textMine:nsubj ?mutation, ?C textMine:advcl ?function, ?E textMine:amod ?impact, ?E textMine:infmod ?C, ]
Match 


890 Studies on North American patients indicated that those with deletions of exon 19 in the EGFR have a better response rate, progression free survival and overall survival after EGFR tyrosine kinase inhibitor treatment than do those with the L858R mutation in exon 21 (Jackman et al  ; Riely et al ) 
[?E textMine:dep ?I, ?C textMine:prep ?E, ?C textMine:dobj ?function, ?C textMine:dobj ?B, ?B textMine:conj ?function, ?B textMine:amod ?impact, ?G textMine:amod ?mutation, ?I textMine:dobj ?A, ?A textMine:prep ?G]
Added to queryTripless!! : ?E textMine:dep ?I. ?C textMine:prep ?E. ?C textMine:dobj ?function. ?C textMine:dobj ?B. ?B textMine:conj ?function. ?B textMine:amod ?positive. ?G textMine:amod ?mutation. ?I textMine:dobj ?A. ?A textMine:prep ?G. 
698

891 Dasatinib treatment of TBP 3743 cells reduced pAKT levels, perhaps permitting apoptosis, whereas the high basal pAKT levels in the PTEN null cells were unaffected by dasatinib treatment, suggesting that the loss of PTEN and the concomitant increase of AKT signaling may be a factor influencing resistance to apoptosis following BRAF V600E  inhibition as has been demonstrated in melanoma [ 62 ] 
[?E textMine:partmod ?F, ?E textMine:nsubj ?impact, ?F textMine:prep ?A, ?F textMine:dobj ?function, ?A textMine:prep ?G, ?G textMine:nn ?mutation]
Added to queryTripless!! : ?E textMine:partmod ?F. ?E textMine:nsubj ?positive. ?F textMine:prep ?A. ?F textMine:dobj ?function. ?A textMine:prep ?G. ?G textMine:nn ?mutation. 
699

892 9   Preclinical studies have shown superior activity of afatinib over first generation TKIs, mainly due to (1) irreversible binding, which confers stronger binding affinity and potency, (2) ability to circumvent first generation TKI resistance mechanism T790M mutation in exon 20, and (3) effectiveness against multiple HER endothelial growth factor receptors   10  
[?A textMine:dobj ?D, ?A textMine:dep ?G, ?function textMine:amod ?impact, ?E textMine:rcmod ?H, ?H textMine:dobj ?function, ?D textMine:nn ?mutation, ?G textMine:prep ?E]
Added to queryTripless!! : ?A textMine:dobj ?D. ?A textMine:dep ?G. ?function textMine:amod ?positive. ?E textMine:rcmod ?H. ?H textMine:dobj ?function. ?D textMine:nn ?mutation. ?G textMine:prep ?E. 
700

893 These two cases illustrate the importance of high assay sensitivity of our ARMS PCR assay to detect low  BRAF  V600E allele burdens in tumor samples 
[?E textMine:dobj ?C, ?E textMine:nsubj ?A, ?function textMine:amod ?impact, ?A textMine:prep ?function, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?E textMine:dobj ?C. ?E textMine:nsubj ?A. ?function textMine:amod ?positive. ?A textMine:prep ?function. ?C textMine:nn ?mutation. 
701

894 Instead, the T790M mutation induces resistance by increasing the binding affinity of ATP by one order of magnitude, which is near the affinity for wild type  EGFR , thus enabling ATP to compete effectively with the kinase inhibitors   
[?E textMine:rcmod ?H, ?D textMine:prepc ?impact, ?D textMine:nsubj ?B, ?B textMine:nn ?mutation, ?H textMine:prep ?function, ?F textMine:prep ?E, ?impact textMine:prep ?F]
Added to queryTripless!! : ?E textMine:rcmod ?H. ?D textMine:prepc ?positive. ?D textMine:nsubj ?B. ?B textMine:nn ?mutation. ?H textMine:prep ?function. ?F textMine:prep ?E. ?positive textMine:prep ?F. 
702

895 In contrast, MEN2B is almost always caused by the same M918T mutation and causes ganglioneuromas to form within the ENS, impairing bowel function 
[?B textMine:xcomp ?C, ?C textMine:xcomp ?impact, ?F textMine:nn ?mutation, ?impact textMine:dobj ?function, ?A textMine:conj ?B, ?A textMine:agent ?F]
Added to queryTripless!! : ?B textMine:xcomp ?C. ?C textMine:xcomp ?negative. ?F textMine:nn ?mutation. ?negative textMine:dobj ?function. ?A textMine:conj ?B. ?A textMine:agent ?F. 
703

896 CYT387 demonstrated efficacy in a JAK2 V617F mutation associated animal model where it inhibited constitutively activated JAK2 associated STAT3 function by neutralizing IL 6 by a negative feed back inhibition   
[?impact textMine:prep ?function, ?B textMine:prepc ?impact, ?E textMine:partmod ?A, ?E textMine:nn ?mutation, ?A textMine:advcl ?B]
Added to queryTripless!! : ?neutral textMine:prep ?function. ?B textMine:prepc ?neutral. ?E textMine:partmod ?A. ?E textMine:nn ?mutation. ?A textMine:advcl ?B. 
704

897 Consistent with published data  , PLX4032 abolished the ERK1/2 activating phosphorylation in BRAF V600E/K  melanoma cells ( Figure 2 , pERK, YULAC, YURIF, YUMAC and YUGEN8) 
[?impact textMine:dobj ?D, ?D textMine:prep ?E, ?D textMine:amod ?function, ?E textMine:nn ?mutation]
Added to queryTripless!! : ?negative textMine:dobj ?D. ?D textMine:prep ?E. ?D textMine:amod ?function. ?E textMine:nn ?mutation. 
705

898 These data, in concert with the evidence described above that BRAF V600E overexpression increases proliferation and DNA instability of thyroid cells and the central role of BRAF as a critical signalling node in RET/PTC induced thyroid cell proliferation, suggest BRAF as an appropriate therapeutic target for thyroid cancer 
[?A textMine:prep ?function, ?B textMine:prep ?A, ?B textMine:prep ?E, ?E textMine:nn ?impact, ?E textMine:nn ?mutation]
Added to queryTripless!! : ?A textMine:prep ?function. ?B textMine:prep ?A. ?B textMine:prep ?E. ?E textMine:nn ?positive. ?E textMine:nn ?mutation. 
706

899 F1174L may therefore stabilize an active conformation that is both more oncogenic and less favored for crizotinib binding 
[?E textMine:rcmod ?impact, ?E textMine:amod ?function, ?B textMine:dobj ?E, ?B textMine:nsubj ?mutation]
Added to queryTripless!! : ?E textMine:rcmod ?positive. ?E textMine:amod ?function. ?B textMine:dobj ?E. ?B textMine:nsubj ?mutation. 
707

900 This becomes important because it may help to explain the surprisingly low or normal blood counts observed in BCS JAK2 V617F  positive patients; the subsequent hemodilution and hypersplenism resulting from the portal hypertension may decrease the actual hemoglobin and other blood cell counts, making the diagnosis of MPN quite challenging in many cases   
[?B textMine:dobj ?C, ?E textMine:partmod ?function, ?H textMine:prep ?J, ?C textMine:partmod ?H, ?impact textMine:nsubj ?E, ?F textMine:parataxis ?impact, ?F textMine:advcl ?I, ?I textMine:xcomp ?B, ?J textMine:nn ?mutation]
Added to queryTripless!! : ?B textMine:dobj ?C. ?E textMine:partmod ?function. ?H textMine:prep ?J. ?C textMine:partmod ?H. ?negative textMine:nsubj ?E. ?F textMine:parataxis ?negative. ?F textMine:advcl ?I. ?I textMine:xcomp ?B. ?J textMine:nn ?mutation. 
708

901 While phosphorylation is reversible under nilotinib treatment in Ba/F3p210 cells, the TKI resistant mutant Ba/F3p210 T315I  cells showed an impaired phosphorylation status (Figure  4 , right panel), suggesting that LASP1 is a direct substrate of BCR ABL 
[?function textMine:amod ?impact, ?F textMine:amod ?function, ?D textMine:dobj ?F, ?D textMine:nsubj ?B, ?B textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:amod ?negative. ?F textMine:amod ?function. ?D textMine:dobj ?F. ?D textMine:nsubj ?B. ?B textMine:nn ?mutation. 
709

902 Similarly, E884K further enhanced the sensitivity of L858R to the inhibition by the irreversible EGFR/ERBB2 inhibitor, CL 387,785 
[?impact textMine:nsubj ?mutation, ?impact textMine:prep ?function]
[?impact textMine:nsubj ?mutation, ?impact textMine:prep ?function, ]
Match 


903 However, cells expressing the Y375C mutation, responded to FGF1 treatment with a small increase in ERK1/2 activation, while phosphorylation levels of FRS2α and PLCγ1 remained unchanged 
[?H textMine:amod ?mutation, ?impact textMine:nsubj ?G, ?A textMine:dobj ?H, ?G textMine:nn ?function, ?C textMine:partmod ?A, ?B textMine:advcl ?impact, ?B textMine:nsubj ?C]
Added to queryTripless!! : ?H textMine:amod ?mutation. ?neutral textMine:nsubj ?G. ?A textMine:dobj ?H. ?G textMine:nn ?function. ?C textMine:partmod ?A. ?B textMine:advcl ?neutral. ?B textMine:nsubj ?C. 
710

904 34 , 35 , 45  On the other hand, the affinity of this cleft for adenosine triphosphate is increased by T790M 
[?impact textMine:agent ?mutation, ?impact textMine:nsubjpass ?function]
[?impact textMine:agent ?mutation, ?impact textMine:nsubjpass ?function, ]
Match 


905 JAK2 inhibition in JAK2 V617F  cells modulates the post translational modification of Bim and levels of Mcl 1
[?A textMine:nn ?mutation, ?function textMine:prep ?A, ?impact textMine:nsubj ?function]
Query : [?A textMine:nn ?mutation, ?function textMine:prep ?A, ?impact textMine:nsubj ?function]
Existing trips : 
?B textMine:nn ?mutation. ?function textMine:prep ?B. ?impact textMine:nsubj ?function. 
Similar Query!!!!


906 Our studies here, using COS 7 transfection model system, show that E884K works in concert with L858R in  cis , in a dominant fashion, to change downstream signaling, differentially induce MAPK ERK1/2 signaling and associated cell proliferation, and differentially alter sensitivity of EGFR phosphorylation inhibition by ERBB family inhibitors in an inhibitor specific fashion 
[?E textMine:nn ?function, ?A textMine:prep ?E, ?B textMine:xsubj ?mutation, ?B textMine:conj ?impact, ?impact textMine:dobj ?A]
Added to queryTripless!! : ?E textMine:nn ?function. ?A textMine:prep ?E. ?B textMine:xsubj ?mutation. ?B textMine:conj ?unknown. ?unknown textMine:dobj ?A. 
711

907 The high potency of afatinib to inhibit the tyrosine kinase activity of wild type EGFR was fully maintained on EGFR with the activating L858R mutation (Solca et al  ; Sos et al ) 
[?impact textMine:prep ?B, ?B textMine:amod ?function, ?B textMine:amod ?mutation]
[?B textMine:amod ?function, ?B textMine:amod ?mutation, ?impact textMine:prep ?B, ]
Match 


908 Instead, the T790M mutation induces resistance by increasing the binding affinity of ATP by one order of magnitude, which is near the affinity for wild type  EGFR , thus enabling ATP to compete effectively with the kinase inhibitors   
[?A textMine:amod ?function, ?B textMine:nn ?mutation, ?impact textMine:dobj ?A, ?D textMine:prepc ?impact, ?D textMine:nsubj ?B]
Added to queryTripless!! : ?A textMine:amod ?function. ?B textMine:nn ?mutation. ?positive textMine:dobj ?A. ?D textMine:prepc ?positive. ?D textMine:nsubj ?B. 
712

998 The increase in BIM expression and apoptosis are inhibited by the secondary resistant mutation, T790M 
[?D textMine:appos ?mutation, ?function textMine:prep ?D, ?function textMine:nsubj ?impact]
Added to queryTripless!! : ?D textMine:appos ?mutation. ?function textMine:prep ?D. ?function textMine:nsubj ?positive. 
713

909 Furthermore, our results show that both insertions confer higher kinase activity than T790M, thus underscoring an important difference between these two types of exon 20 alterations 
[?function textMine:amod ?impact, ?C textMine:prep ?mutation, ?C textMine:dobj ?function]
Query : [?function textMine:amod ?impact, ?C textMine:prep ?mutation, ?C textMine:dobj ?function]
Existing trips : 
?B textMine:dobj ?function. ?B textMine:prep ?mutation. ?function textMine:amod ?impact. 
Similar Query!!!!


910 This result indicates that the secondary T790M mutation retains the active conformation of the binding site as proved by Yoshikawa et al (2013) 
[?B textMine:amod ?function, ?impact textMine:dobj ?B, ?impact textMine:nsubj ?E, ?E textMine:nn ?mutation]
Query : [?B textMine:amod ?function, ?impact textMine:dobj ?B, ?impact textMine:nsubj ?E, ?E textMine:nn ?mutation]
Existing trips : 
?B textMine:amod ?function. ?D textMine:nn ?mutation. ?impact textMine:dobj ?B. ?impact textMine:nsubj ?D. 
Similar Query!!!!


912 In comparison, the activity of some FOP mutants was generally increased to a level similar to caALK2, revealing an inherent gain of function in their catalytic domain in the absence of added BMP ligand ( Fig. 1  B )  Significantly, the signaling by R206H was increased by FK506 to a far greater extent than other GS domain mutants, such as L196P ( Fig 1  B ) 
[?C textMine:parataxis ?D, ?A textMine:amod ?B, ?D textMine:auxpass ?mutation, ?G textMine:prep ?A, ?G textMine:nsubjpass ?function, ?B textMine:prepc ?C]
Added to queryTripless!! : ?C textMine:parataxis ?D. ?A textMine:amod ?B. ?D textMine:auxpass ?mutation. ?G textMine:prep ?A. ?G textMine:nsubjpass ?function. ?B textMine:prepc ?C. 
714

913 Overexpression of LRRK2 WT and all LRRK2 mutants, including kinase active (G2019S), kinase dead (D1994A), and WD domain (G2385R) mutants, tended to increase basal levels of phosphorylated p38 compared to empty vector transfected (mock) cells, although the extent of the increase varied depending on the specific LRRK2 variant 
[?D textMine:nsubj ?C, ?J textMine:pobj ?K, ?J textMine:dobj ?L, ?J textMine:xsubj ?E, ?F textMine:amod ?function, ?A textMine:appos ?mutation, ?B textMine:advcl ?D, ?E textMine:prep ?A, ?C textMine:prep ?impact, ?K textMine:partmod ?B, ?L textMine:prep ?F]
Added to queryTripless!! : ?D textMine:nsubj ?C. ?J textMine:pobj ?K. ?J textMine:dobj ?L. ?J textMine:xsubj ?E. ?F textMine:amod ?function. ?A textMine:appos ?mutation. ?B textMine:advcl ?D. ?E textMine:prep ?A. ?C textMine:prep ?positive. ?K textMine:partmod ?B. ?L textMine:prep ?F. 
715

914 Since RKO cells harbor a V600E BRAF mutation , resulting in constitutive ERK activation, it was of interest to determine whether km23 1 knockdown could inhibit the constitutive ERK activity in this model system 
[?G textMine:dobj ?function, ?function textMine:amod ?impact, ?A textMine:xcomp ?E, ?A textMine:advcl ?B, ?E textMine:ccomp ?G, ?H textMine:nn ?mutation, ?B textMine:dobj ?H]
Added to queryTripless!! : ?G textMine:dobj ?function. ?function textMine:amod ?positive. ?A textMine:xcomp ?E. ?A textMine:advcl ?B. ?E textMine:ccomp ?G. ?H textMine:nn ?mutation. ?B textMine:dobj ?H. 
716

915 Both mutations lead to ALK constitutive activation by autophosphorylation, although ALK F1174L displays a higher degree of phosphorylation, and an increased tumorigenic potential compared to other ALK mutations [ 10 ,  13 ,  20   22 ,  26 ] 
[?C textMine:prep ?function, ?C textMine:amod ?impact, ?B textMine:dobj ?C, ?B textMine:nsubj ?mutation]
Query : [?C textMine:prep ?function, ?C textMine:amod ?impact, ?B textMine:dobj ?C, ?B textMine:nsubj ?mutation]
Existing trips : 
?C textMine:amod ?impact. ?D textMine:dobj ?C. ?D textMine:nsubj ?mutation. ?D textMine:prep ?function. 
Similar Query!!!!


916 Previous studies demonstrated that expression of AKT1 E17K protein in NIH 3T3 cells increased AKT phosphorylation in those cells ( Carpten  et al , 2007 ) 
[?B textMine:prep ?A, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?A textMine:nn ?mutation]
Query : [?B textMine:prep ?A, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?A textMine:nn ?mutation]
Existing trips : 
?A textMine:prep ?B. ?B textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?A. 
Similar Query!!!!


917 S252W fibroblasts showed 6 fold increase in ALP activity in comparison to WT fibroblasts ( p  < 0.001) (Fig.  2a ), while S252W MSCs had 3 fold increase in comparison to WT MSCs ( p  < 0 001) (Fig  2b ) 
[?F textMine:dobj ?impact, ?F textMine:nsubj ?A, ?A textMine:nn ?mutation, ?E textMine:advcl ?F, ?E textMine:dobj ?G, ?G textMine:prep ?function]
Added to queryTripless!! : ?F textMine:dobj ?positive. ?F textMine:nsubj ?A. ?A textMine:nn ?mutation. ?E textMine:advcl ?F. ?E textMine:dobj ?G. ?G textMine:prep ?function. 
717

918 In our recent studies on the effects of PLX4032, we demonstrated that the high enzymatic activity of both V600E and V600K BRAF mutants in melanoma cells is suppressed by treatment with PLX4032   
[?function textMine:amod ?impact, ?function textMine:prep ?D, ?D textMine:nn ?mutation]
Query : [?function textMine:amod ?impact, ?function textMine:prep ?D, ?D textMine:nn ?mutation]
Existing trips : 
?A textMine:nn ?mutation. ?function textMine:amod ?impact. ?function textMine:prep ?A. 
Similar Query!!!!


919 HEK293 cells were transfected with expression plasmids for TAK1 and constitutively active (K650E) FGFR3 
[?function textMine:dep ?mutation, ?function textMine:advmod ?impact]
[?function textMine:advmod ?impact, ?function textMine:dep ?mutation, ]
Match 


920 In TERT NHUC, abolishing PLCγ1 phosphorylation significantly reduced the increase in saturation density associated with S249C FGFR3 (13% vs  24%, p=005) ( Figure 6a ), suggesting that PLCγ1 signaling contributes to this phenotype 
[?C textMine:partmod ?function, ?impact textMine:prep ?C, ?function textMine:prep ?E, ?E textMine:nn ?mutation]
Added to queryTripless!! : ?C textMine:partmod ?function. ?negative textMine:prep ?C. ?function textMine:prep ?E. ?E textMine:nn ?mutation. 
718

921 In melanomas, this mutation gives rise to constitutive signalling through the MEK/ERK cascade and leads to increased proliferation, transformation and tumourigenicity, characteristics that can all be suppressed by  V600E BRAF inhibition (Hingorani et al, ; Karasarides et al, ; Wellbrock et al, ) 
[?B textMine:agent ?G, ?E textMine:rcmod ?B, ?A textMine:dobj ?E, ?A textMine:prep ?function, ?function textMine:amod ?impact, ?G textMine:nn ?mutation]
Added to queryTripless!! : ?B textMine:agent ?G. ?E textMine:rcmod ?B. ?A textMine:dobj ?E. ?A textMine:prep ?function. ?function textMine:amod ?positive. ?G textMine:nn ?mutation. 
719

922 EGFR knock down by siRNA enhanced the growth inhibitory effect of afatinib or cetuximab in a panel of five NSCLC cell lines, including those with T790M mutation (Chen et al ) 
[?E textMine:prep ?C, ?impact textMine:prep ?E, ?impact textMine:dobj ?function, ?C textMine:amod ?mutation]
Added to queryTripless!! : ?E textMine:prep ?C. ?positive textMine:prep ?E. ?positive textMine:dobj ?function. ?C textMine:amod ?mutation. 
720

923 We found that the expression of TGF β1, TGF β2R, and TGF β3 were all increased in BRAF V600E  mice thyroid tumors compared to wild type normal thyroid tissue (Figure  3 B) 
[?impact textMine:prep ?C, ?impact textMine:nsubjpass ?function, ?C textMine:nn ?mutation]
Query : [?impact textMine:prep ?C, ?impact textMine:nsubjpass ?function, ?C textMine:nn ?mutation]
Existing trips : 
?D textMine:nn ?mutation. ?impact textMine:nsubjpass ?function. ?impact textMine:prep ?D. 
Similar Query!!!!


924 Our studies here, using COS 7 transfection model system, show that E884K works in concert with L858R in  cis , in a dominant fashion, to change downstream signaling, differentially induce MAPK ERK1/2 signaling and associated cell proliferation, and differentially alter sensitivity of EGFR phosphorylation inhibition by ERBB family inhibitors in an inhibitor specific fashion 
[?A textMine:prep ?function, ?B textMine:xsubj ?mutation, ?B textMine:conj ?impact, ?impact textMine:dobj ?A]
Added to queryTripless!! : ?A textMine:prep ?function. ?B textMine:xsubj ?mutation. ?B textMine:conj ?unknown. ?unknown textMine:dobj ?A. 
721

925 Some mutations (P112Q, R895C, E897K) enhance angiotensin II receptor mediated activation of TRPC6 when expressed in HEK293 cells, while neither the S270T nor the N143S missense mutations, nor a 57 amino acid truncation mutation (K874X), altered the channel activity   
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ?E textMine:advcl ?D, ?C textMine:partmod ?E, ?D textMine:advcl ?G, ?G textMine:nsubj ?mutation]
[?C textMine:partmod ?E, ?D textMine:advcl ?G, ?E textMine:advcl ?D, ?G textMine:nsubj ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ]
Match 


926 This mutation ( E17K ) increases recruitment of AKT1 to the membrane, increases AKT1 phosphorylation and activity, transforms Rat1 fibroblasts, and induces leukaemia in transgenic mice ( Carpten  et al , 2007 ) 
[?A textMine:appos ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?A]
[?A textMine:appos ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?A, ]
Match 


927 We hypothesized that the R958D substitution would disrupt the ion pair with E884 through electrostatic repulsion, in a way similar to the effect of the E884K substitution 
[?A textMine:nn ?mutation, ?B textMine:amod ?E, ?E textMine:prep ?function, ?function textMine:prep ?A, ?impact textMine:prep ?B]
[?A textMine:nn ?mutation, ?B textMine:amod ?E, ?E textMine:prep ?function, ?function textMine:prep ?A, ?impact textMine:prep ?B, ]
Match 


928 It has been reported that BRAF V600E inhibitor improves recognition of human melanoma cells by antigen specific T lymphocytes through increased expression of melanoma differentiation antigens (MDAs)   
[?function textMine:amod ?impact, ?D textMine:prep ?function, ?D textMine:nsubj ?B, ?B textMine:nn ?mutation]
Query : [?function textMine:amod ?impact, ?D textMine:prep ?function, ?D textMine:nsubj ?B, ?B textMine:nn ?mutation]
Existing trips : 
?B textMine:nn ?mutation. ?E textMine:nsubj ?B. ?E textMine:prep ?function. ?function textMine:amod ?impact. 
Similar Query!!!!


929 Tyrosine phosphorylation of MIG6 appears to be increased in cancer cell lines containing Δ746–750 or L858R EGFRs, suggesting that in addition to inhibiting EGFR, MIG6 may also be a direct substrate of these mutant receptor EGFRs  
[?E textMine:dobj ?C, ?impact textMine:xcomp ?E, ?impact textMine:xsubj ?function, ?A textMine:num ?mutation, ?C textMine:dep ?A]
Added to queryTripless!! : ?E textMine:dobj ?C. ?positive textMine:xcomp ?E. ?positive textMine:xsubj ?function. ?A textMine:num ?mutation. ?C textMine:dep ?A. 
722

930 Leukocytes from ET patients harboring the JAK2 V617F mutation showed higher expression of PRV1  (median = 4.88) in comparison to those negative for the JAK2 V617F mutation (1.91) (p = 0.0074) (Figure  6A ) and, consequently, a positive correlation between  PRV1  expression and JAK2 V617F allele burden was observed in ET patient leukocytes (r = 0 4785; p = 00067) (Figure  6B ) 
[?G textMine:nsubjpass ?D, ?A textMine:conj ?G, ?A textMine:dobj ?E, ?C textMine:nn ?mutation, ?D textMine:prep ?C, ?D textMine:prep ?function, ?function textMine:conj ?C, ?E textMine:amod ?impact]
Added to queryTripless!! : ?G textMine:nsubjpass ?D. ?A textMine:conj ?G. ?A textMine:dobj ?E. ?C textMine:nn ?mutation. ?D textMine:prep ?C. ?D textMine:prep ?function. ?function textMine:conj ?C. ?E textMine:amod ?positive. 
723

931 JAK2  wt Ba/F3 cells engineered to express the erythropoietin receptor (Ba/F3 EPOR wt) and the cytokine independent counterpart with ectopic expression of  JAK2 V617F (Ba/F3 EPOR VF) were exposed to increasing drug concentrations in proliferation (48 h;  Figure 1A ) and clonogenic (7 days;  Figure 1B ) assay 
[?I textMine:prep ?function, ?I textMine:amod ?impact, ?C textMine:partmod ?A, ?A textMine:xcomp ?B, ?B textMine:dobj ?J, ?G textMine:prep ?mutation, ?D textMine:prep ?I, ?D textMine:nsubjpass ?C, ?J textMine:prep ?G]
Added to queryTripless!! : ?I textMine:prep ?function. ?I textMine:amod ?positive. ?C textMine:partmod ?A. ?A textMine:xcomp ?B. ?B textMine:dobj ?J. ?G textMine:prep ?mutation. ?D textMine:prep ?I. ?D textMine:nsubjpass ?C. ?J textMine:prep ?G. 
724

932 At high cell densities,  BRAF   V600E   HEK293A cells showed increased  ITGB2  expression compared with  BRAF   WT   HEK293A cells ( Figure 2c ) 
[?A textMine:dobj ?function, ?A textMine:nsubj ?B, ?function textMine:amod ?impact, ?B textMine:nn ?mutation]
Query : [?A textMine:dobj ?function, ?A textMine:nsubj ?B, ?function textMine:amod ?impact, ?B textMine:nn ?mutation]
Existing trips : 
?C textMine:nn ?mutation. ?E textMine:dobj ?function. ?E textMine:nsubj ?C. ?function textMine:amod ?impact. 
Similar Query!!!!


933 Patients with Apert syndrome with the S252W mutation in the FGFR2  gene enhanced osteoblastic marker gene expression and ALP activity  
[?D textMine:prep ?F, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?A, ?A textMine:prep ?D, ?F textMine:amod ?mutation]
Query : [?D textMine:prep ?F, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?A, ?A textMine:prep ?D, ?F textMine:amod ?mutation]
Existing trips : 
?B textMine:prep ?E. ?E textMine:prep ?F. ?F textMine:amod ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?B. 
Similar Query!!!!


934 Although Akt was found constitutively activate in  JAK2 V617F mutated cells  in vitro and in V617F transgenic or knock in mice , the contribution of PI3K/Akt signaling to the pathogenesis of MPN is still poorly characterized 
[?function textMine:advmod ?impact, ?D textMine:amod ?mutation, ?H textMine:partmod ?C, ?C textMine:prep ?A, ?A textMine:pobj ?D, ?G textMine:prep ?H, ?G textMine:acomp ?function]
Added to queryTripless!! : ?function textMine:advmod ?positive. ?D textMine:amod ?mutation. ?H textMine:partmod ?C. ?C textMine:prep ?A. ?A textMine:pobj ?D. ?G textMine:prep ?H. ?G textMine:acomp ?function. 
725

935 The coexistent mutations of  AKT3  and  PIK3CA  in one sample suggest that some types of  AKT  mutations (non E17K) might coexist with  PIK3CA  mutations to enhance the activation of the PI3 kinase–AKT pathway 
[?A textMine:appos ?mutation, ?impact textMine:dobj ?function, ?impact textMine:xsubj ?A]
Added to queryTripless!! : ?A textMine:appos ?mutation. ?positive textMine:dobj ?function. ?positive textMine:xsubj ?A. 
726

936 These data suggest that binding to PtsInsP species is enhanced by the E416A mutation, in agreement with the MD results reported above 
[?E textMine:nn ?mutation, ?impact textMine:prep ?A, ?impact textMine:agent ?E, ?A textMine:prep ?function]
Added to queryTripless!! : ?E textMine:nn ?mutation. ?positive textMine:prep ?A. ?positive textMine:agent ?E. ?A textMine:prep ?function. 
727

937 We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated (native) BCR/ABL ( 15 – 17 ) 
[?D textMine:dobj ?A, ?D textMine:nsubj ?F, ?A textMine:infmod ?function, ?A textMine:amod ?impact, ?F textMine:nn ?mutation]
[?A textMine:amod ?impact, ?A textMine:infmod ?function, ?D textMine:dobj ?A, ?D textMine:nsubj ?F, ?F textMine:nn ?mutation, ]
Match 


938 The phosphorylation of ERK1/2 in cells expressing C121S MEK1 was elevated and this variant was permissive for growth in vemurafenib treated mutant BRAF cell lines 
[?function textMine:dep ?impact, ?impact textMine:nsubj ?B, ?B textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:dep ?positive. ?positive textMine:nsubj ?B. ?B textMine:nn ?mutation. 
728

999 The EphA3 G518L lung cancer mutation enhances cis interaction with coexpressed ephrin A3
[?C textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?C]
[?C textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ]
Match 


939 Because aberrant activation of FGFR2 S252W  is related primarily to its broadened ligand binding specificity and increased ligand binding affinity, its pathological activities must necessarily be linked to local or cell intrinsic ligand levels 
[?B textMine:prep ?mutation, ?C textMine:prep ?function, ?C textMine:nsubjpass ?B, ?function textMine:amod ?impact]
Added to queryTripless!! : ?B textMine:prep ?mutation. ?C textMine:prep ?function. ?C textMine:nsubjpass ?B. ?function textMine:amod ?positive. 
729

940 The mutations T315I, E255V, F317L and F317V contribute to decreased vdW interactions with Ala269 
[?C textMine:prep ?function, ?C textMine:dep ?E, ?function textMine:amod ?impact, ?E textMine:dep ?mutation]
Query : [?C textMine:prep ?function, ?C textMine:dep ?E, ?function textMine:amod ?impact, ?E textMine:dep ?mutation]
Existing trips : 
?D textMine:dep ?E. ?D textMine:prep ?function. ?E textMine:dep ?mutation. ?function textMine:amod ?impact. 
Similar Query!!!!


941 BCR ABL mutations respond differently to three tyrosine kinase inhibitors approved for first line treatment of CML, e g, Y253F and G250E mutations resistant to imatinib can respond to nilotinib or/and dasatinib, T315A shows better response to imatinib though resistant to Dasatinib and Nilotinib, while some mutations are less sensitive to nilotinib (E255K/V and F359V/C) or dasatinib (F317L and V299L)  
[?B textMine:cop ?impact, ?B textMine:advmod ?function]
[?B textMine:advmod ?function, ?B textMine:cop ?impact, ]
Match 


942 E255K and T315I are the most predominant mutations of BCR/ABL causing imatinib resistance in patients and may increase the kinase activity or change the substrate preferences of BCR/ABL ( 15 , 18 ) 
[?E textMine:conj ?B, ?E textMine:conj ?impact, ?E textMine:nsubj ?mutation, ?E textMine:nsubj ?G, ?impact textMine:conj ?B, ?impact textMine:nsubj ?G, ?A textMine:amod ?function, ?G textMine:conj ?mutation, ?B textMine:dobj ?A]
Added to queryTripless!! : ?E textMine:conj ?B. ?E textMine:conj ?positive. ?E textMine:nsubj ?mutation. ?E textMine:nsubj ?G. ?positive textMine:conj ?B. ?positive textMine:nsubj ?G. ?A textMine:amod ?function. ?G textMine:conj ?mutation. ?B textMine:dobj ?A. 
730

943 It was previously reported that FGFR2 S252W  has enhanced affinity to different FGFs  , therefore, the altered S252W cell proliferation and cell migration in response to different FBS concentrations suggests that FBS contains growth stimulating FGFs to which S252W fibroblasts are more sensitive to, and FGFs that in high concentration inhibit migration of S252W fibroblasts 
[?B textMine:num ?mutation, ?function textMine:amod ?impact, ?D textMine:dobj ?A, ?G textMine:nsubj ?function, ?H textMine:conj ?D, ?H textMine:conj ?G, ?A textMine:prep ?B]
Added to queryTripless!! : ?B textMine:num ?mutation. ?function textMine:amod ?unknown. ?D textMine:dobj ?A. ?G textMine:nsubj ?function. ?H textMine:conj ?D. ?H textMine:conj ?G. ?A textMine:prep ?B. 
731

944 Tyrosine phosphorylation of MIG6 appears to be increased in cancer cell lines containing Δ746–750 or L858R EGFRs, suggesting that in addition to inhibiting EGFR, MIG6 may also be a direct substrate of these mutant receptor EGFRs  
[?E textMine:dep ?A, ?B textMine:prepc ?function, ?A textMine:num ?mutation, ?G textMine:xcomp ?F, ?G textMine:dobj ?E, ?impact textMine:xcomp ?G, ?F textMine:ccomp ?B]
Added to queryTripless!! : ?E textMine:dep ?A. ?B textMine:prepc ?function. ?A textMine:num ?mutation. ?G textMine:xcomp ?F. ?G textMine:dobj ?E. ?positive textMine:xcomp ?G. ?F textMine:ccomp ?B. 
732

945 We find an increased activity of SIRT1 in PLX4032 resistant BRAF V600E  mutated melanoma cells compared with their sensitive counterpart, thereby linking SIRT1 to drug resistance and poor prognosis in melanoma 
[?function textMine:amod ?impact, ?function textMine:prep ?mutation]
[?function textMine:amod ?impact, ?function textMine:prep ?mutation, ]
Match 


946 A375 is a human derived melanoma cell line harboring a BRAF mutation due to the substitution of valine for glutamic acid at codon 600, termed V600E resulting in constitutive activation, aggressive proliferation, and high BCL 2 expression 
[?E textMine:prep ?D, ?E textMine:dobj ?mutation, ?E textMine:nsubj ?function, ?D textMine:amod ?impact]
Added to queryTripless!! : ?E textMine:prep ?D. ?E textMine:dobj ?mutation. ?E textMine:nsubj ?function. ?D textMine:amod ?positive. 
733

947 Our studies here, using COS 7 transfection model system, show that E884K works in concert with L858R in  cis , in a dominant fashion, to change downstream signaling, differentially induce MAPK ERK1/2 signaling and associated cell proliferation, and differentially alter sensitivity of EGFR phosphorylation inhibition by ERBB family inhibitors in an inhibitor specific fashion 
[?D textMine:nn ?function, ?A textMine:prep ?D, ?impact textMine:dobj ?A, ?B textMine:prep ?mutation, ?B textMine:xcomp ?impact]
Added to queryTripless!! : ?D textMine:nn ?function. ?A textMine:prep ?D. ?unknown textMine:dobj ?A. ?B textMine:prep ?mutation. ?B textMine:xcomp ?unknown. 
734

948 Now, recent work from the Rosen lab at Memorial Sloan Kettering Cancer Center has uncovered data that vemurafenib reduces feedback inhibition in BRAF V600E  expressing cells such that these cells become sensitized to extracellular growth factors like hepatocyte and epidermal growth factors 
[?mutation textMine:partmod ?function, ?impact textMine:prep ?mutation]
[?impact textMine:prep ?mutation, ?mutation textMine:partmod ?function, ]
Match 


950 Thus, we asked next whether the Apert S252W mutation confers higher functional stem cell activity and a selective advantage that enables mutants to outcompete WT counterparts 
[?C textMine:ccomp ?A, ?C textMine:nsubj ?D, ?D textMine:nn ?mutation, ?function textMine:amod ?impact, ?A textMine:nsubj ?function]
Added to queryTripless!! : ?C textMine:ccomp ?A. ?C textMine:nsubj ?D. ?D textMine:nn ?mutation. ?function textMine:amod ?positive. ?A textMine:nsubj ?function. 
735

951 Previous studies demonstrated that expression of AKT1 E17K protein in NIH 3T3 cells increased AKT phosphorylation in those cells ( Carpten  et al , 2007 ) 
[?function textMine:prep ?A, ?impact textMine:nsubj ?function, ?A textMine:nn ?mutation]
Query : [?function textMine:prep ?A, ?impact textMine:nsubj ?function, ?A textMine:nn ?mutation]
Existing trips : 
?B textMine:nn ?mutation. ?function textMine:prep ?B. ?impact textMine:nsubj ?function. 
Similar Query!!!!


952 Mutations to this protein such as G469A, E586K, V600E, and K601E can increase BRAF catalytic activity  
[?C textMine:prep ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?D, ?D textMine:prep ?C]
[?C textMine:prep ?mutation, ?D textMine:prep ?C, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?D, ]
Match 


953 Importantly, whereas mice receiving 10 6  JAK2 V617F  cells retained a balanced production of myeloid and lymphoid lineages, those receiving 10 5  JAK2 V617F  cells exhibited marked lineage skewing ( Figure 1B ) as determined by the relative production of myeloid and lymphoid elements by donor and competitor cells 
[?C textMine:appos ?E, ?K textMine:npadvmod ?G, ?impact textMine:dobj ?B, ?F textMine:partmod ?A, ?F textMine:nn ?mutation, ?B textMine:prep ?C, ?A textMine:advmod ?K, ?G textMine:amod ?function, ?E textMine:partmod ?I, ?I textMine:dobj ?F]
Added to queryTripless!! : ?C textMine:appos ?E. ?K textMine:npadvmod ?G. ?neutral textMine:dobj ?B. ?F textMine:partmod ?A. ?F textMine:nn ?mutation. ?B textMine:prep ?C. ?A textMine:advmod ?K. ?G textMine:amod ?function. ?E textMine:partmod ?I. ?I textMine:dobj ?F. 
736

954 Our studies here, using COS 7 transfection model system, show that E884K works in concert with L858R in  cis , in a dominant fashion, to change downstream signaling, differentially induce MAPK ERK1/2 signaling and associated cell proliferation, and differentially alter sensitivity of EGFR phosphorylation inhibition by ERBB family inhibitors in an inhibitor specific fashion 
[?A textMine:prep ?function, ?B textMine:xsubj ?mutation, ?B textMine:conj ?impact, ?impact textMine:dobj ?A]
[?A textMine:prep ?function, ?B textMine:conj ?impact, ?B textMine:xsubj ?mutation, ?impact textMine:dobj ?A, ]
Match 


955 As summarized in Table  II , five nsSNPs (ERCC5 S311C, OGG1 S326C, XRCC3 T241M, CCND3 S259A, and CDKN1A S31R) were predicted to abolish putative phosphorylation sites, whereas four nsSNPs were predicted to create putative phosphorylation sites in the proteins (ERCC2 H201Y, ERCC4 P379S, LIG4 P231S, and XRCC1 P309S) 
[?H textMine:dobj ?F, ?H textMine:prep ?D, ?D textMine:dep ?mutation, ?F textMine:nn ?function, ?B textMine:xcomp ?H, ?C textMine:xcomp ?impact, ?C textMine:advcl ?B]
Added to queryTripless!! : ?H textMine:dobj ?F. ?H textMine:prep ?D. ?D textMine:dep ?mutation. ?F textMine:nn ?function. ?B textMine:xcomp ?H. ?C textMine:xcomp ?negative. ?C textMine:advcl ?B. 
737

956 These results indicate that despite the reduced levels of MITF activity in  BRAF   V600E   mitf  melanomas, there is sufficient MITF activity to control MITF target genes involved in cell proliferation and survival 
[?A textMine:prep ?E, ?A textMine:amod ?impact, ?B textMine:nn ?mutation, ?F textMine:nsubj ?function, ?F textMine:prep ?A, ?E textMine:prep ?B]
Added to queryTripless!! : ?A textMine:prep ?E. ?A textMine:amod ?negative. ?B textMine:nn ?mutation. ?F textMine:nsubj ?function. ?F textMine:prep ?A. ?E textMine:prep ?B. 
738

957 However, we failed to detect new co occurring mutations in the  EGFR  gene (including the gatekeeper EGFR  T790M  mutation, in the tumors generated by the PC 9/Erl R cells, which maintained the same expression level of EGFR Δ E746 A750  as the PC 9 cells ( Supplementary Fig 1 ) 
[?D textMine:dep ?G, ?impact textMine:iobj ?B, ?F textMine:prep ?I, ?F textMine:nn ?mutation, ?I textMine:partmod ?E, ?E textMine:agent ?D, ?G textMine:rcmod ?impact, ?B textMine:nn ?function]
Added to queryTripless!! : ?D textMine:dep ?G. ?neutral textMine:iobj ?B. ?F textMine:prep ?I. ?F textMine:nn ?mutation. ?I textMine:partmod ?E. ?E textMine:agent ?D. ?G textMine:rcmod ?neutral. ?B textMine:nn ?function. 
739

958 The NS1 mutants D2N †  and V226I bound F2F3 FLAG with comparable affinity to HK wt NS1, but NS1 mutants V23A and R227K †  demonstrated a 2 fold increase in binding affinity (p<0 05 and p<001, two tailed student's t test) 
[?impact textMine:prep ?function, ?E textMine:dobj ?impact, ?A textMine:nn ?mutation, ?B textMine:conj ?E, ?B textMine:nsubj ?A]
Added to queryTripless!! : ?positive textMine:prep ?function. ?E textMine:dobj ?positive. ?A textMine:nn ?mutation. ?B textMine:conj ?E. ?B textMine:nsubj ?A. 
740

959 In pathological LCH cells, constitutive activity of the mutant BRAF V600E protein may lead to a deregulated signaling through this pathway, thereby resulting in increased cell survival   
[?function textMine:amod ?impact, ?F textMine:dep ?C, ?C textMine:dep ?A, ?H textMine:prep ?D, ?I textMine:prep ?F, ?I textMine:nsubj ?H, ?A textMine:prep ?function, ?D textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:amod ?positive. ?F textMine:dep ?C. ?C textMine:dep ?A. ?H textMine:prep ?D. ?I textMine:prep ?F. ?I textMine:nsubj ?H. ?A textMine:prep ?function. ?D textMine:nn ?mutation. 
741

960 To challenge the prediction that JAK2V617F alters the balance between proliferation and differentiation at the apex of the stem cell hierarchy, we undertook a paired daughter cell analysis to assess the fate outcome of the first division of HSCs from JAK2 V617F  mice and their littermate controls 
[?impact textMine:dobj ?F, ?G textMine:ccomp ?impact, ?F textMine:prep ?function, ?H textMine:nn ?mutation, ?B textMine:xcomp ?C, ?B textMine:advcl ?G, ?C textMine:prep ?H]
Added to queryTripless!! : ?unknown textMine:dobj ?F. ?G textMine:ccomp ?unknown. ?F textMine:prep ?function. ?H textMine:nn ?mutation. ?B textMine:xcomp ?C. ?B textMine:advcl ?G. ?C textMine:prep ?H. 
742

961 As seen in  Fig 4E , the expression of BRAF V600E  completely abolished MST1 kinase activity 
[?function textMine:prep ?mutation, ?impact textMine:nsubj ?function]
[?function textMine:prep ?mutation, ?impact textMine:nsubj ?function, ]
Match 


962 According to the Ki67 positive cells,  BRaf  V600E  expression increased lung cell proliferation index from 33.51% ±2.389% (n = 8 20X fields from 3 different mice) in 10 days old WT to 42.56% ±2 861% (n = 11 20X fields from 3 different mice) in age matched  Braf  CA  mice (each 20X field quantified contained between 2500–5000 nucleus;  P  = 00345;  Figure 1E ) 
[?function textMine:nn ?mutation, ?impact textMine:nsubj ?function]
[?function textMine:nn ?mutation, ?impact textMine:nsubj ?function, ]
Match 


963 In V617Y (Figure  4  and Figure  5 ), Y617 also interacts with F595 and blocks the contacts between the JH1 activation loop and JH2 C helix in a way very similar to V617F, in that the I 2 interactions (vdw [JH1:A, JH2:C]) are severely damaged 
[?impact textMine:nsubj ?function, ?mutation textMine:rcmod ?impact]
Added to queryTripless!! : ?negative textMine:nsubj ?function. ?mutation textMine:rcmod ?negative. 
743

964 Several resistance mechanisms, such as EGFR T790M secondary mutation that leads to a higher ATP binding capacity, and MET amplification resulting in an aberrantly activated alternative pathway that bypasses the inhibited EGF receptors, had been discovered 
[?F textMine:partmod ?function, ?E textMine:prep ?F, ?E textMine:prep ?G, ?G textMine:conj ?F, ?G textMine:amod ?impact, ?C textMine:rcmod ?E, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?F textMine:partmod ?function. ?E textMine:prep ?F. ?E textMine:prep ?G. ?G textMine:conj ?F. ?G textMine:amod ?positive. ?C textMine:rcmod ?E. ?C textMine:nn ?mutation. 
744

965 Moreover, E cadherin protein levels were significantly diminished in B RAF V600E  transduced normal melanocytes derived from three individuals ( Figure 2b ) and E cadherin protein levels increased when B RAF V600E  was specifically silenced by shRNA or inhibited using the targeted B RAF inhibitor Vemurafenib (PLX4032) in two B RAF V600E  positive melanoma cell lines (NM176 and ME1042) ( Figure 2c ) 
[?A textMine:prep ?B, ?B textMine:nn ?mutation, ?function textMine:xcomp ?E, ?impact textMine:conj ?function, ?E textMine:dobj ?A]
Query : [?A textMine:prep ?B, ?B textMine:nn ?mutation, ?function textMine:xcomp ?E, ?impact textMine:conj ?function, ?E textMine:dobj ?A]
Existing trips : 
?B textMine:prep ?C. ?C textMine:nn ?mutation. ?E textMine:dobj ?B. ?function textMine:xcomp ?E. ?impact textMine:conj ?function. 
Similar Query!!!!


966 BCR ABL mutations respond differently to three tyrosine kinase inhibitors approved for first line treatment of CML, e g, Y253F and G250E mutations resistant to imatinib can respond to nilotinib or/and dasatinib, T315A shows better response to imatinib though resistant to Dasatinib and Nilotinib, while some mutations are less sensitive to nilotinib (E255K/V and F359V/C) or dasatinib (F317L and V299L)  
[?B textMine:cop ?impact, ?B textMine:advmod ?function]
[?B textMine:advmod ?function, ?B textMine:cop ?impact, ]
Match 


967 Under restrictive media conditions, only S252W fibroblasts showed enhanced migration 
[?D textMine:num ?mutation, ?E textMine:dobj ?function, ?E textMine:nsubj ?D, ?function textMine:amod ?impact]
Added to queryTripless!! : ?D textMine:num ?mutation. ?E textMine:dobj ?function. ?E textMine:nsubj ?D. ?function textMine:amod ?positive. 
745

968 The G370C and S371C mutants produced higher levels of constitutive activation of MAPK in L8 cells and c  fos  transcription in RCJ cells than the G375C mutant, consistent with the fact that TD1 is much more severe than ACH 
[?C textMine:prep ?function, ?C textMine:amod ?impact, ?A textMine:nn ?mutation, ?F textMine:dobj ?C, ?F textMine:nsubj ?A]
Query : [?C textMine:prep ?function, ?C textMine:amod ?impact, ?A textMine:nn ?mutation, ?F textMine:dobj ?C, ?F textMine:nsubj ?A]
Existing trips : 
?A textMine:dobj ?D. ?A textMine:nsubj ?B. ?B textMine:nn ?mutation. ?D textMine:amod ?impact. ?D textMine:prep ?function. 
Similar Query!!!!


969 Our analysis revealed that the T790M mutation significantly increased the distance between the P loop and activation loop, whereas the G719S mutation significantly shortened the distance between the P loop and activation loop ( Supplementary Figure 2 ) 
[?impact textMine:dobj ?B, ?I textMine:nn ?function, ?F textMine:nn ?mutation, ?H textMine:dep ?D, ?D textMine:dobj ?E, ?D textMine:nsubj ?F, ?E textMine:prep ?I, ?B textMine:prep ?H]
Added to queryTripless!! : ?positive textMine:dobj ?B. ?I textMine:nn ?function. ?F textMine:nn ?mutation. ?H textMine:dep ?D. ?D textMine:dobj ?E. ?D textMine:nsubj ?F. ?E textMine:prep ?I. ?B textMine:prep ?H. 
746

970 This led us to question whether in solution, perturbation of the autoP trajectory by RET M918T could arise through presentation of a better intermolecular substrate by favoring an “AL out” conformer presenting Y900 or Y905 as a substrate to an active RET kinase in  trans  
[?C textMine:amod ?impact, ?D textMine:partmod ?B, ?E textMine:prep ?mutation, ?B textMine:prep ?function, ?G textMine:prep ?E, ?I textMine:dobj ?D, ?F textMine:prepc ?I, ?F textMine:prep ?A, ?F textMine:nsubj ?G, ?A textMine:prep ?C]
Added to queryTripless!! : ?C textMine:amod ?positive. ?D textMine:partmod ?B. ?E textMine:prep ?mutation. ?B textMine:prep ?function. ?G textMine:prep ?E. ?I textMine:dobj ?D. ?F textMine:prepc ?I. ?F textMine:prep ?A. ?F textMine:nsubj ?G. ?A textMine:prep ?C. 
747

971 Hence, the double mutation L858R+E884K modulated downstream EGFR signaling differentially with distinctly different effects on the AKT (downregulated) and MAPK ERK1/2 phosphorylation (upregulated) 
[?D textMine:partmod ?A, ?impact textMine:dobj ?D, ?impact textMine:nsubj ?mutation, ?A textMine:prep ?function]
[?A textMine:prep ?function, ?D textMine:partmod ?A, ?impact textMine:dobj ?D, ?impact textMine:nsubj ?mutation, ]
Match 


972 The mutations T315I, E255V, F317L and F317V contribute to decreased vdW interactions with Ala269 
[?function textMine:amod ?impact, ?C textMine:prep ?function, ?C textMine:dep ?E, ?D textMine:num ?mutation, ?E textMine:dep ?D]
Added to queryTripless!! : ?function textMine:amod ?negative. ?C textMine:prep ?function. ?C textMine:dep ?E. ?D textMine:num ?mutation. ?E textMine:dep ?D. 
748

973 Some variants seem to consistently decrease kinase activity, including the G2385R variant   that is a genetic risk factor for PD in some populations 
[?D textMine:amod ?mutation, ?impact textMine:prep ?D, ?impact textMine:dobj ?function]
Added to queryTripless!! : ?D textMine:amod ?mutation. ?negative textMine:prep ?D. ?negative textMine:dobj ?function. 
749

974 Here, we show for the first time that activation of FGFR3 is associated with an increase in FGFR3b expression in S249C mutated tumors 
[?impact textMine:prep ?function, ?function textMine:prep ?D, ?D textMine:nn ?mutation]
Added to queryTripless!! : ?positive textMine:prep ?function. ?function textMine:prep ?D. ?D textMine:nn ?mutation. 
750

975 Synergy is particularly important as it may permit lower doses of PLX4720 to be used, potentially translating to a benefit in the clinic by reducing side effects associated with BRAF V600E  inhibition including squamous cell carcinoma [ 54   56 ] 
[?B textMine:prep ?function, ?E textMine:partmod ?B, ?impact textMine:dobj ?E, ?function textMine:nn ?mutation]
Added to queryTripless!! : ?B textMine:prep ?function. ?E textMine:partmod ?B. ?negative textMine:dobj ?E. ?function textMine:nn ?mutation. 
751

976 Further elevated CDK4 levels in the embryonic pancreas, through the CDK4 R24C  mutant, showed increased proliferation of early mesenchymal endocrine precursors   
[?G textMine:prep ?C, ?C textMine:partmod ?E, ?impact textMine:nsubj ?G, ?E textMine:dobj ?function, ?E textMine:prep ?A, ?A textMine:nn ?mutation]
Added to queryTripless!! : ?G textMine:prep ?C. ?C textMine:partmod ?E. ?positive textMine:nsubj ?G. ?E textMine:dobj ?function. ?E textMine:prep ?A. ?A textMine:nn ?mutation. 
752

977 However, cells expressing the Y375C mutation, responded to FGF1 treatment with a small increase in ERK1/2 activation, while phosphorylation levels of FRS2α and PLCγ1 remained unchanged 
[?G textMine:amod ?mutation, ?impact textMine:prep ?function, ?B textMine:dobj ?G, ?D textMine:partmod ?B, ?C textMine:prep ?impact, ?C textMine:nsubj ?D]
Added to queryTripless!! : ?G textMine:amod ?mutation. ?positive textMine:prep ?function. ?B textMine:dobj ?G. ?D textMine:partmod ?B. ?C textMine:prep ?positive. ?C textMine:nsubj ?D. 
753

978 We show that PAK6 kinase activity is regulated by its N terminal pseudosubstrate  in vitro  and that a melanoma associated mutation, P52L, in the pseudosubstrate sequence displays reduced inhibition 
[?function textMine:amod ?impact, ?A textMine:dobj ?function, ?A textMine:nsubj ?F, ?C textMine:dobj ?D, ?D textMine:appos ?mutation, ?F textMine:partmod ?C]
Added to queryTripless!! : ?function textMine:amod ?negative. ?A textMine:dobj ?function. ?A textMine:nsubj ?F. ?C textMine:dobj ?D. ?D textMine:appos ?mutation. ?F textMine:partmod ?C. 
754

979 SIRT1 inhibition decreases melanoma cell growth and rescues the sensibility to PLX4032 of PLX4032 resistant BRAF V600E  mutated melanoma cells 
[?impact textMine:conj ?B, ?impact textMine:nsubj ?function, ?D textMine:prep ?mutation, ?B textMine:prep ?D, ?B textMine:nsubj ?function]
Added to queryTripless!! : ?negative textMine:conj ?B. ?negative textMine:nsubj ?function. ?D textMine:prep ?mutation. ?B textMine:prep ?D. ?B textMine:nsubj ?function. 
755

980 The presence of R164Q in cluster 2, rather than in cluster 1 with wt  K Ras  was therefore initially surprising, but suggests that the R164Q mutation also has an 'activating' phenotype, albeit attenuated relative to the other mutations studied 
[?impact textMine:nsubj ?B, ?impact textMine:dobj ?function, ?B textMine:nn ?mutation]
Query : [?impact textMine:nsubj ?B, ?impact textMine:dobj ?function, ?B textMine:nn ?mutation]
Existing trips : 
?C textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?C. 
Similar Query!!!!


981 RNAi against  JAK2  reduced  SPI1  expression in  JAK2  V617F positive HEL cells 
[?impact textMine:prep ?mutation, ?impact textMine:dobj ?function]
[?impact textMine:dobj ?function, ?impact textMine:prep ?mutation, ]
Match 


982 These observations indicate that activation by the L858R substitution is coupled to kinase dimer formation and that inhibiting dimer formation by mutation increases accessibility of the inactive kinase conformation 
[?D textMine:nn ?mutation, ?E textMine:conj ?impact, ?E textMine:nsubjpass ?F, ?F textMine:prep ?D, ?impact textMine:csubj ?function]
Added to queryTripless!! : ?D textMine:nn ?mutation. ?E textMine:conj ?positive. ?E textMine:nsubjpass ?F. ?F textMine:prep ?D. ?positive textMine:csubj ?function. 
756

983 Although inhibition of MEK and ERK phosphorylation was achieved in BRAF V600E/K  mutant melanoma, significantly increased tumour growth was seen in BRAF wild type melanomas with upstream RAS mutations 
[?impact textMine:advcl ?B, ?C textMine:prep ?function, ?B textMine:prep ?D, ?B textMine:nsubjpass ?C, ?D textMine:nn ?mutation]
[?B textMine:nsubjpass ?C, ?B textMine:prep ?D, ?C textMine:prep ?function, ?D textMine:nn ?mutation, ?impact textMine:advcl ?B, ]
Match 


984 This mutation ( E17K ) increases recruitment of AKT1 to the membrane, increases AKT1 phosphorylation and activity, transforms Rat1 fibroblasts, and induces leukaemia in transgenic mice ( Carpten  et al , 2007 ) 
[?A textMine:appos ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?A]
[?A textMine:appos ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?A, ]
Match 


985 In addition, in PMF, JAK2 V617F positive patients, compared to their mutation negative counterparts, were more likely to display higher plasma levels of IL 1RA, IL 2R, IL 6, IL 12, hepatocyte growth factor (HGF), CXCL10 and monokine induced by interferon (IFN) γ other phenotypic correlates included increased levels of (i) IL 6 and IL 8 with constitutional symptoms, (ii) HGF with marked splenomegaly, (iii) IL 2R, IL 8, IL 10, macrophage inflammatory protein (MIP) 1α and monocyte chemotactic protein 1 with red cell transfusion dependency, (iv) IL 2R, HGF and CXCL10 with leukocytosis and (v) CXCL10 with thrombocytopenia 
[?D textMine:partmod ?I, ?A textMine:dobj ?C, ?A textMine:dobj ?G, ?A textMine:xsubj ?J, ?E textMine:amod ?function, ?F textMine:rcmod ?H, ?H textMine:nsubj ?E, ?C textMine:conj ?D, ?G textMine:conj ?D, ?G textMine:conj ?C, ?G textMine:amod ?impact, ?I textMine:agent ?F, ?J textMine:num ?mutation]
Added to queryTripless!! : ?D textMine:partmod ?I. ?A textMine:dobj ?C. ?A textMine:dobj ?G. ?A textMine:xsubj ?J. ?E textMine:amod ?function. ?F textMine:rcmod ?H. ?H textMine:nsubj ?E. ?C textMine:conj ?D. ?G textMine:conj ?D. ?G textMine:conj ?C. ?G textMine:amod ?positive. ?I textMine:agent ?F. ?J textMine:num ?mutation. 
757

986 Compared to L858R alone, the L858R+E884K dual mutant was less sensitive to erlotinib in the inhibition of tyrosine phosphorylation of EGFR 
[?B textMine:nn ?mutation, ?function textMine:advmod ?impact, ?function textMine:nsubj ?B]
[?B textMine:nn ?mutation, ?function textMine:advmod ?impact, ?function textMine:nsubj ?B, ]
Match 


987 Notably, the M918T mutant protein also shows constitutively high levels of tyrosine phosphorylation especially at Y1062, the docking site that influences SSC self renewal in mice 
[?A textMine:dobj ?F, ?A textMine:nsubj ?E, ?F textMine:prep ?function, ?F textMine:amod ?impact, ?E textMine:nn ?mutation]
Query : [?A textMine:dobj ?F, ?A textMine:nsubj ?E, ?F textMine:prep ?function, ?F textMine:amod ?impact, ?E textMine:nn ?mutation]
Existing trips : 
?A textMine:dobj ?D. ?A textMine:nsubj ?B. ?B textMine:nn ?mutation. ?D textMine:amod ?impact. ?D textMine:prep ?function. 
Similar Query!!!!


988 The D816V mutant destabilizes the inactivated form of Kit, in a way that the ability of the protein to adopt the "DFG out" (inactive) conformation is much reduced or even eliminated; thus, the mutation prevents both motesanib and imatinib from binding to the ATP pocket   
[?D textMine:prep ?C, ?D textMine:nsubj ?A, ?C textMine:dep ?impact, ?A textMine:nn ?mutation, ?impact textMine:nsubjpass ?function]
Added to queryTripless!! : ?D textMine:prep ?C. ?D textMine:nsubj ?A. ?C textMine:dep ?negative. ?A textMine:nn ?mutation. ?negative textMine:nsubjpass ?function. 
758

989 The up regulation of BIM was also attenuated in a similar dose–response manner as seen in the apoptosis assay ( Figure 6 A, bottom), with L858R T790M completely abrogating the induction of BIM and L858R L747S attenuating both the up regulation of BIM and apoptosis 
[?impact textMine:dep ?mutation, ?impact textMine:prep ?C, ?C textMine:prep ?function]
Added to queryTripless!! : ?negative textMine:dep ?mutation. ?negative textMine:prep ?C. ?C textMine:prep ?function. 
759

990 It has been postulated that FGFR2 S252W  enhances cell proliferation, which would account for the higher ossification rate at the sutures   
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation]
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation, ]
Match 


991 Motesanib and imatinib have much diminished activity against the activation loop mutant (D816V) 
[?B textMine:appos ?mutation, ?F textMine:nsubj ?B, ?F textMine:dobj ?G, ?E textMine:nn ?function, ?G textMine:prep ?E, ?G textMine:amod ?impact]
[?B textMine:appos ?mutation, ?E textMine:nn ?function, ?F textMine:dobj ?G, ?F textMine:nsubj ?B, ?G textMine:amod ?impact, ?G textMine:prep ?E, ]
Match 


992 It was noted that PLX4720 also reduced pRB protein phosphorylation, increased p27 expression, suppressed cyclin D1 expression and induced cleavage of PARP only in melanoma cell lines harbouring the  BRAF  V600E mutation ( Figure 1D ) 
[?C textMine:nn ?mutation, ?D textMine:amod ?impact, ?A textMine:dobj ?C, ?E textMine:partmod ?A, ?B textMine:appos ?D, ?F textMine:prep ?E, ?F textMine:dobj ?function, ?F textMine:nsubj ?B]
Added to queryTripless!! : ?C textMine:nn ?mutation. ?D textMine:amod ?positive. ?A textMine:dobj ?C. ?E textMine:partmod ?A. ?B textMine:appos ?D. ?F textMine:prep ?E. ?F textMine:dobj ?function. ?F textMine:nsubj ?B. 
760

993 Some of these mutations alter specifically the configuration of the ATP binding kinase pocket (V654A and T670I), inhibiting imatinib binding 
[?C textMine:amod ?function, ?D textMine:prep ?B, ?impact textMine:dobj ?D, ?B textMine:appos ?C, ?B textMine:appos ?mutation]
[?B textMine:appos ?C, ?B textMine:appos ?mutation, ?C textMine:amod ?function, ?D textMine:prep ?B, ?impact textMine:dobj ?D, ]
Match 


994 On the other hand, YFP EGFR ICD proteins bearing the uncommon exon 21 mutation P848L and A859T showed markedly lower autophosphorylation levels than YFP EGFR ICD L858R (Figure  4C ) 
[?D textMine:amod ?impact, ?D textMine:nn ?function, ?C textMine:dobj ?D, ?C textMine:prep ?mutation]
Added to queryTripless!! : ?D textMine:amod ?negative. ?D textMine:nn ?function. ?C textMine:dobj ?D. ?C textMine:prep ?mutation. 
761

995 In a conclusion, our findings offer preclinical proof of principle for combined inhibition as a promising treatment strategy for NSCLC, especially for patients in whom current EGFR targeted treatments fail due to the presence of the T790M EGFR mutation or high c MET expression 
[?D textMine:nn ?mutation, ?D textMine:conj ?function, ?function textMine:amod ?impact]
[?D textMine:conj ?function, ?D textMine:nn ?mutation, ?function textMine:amod ?impact, ]
Match 


996 In summary, the BRAF V600E  inhibitor PLX4720 and the SRC inhibitor dasatinib synergize to inhibit proliferation, reduce cellular migration and induce apoptosis in a variety of BRAF V600E  positive PTC and ATC cell lines 
[?function textMine:conj ?impact, ?function textMine:conj ?E, ?E textMine:prep ?C, ?B textMine:amod ?mutation, ?C textMine:prep ?B]
Added to queryTripless!! : ?function textMine:conj ?negative. ?function textMine:conj ?E. ?E textMine:prep ?C. ?B textMine:amod ?mutation. ?C textMine:prep ?B. 
762

997 Some of these mutations alter specifically the configuration of the ATP binding kinase pocket (V654A and T670I), inhibiting imatinib binding 
[?C textMine:amod ?function, ?D textMine:prep ?B, ?impact textMine:dobj ?D, ?B textMine:appos ?C, ?B textMine:appos ?mutation]
[?B textMine:appos ?C, ?B textMine:appos ?mutation, ?C textMine:amod ?function, ?D textMine:prep ?B, ?impact textMine:dobj ?D, ]
Match 


1000 In vitro , the V617F substitution increases JAK2 kinase activity, thus causing cytokine independent growth of cell lines and cultured bone marrow cells 
[?C textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?C]
[?C textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ]
Match 


1001 Panitumumab remained active in a patient with S492R mutation, which abrogated cetuximab binding 
[?C textMine:prep ?mutation, ?E textMine:amod ?C, ?function textMine:prep ?E, ?function textMine:cop ?impact]
Added to queryTripless!! : ?C textMine:prep ?mutation. ?E textMine:amod ?C. ?function textMine:prep ?E. ?function textMine:cop ?neutral. 
763

1002 Compared to wild type BRAF, BRAF V600E  shows around 500 fold higher activity, causing sustained activation of ERK signaling ( Hingorani et al 2003 ,  Houben et al 2004 ,  Ikenoue et al 2003 ,  Ikenoue et al 2004 ,  Karasarides et al 2004 ) 
[?C textMine:dobj ?function, ?F textMine:partmod ?C, ?F textMine:amod ?impact, ?B textMine:prep ?F, ?B textMine:nsubj ?mutation]
Added to queryTripless!! : ?C textMine:dobj ?function. ?F textMine:partmod ?C. ?F textMine:amod ?positive. ?B textMine:prep ?F. ?B textMine:nsubj ?mutation. 
764

1003 The PNAcqPCR detects the  BRAF  V600E  mutation with high sensitivity 
[?function textMine:amod ?impact, ?D textMine:prep ?function, ?D textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:amod ?positive. ?D textMine:prep ?function. ?D textMine:nn ?mutation. 
765

1004 Notably, inhibition of phosphorylation of the D816V mutation was significantly reduced compared to the D816Y and D816F isoforms 
[?impact textMine:nsubjpass ?function, ?impact textMine:pobj ?B, ?B textMine:nn ?mutation]
[?B textMine:nn ?mutation, ?impact textMine:nsubjpass ?function, ?impact textMine:pobj ?B, ]
Match 


1005 Consistent with this differential signaling effect, the L858R+E884K COS 7 cells had a significantly higher cell proliferation rate than that of the L858R COS 7 cells in the MTS cell proliferation assay for 5 days ( Figure 3B ) 
[?L textMine:appos ?G, ?B textMine:prep ?C, ?D textMine:dobj ?L, ?H textMine:partmod ?D, ?C textMine:nn ?function, ?K textMine:dobj ?E, ?E textMine:amod ?impact, ?G textMine:nn ?mutation, ?A textMine:nsubj ?B, ?A textMine:dep ?K, ?A textMine:prep ?H]
[?A textMine:dep ?K, ?A textMine:nsubj ?B, ?A textMine:prep ?H, ?B textMine:prep ?C, ?C textMine:nn ?function, ?D textMine:dobj ?L, ?E textMine:amod ?impact, ?G textMine:nn ?mutation, ?H textMine:partmod ?D, ?K textMine:dobj ?E, ?L textMine:appos ?G, ]
Match 


1006 On the contrary, when F595 was replaced by an aromatic residue (Tyr or Trp) in the context of V617F, the constitutive activity was maintained 
[?D textMine:nsubjpass ?function, ?D textMine:advcl ?B, ?G textMine:prep ?A, ?A textMine:prep ?mutation, ?B textMine:agent ?G, ?function textMine:amod ?impact]
Added to queryTripless!! : ?D textMine:nsubjpass ?function. ?D textMine:advcl ?B. ?G textMine:prep ?A. ?A textMine:prep ?mutation. ?B textMine:agent ?G. ?function textMine:amod ?positive. 
766

1007 FLT3  D835V and  KIT  D816Y) retained some level of sensitivity with regard to induction of apoptosis 
[?C textMine:prep ?function, ?impact textMine:dobj ?C, ?impact textMine:nsubj ?mutation]
Query : [?C textMine:prep ?function, ?impact textMine:dobj ?C, ?impact textMine:nsubj ?mutation]
Existing trips : 
?B textMine:prep ?function. ?impact textMine:dobj ?B. ?impact textMine:nsubj ?mutation. 
Similar Query!!!!


1008 Despite the fact that we have no data concerning the frequency of BRAF V600E  in the present series of tumours, NrCAM transcript expression was significantly higher in every analysed cancer 
[?D textMine:prep ?E, ?E textMine:prep ?mutation, ?G textMine:dep ?F, ?impact textMine:nsubj ?function, ?impact textMine:prep ?G, ?F textMine:dobj ?D]
Added to queryTripless!! : ?D textMine:prep ?E. ?E textMine:prep ?mutation. ?G textMine:dep ?F. ?positive textMine:nsubj ?function. ?positive textMine:prep ?G. ?F textMine:dobj ?D. 
767

1009 The mutations F317V, Y253F, Y253H and E255K experience increased vdW interactions with residue Leu248 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?D, ?C textMine:num ?mutation, ?D textMine:amod ?F, ?F textMine:dep ?C]
[?C textMine:num ?mutation, ?D textMine:amod ?F, ?F textMine:dep ?C, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?D, ]
Match 


1010 Hence, E884K in  cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone, through differential inhibition of the pro survival AKT and STAT3 signaling pathways associated with altered induction of cleaved PARP(Asp214) 
[?function textMine:partmod ?D, ?B textMine:prep ?function, ?B textMine:nsubj ?mutation, ?D textMine:prep ?E, ?E textMine:amod ?impact]
Added to queryTripless!! : ?function textMine:partmod ?D. ?B textMine:prep ?function. ?B textMine:nsubj ?mutation. ?D textMine:prep ?E. ?E textMine:amod ?unknown. 
768

1011 Similar to E884K, R958D modulated the sensitizing effect of L858R differentially to reversible EGFR inhibitors when in  cis  (with L858R) 
[?impact textMine:prep ?D, ?impact textMine:dobj ?function, ?D textMine:prep ?mutation]
Added to queryTripless!! : ?unknown textMine:prep ?D. ?unknown textMine:dobj ?function. ?D textMine:prep ?mutation. 
769

1012 This result indicates that the secondary T790M mutation retains the active conformation of the binding site as proved by Yoshikawa et al (2013) 
[?E textMine:amod ?function, ?C textMine:prep ?E, ?impact textMine:dobj ?C, ?impact textMine:nsubj ?F, ?F textMine:nn ?mutation]
Query : [?E textMine:amod ?function, ?C textMine:prep ?E, ?impact textMine:dobj ?C, ?impact textMine:nsubj ?F, ?F textMine:nn ?mutation]
Existing trips : 
?A textMine:nn ?mutation. ?B textMine:prep ?A. ?E textMine:amod ?function. ?impact textMine:dobj ?E. ?impact textMine:nsubj ?B. 
Similar Query!!!!


1013 Increased activation of Akt1 by E17K, L52R, C77F, and Q79K mutants led, as expected, to increased phosphorylation of Akt target proteins including FOXO1/3 and PRAS40 
[?D textMine:amod ?impact, ?A textMine:prep ?D, ?A textMine:nsubj ?function, ?C textMine:prep ?B, ?function textMine:prep ?C, ?B textMine:num ?mutation]
Added to queryTripless!! : ?D textMine:amod ?positive. ?A textMine:prep ?D. ?A textMine:nsubj ?function. ?C textMine:prep ?B. ?function textMine:prep ?C. ?B textMine:num ?mutation. 
770

1014 Melanomas with  V600E   BRAF  mutations frequently accumulate nuclear β catenin and, interestingly, GSK3A and GSK3B were recently shown to be negatively regulated by  V600E Braf/Mek/Erk signalling in a phosphoproteomic screen of human melanoma cells following MEK inhibition (Old et al, ) 
[?function textMine:agent ?B, ?function textMine:advmod ?impact, ?B textMine:nn ?mutation]
Query : [?function textMine:agent ?B, ?function textMine:advmod ?impact, ?B textMine:nn ?mutation]
Existing trips : 
?C textMine:nn ?mutation. ?function textMine:advmod ?impact. ?function textMine:agent ?C. 
Similar Query!!!!


1015 However, Yun et al (2008) showed that both the single T790M mutant and the double mutant L858R/T790M maintain the same low nanomolar affinity for gefitinib as the L858R mutant 
[?impact textMine:dobj ?function, ?impact textMine:prep ?mutation]
[?impact textMine:dobj ?function, ?impact textMine:prep ?mutation, ]
Match 


1016 The up regulation of BIM was also attenuated in a similar dose–response manner as seen in the apoptosis assay ( Figure 6 A, bottom), with L858R T790M completely abrogating the induction of BIM and L858R L747S attenuating both the up regulation of BIM and apoptosis 
[?impact textMine:prep ?D, ?E textMine:nsubj ?mutation, ?C textMine:prepc ?E, ?C textMine:conj ?impact, ?D textMine:prep ?function]
Added to queryTripless!! : ?negative textMine:prep ?D. ?E textMine:nsubj ?mutation. ?C textMine:prepc ?E. ?C textMine:conj ?negative. ?D textMine:prep ?function. 
771

1017 Intriguingly, the imatinib resistant BCR/ABL mutants E255K and T315I showed increased ability as compared with native BCR/ABL to induce tyrosine phosphorylation of PECAM 1 when expressed in the murine model hematopoietic cell line BaF3 cells or in 293T cells ( Fig 4 ) 
[?D textMine:infmod ?function, ?D textMine:amod ?impact, ?A textMine:dobj ?D, ?A textMine:nsubj ?mutation]
[?A textMine:dobj ?D, ?A textMine:nsubj ?mutation, ?D textMine:amod ?impact, ?D textMine:infmod ?function, ]
Match 


1018 Somatic mutations of the EGFR gene, most commonly L858R (exon 21) and short in frame exon 19 deletions, have been found to confer enhanced sensitivity towards the inhibitors gefitinib and erlotinib 
[?function textMine:amod ?impact, ?D textMine:amod ?mutation, ?B textMine:xsubj ?D, ?B textMine:dobj ?function]
Added to queryTripless!! : ?function textMine:amod ?positive. ?D textMine:amod ?mutation. ?B textMine:xsubj ?D. ?B textMine:dobj ?function. 
772

1019 Among the exon 20 mutations tested, Ins770SVD showed an intermediate level of autophosphorylation, lower than S768I, but higher than T790M (Figure  4B ) 
[?A textMine:amod ?impact, ?A textMine:prep ?function, ?E textMine:prep ?mutation, ?E textMine:dobj ?A]
Added to queryTripless!! : ?A textMine:amod ?positive. ?A textMine:prep ?function. ?E textMine:prep ?mutation. ?E textMine:dobj ?A. 
773

1020 Furthermore, the nuclear activation of YAP1 was maintained in 8505C and K1 cells, and resistant to RAF, BRAF V600E  and MEK inhibitors 
[?impact textMine:prep ?A, ?impact textMine:nsubjpass ?function, ?A textMine:amod ?C, ?C textMine:prep ?mutation]
Added to queryTripless!! : ?neutral textMine:prep ?A. ?neutral textMine:nsubjpass ?function. ?A textMine:amod ?C. ?C textMine:prep ?mutation. 
774

1021 Here, we present evidence that BRAF V600E  enhances migration and invasion properties in colon carcinoma cells through RhoA activation, while KRAS G12V  induces these properties less efficiently as compared to BRAF V600E , albeit through Cdc42 activation and filopodia formation 
[?impact textMine:advcl ?function, ?function textMine:pobj ?mutation]
Added to queryTripless!! : ?positive textMine:advcl ?function. ?function textMine:pobj ?mutation. 
775

1022 Mutations to this protein such as G469A, E586K, V600E, and K601E can increase BRAF catalytic activity  
[?C textMine:prep ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?D, ?D textMine:prep ?C]
[?C textMine:prep ?mutation, ?D textMine:prep ?C, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?D, ]
Match 


1023 Increased activation of Akt1 by E17K, L52R, C77F, and Q79K mutants led, as expected, to increased phosphorylation of Akt target proteins including FOXO1/3 and PRAS40 
[?G textMine:nn ?mutation, ?D textMine:amod ?impact, ?A textMine:prep ?D, ?A textMine:nsubj ?function, ?B textMine:prep ?G, ?function textMine:prep ?B]
Added to queryTripless!! : ?G textMine:nn ?mutation. ?D textMine:amod ?positive. ?A textMine:prep ?D. ?A textMine:nsubj ?function. ?B textMine:prep ?G. ?function textMine:prep ?B. 
776

1024 Later, Nehs et al [ 78 ] elegantly demonstrated the remarkable efficacy of PLX4720 compound, which is an ATP analog that selectively inhibits B Raf V600E  by stabilizing it in an inactive conformation [ 79 ], to induce significant regression in an orthotopic mouse model of ATC even when administered at a very late therapeutic intervention stage 
[?A textMine:prepc ?function, ?A textMine:dobj ?mutation]
Added to queryTripless!! : ?A textMine:prepc ?function. ?A textMine:dobj ?mutation. 
777

1025 Moreover, high expression of the glucose transporter type 1 gene supports the use of PET with specific tracers in the clinical management of such cancers, and BRAF V600E point mutations may lead to less differentiated phenotypes and lower expression of NIS, suggesting a worse prognosis [ 15 ] 
[?E textMine:prep ?function, ?E textMine:nsubj ?B, ?function textMine:amod ?impact, ?B textMine:nn ?mutation]
[?B textMine:nn ?mutation, ?E textMine:nsubj ?B, ?E textMine:prep ?function, ?function textMine:amod ?impact, ]
Match 


1026 It is also possible that binding of the drug to one p61B RAF V600E  monomer inhibits drug binding to the other, resulting in one active monomer per dimer and abolishing drug resistance 
[?C textMine:prep ?D, ?D textMine:prep ?A, ?A textMine:nn ?mutation, ?function textMine:ccomp ?impact, ?function textMine:nsubj ?C]
Added to queryTripless!! : ?C textMine:prep ?D. ?D textMine:prep ?A. ?A textMine:nn ?mutation. ?function textMine:ccomp ?negative. ?function textMine:nsubj ?C. 
778

1027 We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated (native) BCR/ABL ( 15 – 17 ) 
[?G textMine:prep ?function, ?B textMine:dobj ?G, ?A textMine:infmod ?B, ?A textMine:amod ?impact, ?H textMine:nn ?mutation, ?E textMine:dobj ?A, ?E textMine:nsubj ?H]
[?A textMine:amod ?impact, ?A textMine:infmod ?B, ?B textMine:dobj ?G, ?E textMine:dobj ?A, ?E textMine:nsubj ?H, ?G textMine:prep ?function, ?H textMine:nn ?mutation, ]
Match 


1028 It is possible that the elevated expression of KRAS V12  coupled with Braf V600E  induces senescence at an early stage in tumor development precluding detection 
[?E textMine:prep ?mutation, ?B textMine:partmod ?E, ?function textMine:prep ?B, ?function textMine:amod ?impact]
Added to queryTripless!! : ?E textMine:prep ?mutation. ?B textMine:partmod ?E. ?function textMine:prep ?B. ?function textMine:amod ?positive. 
779

1029 For example,  hsf1  knockout dramatically delayed overall development of various tumors and increased survival of  p53  knock in mutant (R172H) mice ( 1 ) 
[?D textMine:prep ?E, ?function textMine:prep ?D, ?function textMine:amod ?impact, ?E textMine:appos ?mutation]
Added to queryTripless!! : ?D textMine:prep ?E. ?function textMine:prep ?D. ?function textMine:amod ?positive. ?E textMine:appos ?mutation. 
780

1030 LGX818 treatment at oral doses as low as 6 mg/kg in human melanoma xenograft models (BRAF V600E ) resulted in strong and sustained (>24 hours) decrease in pMEK   
[?B textMine:prep ?A, ?function textMine:prep ?impact, ?function textMine:nsubj ?E, ?A textMine:appos ?mutation, ?E textMine:prep ?B]
Added to queryTripless!! : ?B textMine:prep ?A. ?function textMine:prep ?negative. ?function textMine:nsubj ?E. ?A textMine:appos ?mutation. ?E textMine:prep ?B. 
781

1031 JAK2 K539L, T875N and R683G were shown to exhibit constitutive STAT5 activation and to transform Ba/F3 cells expressing the EpoR to cytokine independence     
[?D textMine:dobj ?function, ?E textMine:ccomp ?D, ?E textMine:nsubjpass ?mutation, ?function textMine:amod ?impact]
[?D textMine:dobj ?function, ?E textMine:ccomp ?D, ?E textMine:nsubjpass ?mutation, ?function textMine:amod ?impact, ]
Match 


1032 BRAF V600E mutation leads to constitutive activation of the MEK/ERK pathway, promoting cancer cell survival and proliferation   
[?impact textMine:dobj ?function, ?impact textMine:xsubj ?A, ?A textMine:nn ?mutation]
[?A textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:xsubj ?A, ]
Match 


1033 In an  in vitro  study, these two types of EGFR mutants demonstrated an enhanced TK activity in response to EGF and increased sensitivity to inhibition by TKI, although the biological activity between tumours with L858R and those with deletions was different ( Paez  et al , 2004 ;  Pao  et al , 2004 ) 
[?G textMine:prep ?mutation, ?function textMine:prep ?G, ?E textMine:nsubj ?function, ?F textMine:amod ?impact, ?B textMine:advcl ?E, ?B textMine:xsubj ?D, ?I textMine:conj ?J, ?I textMine:dobj ?F, ?I textMine:nsubj ?D, ?J textMine:xcomp ?B, ?J textMine:nsubj ?D]
Added to queryTripless!! : ?G textMine:prep ?mutation. ?function textMine:prep ?G. ?E textMine:nsubj ?function. ?F textMine:amod ?positive. ?B textMine:advcl ?E. ?B textMine:xsubj ?D. ?I textMine:conj ?J. ?I textMine:dobj ?F. ?I textMine:nsubj ?D. ?J textMine:xcomp ?B. ?J textMine:nsubj ?D. 
782

1065 An accumulation of alternative mutations, including a T790M insensitive mutation, in addition to the primary activating mutation could modulate the sensitivity to EGFR TKI 
[?A textMine:amod ?function, ?G textMine:prep ?A, ?G textMine:prep ?F, ?impact textMine:nsubj ?G, ?F textMine:conj ?A, ?F textMine:prep ?C, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?A textMine:amod ?function. ?G textMine:prep ?A. ?G textMine:prep ?F. ?unknown textMine:nsubj ?G. ?F textMine:conj ?A. ?F textMine:prep ?C. ?C textMine:nn ?mutation. 
783

1034 This latter type of resistance mechanism is highly reminiscent of that previously described for resistance of EGFR to gefitinib (Iressa) and erlotinib (Tarceva) in NSCLC patients as a result of the T790M secondary mutation in EGFR (Yun et al, ) and by analogy, all ALK inhibitors with an ATP competitive binding mechanism may be destined to display decreased inhibitory activity when the F1174L mutation appears 
[?D textMine:prep ?B, ?E textMine:xcomp ?I, ?E textMine:csubjpass ?C, ?A textMine:prep ?D, ?B textMine:prep ?F, ?function textMine:amod ?impact, ?C textMine:prep ?A, ?F textMine:amod ?mutation, ?I textMine:dobj ?function]
Added to queryTripless!! : ?D textMine:prep ?B. ?E textMine:xcomp ?I. ?E textMine:csubjpass ?C. ?A textMine:prep ?D. ?B textMine:prep ?F. ?function textMine:amod ?negative. ?C textMine:prep ?A. ?F textMine:amod ?mutation. ?I textMine:dobj ?function. 
784

1035 The most common BRAF mutation is a substitution of valine with glutamic acid at amino acid position 600 (V600E), which locks BRAF into its active conformation, resulting in a ten fold increase in activity over wild type BRAF  
[?B textMine:partmod ?D, ?mutation textMine:rcmod ?B, ?D textMine:prep ?function, ?D textMine:prep ?impact]
Added to queryTripless!! : ?B textMine:partmod ?D. ?mutation textMine:rcmod ?B. ?D textMine:prep ?function. ?D textMine:prep ?positive. 
785

1036 Regarding BCR ABL kinase mutations, the multi resistant T315I one remains a crucial clinical challenge, since until recently, there is no effective treatment for the patients carrying this particular type of mutation 
[?G textMine:dep ?B, ?A textMine:dep ?mutation, ?E textMine:amod ?function, ?D textMine:amod ?A, ?impact textMine:nsubj ?G, ?impact textMine:prep ?I, ?B textMine:nsubj ?E, ?I textMine:appos ?D]
Added to queryTripless!! : ?G textMine:dep ?B. ?A textMine:dep ?mutation. ?E textMine:amod ?function. ?D textMine:amod ?A. ?neutral textMine:nsubj ?G. ?neutral textMine:prep ?I. ?B textMine:nsubj ?E. ?I textMine:appos ?D. 
786

1037 S768I : S768I is a frequently occurring mutation ( Table 1 ) in the C helix of EGFR that increases basal kinase activity  
[?A textMine:rcmod ?impact, ?E textMine:prep ?A, ?E textMine:nsubj ?mutation, ?impact textMine:dobj ?function]
Added to queryTripless!! : ?A textMine:rcmod ?positive. ?E textMine:prep ?A. ?E textMine:nsubj ?mutation. ?positive textMine:dobj ?function. 
787

1038 Of relevance, BRAF V600E  oncoprotein elicits elevated kinase activity that leads to activation of the MAPK (ie 
[?function textMine:xsubj ?C, ?impact textMine:dobj ?C, ?impact textMine:nsubj ?A, ?A textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:xsubj ?C. ?positive textMine:dobj ?C. ?positive textMine:nsubj ?A. ?A textMine:nn ?mutation. 
788

1039 E884K EGFR modulates inhibitor sensitivity effects in an inhibitor specific fashion
[?impact textMine:dobj ?D, ?impact textMine:nsubj ?B, ?D textMine:nn ?function, ?B textMine:nn ?mutation]
[?B textMine:nn ?mutation, ?D textMine:nn ?function, ?impact textMine:dobj ?D, ?impact textMine:nsubj ?B, ]
Match 


1040 In this study, a high sensitivity DHPLC based method, as well as conventional direct sequencing, were performed to screen deletions in exon 19 and L858R mutation in exon 21 of the  EGFR  gene in 127 Chinese ESCC patients, respectively 
[?D textMine:ccomp ?H, ?D textMine:nsubj ?G, ?I textMine:prep ?C, ?A textMine:dep ?mutation, ?C textMine:amod ?A, ?G textMine:nn ?function, ?G textMine:amod ?impact, ?H textMine:xcomp ?I]
Added to queryTripless!! : ?D textMine:ccomp ?H. ?D textMine:nsubj ?G. ?I textMine:prep ?C. ?A textMine:dep ?mutation. ?C textMine:amod ?A. ?G textMine:nn ?function. ?G textMine:amod ?positive. ?H textMine:xcomp ?I. 
789

1041 E884K EGFR modulates inhibitor sensitivity effects in an inhibitor specific fashion
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:nn ?mutation]
Query : [?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:nn ?mutation]
Existing trips : 
?C textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?C. 
Similar Query!!!!


1042 Time activity studies showed that the treatment of PC12/MEN2A cells at 200 nM for 1 h was sufficient to significantly inhibit RET C634Y  autophosphorylation and to drastically reduce ERK phosphorylation ( Figure 3 B, right panel) 
[?C textMine:conj ?impact, ?C textMine:xcomp ?A, ?A textMine:nsubj ?mutation, ?impact textMine:dobj ?function]
Added to queryTripless!! : ?C textMine:conj ?negative. ?C textMine:xcomp ?A. ?A textMine:nsubj ?mutation. ?negative textMine:dobj ?function. 
790

1043 As expected, BRAF V600E  inhibited MST1 induced 3XIRS reporter activation in a dose dependent manner and MST1 abolished the inhibitory effect of BRAF V600E  on FoxO3 transactivation ( Fig 3B & 3C ) 
[?impact textMine:dobj ?D, ?D textMine:prep ?mutation, ?function textMine:ccomp ?impact]
Added to queryTripless!! : ?negative textMine:dobj ?D. ?D textMine:prep ?mutation. ?function textMine:ccomp ?negative. 
791

1044 The mutations Y253F, E255V and H396P experience decreased vdW interactions with Phe382 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:amod ?D, ?F textMine:num ?mutation, ?D textMine:dep ?F]
Query : [?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:amod ?D, ?F textMine:num ?mutation, ?D textMine:dep ?F]
Existing trips : 
?C textMine:num ?mutation. ?D textMine:amod ?F. ?F textMine:dep ?C. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?D. 
Similar Query!!!!


1045 BRAF V600E , which accounts for more than 90% of BRAF mutations, leads to constitutive activation of downstream signaling via the MAPK cascade, a pathway that is critical in cell cycle regulation and proliferation  
[?impact textMine:xsubj ?mutation, ?impact textMine:dobj ?function]
[?impact textMine:dobj ?function, ?impact textMine:xsubj ?mutation, ]
Match 


1046 EGFR mutation positive NSCLCs which also test positive for mutations associated with primary or, most frequently, secondary resistance to first generation TKIs (first of all the T790M substitution) may respond better to newer agents like afatinib, and dacomitinib, which have demonstrated a greater effectiveness in these clinical situations, but more clinical data are required      
[?C textMine:prep ?D, ?H textMine:dobj ?function, ?I textMine:dep ?C, ?A textMine:dep ?I, ?A textMine:rcmod ?H, ?J textMine:prep ?B, ?function textMine:amod ?impact, ?B textMine:amod ?mutation, ?D textMine:dep ?J]
Added to queryTripless!! : ?C textMine:prep ?D. ?H textMine:dobj ?function. ?I textMine:dep ?C. ?A textMine:dep ?I. ?A textMine:rcmod ?H. ?J textMine:prep ?B. ?function textMine:amod ?positive. ?B textMine:amod ?mutation. ?D textMine:dep ?J. 
792

1047 Immunoblotting for phospho AKT was performed after successful transfection and weaning of IL3 dependent growth (true autoactivating TK mutations result in IL3 independent growth) and found that AKT activation increases after transfection of plasmid vectors encoding for a  FLT3  ITD,  FLT3  D835V,  KIT  D816Y or  BCR ABL1  isoform 
[?F textMine:partmod ?C, ?C textMine:prep ?mutation, ?D textMine:prep ?F, ?impact textMine:nsubj ?function, ?impact textMine:prep ?D]
Query : [?F textMine:partmod ?C, ?C textMine:prep ?mutation, ?D textMine:prep ?F, ?impact textMine:nsubj ?function, ?impact textMine:prep ?D]
Existing trips : 
?B textMine:prep ?mutation. ?C textMine:prep ?F. ?F textMine:partmod ?B. ?impact textMine:nsubj ?function. ?impact textMine:prep ?C. 
Similar Query!!!!


1048 Furthermore, transfection of another activated mutant L858R EGFR cDNA also induced enhanced expression ( Figure 7C ) and restored drug sensitivity to erlotinib in 11–18/ER1 7 cells ( Figure 7D ) 
[?impact textMine:nsubj ?B, ?E textMine:nn ?mutation, ?E textMine:amod ?function, ?B textMine:prep ?E]
Added to queryTripless!! : ?positive textMine:nsubj ?B. ?E textMine:nn ?mutation. ?E textMine:amod ?function. ?B textMine:prep ?E. 
793

1049 Notably, melanomas that have the V600E  BRAF  mutation exhibit increased HIF 1α expression 
[?F textMine:dobj ?D, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:rcmod ?F, ?D textMine:nn ?mutation]
[?B textMine:rcmod ?F, ?D textMine:nn ?mutation, ?F textMine:dobj ?D, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ]
Match 


1050 Figure 1A  shows that both catalytic mutations rescued the temperature sensitivity of the  gcn5 Δ  sas3  mutant, with  isw1 K227R  having the stronger effect 
[?C textMine:dobj ?function, ?function textMine:amod ?impact, ?mutation textMine:partmod ?C]
Added to queryTripless!! : ?C textMine:dobj ?function. ?function textMine:amod ?positive. ?mutation textMine:partmod ?C. 
794

1051 The results show that only BRAF carrying the L505H amino acid substitution significantly increased resistance to PLX4032 [IC 50  from 0.18 to 4.58  μ M for YUMAC (P value < 0.0001) and 0.1 to 1 0  μ M for YUGEN8 (P value < 00001)] and activated the MAPK cascade (Figure  3 C–E,  Figure S4 ) 
[?E textMine:dobj ?F, ?A textMine:partmod ?E, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?A, ?F textMine:amod ?mutation]
Query : [?E textMine:dobj ?F, ?A textMine:partmod ?E, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?A, ?F textMine:amod ?mutation]
Existing trips : 
?B textMine:amod ?mutation. ?D textMine:partmod ?F. ?F textMine:dobj ?B. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?D. 
Similar Query!!!!


1052 Hence, the double mutation L858R+E884K modulated basal and stimulated downstream EGFR signaling differentially with differential effects on the AKT (down regulated), CBL and MAPK ERK1/2 phosphorylation (up regulated) 
[?A textMine:appos ?function, ?impact textMine:xcomp ?B, ?impact textMine:nsubj ?mutation, ?B textMine:prep ?A]
[?A textMine:appos ?function, ?B textMine:prep ?A, ?impact textMine:nsubj ?mutation, ?impact textMine:xcomp ?B, ]
Match 


1053 The activity of DAS is maintained despite the presence of mutations that confer resistance to IM with the exception of the T315I mutation, and to a large degree, mutations affecting the residue 317 (F317L, F317V) 
[?A textMine:dobj ?function, ?impact textMine:prep ?E, ?E textMine:prep ?F, ?F textMine:appos ?C, ?F textMine:rcmod ?A, ?C textMine:dep ?mutation]
[?A textMine:dobj ?function, ?C textMine:dep ?mutation, ?E textMine:prep ?F, ?F textMine:appos ?C, ?F textMine:rcmod ?A, ?impact textMine:prep ?E, ]
Match 


1054 Overexpression of the  JAK2  V617F mutant but not the wild type  JAK2  in K562 cells also resulted in increased  SPI1  expression 
[?C textMine:prep ?E, ?F textMine:prep ?function, ?F textMine:nsubj ?C, ?function textMine:amod ?impact, ?E textMine:nn ?mutation]
Added to queryTripless!! : ?C textMine:prep ?E. ?F textMine:prep ?function. ?F textMine:nsubj ?C. ?function textMine:amod ?positive. ?E textMine:nn ?mutation. 
795

1055 The results of this system evaluation suggest that in III IV NSCLC patients with EGFR mutations, patients with the exon 19 deletion have a better response rate, and a significantly longer progression free survival and overall survival than patients with the L858R mutation 
[?C textMine:dep ?function, ?C textMine:dep ?G, ?C textMine:amod ?impact, ?A textMine:prep ?F, ?G textMine:prep ?A, ?G textMine:conj ?function, ?F textMine:nn ?mutation]
Added to queryTripless!! : ?C textMine:dep ?function. ?C textMine:dep ?G. ?C textMine:amod ?positive. ?A textMine:prep ?F. ?G textMine:prep ?A. ?G textMine:conj ?function. ?F textMine:nn ?mutation. 
796

1056 We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated (native) BCR/ABL ( 15 – 17 ) 
[?D textMine:dobj ?A, ?D textMine:nsubj ?G, ?A textMine:infmod ?B, ?A textMine:amod ?impact, ?G textMine:nn ?mutation, ?B textMine:dobj ?function]
[?A textMine:amod ?impact, ?A textMine:infmod ?B, ?B textMine:dobj ?function, ?D textMine:dobj ?A, ?D textMine:nsubj ?G, ?G textMine:nn ?mutation, ]
Match 


1057 These NB tumors expressed reduced levels of CD44, but increased levels of Ncam1, compared to undifferentiated tumors derived either from MONC 1 or MONC 1 ALK F1174L cells (Figure  1C ,,) 
[?C textMine:pobj ?A, ?D textMine:prep ?F, ?impact textMine:dobj ?H, ?function textMine:conj ?impact, ?A textMine:partmod ?D, ?H textMine:prep ?C, ?F textMine:dep ?B, ?B textMine:nn ?mutation]
Added to queryTripless!! : ?C textMine:pobj ?A. ?D textMine:prep ?F. ?positive textMine:dobj ?H. ?function textMine:conj ?positive. ?A textMine:partmod ?D. ?H textMine:prep ?C. ?F textMine:dep ?B. ?B textMine:nn ?mutation. 
797

1058 The effect on the downstream signal mediators p AKT [S473] and p STAT3 [Y705] correlated well with the inhibition of EGFR phosphorylation ( Figure 1A ); E884K in  cis  with L858R decreased erlotinib inhibition of AKT and STAT3 phosphorylation but increased inhibition by gefitinib 
[?D textMine:prep ?C, ?impact textMine:conj ?F, ?impact textMine:nsubj ?D, ?C textMine:prep ?mutation, ?F textMine:dobj ?function, ?F textMine:nsubj ?D]
Added to queryTripless!! : ?D textMine:prep ?C. ?negative textMine:conj ?F. ?negative textMine:nsubj ?D. ?C textMine:prep ?mutation. ?F textMine:dobj ?function. ?F textMine:nsubj ?D. 
798

1059 At a later time point in pancreas development, S33Y mutant β cat expression enhanced islet cell proliferation and increased the size of pancreas [ 49 ] 
[?impact textMine:nsubj ?function, ?function textMine:num ?mutation]
[?function textMine:num ?mutation, ?impact textMine:nsubj ?function, ]
Match 


1060 Here we provide the first evidence that  V600E BRAF causes the upregulation of genes involved in glycolysis, whereas knock down of  V600E BRAF in melanoma cells conversely reduces the expression of these genes, lowers the rate of glycolysis and causes the reversal of the Warburg phenotype 
[?D textMine:nn ?mutation, ?C textMine:prep ?D, ?impact textMine:csubj ?C, ?impact textMine:dobj ?function]
Added to queryTripless!! : ?D textMine:nn ?mutation. ?C textMine:prep ?D. ?negative textMine:csubj ?C. ?negative textMine:dobj ?function. 
799

1061 Among the 30  BRAF  V600E positive tumors detected with ARMS PCR assay, direct sequencing identified the mutation in 27 tumors, but failed to identify 3 tumors that had  BRAF  V600E mutation, possibly due to the lower sensitivity of detection of automated dideoxy sequencing 
[?function textMine:amod ?impact, ?B textMine:prep ?function, ?B textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:amod ?negative. ?B textMine:prep ?function. ?B textMine:nn ?mutation. 
800

1062 Compared to wild type EGFR, the ectodomain mutant A289V EGFR showed a marked increase in receptor autophosphorylation in the absence of ligand or serum 
[?E textMine:nn ?mutation, ?C textMine:prep ?function, ?C textMine:dobj ?impact, ?C textMine:nsubj ?E]
Added to queryTripless!! : ?E textMine:nn ?mutation. ?C textMine:prep ?function. ?C textMine:dobj ?positive. ?C textMine:nsubj ?E. 
801

1063 In the two cell lines with wt EGFR (H460 and A549), we found positive (score 3) expression of EGFR (D38B1) protein (100%) and negative (score 0) expression of EGFR E746 A750 deletion specific (6B6) and EGFR L858R mutant specific (43B2) 
[?A textMine:nn ?mutation, ?function textMine:amod ?impact, ?function textMine:prep ?A]
[?A textMine:nn ?mutation, ?function textMine:amod ?impact, ?function textMine:prep ?A, ]
Match 


1064 In colorectal cancer patients, a mutation in the extracellular domain of EGFR (S492R), which abrogates cetuximab binding but retains panitumumab sensitivity, has been recently described as a mechanism of acquired resistance   (Fig  2c ) 
[?C textMine:appos ?mutation, ?D textMine:prep ?B, ?D textMine:rcmod ?impact, ?G textMine:amod ?function, ?impact textMine:dobj ?G, ?B textMine:prep ?C]
Added to queryTripless!! : ?C textMine:appos ?mutation. ?D textMine:prep ?B. ?D textMine:rcmod ?negative. ?G textMine:amod ?function. ?negative textMine:dobj ?G. ?B textMine:prep ?C. 
802

1066 Ganetespib effectively targets the upstream regulator JAK2, including the constitutively active JAK2 V617F  mutant, for degradation in a range of hematological and solid tumor types with subsequent prolonged loss of STAT3 and STAT5 signaling 
[?A textMine:nn ?mutation, ?A textMine:amod ?function, ?function textMine:advmod ?impact]
Added to queryTripless!! : ?A textMine:nn ?mutation. ?A textMine:amod ?function. ?function textMine:advmod ?positive. 
803

1067 Some of these mutations alter specifically the configuration of the ATP binding kinase pocket (V654A and T670I), inhibiting imatinib binding 
[?C textMine:amod ?function, ?D textMine:prep ?B, ?impact textMine:dobj ?D, ?B textMine:appos ?C, ?B textMine:appos ?mutation]
[?B textMine:appos ?C, ?B textMine:appos ?mutation, ?C textMine:amod ?function, ?D textMine:prep ?B, ?impact textMine:dobj ?D, ]
Match 


1068 Several resistance mechanisms, such as EGFR T790M secondary mutation that leads to a higher ATP binding capacity, and MET amplification resulting in an aberrantly activated alternative pathway that bypasses the inhibited EGF receptors, had been discovered 
[?F textMine:prep ?H, ?F textMine:prep ?I, ?I textMine:conj ?H, ?I textMine:amod ?impact, ?E textMine:rcmod ?F, ?E textMine:nn ?mutation, ?G textMine:prep ?A, ?H textMine:partmod ?G, ?A textMine:amod ?function]
Added to queryTripless!! : ?F textMine:prep ?H. ?F textMine:prep ?I. ?I textMine:conj ?H. ?I textMine:amod ?positive. ?E textMine:rcmod ?F. ?E textMine:nn ?mutation. ?G textMine:prep ?A. ?H textMine:partmod ?G. ?A textMine:amod ?function. 
804

1069 Therefore,  BRAF  V600E increases the kinase activity that provides cancer cells with both proliferation and survival signals and promotes them to become tumors in the model system 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation]
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation, ]
Match 


1070 The specific type of mutation may hold predictive relevance in that some mutations confer higher affinity for certain EGFR TKIs and some confer resistance to certain EGFR TKIs, for example, mutations in exon 20 and the T790M mutation 
[?D textMine:prep ?function, ?D textMine:amod ?impact, ?A textMine:dobj ?D, ?A textMine:prep ?F, ?F textMine:amod ?mutation]
Added to queryTripless!! : ?D textMine:prep ?function. ?D textMine:amod ?positive. ?A textMine:dobj ?D. ?A textMine:prep ?F. ?F textMine:amod ?mutation. 
805

1071 As expected, we found that the combination of both reduced ATP and V600E BRAF levels caused activation of AMPK as seen from increased phosphorylation at Thr172 of the alpha subunit of AMPK in doxycycline treated samples (Figure  6F ) 
[?G textMine:advcl ?B, ?G textMine:nsubj ?E, ?C textMine:prep ?function, ?D textMine:nn ?mutation, ?E textMine:prep ?D, ?function textMine:amod ?impact, ?B textMine:csubj ?C]
Added to queryTripless!! : ?G textMine:advcl ?B. ?G textMine:nsubj ?E. ?C textMine:prep ?function. ?D textMine:nn ?mutation. ?E textMine:prep ?D. ?function textMine:amod ?positive. ?B textMine:csubj ?C. 
806

1072 Tyrosine phosphorylation of PECAM 1 is enhanced by the E255K or T315I imatinib resistant mutation in BCR/ABL
[?A textMine:num ?mutation, ?impact textMine:agent ?C, ?impact textMine:nsubjpass ?function, ?F textMine:npadvmod ?A, ?C textMine:amod ?F]
Added to queryTripless!! : ?A textMine:num ?mutation. ?positive textMine:agent ?C. ?positive textMine:nsubjpass ?function. ?F textMine:npadvmod ?A. ?C textMine:amod ?F. 
807

1073 According to the Ki67 positive cells,  BRaf  V600E  expression increased lung cell proliferation index from 33.51% ±2.389% (n = 8 20X fields from 3 different mice) in 10 days old WT to 42.56% ±2 861% (n = 11 20X fields from 3 different mice) in age matched  Braf  CA  mice (each 20X field quantified contained between 2500–5000 nucleus;  P  = 00345;  Figure 1E ) 
[?C textMine:nn ?mutation, ?impact textMine:dobj ?A, ?impact textMine:nsubj ?C, ?A textMine:nn ?function]
Query : [?C textMine:nn ?mutation, ?impact textMine:dobj ?A, ?impact textMine:nsubj ?C, ?A textMine:nn ?function]
Existing trips : 
?B textMine:nn ?mutation. ?D textMine:nn ?function. ?impact textMine:dobj ?D. ?impact textMine:nsubj ?B. 
Similar Query!!!!


1074 The T315I mutation experiences increased (−4.11 kcal/mol) and T315A mutation experiences decreased electrostatic interactions (−2 05 kcal/mol), and the mutation G250E contributes increased electrostatic interaction (−032 kcal/mol) while binding to ponatinib 
[?D textMine:dobj ?F, ?B textMine:nn ?mutation, ?G textMine:conj ?D, ?G textMine:conj ?impact, ?impact textMine:nsubj ?B, ?F textMine:amod ?function]
Added to queryTripless!! : ?D textMine:dobj ?F. ?B textMine:nn ?mutation. ?G textMine:conj ?D. ?G textMine:conj ?negative. ?negative textMine:nsubj ?B. ?F textMine:amod ?function. 
808

1075 Hence, E884K in  cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone, through differential inhibition of the pro survival AKT and STAT3 signaling pathways associated with altered induction of cleaved PARP(Asp214) 
[?function textMine:partmod ?D, ?B textMine:prep ?function, ?B textMine:pobj ?mutation, ?D textMine:prep ?E, ?E textMine:amod ?impact]
Added to queryTripless!! : ?function textMine:partmod ?D. ?B textMine:prep ?function. ?B textMine:pobj ?mutation. ?D textMine:prep ?E. ?E textMine:amod ?unknown. 
809

1076 Expression of BRAF V600E  in BRAF mutant naïve cells resulted in increased expression and activation of Usp5, suggesting that pathway activation or phospho regulation underlie Usp5 activation 
[?function textMine:amod ?impact, ?C textMine:prep ?mutation, ?A textMine:prep ?function, ?A textMine:nsubj ?C]
Added to queryTripless!! : ?function textMine:amod ?positive. ?C textMine:prep ?mutation. ?A textMine:prep ?function. ?A textMine:nsubj ?C. 
810

1077 The V600E mutant expresses a 10 fold increased kinase activity compared to the wild type BRAF   
[?D textMine:ccomp ?A, ?D textMine:nsubj ?B, ?B textMine:nn ?mutation, ?A textMine:dobj ?function, ?function textMine:amod ?impact]
Added to queryTripless!! : ?D textMine:ccomp ?A. ?D textMine:nsubj ?B. ?B textMine:nn ?mutation. ?A textMine:dobj ?function. ?function textMine:amod ?positive. 
811

1078 Consistent with published data  , PLX4032 abolished the ERK1/2 activating phosphorylation in BRAF V600E/K  melanoma cells ( Figure 2 , pERK, YULAC, YURIF, YUMAC and YUGEN8) 
[?impact textMine:dobj ?D, ?D textMine:prep ?E, ?D textMine:amod ?function, ?E textMine:nn ?mutation]
[?D textMine:amod ?function, ?D textMine:prep ?E, ?E textMine:nn ?mutation, ?impact textMine:dobj ?D, ]
Match 


1079 Comparing the efficiency between PNAcqPCR and DS for the detection of the  BRAF  V600E  mutation, the sensitivity and accuracy of PNAcqPCR method were both higher than those of DS 
[?E textMine:prep ?D, ?impact textMine:nsubj ?function, ?impact textMine:partmod ?E, ?D textMine:prep ?B, ?B textMine:nn ?mutation]
Added to queryTripless!! : ?E textMine:prep ?D. ?positive textMine:nsubj ?function. ?positive textMine:partmod ?E. ?D textMine:prep ?B. ?B textMine:nn ?mutation. 
812

1081 The data suggest that low BRCA1 level may neutralize the negative effects of the EGFR T790M mutation on erlotinib sensitivity and that high BRCA1 expression may lead to de novo EGFR TKI resistance potentially through increased DNA damage repair capacity   
[?A textMine:nn ?mutation, ?function textMine:prep ?A, ?impact textMine:dobj ?function]
Query : [?A textMine:nn ?mutation, ?function textMine:prep ?A, ?impact textMine:dobj ?function]
Existing trips : 
?D textMine:nn ?mutation. ?function textMine:prep ?D. ?impact textMine:dobj ?function. 
Similar Query!!!!


1082 The mutations Y253F, E255V and H396P experience decreased vdW interactions with Phe382 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ?B textMine:amod ?E, ?E textMine:dep ?mutation]
[?B textMine:amod ?E, ?E textMine:dep ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?B, ]
Match 


1083 We note that M918T also has increased activity toward exogenous substrates and is itself phosphorylated to a greater degree by exogenous kinases such as FAK ( Figure S7 ) 
[?A textMine:prep ?function, ?A textMine:amod ?impact, ?E textMine:dobj ?A, ?E textMine:nsubj ?mutation]
Query : [?A textMine:prep ?function, ?A textMine:amod ?impact, ?E textMine:dobj ?A, ?E textMine:nsubj ?mutation]
Existing trips : 
?C textMine:amod ?impact. ?D textMine:dobj ?C. ?D textMine:nsubj ?mutation. ?D textMine:prep ?function. 
Similar Query!!!!


1084 Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR ABL and BCR ABL T315I
[?impact textMine:nsubj ?function, ?impact textMine:prep ?mutation]
[?impact textMine:nsubj ?function, ?impact textMine:prep ?mutation, ]
Match 


1085 The M918T mutation appears to increase the stability of monomeric active forms of RET, but activation of these mutants can also be further enhanced by binding of GDNF–GFRα complexes, suggesting that these mutant RET forms may induce signal transduction from both within and outside the lipid rafts, perhaps via distinct signaling complexes ( Figure 2B ) 
[?A textMine:nn ?mutation, ?C textMine:nsubjpass ?function, ?impact textMine:xsubj ?A, ?E textMine:conj ?C, ?E textMine:xcomp ?impact, ?E textMine:nsubj ?A]
Added to queryTripless!! : ?A textMine:nn ?mutation. ?C textMine:nsubjpass ?function. ?positive textMine:xsubj ?A. ?E textMine:conj ?C. ?E textMine:xcomp ?positive. ?E textMine:nsubj ?A. 
813

1086 In a study of four categories of imatinib  and dasatinib treated patients (imatinib resistant/dasatinib responsive; dasatinib resistant; blast crisis or CML progression and T315I or F317L mutated patient receiving omacetaxine treatment)  , transcriptional and translational levels of HCK, LYN and another SFK related gene BTK were elevated in more than 50% of resistant CML patients 
[?A textMine:nn ?function, ?C textMine:nn ?mutation, ?B textMine:prep ?I, ?G textMine:prep ?A, ?E textMine:prep ?B, ?impact textMine:prep ?G, ?impact textMine:prep ?E, ?I textMine:dep ?C]
[?A textMine:nn ?function, ?B textMine:prep ?I, ?C textMine:nn ?mutation, ?E textMine:prep ?B, ?G textMine:prep ?A, ?I textMine:dep ?C, ?impact textMine:prep ?E, ?impact textMine:prep ?G, ]
Match 


1087 Furthermore, from a gefitinib resistant patient carrying the activating L858R mutation, we identified a novel secondary resistant mutation, L747S in cis to the activating mutation, which attenuated the up regulation of BIM and reduced apoptosis 
[?G textMine:partmod ?C, ?function textMine:amod ?impact, ?C textMine:dobj ?E, ?E textMine:nn ?mutation, ?B textMine:rcmod ?D, ?J textMine:prep ?B, ?J textMine:prep ?G, ?D textMine:dobj ?F, ?F textMine:prep ?function]
Added to queryTripless!! : ?G textMine:partmod ?C. ?function textMine:amod ?negative. ?C textMine:dobj ?E. ?E textMine:nn ?mutation. ?B textMine:rcmod ?D. ?J textMine:prep ?B. ?J textMine:prep ?G. ?D textMine:dobj ?F. ?F textMine:prep ?function. 
814

1088 As expected, BRAF V600E  inhibited MST1 induced 3XIRS reporter activation in a dose dependent manner and MST1 abolished the inhibitory effect of BRAF V600E  on FoxO3 transactivation ( Fig 3B & 3C ) 
[?impact textMine:dobj ?function, ?function textMine:prep ?mutation]
[?function textMine:prep ?mutation, ?impact textMine:dobj ?function, ]
Match 


1089 Our biochemical studies here now show that E884K mutation in  cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone, through differential inhibition of the pro survival AKT and STAT3 signaling pathways associated with altered induction of cleaved PARP(Asp214) 
[?function textMine:partmod ?C, ?C textMine:prep ?A, ?A textMine:amod ?impact, ?E textMine:prep ?function, ?E textMine:pobj ?mutation]
Added to queryTripless!! : ?function textMine:partmod ?C. ?C textMine:prep ?A. ?A textMine:amod ?unknown. ?E textMine:prep ?function. ?E textMine:pobj ?mutation. 
815

1090 A gain of function JAK2 ( JAK2 V617F  ) mutation leads to enhanced GATA 1 expression, whereas morpholino knock down of  jak2a  or a specific JAK2 inhibitor (TG101209) significantly suppresses GATA 1 expression in zebrafish embryos   
[?A textMine:prep ?C, ?E textMine:amod ?impact, ?G textMine:dobj ?function, ?C textMine:appos ?mutation, ?F textMine:advcl ?G, ?F textMine:prep ?E, ?F textMine:nsubj ?A]
Added to queryTripless!! : ?A textMine:prep ?C. ?E textMine:amod ?positive. ?G textMine:dobj ?function. ?C textMine:appos ?mutation. ?F textMine:advcl ?G. ?F textMine:prep ?E. ?F textMine:nsubj ?A. 
816

1091 The mutations E255V, M244V, T315A, Y253H, experience increased vdW interactions with Met290 and the mutation M244V experiences increased vdW interactions with Ile293 
[?B textMine:dobj ?function, ?D textMine:ccomp ?B, ?D textMine:nsubj ?F, ?function textMine:amod ?impact, ?F textMine:dep ?mutation]
Added to queryTripless!! : ?B textMine:dobj ?function. ?D textMine:ccomp ?B. ?D textMine:nsubj ?F. ?function textMine:amod ?positive. ?F textMine:dep ?mutation. 
817

1092 The G370C and S371C mutants produced higher levels of constitutive activation of MAPK in L8 cells and c  fos  transcription in RCJ cells than the G375C mutant, consistent with the fact that TD1 is much more severe than ACH 
[?A textMine:prep ?function, ?D textMine:nn ?mutation, ?function textMine:amod ?impact, ?F textMine:prep ?D, ?F textMine:dobj ?A]
Added to queryTripless!! : ?A textMine:prep ?function. ?D textMine:nn ?mutation. ?function textMine:amod ?positive. ?F textMine:prep ?D. ?F textMine:dobj ?A. 
818

1093 Substitution of S252W and P253R alter the ligand binding specificities of FGFR2b and FGFR2c, but retain the ligand dependent activation properties  , whereas K659N causes receptor hyperactivation   
[?E textMine:dobj ?A, ?E textMine:nsubj ?F, ?impact textMine:conj ?E, ?impact textMine:nsubj ?F, ?A textMine:amod ?D, ?F textMine:prep ?mutation, ?D textMine:amod ?function]
Added to queryTripless!! : ?E textMine:dobj ?A. ?E textMine:nsubj ?F. ?unknown textMine:conj ?E. ?unknown textMine:nsubj ?F. ?A textMine:amod ?D. ?F textMine:prep ?mutation. ?D textMine:amod ?function. 
819

1094 If exon 19 deletion results in EGFR structural alterations which bind TKIs more tightly than L858R mutation, it could support our hypothesis 
[?C textMine:prep ?A, ?A textMine:amod ?mutation, ?impact textMine:rcmod ?C, ?function textMine:prep ?impact]
Added to queryTripless!! : ?C textMine:prep ?A. ?A textMine:amod ?mutation. ?unknown textMine:rcmod ?C. ?function textMine:prep ?unknown. 
820

1095 Furthermore, transfection of another activated mutant L858R EGFR cDNA also induced enhanced expression ( Figure 7C ) and restored drug sensitivity to erlotinib in 11–18/ER1 7 cells ( Figure 7D ) 
[?impact textMine:conj ?E, ?impact textMine:nsubj ?B, ?E textMine:dobj ?function, ?E textMine:nsubj ?B, ?F textMine:nn ?mutation, ?B textMine:prep ?F]
Added to queryTripless!! : ?positive textMine:conj ?E. ?positive textMine:nsubj ?B. ?E textMine:dobj ?function. ?E textMine:nsubj ?B. ?F textMine:nn ?mutation. ?B textMine:prep ?F. 
821

1096 Hence, E884K mutation can work in concert with L858R to modulate mutant receptor sensitivity to different targeted inhibitors 
[?A textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:xsubj ?A]
[?A textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:xsubj ?A, ]
Match 


1127 The coexistent mutations of  AKT3  and  PIK3CA  in one sample suggest that some types of  AKT  mutations (non E17K) might coexist with  PIK3CA  mutations to enhance the activation of the PI3 kinase–AKT pathway 
[?A textMine:appos ?mutation, ?impact textMine:dobj ?function, ?impact textMine:xsubj ?A]
[?A textMine:appos ?mutation, ?impact textMine:dobj ?function, ?impact textMine:xsubj ?A, ]
Match 


1097 While many JAK2 inhibitors are able to achieve normalization of leukocytosis and thrombocytosis, as well as improve symptoms in cancer patients [ 15 ,  16 ], they are less effective in achieving consistent hematologic remissions and reducing JAK2(V617F) allelic burden [ 15 ,  17   20 ] 
[?A textMine:nn ?mutation, ?impact textMine:dobj ?A, ?function textMine:prepc ?impact]
Added to queryTripless!! : ?A textMine:nn ?mutation. ?negative textMine:dobj ?A. ?function textMine:prepc ?negative. 
822

1098 Thus, certain P loop mutations (Y253F, E255K) and the T315I mutation display a high oncogenic potential, which is consistent with the clinical observation of a poor outcome concerning overall and progression free survival   
[?E textMine:xcomp ?F, ?F textMine:dobj ?function, ?G textMine:appos ?B, ?H textMine:rcmod ?E, ?H textMine:amod ?impact, ?B textMine:dep ?mutation, ?C textMine:dobj ?H, ?C textMine:nsubj ?G]
Added to queryTripless!! : ?E textMine:xcomp ?F. ?F textMine:dobj ?function. ?G textMine:appos ?B. ?H textMine:rcmod ?E. ?H textMine:amod ?positive. ?B textMine:dep ?mutation. ?C textMine:dobj ?H. ?C textMine:nsubj ?G. 
823

1099 Overall, SP inhibitors represent an innovative mechanism of KIT inhibition whose dual suppression of KIT D816V neoplastic mast cell proliferation and SCF enhanced mast cell activation may provide significant therapeutic benefits 
[?D textMine:prep ?mutation, ?D textMine:poss ?A, ?A textMine:rcmod ?impact, ?A textMine:prep ?function, ?impact textMine:dobj ?D]
Added to queryTripless!! : ?D textMine:prep ?mutation. ?D textMine:poss ?A. ?A textMine:rcmod ?positive. ?A textMine:prep ?function. ?positive textMine:dobj ?D. 
824

1100 As expected, BRAF V600E  inhibited MST1 induced 3XIRS reporter activation in a dose dependent manner and MST1 abolished the inhibitory effect of BRAF V600E  on FoxO3 transactivation ( Fig 3B & 3C ) 
[?impact textMine:dobj ?D, ?impact textMine:nsubj ?B, ?D textMine:prep ?mutation, ?F textMine:dobj ?function, ?B textMine:partmod ?F]
Added to queryTripless!! : ?negative textMine:dobj ?D. ?negative textMine:nsubj ?B. ?D textMine:prep ?mutation. ?F textMine:dobj ?function. ?B textMine:partmod ?F. 
825

1101 Of note is that same epitopes are also exposed in the constitutively active L858R EGFR mutant, and, therefore, such a mutant also binds efficiently the α4 2 mAb   
[?function textMine:advmod ?impact, ?C textMine:nn ?mutation, ?C textMine:amod ?function]
Query : [?function textMine:advmod ?impact, ?C textMine:nn ?mutation, ?C textMine:amod ?function]
Existing trips : 
?A textMine:amod ?function. ?A textMine:nn ?mutation. ?function textMine:advmod ?impact. 
Similar Query!!!!


1102 Vemurafenib, metformin or the combination resulted in decreased phosphorylation of AKT in BRAF V600E  and BRAF WT  cell lines (Additional File  3 ) 
[?function textMine:prep ?mutation, ?function textMine:amod ?impact]
[?function textMine:amod ?impact, ?function textMine:prep ?mutation, ]
Match 


1103 Complicating this interpretation, Ocm1 cells have been shown to carry the common V600E BRAF mutation that constitutively activates the MAPK pathway  
[?function textMine:advmod ?impact, ?C textMine:rcmod ?function, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:advmod ?positive. ?C textMine:rcmod ?function. ?C textMine:nn ?mutation. 
826

1104 The T790M EGFR mutant has increased affinity for ATP, which is the primary mechanism responsible for the development of resistance to small molecule tyrosine kinase inhibitors (TKIs), such as gefitinib and erlotinib  [36]  
[?D textMine:prep ?function, ?G textMine:amod ?H, ?H textMine:prep ?D, ?B textMine:rcmod ?G, ?impact textMine:prep ?B, ?impact textMine:nsubj ?F, ?F textMine:nn ?mutation]
Added to queryTripless!! : ?D textMine:prep ?function. ?G textMine:amod ?H. ?H textMine:prep ?D. ?B textMine:rcmod ?G. ?positive textMine:prep ?B. ?positive textMine:nsubj ?F. ?F textMine:nn ?mutation. 
827

1105 Ectopic expression of  V600E BRAF or  Q61L NRAS increases the expression of metabolic genes
[?D textMine:dep ?function, ?D textMine:prep ?impact, ?D textMine:prep ?B, ?B textMine:conj ?impact, ?B textMine:nn ?mutation]
Added to queryTripless!! : ?D textMine:dep ?function. ?D textMine:prep ?positive. ?D textMine:prep ?B. ?B textMine:conj ?positive. ?B textMine:nn ?mutation. 
828

1106 Similarly, E884K further enhanced the sensitivity of L858R to the inhibition by the irreversible EGFR/ERBB2 inhibitor, CL 387,785 
[?function textMine:prep ?mutation, ?impact textMine:dobj ?function]
[?function textMine:prep ?mutation, ?impact textMine:dobj ?function, ]
Match 


1107 PLX4032 was recently demonstrated to reduce the uptake of 2(18F)fluoro 2 deoxy D glucose (18F FDG) in melanoma cells, whereas inducible expression of V600E BRAF increased the glucose uptake rate and decreased O 2  consumption in thyroid cancer cells   
[?function textMine:prep ?A, ?A textMine:nn ?mutation, ?impact textMine:nsubj ?function]
Query : [?function textMine:prep ?A, ?A textMine:nn ?mutation, ?impact textMine:nsubj ?function]
Existing trips : 
?B textMine:nn ?mutation. ?function textMine:prep ?B. ?impact textMine:nsubj ?function. 
Similar Query!!!!


1108 We have shown previously that co treatment of several melanoma cell lines with WNT3A and with a targeted BRAF V600E inhibitor synergistically increases Wnt/β catenin signaling and apoptosis   
[?B textMine:prep ?C, ?function textMine:nsubj ?E, ?E textMine:prep ?B, ?impact textMine:conj ?function, ?impact textMine:nsubj ?E, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?B textMine:prep ?C. ?function textMine:nsubj ?E. ?E textMine:prep ?B. ?positive textMine:conj ?function. ?positive textMine:nsubj ?E. ?C textMine:nn ?mutation. 
829

1109 The level of activation of the K652E receptor was higher than the S249C and Y375C mutants ( Figure 3a ,  Supplementary Figure 4a ) 
[?D textMine:prep ?function, ?B textMine:nn ?mutation, ?impact textMine:prep ?B, ?impact textMine:nsubj ?D]
Added to queryTripless!! : ?D textMine:prep ?function. ?B textMine:nn ?mutation. ?positive textMine:prep ?B. ?positive textMine:nsubj ?D. 
830

1110 Our results showed diminished expression of  MLH1  in patients harbouring BRAF V600E mutations, RET/PTC rearrangements and transitions ( IDH1  and  NRAS )  
[?G textMine:prep ?E, ?G textMine:dobj ?function, ?B textMine:nn ?mutation, ?A textMine:dobj ?B, ?function textMine:amod ?impact, ?E textMine:partmod ?A]
Query : [?G textMine:prep ?E, ?G textMine:dobj ?function, ?B textMine:nn ?mutation, ?A textMine:dobj ?B, ?function textMine:amod ?impact, ?E textMine:partmod ?A]
Existing trips : 
?A textMine:dobj ?function. ?A textMine:prep ?D. ?C textMine:dobj ?G. ?D textMine:partmod ?C. ?G textMine:nn ?mutation. ?function textMine:amod ?impact. 
Similar Query!!!!


1111 TBP 3868 exhibits high basal Ras activity relative to the PLX4720 sensitive line, TBP 3743 suggesting that the resistance to BRAF V600E  inhibition in TBP 3868 may be attributed to Ras dependent transactivation of RAF dimers 
[?D textMine:prep ?A, ?function textMine:advmod ?E, ?function textMine:amod ?impact, ?B textMine:nsubjpass ?D, ?J textMine:appos ?C, ?E textMine:prep ?J, ?C textMine:partmod ?H, ?H textMine:ccomp ?B, ?A textMine:nn ?mutation]
Added to queryTripless!! : ?D textMine:prep ?A. ?function textMine:advmod ?E. ?function textMine:amod ?positive. ?B textMine:nsubjpass ?D. ?J textMine:appos ?C. ?E textMine:prep ?J. ?C textMine:partmod ?H. ?H textMine:ccomp ?B. ?A textMine:nn ?mutation. 
831

1112 The effect on the downstream signal mediators p AKT [S473] and p STAT3 [Y705] correlated well with the inhibition of EGFR phosphorylation ( Figure 1A ); E884K in  cis  with L858R decreased erlotinib inhibition of AKT and STAT3 phosphorylation but increased inhibition by gefitinib 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation]
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation, ]
Match 


1113 To avoid the influence of mutant  BRAF V600E   in the ERK phosphorylation assay, we used EpoR siRNA for transient transfection in WM3211 melanoma cells which have wild type BRAF and NRAS proteins 
[?impact textMine:dobj ?C, ?D textMine:nn ?function, ?mutation textMine:prep ?D, ?C textMine:prep ?mutation]
Added to queryTripless!! : ?negative textMine:dobj ?C. ?D textMine:nn ?function. ?mutation textMine:prep ?D. ?C textMine:prep ?mutation. 
832

1114 Our biochemical studies here now show that E884K mutation in  cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone, through differential inhibition of the pro survival AKT and STAT3 signaling pathways associated with altered induction of cleaved PARP(Asp214) 
[?F textMine:amod ?mutation, ?function textMine:prep ?A, ?E textMine:prep ?C, ?E textMine:nsubj ?F, ?A textMine:amod ?impact, ?C textMine:partmod ?function]
[?A textMine:amod ?impact, ?C textMine:partmod ?function, ?E textMine:nsubj ?F, ?E textMine:prep ?C, ?F textMine:amod ?mutation, ?function textMine:prep ?A, ]
Match 


1115 The former is the case of the S492R mutant, which confers resistance to cetuximab since the mutation is located in its binding epitope on the EGFR external domain  ; whereas the later is the case of the T790M mutant (mutation in the kinase domain), which confers resistance to gefitinib or erlotinib in lung adenocarcinomas   by stabilizing the active tyrosine kinase conformation and enhancing aTP binding   
[?D textMine:dobj ?F, ?E textMine:prepc ?D, ?B textMine:nn ?mutation, ?B textMine:rcmod ?E, ?F textMine:amod ?function]
Added to queryTripless!! : ?D textMine:dobj ?F. ?E textMine:prepc ?D. ?B textMine:nn ?mutation. ?B textMine:rcmod ?E. ?F textMine:amod ?function. 
833

1116 The mutations G250E, Y253H and T315I experience decreased vdW interactions with Phe359 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?D, ?D textMine:amod ?F, ?A textMine:num ?mutation, ?F textMine:dep ?A]
Query : [?impact textMine:dobj ?function, ?impact textMine:nsubj ?D, ?D textMine:amod ?F, ?A textMine:num ?mutation, ?F textMine:dep ?A]
Existing trips : 
?C textMine:num ?mutation. ?D textMine:amod ?F. ?F textMine:dep ?C. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?D. 
Similar Query!!!!


1117 Phosphorylation of Ser 910 /Ser 935  and 14 3 3 binding were significantly reduced in six other mutants (M712V, R1441H, R1441C, A1442P, L1795F and G2385R) ( Figure 5 , lower panel) 
[?C textMine:amod ?function, ?A textMine:dep ?mutation, ?impact textMine:prep ?A, ?impact textMine:nsubjpass ?D, ?D textMine:prep ?C]
Added to queryTripless!! : ?C textMine:amod ?function. ?A textMine:dep ?mutation. ?negative textMine:prep ?A. ?negative textMine:nsubjpass ?D. ?D textMine:prep ?C. 
834

1118 Tyrosine phosphorylation of STAT5 was also enhanced, though not as significantly as that of PECAM 1, in cells expressing the E255K or T315I mutant ( Fig 4C ) 
[?impact textMine:prep ?D, ?function textMine:dobj ?C, ?D textMine:partmod ?function, ?C textMine:nn ?mutation]
Query : [?impact textMine:prep ?D, ?function textMine:dobj ?C, ?D textMine:partmod ?function, ?C textMine:nn ?mutation]
Existing trips : 
?A textMine:nn ?mutation. ?C textMine:partmod ?function. ?function textMine:dobj ?A. ?impact textMine:prep ?C. 
Similar Query!!!!


1119 Meclozine also ameliorated abnormally suppressed proliferation of human chondrosarcoma (HCS 2/8) cells that were infected with lentivirus expressing constitutively active mutants of FGFR3 K650E causing thanatophoric dysplasia, FGFR3 K650M causing SADDAN, and FGFR3 G380R causing ACH 
[?G textMine:dobj ?L, ?J textMine:partmod ?G, ?B textMine:conj ?A, ?B textMine:ccomp ?I, ?L textMine:amod ?function, ?H textMine:prep ?J, ?A textMine:nsubj ?mutation, ?I textMine:iobj ?D, ?E textMine:rcmod ?H, ?function textMine:advmod ?impact, ?D textMine:dep ?E]
Added to queryTripless!! : ?G textMine:dobj ?L. ?J textMine:partmod ?G. ?B textMine:conj ?A. ?B textMine:ccomp ?I. ?L textMine:amod ?function. ?H textMine:prep ?J. ?A textMine:nsubj ?mutation. ?I textMine:iobj ?D. ?E textMine:rcmod ?H. ?function textMine:advmod ?positive. ?D textMine:dep ?E. 
835

1120 Since the depletion of KLF2 causes enhanced apoptosis of HMC 1(V560G c Kit), KLF2 may play a role in the NGF mediated survival signal 
[?C textMine:nn ?mutation, ?function textMine:appos ?C, ?function textMine:amod ?impact]
Query : [?C textMine:nn ?mutation, ?function textMine:appos ?C, ?function textMine:amod ?impact]
Existing trips : 
?B textMine:nn ?mutation. ?function textMine:amod ?impact. ?function textMine:appos ?B. 
Similar Query!!!!


1121 The mutants T316A, K323A and R326A, which were engineered to abrogate the hydrophilic interactions, also moderately impaired the kinase activity 
[?D textMine:num ?mutation, ?impact textMine:nsubj ?D, ?impact textMine:dobj ?function]
[?D textMine:num ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?D, ]
Match 


1122 Plasmid expression vectors were generated by cloning cDNAs of interest into a Gateway cloning compatible variant of the vector pCIG as follows: PLZF, full length chick clone isolated by PCR from e4 chick cDNA; EnR PLZF and VP16 PLZF were created by respectively fusing either the Drosophila  Engrailed repressor domain or the herpes simplex VP16 transactivation domain to aa 300–665 of chick PLZF; FGFR3, WT form of the human FGFR3 ; caFGFR3, myristoylated and constitutively activated (K650E) form of the human FGFR3 cytoplasmic domain (aa 399–806) ; STAT3 C, mouse STAT3 containing two activating mutations (A662C, N664C) obtained from Addgene; and dnSTAT3 was created by incorporating into the mouse STAT3 nonphosphorylatable Y705F mutant , obtained from Addgene, an additional H332Y mutation that disrupts DNA binding  
[?M textMine:dobj ?C, ?E textMine:agent ?M, ?N textMine:conj ?E, ?N textMine:conj ?A, ?A textMine:agent ?L, ?P textMine:rcmod ?impact, ?C textMine:partmod ?I, ?impact textMine:xcomp ?function, ?H textMine:appos ?P, ?D textMine:dep ?G, ?I textMine:prep ?H, ?L textMine:dep ?O, ?G textMine:amod ?J, ?J textMine:dep ?mutation, ?O textMine:nsubj ?D]
Added to queryTripless!! : ?M textMine:dobj ?C. ?E textMine:agent ?M. ?N textMine:conj ?E. ?N textMine:conj ?A. ?A textMine:agent ?L. ?P textMine:rcmod ?negative. ?C textMine:partmod ?I. ?negative textMine:xcomp ?function. ?H textMine:appos ?P. ?D textMine:dep ?G. ?I textMine:prep ?H. ?L textMine:dep ?O. ?G textMine:amod ?J. ?J textMine:dep ?mutation. ?O textMine:nsubj ?D. 
836

1123 The G370C and S371C mutants produced higher levels of constitutive activation of MAPK in L8 cells and c  fos  transcription in RCJ cells than the G375C mutant, consistent with the fact that TD1 is much more severe than ACH 
[?C textMine:prep ?function, ?function textMine:amod ?impact, ?A textMine:nn ?mutation, ?F textMine:dobj ?C, ?F textMine:nsubj ?A]
Added to queryTripless!! : ?C textMine:prep ?function. ?function textMine:amod ?positive. ?A textMine:nn ?mutation. ?F textMine:dobj ?C. ?F textMine:nsubj ?A. 
837

1124 To further delineate whether these gene expression circuitry modifications were consequence of altered ligand binding affinity of FGFR2 or of constitutively active intracellular signaling by the receptor, we sought for BAT3, BDP1, CYP51A1, TCF19 and RFC3 (DEGs in S252W fibroblasts treated with FGF2) expression levels in a C342Y fibroblast through qRT PCR 
[?C textMine:amod ?function, ?D textMine:pobj ?C, ?function textMine:advmod ?impact, ?A textMine:num ?mutation, ?G textMine:prep ?A, ?H textMine:dep ?G, ?H textMine:ccomp ?B, ?B textMine:dep ?D]
Added to queryTripless!! : ?C textMine:amod ?function. ?D textMine:pobj ?C. ?function textMine:advmod ?positive. ?A textMine:num ?mutation. ?G textMine:prep ?A. ?H textMine:dep ?G. ?H textMine:ccomp ?B. ?B textMine:dep ?D. 
838

1125 Both DP 2976 and DP 4851 decreased the autophosphorylation of both wild type and KIT D816V in a concentration dependent manner ( Figure 2 ) 
[?function textMine:prep ?mutation, ?impact textMine:dobj ?function]
[?function textMine:prep ?mutation, ?impact textMine:dobj ?function, ]
Match 


1126 Synergy is particularly important as it may permit lower doses of PLX4720 to be used, potentially translating to a benefit in the clinic by reducing side effects associated with BRAF V600E  inhibition including squamous cell carcinoma [ 54   56 ] 
[?B textMine:prep ?C, ?function textMine:partmod ?B, ?impact textMine:dobj ?function, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?B textMine:prep ?C. ?function textMine:partmod ?B. ?negative textMine:dobj ?function. ?C textMine:nn ?mutation. 
839

1128 Levels of L858R EGFR expression necessary to achieve transformation in this model cell culture system were no higher than expression levels observed in the human lung adenocarcinoma cell line H3255 bearing the L858R mutation ( Figure 1 C) 
[?A textMine:xcomp ?E, ?A textMine:nsubj ?B, ?E textMine:dobj ?F, ?F textMine:amod ?mutation, ?impact textMine:ccomp ?A, ?B textMine:nn ?function]
Added to queryTripless!! : ?A textMine:xcomp ?E. ?A textMine:nsubj ?B. ?E textMine:dobj ?F. ?F textMine:amod ?mutation. ?positive textMine:ccomp ?A. ?B textMine:nn ?function. 
840

1129 Now, recent work from the Rosen lab at Memorial Sloan Kettering Cancer Center has uncovered data that vemurafenib reduces feedback inhibition in BRAF V600E  expressing cells such that these cells become sensitized to extracellular growth factors like hepatocyte and epidermal growth factors 
[?mutation textMine:partmod ?A, ?impact textMine:prep ?mutation, ?A textMine:ccomp ?function]
Added to queryTripless!! : ?mutation textMine:partmod ?A. ?negative textMine:prep ?mutation. ?A textMine:ccomp ?function. 
841

1130 Kinase activation in the clinically benign mutant L196P is far weaker than R206H but yields equivalent signals due to the stronger interaction of FKBP12 with R206H 
[?A textMine:prep ?mutation, ?function textMine:prep ?A, ?function textMine:amod ?impact]
Added to queryTripless!! : ?A textMine:prep ?mutation. ?function textMine:prep ?A. ?function textMine:amod ?positive. 
842

1131 In contrast, G2385R variant within the WD40 domain results in a loss of function mutation (associated with the reduced kinase activity) and is a common susceptibility allele in Asian populations, but absent in Caucasians  
[?A textMine:dep ?F, ?function textMine:amod ?impact, ?F textMine:prep ?function, ?E textMine:prep ?A, ?E textMine:nsubj ?mutation]
Added to queryTripless!! : ?A textMine:dep ?F. ?function textMine:amod ?negative. ?F textMine:prep ?function. ?E textMine:prep ?A. ?E textMine:nsubj ?mutation. 
843

1132 Moreover, we showed that the expression of genes encoding three inflammation related genes (CCL20, CXCL8, and l selectin) was enhanced either in  BRAF  V600E  or in  RET / PTC  tumors, compared with normal samples 
[?impact textMine:nsubjpass ?function, ?impact textMine:prep ?mutation]
[?impact textMine:nsubjpass ?function, ?impact textMine:prep ?mutation, ]
Match 


1133 The BRAF V600E  mutation results in the constitutive activation of the Ras/Raf/MEK/ERK signaling pathway   
[?function textMine:amod ?impact, ?D textMine:prep ?function, ?D textMine:nsubj ?B, ?B textMine:nn ?mutation]
Query : [?function textMine:amod ?impact, ?D textMine:prep ?function, ?D textMine:nsubj ?B, ?B textMine:nn ?mutation]
Existing trips : 
?B textMine:nn ?mutation. ?E textMine:nsubj ?B. ?E textMine:prep ?function. ?function textMine:amod ?impact. 
Similar Query!!!!


1134 While FLT3 ITD (red) and FLT3 D835Y (blue) displayed very high sensitivity towards 17 AAG treatment, the efficacy was slightly lower against FLT3 ITD N676K and FLT3 ITD F691L at 1 µM ( Figure 3B ) 
[?impact textMine:advcl ?B, ?impact textMine:prep ?mutation, ?B textMine:dobj ?function]
Added to queryTripless!! : ?negative textMine:advcl ?B. ?negative textMine:prep ?mutation. ?B textMine:dobj ?function. 
844

1135 PLX4032 was recently demonstrated to reduce the uptake of 2(18F)fluoro 2 deoxy D glucose (18F FDG) in melanoma cells, whereas inducible expression of V600E BRAF increased the glucose uptake rate and decreased O 2  consumption in thyroid cancer cells   
[?D textMine:prep ?B, ?D textMine:amod ?function, ?B textMine:nn ?mutation, ?impact textMine:nsubj ?D]
Query : [?D textMine:prep ?B, ?D textMine:amod ?function, ?B textMine:nn ?mutation, ?impact textMine:nsubj ?D]
Existing trips : 
?B textMine:prep ?E. ?E textMine:amod ?function. ?E textMine:nn ?mutation. ?impact textMine:nsubj ?B. 
Similar Query!!!!


1136 As seen in  Fig 4E , the expression of BRAF V600E  completely abolished MST1 kinase activity 
[?A textMine:prep ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?A]
[?A textMine:prep ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?A, ]
Match 


1137 The data suggest that low BRCA1 level may neutralize the negative effects of the EGFR T790M mutation on erlotinib sensitivity and that high BRCA1 expression may lead to de novo EGFR TKI resistance potentially through increased DNA damage repair capacity   
[?A textMine:nn ?mutation, ?E textMine:prep ?A, ?impact textMine:prep ?function, ?impact textMine:dobj ?E]
Added to queryTripless!! : ?A textMine:nn ?mutation. ?E textMine:prep ?A. ?neutral textMine:prep ?function. ?neutral textMine:dobj ?E. 
845

1138 While many JAK2 inhibitors are able to achieve normalization of leukocytosis and thrombocytosis, as well as improve symptoms in cancer patients [ 15 ,  16 ], they are less effective in achieving consistent hematologic remissions and reducing JAK2(V617F) allelic burden [ 15 ,  17   20 ] 
[?A textMine:nn ?mutation, ?B textMine:dobj ?A, ?function textMine:advmod ?impact, ?function textMine:prepc ?B]
Added to queryTripless!! : ?A textMine:nn ?mutation. ?B textMine:dobj ?A. ?function textMine:advmod ?negative. ?function textMine:prepc ?B. 
846

1139 Substitution of S252W and P253R alter the ligand binding specificities of FGFR2b and FGFR2c, but retain the ligand dependent activation properties  , whereas K659N causes receptor hyperactivation   
[?impact textMine:dobj ?C, ?impact textMine:nsubj ?D, ?D textMine:prep ?mutation, ?C textMine:amod ?function]
Added to queryTripless!! : ?unknown textMine:dobj ?C. ?unknown textMine:nsubj ?D. ?D textMine:prep ?mutation. ?C textMine:amod ?function. 
847

1140 BRAF  cDNA from syndromic SSA/Ps, hyperplastic polyps (HPs) and normal colon was amplified by PCR and sequenced since T to A mutations in codon 600 resulting in a valine to glutamic acid (V600E) amino acid change with increased kinase activity have been reported in SSA/Ps (Materials and Methods)  [14]  
[?C textMine:prep ?function, ?function textMine:amod ?impact, ?F textMine:appos ?mutation, ?B textMine:dobj ?C, ?B textMine:prep ?F]
Added to queryTripless!! : ?C textMine:prep ?function. ?function textMine:amod ?positive. ?F textMine:appos ?mutation. ?B textMine:dobj ?C. ?B textMine:prep ?F. 
848

1141 Intriguingly, tyrosine phosphorylation of PECAM 1 as well as its physical association with SHP2 was enhanced by the imatinib resistance E255K or T315I mutation 
[?impact textMine:agent ?mutation, ?impact textMine:nsubjpass ?D, ?D textMine:prep ?function]
Added to queryTripless!! : ?positive textMine:agent ?mutation. ?positive textMine:nsubjpass ?D. ?D textMine:prep ?function. 
849

1142 27   Cells expressing G719X were less resistant to erlotinib than gefitinib in vitro; however, L861Q was resistant to both erlotinib and gefitinib 
[?function textMine:nsubj ?mutation, ?A textMine:parataxis ?function, ?A textMine:advmod ?impact]
Added to queryTripless!! : ?function textMine:nsubj ?mutation. ?A textMine:parataxis ?function. ?A textMine:advmod ?negative. 
850

1143 Consistent with this differential signaling effect, the L858R+E884K COS 7 cells had a significantly higher cell proliferation rate than that of the L858R COS 7 cells in the MTS cell proliferation assay for 5 days ( Figure 3B ) 
[?B textMine:prep ?F, ?C textMine:nn ?mutation, ?F textMine:nn ?function, ?J textMine:dobj ?G, ?G textMine:prep ?E, ?G textMine:amod ?impact, ?E textMine:prep ?C, ?A textMine:nsubj ?B, ?A textMine:dep ?J]
Added to queryTripless!! : ?B textMine:prep ?F. ?C textMine:nn ?mutation. ?F textMine:nn ?function. ?J textMine:dobj ?G. ?G textMine:prep ?E. ?G textMine:amod ?positive. ?E textMine:prep ?C. ?A textMine:nsubj ?B. ?A textMine:dep ?J. 
851

1144 In an overlay assay using ERK4 peptides with wild type sequence or single amino acid substitutions bound to cellulose membrane, the authors showed that D336N, but not E331D reduced  in vitro  binding of recombinant MK5 
[?impact textMine:nsubj ?mutation, ?impact textMine:prep ?function]
[?impact textMine:nsubj ?mutation, ?impact textMine:prep ?function, ]
Match 


1145 The T315I mutation experiences increased (−4.11 kcal/mol) and T315A mutation experiences decreased electrostatic interactions (−2 05 kcal/mol), and the mutation G250E contributes increased electrostatic interaction (−032 kcal/mol) while binding to ponatinib 
[?impact textMine:dobj ?E, ?impact textMine:nsubj ?C, ?C textMine:nn ?mutation, ?E textMine:amod ?function]
Query : [?impact textMine:dobj ?E, ?impact textMine:nsubj ?C, ?C textMine:nn ?mutation, ?E textMine:amod ?function]
Existing trips : 
?B textMine:amod ?function. ?D textMine:nn ?mutation. ?impact textMine:dobj ?B. ?impact textMine:nsubj ?D. 
Similar Query!!!!


1146 Furthermore, from a gefitinib resistant patient carrying the activating L858R mutation, we identified a novel secondary resistant mutation, L747S in cis to the activating mutation, which attenuated the up regulation of BIM and reduced apoptosis 
[?G textMine:partmod ?C, ?C textMine:dobj ?F, ?F textMine:nn ?mutation, ?B textMine:rcmod ?impact, ?B textMine:amod ?function, ?H textMine:prep ?B, ?H textMine:prep ?G]
Added to queryTripless!! : ?G textMine:partmod ?C. ?C textMine:dobj ?F. ?F textMine:nn ?mutation. ?B textMine:rcmod ?negative. ?B textMine:amod ?function. ?H textMine:prep ?B. ?H textMine:prep ?G. 
852

1147 Regarding the interference with the ERK signaling, cell lines with BRAF V600D/R  mutations presented a faster and stronger inhibition of phosphorylated ERK as compared to control cells with a wild type  BRAF  (Figure  1 C) 
[?C textMine:nsubj ?function, ?C textMine:prep ?E, ?function textMine:amod ?impact, ?E textMine:prep ?D, ?B textMine:prep ?A, ?A textMine:nn ?mutation, ?D textMine:appos ?B]
[?A textMine:nn ?mutation, ?B textMine:prep ?A, ?C textMine:nsubj ?function, ?C textMine:prep ?E, ?D textMine:appos ?B, ?E textMine:prep ?D, ?function textMine:amod ?impact, ]
Match 


1148 The M918T mutation appears to increase the stability of monomeric active forms of RET, but activation of these mutants can also be further enhanced by binding of GDNF–GFRα complexes, suggesting that these mutant RET forms may induce signal transduction from both within and outside the lipid rafts, perhaps via distinct signaling complexes ( Figure 2B ) 
[?A textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:xsubj ?A]
[?A textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:xsubj ?A, ]
Match 


1149 ALK F1174L expression in murine NCPC MONC 1 impairs differentiation of NC cell derived tumors
[?C textMine:dep ?impact, ?C textMine:dep ?function, ?function textMine:nn ?mutation]
Added to queryTripless!! : ?C textMine:dep ?negative. ?C textMine:dep ?function. ?function textMine:nn ?mutation. 
853

1150 Following mutant BRAF V600E  overexpression, the phosphorylation of both BRAF/ CRAF kinases was significantly increased, which resulted in the downstream activation of MEK but not ERK signalling ( Figure 9  upper panel, lanes 3–4) 
[?impact textMine:rcmod ?function, ?D textMine:nsubj ?impact, ?D textMine:prep ?A, ?A textMine:nn ?mutation]
Added to queryTripless!! : ?positive textMine:rcmod ?function. ?D textMine:nsubj ?positive. ?D textMine:prep ?A. ?A textMine:nn ?mutation. 
854

1151 Binding of DACH1 to the R273H mutant was reduced 60% and the R248Q mutant was incapable of binding DACH1 ( S 3A,B ) 
[?D textMine:prep ?A, ?impact textMine:dobj ?mutation, ?A textMine:amod ?function, ?F textMine:nsubj ?D, ?F textMine:aux ?impact]
Added to queryTripless!! : ?D textMine:prep ?A. ?negative textMine:dobj ?mutation. ?A textMine:amod ?function. ?F textMine:nsubj ?D. ?F textMine:aux ?negative. 
855

1152 Consistent with the observed transcription profile, melanocytes expressing B RAF V600E  show rounded cell morphology and diminished substrate and cell adhesion as reported previously   
[?function textMine:amod ?impact, ?B textMine:dep ?function, ?A textMine:acomp ?B, ?A textMine:nsubj ?mutation]
Added to queryTripless!! : ?function textMine:amod ?negative. ?B textMine:dep ?function. ?A textMine:acomp ?B. ?A textMine:nsubj ?mutation. 
856

1153 In light of the reports of c Met signaling as the target for lung cancer treatment , it is of interest to study whether c Met N375S cells are less sensitive to SU11275 in the presence of HGF 
[?function textMine:advmod ?impact, ?mutation textMine:rcmod ?function]
Added to queryTripless!! : ?function textMine:advmod ?negative. ?mutation textMine:rcmod ?function. 
857

1154 Consistent with that result, BRAF CT V600E and K601E induced a stronger ERK activation compared with BRAF CT wild type 
[?function textMine:amod ?impact, ?B textMine:nsubj ?function, ?B textMine:prep ?E, ?E textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:amod ?positive. ?B textMine:nsubj ?function. ?B textMine:prep ?E. ?E textMine:nn ?mutation. 
858

1155 BRAF V600E  mutations in malignant melanoma are associated with increased expressions of BAALC
[?B textMine:prep ?function, ?B textMine:nsubjpass ?D, ?D textMine:nn ?mutation, ?function textMine:amod ?impact]
Added to queryTripless!! : ?B textMine:prep ?function. ?B textMine:nsubjpass ?D. ?D textMine:nn ?mutation. ?function textMine:amod ?positive. 
859

1156 Consistent with our structural analysis, we found that both the Y931C as well as the G935R mutation resulted in the largest increase (33 3 fold and 195 fold, respectively) in EC 50  values, compared to native JAK2V617F ( Figure 2A ) 
[?A textMine:dep ?mutation, ?function textMine:prep ?impact, ?function textMine:nsubj ?A]
Added to queryTripless!! : ?A textMine:dep ?mutation. ?function textMine:prep ?positive. ?function textMine:nsubj ?A. 
860

1157 We show that low levels of wild type MITF activity are oncogenic with BRAF V600E  to promote melanoma  in vivo , and that abrogating MITF activity in melanoma leads to rapid tumor regression 
[?A textMine:conj ?C, ?A textMine:prep ?mutation, ?function textMine:amod ?impact, ?C textMine:nsubj ?function]
Query : [?A textMine:conj ?C, ?A textMine:prep ?mutation, ?function textMine:amod ?impact, ?C textMine:nsubj ?function]
Existing trips : 
?A textMine:nsubj ?function. ?D textMine:conj ?A. ?D textMine:prep ?mutation. ?function textMine:amod ?impact. 
Similar Query!!!!


1158 These experiments also indicated that HEL cells, that display multiple copies of  JAK2 V617F, resulted significantly less sensitive than the  JAK2 V617F heterozygous SET2 cells 
[?C textMine:nsubj ?mutation, ?D textMine:acomp ?function, ?D textMine:advcl ?C, ?function textMine:advmod ?impact]
Added to queryTripless!! : ?C textMine:nsubj ?mutation. ?D textMine:acomp ?function. ?D textMine:advcl ?C. ?function textMine:advmod ?negative. 
861

1159 Cells expressing the L747_E749del A750P and D770_N771insNPG  EGFR  mutants also exhibited a greater degree of loss of contact inhibition than was observed in cells expressing the L858R or G719S EGFR mutants in a primary focus formation assay (unpublished data) 
[?C textMine:prep ?F, ?C textMine:amod ?impact, ?F textMine:prep ?function, ?D textMine:dobj ?C, ?D textMine:nsubj ?H, ?H textMine:partmod ?A, ?A textMine:dobj ?mutation]
Added to queryTripless!! : ?C textMine:prep ?F. ?C textMine:amod ?positive. ?F textMine:prep ?function. ?D textMine:dobj ?C. ?D textMine:nsubj ?H. ?H textMine:partmod ?A. ?A textMine:dobj ?mutation. 
862

1160 In the context of wildtype RAF (BRAF or CRAF)  and  high Ras activity, BRAF V600E  inhibition may “paradoxically” enhance MAPK activity [ 60 ,  61 ] 
[?A textMine:dobj ?function, ?A textMine:nsubj ?B, ?A textMine:prep ?G, ?F textMine:amod ?impact, ?G textMine:prep ?F, ?B textMine:nn ?mutation]
Added to queryTripless!! : ?A textMine:dobj ?function. ?A textMine:nsubj ?B. ?A textMine:prep ?G. ?F textMine:amod ?positive. ?G textMine:prep ?F. ?B textMine:nn ?mutation. 
863

1161 While FLT3 ITD (red) and FLT3 D835Y (blue) displayed very high sensitivity towards 17 AAG treatment, the efficacy was slightly lower against FLT3 ITD N676K and FLT3 ITD F691L at 1 µM ( Figure 3B ) 
[?function textMine:amod ?impact, ?A textMine:prep ?mutation, ?A textMine:advcl ?B, ?B textMine:dobj ?function]
Added to queryTripless!! : ?function textMine:amod ?positive. ?A textMine:prep ?mutation. ?A textMine:advcl ?B. ?B textMine:dobj ?function. 
864

1162 In colon cancer suppression of BRAF in cell lines with BRAF V600E  showed significant decreased proliferation through cyclin D1 and p27 Kip1  and induces apoptosis by a significant decrease in the levels of anti apoptotic protein Bcl 2   
[?A textMine:prep ?impact, ?A textMine:nsubj ?mutation, ?B textMine:conj ?A, ?B textMine:dobj ?function, ?B textMine:nsubj ?mutation]
Added to queryTripless!! : ?A textMine:prep ?negative. ?A textMine:nsubj ?mutation. ?B textMine:conj ?A. ?B textMine:dobj ?function. ?B textMine:nsubj ?mutation. 
865

1163 P61BRAF V600E  expressing cells remained sensitive to the MEK inhibitor Selumetinib 
[?function textMine:cop ?impact, ?function textMine:nsubj ?mutation]
Added to queryTripless!! : ?function textMine:cop ?neutral. ?function textMine:nsubj ?mutation. 
866

1164 Studying how BRAF V600E  altered kinase activity in patients with PTC creates alterations in the already complex tumor cell–ECM interactions has been a logical next step for our laboratory 
[?B textMine:nsubj ?impact, ?B textMine:ccomp ?C, ?A textMine:nsubj ?function, ?D textMine:dep ?A, ?C textMine:nsubj ?mutation, ?impact textMine:prep ?D]
Added to queryTripless!! : ?B textMine:nsubj ?unknown. ?B textMine:ccomp ?C. ?A textMine:nsubj ?function. ?D textMine:dep ?A. ?C textMine:nsubj ?mutation. ?unknown textMine:prep ?D. 
867

1165 One includes ERK signaling reactivation, caused by point mutations in MEK1[ 10 ,  15 ], amplification of mutant BRAF(V600E)[ 16 ], elevated CRAF activity[ 17 ], activating NRAS mutations [ 11 ], increased levels of COT/Tpl2[ 12 ] and/or aberrantly spliced BRAF(V600E)[ 13 ] 
[?D textMine:partmod ?function, ?D textMine:partmod ?E, ?I textMine:rcmod ?impact, ?F textMine:appos ?mutation, ?E textMine:prep ?I, ?H textMine:conj ?C, ?H textMine:dep ?A, ?C textMine:dobj ?F, ?A textMine:dobj ?D]
Added to queryTripless!! : ?D textMine:partmod ?function. ?D textMine:partmod ?E. ?I textMine:rcmod ?positive. ?F textMine:appos ?mutation. ?E textMine:prep ?I. ?H textMine:conj ?C. ?H textMine:dep ?A. ?C textMine:dobj ?F. ?A textMine:dobj ?D. 
868

1166 Preliminary studies by transfection of cell lines with EGFR  mutant constructs revealed that in the absence of ligand (EGF), an enhanced tyrosine autophosphorylation can be observed in cells harbouring the plasmid containing EGFR R776G when compared with wild type EGFR, providing biochemical evidence of the functional relevance of this mutation 
[?A textMine:partmod ?G, ?H textMine:partmod ?B, ?B textMine:dobj ?A, ?G textMine:dobj ?mutation, ?function textMine:amod ?impact, ?F textMine:prep ?H, ?F textMine:nsubjpass ?function]
Added to queryTripless!! : ?A textMine:partmod ?G. ?H textMine:partmod ?B. ?B textMine:dobj ?A. ?G textMine:dobj ?mutation. ?function textMine:amod ?positive. ?F textMine:prep ?H. ?F textMine:nsubjpass ?function. 
869

1167 Hence, E884K mutation can work in concert with L858R to modulate mutant receptor sensitivity to different targeted inhibitors 
[?A textMine:prep ?mutation, ?B textMine:xcomp ?impact, ?B textMine:prep ?A, ?impact textMine:dobj ?function]
Added to queryTripless!! : ?A textMine:prep ?mutation. ?B textMine:xcomp ?unknown. ?B textMine:prep ?A. ?unknown textMine:dobj ?function. 
870

1168 AP26113 has a fivefold greater potency than does crizotinib in inhibiting ALK as well as the L1196M gatekeeper mutation (Katayama et al, 2011) 
[?function textMine:dobj ?A, ?F textMine:dep ?B, ?F textMine:amod ?impact, ?A textMine:amod ?mutation, ?B textMine:prepc ?function]
Added to queryTripless!! : ?function textMine:dobj ?A. ?F textMine:dep ?B. ?F textMine:amod ?positive. ?A textMine:amod ?mutation. ?B textMine:prepc ?function. 
871

1169 Patient  # 1 lacked the KIT D816V mutation and mast cells from this patient exhibited a dose dependent decrease in survival in response to the SP inhibitors ( Figure 5A ) 
[?D textMine:partmod ?A, ?A textMine:dobj ?impact, ?C textMine:prep ?D, ?C textMine:dobj ?F, ?impact textMine:prep ?function, ?F textMine:nn ?mutation]
Added to queryTripless!! : ?D textMine:partmod ?A. ?A textMine:dobj ?negative. ?C textMine:prep ?D. ?C textMine:dobj ?F. ?negative textMine:prep ?function. ?F textMine:nn ?mutation. 
872

1170 For instance, Das Thakur and colleagues argued that vemurafenib resistant melanoma cells exhibit similar resistance to the MEK inhibitor AZD6244, due to elevated BRAF (V600E) expression  7  
[?function textMine:amod ?impact, ?function textMine:appos ?mutation]
Added to queryTripless!! : ?function textMine:amod ?positive. ?function textMine:appos ?mutation. 
873

1171 Hence, E884K in  cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone, through differential inhibition of the pro survival AKT and STAT3 signaling pathways associated with altered induction of cleaved PARP(Asp214) 
[?G textMine:partmod ?E, ?C textMine:prep ?G, ?C textMine:dobj ?function, ?C textMine:nsubj ?mutation, ?E textMine:prep ?F, ?F textMine:amod ?impact]
Added to queryTripless!! : ?G textMine:partmod ?E. ?C textMine:prep ?G. ?C textMine:dobj ?function. ?C textMine:nsubj ?mutation. ?E textMine:prep ?F. ?F textMine:amod ?unknown. 
874

1172 The EGFR  T790M variant changes the structural conformation of the ATP binding site, thereby increasing the affinity of ATP to EGFR, while the affinity of gefitinib to ATP is unchanged 
[?impact textMine:nsubj ?function, ?H textMine:advcl ?impact, ?E textMine:dobj ?C, ?E textMine:nsubj ?G, ?C textMine:prep ?F, ?F textMine:partmod ?H, ?G textMine:nn ?mutation]
Added to queryTripless!! : ?neutral textMine:nsubj ?function. ?H textMine:advcl ?neutral. ?E textMine:dobj ?C. ?E textMine:nsubj ?G. ?C textMine:prep ?F. ?F textMine:partmod ?H. ?G textMine:nn ?mutation. 
875

1173 As previously reported  , levels of phosphorylated RET and ERK were constitutively high in untreated PC12/MEN2A cells due to the presence of the active RET C634Y  allele 
[?A textMine:prep ?C, ?impact textMine:prep ?B, ?B textMine:prep ?A, ?C textMine:nn ?mutation, ?C textMine:amod ?function]
Added to queryTripless!! : ?A textMine:prep ?C. ?positive textMine:prep ?B. ?B textMine:prep ?A. ?C textMine:nn ?mutation. ?C textMine:amod ?function. 
876

1174 A mutant form of E17K, which has increased phosphorylation, is located at the plasma membrane in response to growth factor stimulation 
[?impact textMine:dobj ?function, ?C textMine:prep ?mutation, ?C textMine:rcmod ?impact]
Added to queryTripless!! : ?positive textMine:dobj ?function. ?C textMine:prep ?mutation. ?C textMine:rcmod ?positive. 
877

1175 Intriguingly, tyrosine phosphorylation of PECAM 1 as well as its physical association with SHP2 was enhanced by the imatinib resistance E255K or T315I mutation 
[?impact textMine:agent ?mutation, ?impact textMine:nsubjpass ?function]
[?impact textMine:agent ?mutation, ?impact textMine:nsubjpass ?function, ]
Match 


1176 Similar to E884K, R958D modulated the sensitizing effect of L858R differentially to reversible EGFR inhibitors when in  cis  (with L858R) 
[?A textMine:nn ?mutation, ?E textMine:amod ?function, ?B textMine:prep ?A, ?impact textMine:dobj ?E, ?impact textMine:nsubj ?B]
[?A textMine:nn ?mutation, ?B textMine:prep ?A, ?E textMine:amod ?function, ?impact textMine:dobj ?E, ?impact textMine:nsubj ?B, ]
Match 


1177 Colorectal cancer has been analyzed with the BRAF V600E mutation specific antibody and most studies find high sensitivities and specificities (988–100%) in comparison with PCR based methods or sequencing   
[?function textMine:amod ?impact, ?D textMine:nn ?mutation, ?B textMine:conj ?C, ?B textMine:prep ?D, ?C textMine:dobj ?function]
Added to queryTripless!! : ?function textMine:amod ?positive. ?D textMine:nn ?mutation. ?B textMine:conj ?C. ?B textMine:prep ?D. ?C textMine:dobj ?function. 
878

1178 To confirm DUB regulation through BRAF activation, mutant BRAF (V600E) was expressed in HEK293T cells and DUB activity assessments were used to demonstrate increased Usp5 activity in cells expressing BRAF V600E  (Fig  1F ) 
[?function textMine:prep ?C, ?function textMine:amod ?impact, ?D textMine:dobj ?mutation, ?C textMine:partmod ?D]
Added to queryTripless!! : ?function textMine:prep ?C. ?function textMine:amod ?positive. ?D textMine:dobj ?mutation. ?C textMine:partmod ?D. 
879

1179 The convincing clinical response observed in the patient with the L576P mutation in exon 11 (Case 3) is interesting to note in the context of  in vitro  data demonstrating reduced sensitivity to imatinib compared with other exon 11 mutations ( Antonescu  et al , 2007 ) 
[?A textMine:dobj ?function, ?function textMine:amod ?impact, ?H textMine:prepc ?A, ?H textMine:xsubj ?E, ?G textMine:amod ?mutation, ?I textMine:prep ?G, ?D textMine:prep ?I, ?E textMine:partmod ?D]
Added to queryTripless!! : ?A textMine:dobj ?function. ?function textMine:amod ?negative. ?H textMine:prepc ?A. ?H textMine:xsubj ?E. ?G textMine:amod ?mutation. ?I textMine:prep ?G. ?D textMine:prep ?I. ?E textMine:partmod ?D. 
880

1180 We also find that a melanoma associated mutation within the pseudosubstrate sequence, P52L, disrupts PAK6 autoinhibition enhancing its kinase activity, potentially correlating with increased expression of PAK6 in prostate cancer, and implied alterations in kinase activity  
[?function textMine:amod ?impact, ?B textMine:prep ?function, ?A textMine:conj ?B, ?A textMine:appos ?mutation]
Added to queryTripless!! : ?function textMine:amod ?positive. ?B textMine:prep ?function. ?A textMine:conj ?B. ?A textMine:appos ?mutation. 
881

1181 MST1 expression significantly increased apoptosis, which is reduced by expression of BRAF V600E  
[?impact textMine:agent ?B, ?function textMine:rcmod ?impact, ?B textMine:prep ?mutation]
Added to queryTripless!! : ?negative textMine:agent ?B. ?function textMine:rcmod ?negative. ?B textMine:prep ?mutation. 
882

1182 Notably, inhibition of phosphorylation of the D816V mutation was significantly reduced compared to the D816Y and D816F isoforms 
[?impact textMine:nsubjpass ?function, ?impact textMine:pobj ?B, ?B textMine:nn ?mutation]
[?B textMine:nn ?mutation, ?impact textMine:nsubjpass ?function, ?impact textMine:pobj ?B, ]
Match 


1183 Conversely, E884K worked in concert with L858R in  cis  to further enhance the sensitivity of the mutant receptor to gefitinib inhibition ( Fig 1A, B ) 
[?B textMine:xcomp ?impact, ?B textMine:prep ?mutation, ?impact textMine:dobj ?function]
[?B textMine:prep ?mutation, ?B textMine:xcomp ?impact, ?impact textMine:dobj ?function, ]
Match 


1184 The mutations E255V, M244V, T315A, Y253H, experience increased vdW interactions with Met290 and the mutation M244V experiences increased vdW interactions with Ile293 
[?B textMine:dobj ?function, ?B textMine:nsubj ?C, ?function textMine:amod ?impact, ?C textMine:prep ?mutation]
Query : [?B textMine:dobj ?function, ?B textMine:nsubj ?C, ?function textMine:amod ?impact, ?C textMine:prep ?mutation]
Existing trips : 
?A textMine:dobj ?function. ?A textMine:nsubj ?C. ?C textMine:prep ?mutation. ?function textMine:amod ?impact. 
Similar Query!!!!


1185 One hypothesis may state that induction of apoptosis is mediated via Thr308: We observed a particular high phosphorylation pattern of Thr308 in cells transfected with the tyrosine kinase domain (TKD) mutated  FLT3  D835V and  KIT  D816Y isoforms in our assays (see Figure  6 ) 
[?G textMine:partmod ?E, ?C textMine:nn ?function, ?C textMine:amod ?impact, ?A textMine:dobj ?mutation, ?E textMine:prep ?F, ?F textMine:partmod ?A, ?I textMine:prep ?G, ?I textMine:dobj ?C]
Added to queryTripless!! : ?G textMine:partmod ?E. ?C textMine:nn ?function. ?C textMine:amod ?positive. ?A textMine:dobj ?mutation. ?E textMine:prep ?F. ?F textMine:partmod ?A. ?I textMine:prep ?G. ?I textMine:dobj ?C. 
883

1186 Among the investigated melanoma cell lines, three display constitutive activation of the Ras/Raf/MEK/ERK pathway through activating V600E BRAF mutation or NRAS mutations: Colo 679 (BRAF V600E mut; Nras wt), IGR 39 (BRAF V600E mut; Nras wt), IPC298 (Braf wt; Nras Q61K mut)  
[?E textMine:appos ?B, ?function textMine:dobj ?C, ?impact textMine:prepc ?function, ?F textMine:nn ?mutation, ?C textMine:dep ?E, ?B textMine:appos ?F]
[?B textMine:appos ?F, ?C textMine:dep ?E, ?E textMine:appos ?B, ?F textMine:nn ?mutation, ?function textMine:dobj ?C, ?impact textMine:prepc ?function, ]
Match 


1187 We noted that the autophosphorylation level (pY1092) of YFP EGFR ICD T790M was indeed higher than that of the wild type protein at lower expression levels (compare graphs in Figure 1D  and Figure  4B ), as reported by Vikis et al   
[?impact textMine:nsubj ?E, ?impact textMine:prep ?C, ?C textMine:nn ?function, ?E textMine:prep ?mutation]
Added to queryTripless!! : ?positive textMine:nsubj ?E. ?positive textMine:prep ?C. ?C textMine:nn ?function. ?E textMine:prep ?mutation. 
884

1188 Introduction  of a melanoma associated mutation, P52L, into this peptide reduces pseudosubstrate autoinhibition of PAK6, and increases phosphorylation of its substrate PACSIN1 (Syndapin I) in cells 
[?B textMine:partmod ?E, ?C textMine:prep ?B, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ?E textMine:dobj ?G, ?G textMine:appos ?mutation]
Added to queryTripless!! : ?B textMine:partmod ?E. ?C textMine:prep ?B. ?positive textMine:dobj ?function. ?positive textMine:nsubj ?C. ?E textMine:dobj ?G. ?G textMine:appos ?mutation. 
885

1189 In vitro studies by Guo and colleagues suggested that Nilotinib in cell lines transfected with a KIT gene containing an exon 9 or 11 mutation with an exon 17 mutation (D820Y and N822 K) demonstrated significant kinase inhibition as well as decreased cell proliferation The Japanese study also documented a partial response in patients whose GIST contained a KIT exon 11 (dup 567–576) and exon 17 (D820G) mutation   
[?F textMine:dobj ?B, ?function textMine:amod ?impact, ?G textMine:nsubj ?C, ?G textMine:dobj ?function, ?B textMine:appos ?mutation, ?J textMine:dep ?F, ?C textMine:partmod ?E, ?E textMine:dobj ?A, ?A textMine:prep ?J]
[?A textMine:prep ?J, ?B textMine:appos ?mutation, ?C textMine:partmod ?E, ?E textMine:dobj ?A, ?F textMine:dobj ?B, ?G textMine:dobj ?function, ?G textMine:nsubj ?C, ?J textMine:dep ?F, ?function textMine:amod ?impact, ]
Match 


1190 The coexistent mutations of  AKT3  and  PIK3CA  in one sample suggest that some types of  AKT  mutations (non E17K) might coexist with  PIK3CA  mutations to enhance the activation of the PI3 kinase–AKT pathway 
[?A textMine:appos ?mutation, ?impact textMine:dobj ?function, ?impact textMine:xsubj ?A]
[?A textMine:appos ?mutation, ?impact textMine:dobj ?function, ?impact textMine:xsubj ?A, ]
Match 


1191 Our analysis revealed that the T790M mutation significantly increased the distance between the P loop and activation loop, whereas the G719S mutation significantly shortened the distance between the P loop and activation loop ( Supplementary Figure 2 ) 
[?impact textMine:dobj ?B, ?impact textMine:nsubj ?H, ?I textMine:nn ?function, ?H textMine:nn ?mutation, ?G textMine:dep ?E, ?E textMine:dobj ?F, ?F textMine:prep ?I, ?B textMine:prep ?G]
Added to queryTripless!! : ?positive textMine:dobj ?B. ?positive textMine:nsubj ?H. ?I textMine:nn ?function. ?H textMine:nn ?mutation. ?G textMine:dep ?E. ?E textMine:dobj ?F. ?F textMine:prep ?I. ?B textMine:prep ?G. 
886

1192 In a recent study  , we found a significantly increased MVD and VEGF expression in MPN compared to controls, particularly in cases with high JAK2 V617F  mutant allele burdens 
[?A textMine:nn ?mutation, ?C textMine:prep ?A, ?E textMine:prep ?C, ?E textMine:dobj ?function, ?E textMine:dobj ?F, ?F textMine:conj ?function, ?F textMine:amod ?impact]
Added to queryTripless!! : ?A textMine:nn ?mutation. ?C textMine:prep ?A. ?E textMine:prep ?C. ?E textMine:dobj ?function. ?E textMine:dobj ?F. ?F textMine:conj ?function. ?F textMine:amod ?positive. 
887

1193 (A) JAK2 K539L, T875N and R683G all induce constitutive activation of JAK2, however all three mutants display a marked decrease in STAT5 transcriptional activity in γ 2A cells when the F595A mutation is also introduced 
[?C textMine:dep ?A, ?C textMine:dobj ?D, ?C textMine:nsubj ?mutation, ?E textMine:prep ?function, ?D textMine:amod ?impact, ?A textMine:dobj ?E]
Query : [?C textMine:dep ?A, ?C textMine:dobj ?D, ?C textMine:nsubj ?mutation, ?E textMine:prep ?function, ?D textMine:amod ?impact, ?A textMine:dobj ?E]
Existing trips : 
?B textMine:dobj ?F. ?D textMine:dep ?B. ?D textMine:dobj ?E. ?D textMine:nsubj ?mutation. ?E textMine:amod ?impact. ?F textMine:prep ?function. 
Similar Query!!!!


1194 Intriguingly, the imatinib resistant BCR/ABL mutants E255K and T315I showed increased ability as compared with native BCR/ABL to induce tyrosine phosphorylation of PECAM 1 when expressed in the murine model hematopoietic cell line BaF3 cells or in 293T cells ( Fig 4 ) 
[?B textMine:dobj ?function, ?E textMine:infmod ?B, ?E textMine:amod ?impact, ?A textMine:dobj ?E, ?A textMine:nsubj ?mutation]
[?A textMine:dobj ?E, ?A textMine:nsubj ?mutation, ?B textMine:dobj ?function, ?E textMine:amod ?impact, ?E textMine:infmod ?B, ]
Match 


1195 Indeed, upon the addition of NN, hTMSC chemotactic migration was significantly reduced compared with the control condition as well as to N C  stimulated cells ( Fig. 3  A )  Furthermore, in NSCLC line H1975, which expresses EGFR with the double mutation L858R and T790M as well as HER2 and HER3  , NN stimulation reduced chemokinesis relative to NRG stimulated and untreated control cells ( Fig 3 ,  B  and  C ) 
[?H textMine:pobj ?G, ?G textMine:partmod ?C, ?A textMine:rcmod ?E, ?F textMine:nsubj ?impact, ?E textMine:dobj ?function, ?I textMine:xcomp ?F, ?I textMine:advcl ?H, ?C textMine:prep ?A]
[?A textMine:rcmod ?E, ?C textMine:prep ?A, ?E textMine:dobj ?function, ?F textMine:nsubj ?impact, ?G textMine:partmod ?C, ?H textMine:pobj ?G, ?I textMine:advcl ?H, ?I textMine:xcomp ?F, ]
Match 


1196 Although inhibition of MEK and ERK phosphorylation was achieved in BRAF V600E/K  mutant melanoma, significantly increased tumour growth was seen in BRAF wild type melanomas with upstream RAS mutations 
[?impact textMine:advcl ?B, ?B textMine:prep ?C, ?B textMine:nsubjpass ?function, ?C textMine:nn ?mutation]
[?B textMine:nsubjpass ?function, ?B textMine:prep ?C, ?C textMine:nn ?mutation, ?impact textMine:advcl ?B, ]
Match 


1197 However, when used in combination, NAC enhanced the inhibitory effect of PLX4032 (BRAF V600E inhibitor) and Gefitinib (EGFR inhibitor), on FO 1 and PT4 cell survival 
[?D textMine:appos ?C, ?C textMine:nn ?mutation, ?impact textMine:prep ?function, ?impact textMine:dobj ?A, ?A textMine:prep ?D]
Added to queryTripless!! : ?D textMine:appos ?C. ?C textMine:nn ?mutation. ?positive textMine:prep ?function. ?positive textMine:dobj ?A. ?A textMine:prep ?D. 
888

1198 In H3255 cells (EGFR L858R ), which display impaired EGF mediated SHP2 phosphorylation relative to cells expressing wild type EGFR (  7  ;  Supplementary Figure S2 ), SHP2 knockdown had no substantial effect on ERK phosphorylation at any concentration of gefitinib 
[?G textMine:nn ?impact, ?A textMine:ccomp ?B, ?E textMine:dobj ?H, ?E textMine:prep ?D, ?B textMine:nsubj ?G, ?D textMine:appos ?mutation, ?D textMine:rcmod ?A, ?H textMine:prep ?function]
Added to queryTripless!! : ?G textMine:nn ?negative. ?A textMine:ccomp ?B. ?E textMine:dobj ?H. ?E textMine:prep ?D. ?B textMine:nsubj ?G. ?D textMine:appos ?mutation. ?D textMine:rcmod ?A. ?H textMine:prep ?function. 
889

1199 Moreover, significant suppression of pERK following BRAF degradation by 17 AAG has also contributed to a MEK dependent DR4 downregulation in the presence of attenuated BRAF V600E  activity 
[?function textMine:amod ?impact, ?function textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:amod ?negative. ?function textMine:nn ?mutation. 
890

1200 The T790M  EGFR  mutant exhibited higher level of tyrosine phosphorylation than wild type  EGFR , and the T790M/L858R double mutant exhibited a substantial increase in phosphorylation levels compared with the L858R mutant alone  
[?B textMine:nn ?mutation, ?D textMine:nn ?function, ?C textMine:pobj ?B, ?C textMine:prep ?D, ?H textMine:conj ?C, ?H textMine:dobj ?A, ?A textMine:amod ?impact]
Added to queryTripless!! : ?B textMine:nn ?mutation. ?D textMine:nn ?function. ?C textMine:pobj ?B. ?C textMine:prep ?D. ?H textMine:conj ?C. ?H textMine:dobj ?A. ?A textMine:amod ?positive. 
891

1201 It is believed that V617F mutation enables JAK2 to be constitutively active by reliving the negative regulatory interaction between its kinase and pseudo kinase domains 
[?E textMine:xcomp ?function, ?E textMine:nsubj ?C, ?C textMine:nn ?mutation, ?function textMine:advmod ?impact]
Query : [?E textMine:xcomp ?function, ?E textMine:nsubj ?C, ?C textMine:nn ?mutation, ?function textMine:advmod ?impact]
Existing trips : 
?A textMine:nn ?mutation. ?C textMine:nsubj ?A. ?C textMine:xcomp ?function. ?function textMine:advmod ?impact. 
Similar Query!!!!


1202 Hence, the double mutation L858R+E884K modulated basal and stimulated downstream EGFR signaling differentially with differential effects on the AKT (down regulated), CBL and MAPK ERK1/2 phosphorylation (up regulated) 
[?impact textMine:xcomp ?B, ?impact textMine:nsubj ?mutation, ?B textMine:prep ?function]
[?B textMine:prep ?function, ?impact textMine:nsubj ?mutation, ?impact textMine:xcomp ?B, ]
Match 


1203 Graph shows that autophosphorylation levels are lower for T790M (white diamonds) than for S768I (white squares) or Ins770SVD (black triangles) 
[?D textMine:pobj ?mutation, ?E textMine:pcomp ?D, ?impact textMine:prep ?E, ?impact textMine:nsubj ?F, ?F textMine:nn ?function]
Added to queryTripless!! : ?D textMine:pobj ?mutation. ?E textMine:pcomp ?D. ?negative textMine:prep ?E. ?negative textMine:nsubj ?F. ?F textMine:nn ?function. 
892

1204 For instance, the A391E mutation in FGFR3 increases FGFR3 phosphorylation at low ligand concentration, similarly to the G380R and G375C ACH mutations studied here  
[?B textMine:amod ?function, ?D textMine:amod ?mutation, ?impact textMine:prep ?B, ?impact textMine:nsubj ?D]
Added to queryTripless!! : ?B textMine:amod ?function. ?D textMine:amod ?mutation. ?positive textMine:prep ?B. ?positive textMine:nsubj ?D. 
893

1205 BCR ABL1 ,  FLT3  D835V and  KIT  D816Y transfectants displayed an intermediate sensitivity pattern (estimated IC50s for NVP BEZ235 ~10 130 nM and ~65 180 nM for NVP BGT226) whereas  FLT3  ITD demonstrated high sensitivity for both agents with IC50s below 10 nM 
[?C textMine:dobj ?function, ?A textMine:nsubj ?mutation, ?A textMine:advcl ?C, ?function textMine:amod ?impact]
Query : [?C textMine:dobj ?function, ?A textMine:nsubj ?mutation, ?A textMine:advcl ?C, ?function textMine:amod ?impact]
Existing trips : 
?A textMine:advcl ?C. ?A textMine:dobj ?function. ?C textMine:nsubj ?mutation. ?function textMine:amod ?impact. 
Similar Query!!!!


1206 Moreover, E884K had a dominant effect over L858R, when in  cis , in these signaling modulatory effects 
[?D textMine:prep ?function, ?D textMine:dobj ?C, ?D textMine:nsubj ?mutation, ?C textMine:amod ?impact]
[?C textMine:amod ?impact, ?D textMine:dobj ?C, ?D textMine:nsubj ?mutation, ?D textMine:prep ?function, ]
Match 


1207 The use of recombinant IFN α (rIFN α 2b) or PEG IFN α 2a in the treatment of PV can result in a significant reduction in the phlebotomy rate and is effective in inducing hematologic remission and in some cases reducing expression of  JAK2  V617F  [ 33 ] 
[?impact textMine:dobj ?function, ?function textMine:prep ?B, ?B textMine:nn ?mutation]
Query : [?impact textMine:dobj ?function, ?function textMine:prep ?B, ?B textMine:nn ?mutation]
Existing trips : 
?D textMine:nn ?mutation. ?function textMine:prep ?D. ?impact textMine:dobj ?function. 
Similar Query!!!!


1208 Immediately after introduction of EphA2 into non transformed immortalized melanocytes, there was a notable increase in the subG1 fraction, which was additive with ectopic Braf V600E  expression ( Figure 5A ) 
[?function textMine:nn ?mutation, ?impact textMine:prep ?C, ?B textMine:prep ?function, ?C textMine:rcmod ?B]
Added to queryTripless!! : ?function textMine:nn ?mutation. ?positive textMine:prep ?C. ?B textMine:prep ?function. ?C textMine:rcmod ?B. 
894

1209 The E17K mutation constitutively activates Akt1 by altering the kinetics and specificity of phospholipid binding, increasing the binding to PIP2, the more abundant plasma membrane phospholipid in the absence of PI3 kinase activation  
[?E textMine:dobj ?function, ?impact textMine:nn ?mutation, ?A textMine:partmod ?E, ?A textMine:nsubj ?impact]
Added to queryTripless!! : ?E textMine:dobj ?function. ?positive textMine:nn ?mutation. ?A textMine:partmod ?E. ?A textMine:nsubj ?positive. 
895

1211 Two of these missense mutants, V689M and L703F are constitutively active, possibly because they stabilize acceptor/donor interactions   
[?A textMine:prep ?mutation, ?C textMine:advcl ?function, ?C textMine:nsubj ?A]
[?A textMine:prep ?mutation, ?C textMine:advcl ?function, ?C textMine:nsubj ?A, ]
Match 


1212 Mutant BRAF(V600E) represents a constitutively active protein serine kinase that leads to the sustained activation of the BRAF→MEK1/2→ERK1/2 MAP kinase pathway[ 3 ,  4 ] 
[?D textMine:rcmod ?G, ?D textMine:amod ?A, ?B textMine:appos ?mutation, ?C textMine:dobj ?D, ?C textMine:nsubj ?B, ?A textMine:advmod ?impact, ?G textMine:prep ?function]
Added to queryTripless!! : ?D textMine:rcmod ?G. ?D textMine:amod ?A. ?B textMine:appos ?mutation. ?C textMine:dobj ?D. ?C textMine:nsubj ?B. ?A textMine:advmod ?positive. ?G textMine:prep ?function. 
896

1213 In particular, it inhibited MET signalling, induced cellular apoptosis, and abrogated cytoskeletal functions (key controlling step in tumour invasion and metastasis)  in vitro  ( Birchmeier  et al , 2003 ), and was effective  in vivo , leading to cytoreduction of murine tumour xenografts of the T790M EGFR expressing erlotinib resistant H1975 cells 
[?A textMine:prep ?D, ?B textMine:nn ?mutation, ?D textMine:prep ?H, ?F textMine:partmod ?A, ?F textMine:dep ?impact, ?H textMine:prep ?B, ?impact textMine:dobj ?function]
Added to queryTripless!! : ?A textMine:prep ?D. ?B textMine:nn ?mutation. ?D textMine:prep ?H. ?F textMine:partmod ?A. ?F textMine:dep ?negative. ?H textMine:prep ?B. ?negative textMine:dobj ?function. 
897

1214 These results suggest that sorafenib distinctively enhanced apoptosis in these cells by inhibiting the T315I mutant to attenuate the Chk1 mediated checkpoint activation 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ?C textMine:nn ?mutation]
[?C textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?C, ]
Match 


1215 Hence, the dynamic control of Mcl 1 levels in cells with wild type JAK2   appears to be maintained in JAK2 V617F  mutant cells 
[?A textMine:num ?mutation, ?C textMine:amod ?function, ?impact textMine:prep ?A, ?impact textMine:xsubj ?C]
Added to queryTripless!! : ?A textMine:num ?mutation. ?C textMine:amod ?function. ?neutral textMine:prep ?A. ?neutral textMine:xsubj ?C. 
898

1216 F1174L, which recapitulates the primary mutation found in neuroblastoma previously shown to render the enzyme insensitive to crizotinib, appears instead to induce a conformational change in the protein which results in increased affinity for ATP itself 
[?D textMine:rcmod ?A, ?function textMine:amod ?impact, ?A textMine:prep ?function, ?E textMine:prep ?D, ?E textMine:xsubj ?mutation]
Added to queryTripless!! : ?D textMine:rcmod ?A. ?function textMine:amod ?positive. ?A textMine:prep ?function. ?E textMine:prep ?D. ?E textMine:xsubj ?mutation. 
899

1217 One of the putative passenger variants, G831E, although negative in the BaF3 assay, was also predicted to alter function 
[?E textMine:prep ?A, ?impact textMine:dobj ?function, ?impact textMine:xsubj ?E, ?A textMine:appos ?mutation]
Added to queryTripless!! : ?E textMine:prep ?A. ?unknown textMine:dobj ?function. ?unknown textMine:xsubj ?E. ?A textMine:appos ?mutation. 
900

1218 We noted that the autophosphorylation level (pY1092) of YFP EGFR ICD T790M was indeed higher than that of the wild type protein at lower expression levels (compare graphs in Figure 1D  and Figure  4B ), as reported by Vikis et al   
[?impact textMine:nsubj ?D, ?D textMine:prep ?mutation, ?D textMine:nn ?function]
Added to queryTripless!! : ?positive textMine:nsubj ?D. ?D textMine:prep ?mutation. ?D textMine:nn ?function. 
901

1219 In addition, the  JAK2  V617F  mutation may increase the stability of the JAK2 protein by rendering it resistant to the effect of SOCS3 binding, as overexpression of SOCS3 results in increased SOCS3 and  JAK2  V617F  phosphorylation [ 68 ] 
[?I textMine:num ?mutation, ?A textMine:amod ?impact, ?C textMine:prep ?function, ?D textMine:prep ?A, ?E textMine:conj ?I, ?E textMine:prep ?H, ?E textMine:prep ?C, ?H textMine:prep ?D]
Added to queryTripless!! : ?I textMine:num ?mutation. ?A textMine:amod ?positive. ?C textMine:prep ?function. ?D textMine:prep ?A. ?E textMine:conj ?I. ?E textMine:prep ?H. ?E textMine:prep ?C. ?H textMine:prep ?D. 
902

1220 Remarkably, abrogating MITF activity in  BRAF V600E mitf  melanoma leads to dramatic tumor regression marked by melanophage infiltration and increased apoptosis 
[?F textMine:partmod ?H, ?B textMine:nn ?mutation, ?H textMine:agent ?function, ?D textMine:prep ?B, ?G textMine:prep ?F, ?G textMine:nsubj ?D, ?function textMine:amod ?impact]
Added to queryTripless!! : ?F textMine:partmod ?H. ?B textMine:nn ?mutation. ?H textMine:agent ?function. ?D textMine:prep ?B. ?G textMine:prep ?F. ?G textMine:nsubj ?D. ?function textMine:amod ?positive. 
903

1221 Cell viability was decreased in all mesothelioma cell lines tested in response to ARQ 197, with those harboring the T1010I MET mutation (H513 and H2596) showing the greatest sensitivity 
[?impact textMine:prep ?F, ?G textMine:nn ?mutation, ?F textMine:partmod ?A, ?C textMine:dobj ?function, ?C textMine:nsubj ?G, ?H textMine:dep ?C, ?A textMine:prepc ?H]
Added to queryTripless!! : ?negative textMine:prep ?F. ?G textMine:nn ?mutation. ?F textMine:partmod ?A. ?C textMine:dobj ?function. ?C textMine:nsubj ?G. ?H textMine:dep ?C. ?A textMine:prepc ?H. 
904

1222 We also find that a melanoma associated mutation within the pseudosubstrate sequence, P52L, disrupts PAK6 autoinhibition enhancing its kinase activity, potentially correlating with increased expression of PAK6 in prostate cancer, and implied alterations in kinase activity  
[?C textMine:prep ?function, ?C textMine:dobj ?E, ?E textMine:prep ?impact, ?E textMine:prep ?B, ?B textMine:conj ?impact, ?B textMine:appos ?mutation]
Added to queryTripless!! : ?C textMine:prep ?function. ?C textMine:dobj ?E. ?E textMine:prep ?unknown. ?E textMine:prep ?B. ?B textMine:conj ?unknown. ?B textMine:appos ?mutation. 
905

1223 This mutation ( E17K ) increases recruitment of AKT1 to the membrane, increases AKT1 phosphorylation and activity, transforms Rat1 fibroblasts, and induces leukaemia in transgenic mice ( Carpten  et al , 2007 ) 
[?A textMine:appos ?mutation, ?E textMine:conj ?function, ?E textMine:conj ?impact, ?E textMine:nsubj ?A, ?function textMine:nsubj ?A, ?impact textMine:nsubj ?A]
[?A textMine:appos ?mutation, ?E textMine:conj ?function, ?E textMine:conj ?impact, ?E textMine:nsubj ?A, ?function textMine:nsubj ?A, ?impact textMine:nsubj ?A, ]
Match 


1224 Structurally, this residue lies in the substrate binding pocket of the kinase, and the M918T mutation appears to increase RET–ATP binding affinity and the stability of the active ATP bound form, effectively making RET more active, more of the time ( 48 )–( 51 ) 
[?C textMine:dep ?function, ?impact textMine:xsubj ?A, ?impact textMine:dobj ?C, ?A textMine:nn ?mutation]
Query : [?C textMine:dep ?function, ?impact textMine:xsubj ?A, ?impact textMine:dobj ?C, ?A textMine:nn ?mutation]
Existing trips : 
?B textMine:nn ?mutation. ?C textMine:dep ?function. ?impact textMine:dobj ?C. ?impact textMine:xsubj ?B. 
Similar Query!!!!


1225 More recently, results were published of another phase III trial comparing the BRAF inhibitor dabrafenib (a newer generation, reversible kinase inhibitor of V600E mutant BRAF with a higher affinity than the wildtype enzyme for mutant BRAF) to dacarbazine [ 22 ] 
[?C textMine:nn ?mutation, ?C textMine:prep ?function, ?function textMine:amod ?impact]
Added to queryTripless!! : ?C textMine:nn ?mutation. ?C textMine:prep ?function. ?function textMine:amod ?positive. 
906

1226 The mutations T315I, E255V, F317L and F317V contribute to decreased vdW interactions with Ala269 
[?D textMine:prep ?function, ?D textMine:dep ?E, ?function textMine:amod ?impact, ?E textMine:dep ?mutation]
[?D textMine:dep ?E, ?D textMine:prep ?function, ?E textMine:dep ?mutation, ?function textMine:amod ?impact, ]
Match 


1227 Vikis et al reported that standalone T790M mutations exhibit increased kinase activity 
[?function textMine:nn ?mutation, ?impact textMine:nsubj ?function]
[?function textMine:nn ?mutation, ?impact textMine:nsubj ?function, ]
Match 


1228 Conversely, E884K worked in concert with L858R in  cis  to further enhance the sensitivity of the mutant receptor to gefitinib inhibition ( Fig 1A, B ) 
[?impact textMine:xsubj ?mutation, ?impact textMine:dobj ?function]
[?impact textMine:dobj ?function, ?impact textMine:xsubj ?mutation, ]
Match 


1229 Some mutations (P112Q, R895C, E897K) enhance angiotensin II receptor mediated activation of TRPC6 when expressed in HEK293 cells, while neither the S270T nor the N143S missense mutations, nor a 57 amino acid truncation mutation (K874X), altered the channel activity   
[?C textMine:dobj ?function, ?C textMine:nsubj ?D, ?F textMine:advcl ?E, ?D textMine:partmod ?F, ?D textMine:nn ?impact, ?E textMine:advcl ?H, ?H textMine:nsubj ?mutation]
Added to queryTripless!! : ?C textMine:dobj ?function. ?C textMine:nsubj ?D. ?F textMine:advcl ?E. ?D textMine:partmod ?F. ?D textMine:nn ?positive. ?E textMine:advcl ?H. ?H textMine:nsubj ?mutation. 
907

1230 AMN107 maintains activity against 32/33 imatinib resistant  BCR ABL  mutants, but has no significant activity against the T315I mutant ( Table 1 ) ( Manley  et al , 2005 ;  O'Hare  et al , 2005 ;  Weisberg  et al , 2005 ) 
[?D textMine:dobj ?function, ?impact textMine:conj ?D, ?A textMine:nn ?mutation, ?function textMine:prep ?A]
Added to queryTripless!! : ?D textMine:dobj ?function. ?neutral textMine:conj ?D. ?A textMine:nn ?mutation. ?function textMine:prep ?A. 
908

1231 While ERBB2 L755S and ERBB2 L755P mutants remained sensitive to AEE788 at very high concentrations (IC90 below 2 µM), the gatekeeper ERBB2 T798M mutation is totally resistant (IC50>2 µM) to AEE788 treatment ( Figure 4B ) 
[?function textMine:cop ?impact, ?function textMine:nsubj ?B, ?B textMine:nn ?mutation]
Query : [?function textMine:cop ?impact, ?function textMine:nsubj ?B, ?B textMine:nn ?mutation]
Existing trips : 
?A textMine:nn ?mutation. ?function textMine:cop ?impact. ?function textMine:nsubj ?A. 
Similar Query!!!!


1232 It appears that PtdIns binding is enhanced in the E416A mutant for two reasons; (i) the Arg 380 –Glu 416  salt bridge, which otherwise blocks the entrance to the binding pocket, is broken, and (ii) the sentry glutamate residue, Glu 416 , is replaced by an alanine in this open state, which further increases the accessibility of the binding site for negatively charged lipid headgroups 
[?E textMine:prep ?A, ?H textMine:rcmod ?B, ?G textMine:agent ?I, ?A textMine:amod ?function, ?I textMine:prep ?H, ?D textMine:nn ?mutation, ?J textMine:conj ?G, ?J textMine:ccomp ?impact, ?B textMine:dobj ?E, ?impact textMine:prep ?D]
Added to queryTripless!! : ?E textMine:prep ?A. ?H textMine:rcmod ?B. ?G textMine:agent ?I. ?A textMine:amod ?function. ?I textMine:prep ?H. ?D textMine:nn ?mutation. ?J textMine:conj ?G. ?J textMine:ccomp ?positive. ?B textMine:dobj ?E. ?positive textMine:prep ?D. 
909

1233 It is striking that several of the variants with reduced activity had altered evolutionarily conserved glycine residues; that is, G220V, G401S, and G465R, suggesting that these residues may be particularly important for OCT1 function   
[?F textMine:prep ?A, ?A textMine:prep ?function, ?impact textMine:dobj ?B, ?impact textMine:nsubj ?F, ?B textMine:rcmod ?mutation]
Added to queryTripless!! : ?F textMine:prep ?A. ?A textMine:prep ?function. ?unknown textMine:dobj ?B. ?unknown textMine:nsubj ?F. ?B textMine:rcmod ?mutation. 
910

1234 Treatment of melanoma cells with BRAF (V600E) specific shRNA or MEK inhibitors resulted in decreased immunosuppressive activity of melanoma cells on DCs, suggesting that MAPK signaling pathway in cancer is associated with impaired DC function in melanoma patients 
[?G textMine:prep ?C, ?D textMine:appos ?mutation, ?C textMine:prep ?D, ?function textMine:amod ?impact, ?B textMine:prep ?function, ?B textMine:nsubj ?G]
Added to queryTripless!! : ?G textMine:prep ?C. ?D textMine:appos ?mutation. ?C textMine:prep ?D. ?function textMine:amod ?negative. ?B textMine:prep ?function. ?B textMine:nsubj ?G. 
911

1235 Finally, the researchers identified a new TKI resistance mutation (L747S, substitution of serine for leucine at position 747) in a patient whose TKI sensitive NSCLC had become resistant to gefitinib, and showed that this resistance mutation also reduced TKI induced apoptosis in cells growing in dishes by interfering with BIM up regulation 
[?B textMine:ccomp ?impact, ?C textMine:conj ?B, ?C textMine:dobj ?F, ?F textMine:dep ?G, ?impact textMine:ccomp ?function, ?G textMine:nn ?mutation]
Added to queryTripless!! : ?B textMine:ccomp ?negative. ?C textMine:conj ?B. ?C textMine:dobj ?F. ?F textMine:dep ?G. ?negative textMine:ccomp ?function. ?G textMine:nn ?mutation. 
912

1236 The presence of R164Q in cluster 2, rather than in cluster 1 with wt  K Ras  was therefore initially surprising, but suggests that the R164Q mutation also has an 'activating' phenotype, albeit attenuated relative to the other mutations studied 
[?impact textMine:nsubj ?B, ?impact textMine:dobj ?D, ?B textMine:nn ?mutation, ?D textMine:nn ?function]
[?B textMine:nn ?mutation, ?D textMine:nn ?function, ?impact textMine:dobj ?D, ?impact textMine:nsubj ?B, ]
Match 


1237 Research into the molecular mechanisms of BRAF V600E  positive tumors has revealed that the missense valine to glutamic acid mutation increases kinase activity, promoting the constitutive activation of MEK ERK signaling and enhancing ERK dependent transcriptional output  
[?D textMine:prep ?F, ?H textMine:dobj ?function, ?E textMine:ccomp ?impact, ?E textMine:nsubj ?D, ?F textMine:prep ?G, ?G textMine:nn ?mutation, ?impact textMine:partmod ?H]
[?D textMine:prep ?F, ?E textMine:ccomp ?impact, ?E textMine:nsubj ?D, ?F textMine:prep ?G, ?G textMine:nn ?mutation, ?H textMine:dobj ?function, ?impact textMine:partmod ?H, ]
Match 


1238 However, response to the EGFR TKIs may be short lived due possibly to a secondary mutation in the EGFR (T790M), or increased signaling through pathways downstream to the EGFR without its activation   
[?F textMine:prep ?I, ?I textMine:partmod ?A, ?D textMine:prep ?B, ?B textMine:appos ?mutation, ?A textMine:prep ?function, ?H textMine:conj ?impact, ?H textMine:prep ?D, ?impact textMine:xcomp ?F]
Added to queryTripless!! : ?F textMine:prep ?I. ?I textMine:partmod ?A. ?D textMine:prep ?B. ?B textMine:appos ?mutation. ?A textMine:prep ?function. ?H textMine:conj ?positive. ?H textMine:prep ?D. ?positive textMine:xcomp ?F. 
913

1239 Here, we present evidence that BRAF V600E  enhances migration and invasion properties in colon carcinoma cells through RhoA activation, while KRAS G12V  induces these properties less efficiently as compared to BRAF V600E , albeit through Cdc42 activation and filopodia formation 
[?C textMine:nn ?function, ?impact textMine:advcl ?D, ?impact textMine:dobj ?C, ?D textMine:pobj ?mutation]
Added to queryTripless!! : ?C textMine:nn ?function. ?positive textMine:advcl ?D. ?positive textMine:dobj ?C. ?D textMine:pobj ?mutation. 
914

1240 More recently, several groups have demonstrated that dasatinib treatment reduces tumor growth and inhibits metastasis in various mouse models of BRAF WT  and BRAF V600E  positive thyroid cancer [ 23 ,  27 ,  31 ] 
[?function textMine:prep ?E, ?C textMine:nn ?mutation, ?E textMine:prep ?C, ?impact textMine:conj ?function]
Added to queryTripless!! : ?function textMine:prep ?E. ?C textMine:nn ?mutation. ?E textMine:prep ?C. ?negative textMine:conj ?function. 
915

1241 BRAF  belongs to the RAF family of serine/threonine kinases and the V600E mutation results in constitutive activation in 45% of papillary thyroid carcinomas in adults 
[?function textMine:amod ?impact, ?D textMine:prep ?function, ?D textMine:amod ?mutation]
Added to queryTripless!! : ?function textMine:amod ?positive. ?D textMine:prep ?function. ?D textMine:amod ?mutation. 
916

1242 However, four mutations (E269S, S448N, K493E and K493Q), that had no effect on the sensitivity of PKR to inhibition by vacK3L H47R or varE3L, resulted in increased resistance to varC3L 
[?A textMine:dep ?mutation, ?function textMine:amod ?impact, ?C textMine:prep ?function, ?C textMine:nsubj ?E, ?E textMine:appos ?A]
Added to queryTripless!! : ?A textMine:dep ?mutation. ?function textMine:amod ?positive. ?C textMine:prep ?function. ?C textMine:nsubj ?E. ?E textMine:appos ?A. 
917

1243 We recently reported that the activity of the tumour suppressor protein phosphatase 2A (PP2A) is markedly inhibited in blast crisis CML patient cells and that molecular or pharmacologic re activation of PP2A phosphatase led to growth suppression, enhanced apoptosis, impaired clonogenic potential and decreased  in vivo  leukaemogenesis of imatinib sensitive and  resistant (T315I included) CML BC patient cells and/or BCR/ABL +  myeloid progenitor cell lines 
[?G textMine:appos ?function, ?C textMine:parataxis ?A, ?C textMine:dep ?D, ?D textMine:prep ?G, ?A textMine:nsubj ?mutation, ?function textMine:amod ?impact]
Added to queryTripless!! : ?G textMine:appos ?function. ?C textMine:parataxis ?A. ?C textMine:dep ?D. ?D textMine:prep ?G. ?A textMine:nsubj ?mutation. ?function textMine:amod ?positive. 
918

1244 Increased activation of Akt1 by E17K, L52R, C77F, and Q79K mutants led, as expected, to increased phosphorylation of Akt target proteins including FOXO1/3 and PRAS40 
[?function textMine:amod ?impact, ?A textMine:prep ?function, ?A textMine:nsubj ?E, ?C textMine:prep ?B, ?E textMine:prep ?C, ?B textMine:num ?mutation]
Added to queryTripless!! : ?function textMine:amod ?positive. ?A textMine:prep ?function. ?A textMine:nsubj ?E. ?C textMine:prep ?B. ?E textMine:prep ?C. ?B textMine:num ?mutation. 
919

1245 Hence, E884K in  cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone, through differential inhibition of the pro survival AKT and STAT3 signaling pathways associated with altered induction of cleaved PARP(Asp214) 
[?G textMine:partmod ?E, ?C textMine:prep ?G, ?C textMine:dobj ?function, ?C textMine:nsubj ?mutation, ?E textMine:prep ?F, ?F textMine:amod ?impact]
[?C textMine:dobj ?function, ?C textMine:nsubj ?mutation, ?C textMine:prep ?G, ?E textMine:prep ?F, ?F textMine:amod ?impact, ?G textMine:partmod ?E, ]
Match 


1246 E255K and T315I are the most predominant mutations of BCR/ABL causing imatinib resistance in patients and may increase the kinase activity or change the substrate preferences of BCR/ABL ( 15 , 18 ) 
[?impact textMine:nsubj ?mutation, ?impact textMine:dobj ?function]
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation, ]
Match 


1247 The former is the case of the S492R mutant, which confers resistance to cetuximab since the mutation is located in its binding epitope on the EGFR external domain  ; whereas the later is the case of the T790M mutant (mutation in the kinase domain), which confers resistance to gefitinib or erlotinib in lung adenocarcinomas   by stabilizing the active tyrosine kinase conformation and enhancing aTP binding   
[?D textMine:prepc ?impact, ?H textMine:parataxis ?E, ?H textMine:prep ?G, ?E textMine:prep ?A, ?impact textMine:acomp ?function, ?G textMine:nn ?mutation, ?A textMine:rcmod ?D]
Added to queryTripless!! : ?D textMine:prepc ?positive. ?H textMine:parataxis ?E. ?H textMine:prep ?G. ?E textMine:prep ?A. ?positive textMine:acomp ?function. ?G textMine:nn ?mutation. ?A textMine:rcmod ?D. 
920

1248 Our previous study also demonstrated that the COS 7 cell expressing c Met N375S  mutation was less sensitive to specific MET kinase inhibitors such as SU11274 compared to cell expressing  c Met  wild type  
[?E textMine:ccomp ?D, ?function textMine:advmod ?impact, ?function textMine:nsubj ?B, ?D textMine:amod ?mutation, ?B textMine:partmod ?E]
Added to queryTripless!! : ?E textMine:ccomp ?D. ?function textMine:advmod ?negative. ?function textMine:nsubj ?B. ?D textMine:amod ?mutation. ?B textMine:partmod ?E. 
921

1249 From  Table 2 , we observed that Leu298 has stable interactions with CF 3  throughout MD simulations in all mutations, while Leu354 experiences increased vdW interactions with mutations E255K and T315A 
[?impact textMine:dobj ?function, ?impact textMine:prep ?mutation]
[?impact textMine:dobj ?function, ?impact textMine:prep ?mutation, ]
Match 


1250 On the contrary, the initial status of the  JAK2 V617F genotype was significantly associated with the risk of incurring into BT (P<0.001); it resulted higher in patients who had either wt or homozygous V617F genotype with respect to those who had heterozygous genotype (HR, 1.98; 95% CI, 1.11 to 3.53; P = 0.019, and HR 2.04; 95% CI, 1.12 to 3 71; P = 0018, respectively) ( Figure 1 ) 
[?E textMine:nn ?mutation, ?D textMine:dobj ?E, ?F textMine:rcmod ?D, ?function textMine:prep ?F, ?function textMine:advmod ?impact]
Added to queryTripless!! : ?E textMine:nn ?mutation. ?D textMine:dobj ?E. ?F textMine:rcmod ?D. ?function textMine:prep ?F. ?function textMine:advmod ?positive. 
922

1251 The gene expression domain of  dlx3  is altered for both expression pattern and intensity of signal, such that there is no  dlx3  detected in the BRAF V600E  expressing embryos 
[?A textMine:prep ?mutation, ?A textMine:xcomp ?function, ?impact textMine:ccomp ?A]
Added to queryTripless!! : ?A textMine:prep ?mutation. ?A textMine:xcomp ?function. ?unknown textMine:ccomp ?A. 
923

1252 This unexpected facet of oncogenic RET M918T is in addition to increasing RET enzymatic activity and ATP affinity ( Figures 5  and  7 ) 
[?B textMine:prep ?mutation, ?function textMine:amod ?impact, ?A textMine:prep ?function, ?A textMine:nsubj ?B]
Added to queryTripless!! : ?B textMine:prep ?mutation. ?function textMine:amod ?positive. ?A textMine:prep ?function. ?A textMine:nsubj ?B. 
924

1253 Graph shows that the common L858R mutation confers higher autophosphorylation levels to YFP EGFR ICD than P848L and A859T 
[?D textMine:nn ?function, ?D textMine:amod ?impact, ?E textMine:prep ?C, ?E textMine:dobj ?D, ?C textMine:prep ?mutation]
[?C textMine:prep ?mutation, ?D textMine:amod ?impact, ?D textMine:nn ?function, ?E textMine:dobj ?D, ?E textMine:prep ?C, ]
Match 


1254 The addition of c MET siRNA to either EGFR wild type or T790M specific siRNAs, resulted in an increased effect on cell growth inhibition and caspase−3/7 activity induction 
[?G textMine:prep ?A, ?G textMine:ccomp ?E, ?E textMine:prep ?F, ?A textMine:prep ?function, ?A textMine:amod ?impact, ?F textMine:num ?mutation]
Added to queryTripless!! : ?G textMine:prep ?A. ?G textMine:ccomp ?E. ?E textMine:prep ?F. ?A textMine:prep ?function. ?A textMine:amod ?positive. ?F textMine:num ?mutation. 
925

1255 This agent has 325 fold greater activity against unmutated BCR ABL in vitro  than imatinib, and displays activity in all but one of the known imatinib resistant BCR ABL mutations (i e, T315I)   
[?C textMine:prep ?function, ?D textMine:amod ?impact, ?D textMine:prep ?C]
Added to queryTripless!! : ?C textMine:prep ?function. ?D textMine:amod ?positive. ?D textMine:prep ?C. 
926

1256 Some studies that investigated human periosteal fibroblasts  , murine osteoblasts  , murine stem cells  , or calvarial cells during embryonic sutures formation in murine AS models   point to the FGFR2 S252W  mutation as responsible for increasing cell proliferation 
[?E textMine:nn ?mutation, ?A textMine:prep ?E, ?function textMine:amod ?impact, ?F textMine:prep ?function, ?F textMine:rcmod ?A]
Query : [?E textMine:nn ?mutation, ?A textMine:prep ?E, ?function textMine:amod ?impact, ?F textMine:prep ?function, ?F textMine:rcmod ?A]
Existing trips : 
?A textMine:nn ?mutation. ?B textMine:prep ?A. ?B textMine:rcmod ?E. ?E textMine:prep ?function. ?function textMine:amod ?impact. 
Similar Query!!!!


1257 FGFR3 mRNA expression is higher in tumors with S249C FGFR3 mutation
[?B textMine:nn ?mutation, ?A textMine:prep ?B, ?impact textMine:prep ?A, ?impact textMine:nsubj ?function]
[?A textMine:prep ?B, ?B textMine:nn ?mutation, ?impact textMine:nsubj ?function, ?impact textMine:prep ?A, ]
Match 


1258 Hence, an effect of PLX4032 was recently demonstrated on the uptake of 18F FDG in melanoma cells, whereas inducible expression of  V600E BRAF increased the glucose uptake rate and decreased O 2  consumption in thyroid cancer cells   
[?C textMine:prep ?E, ?C textMine:amod ?function, ?impact textMine:nsubj ?C, ?E textMine:nn ?mutation]
Query : [?C textMine:prep ?E, ?C textMine:amod ?function, ?impact textMine:nsubj ?C, ?E textMine:nn ?mutation]
Existing trips : 
?B textMine:prep ?E. ?E textMine:amod ?function. ?E textMine:nn ?mutation. ?impact textMine:nsubj ?B. 
Similar Query!!!!


1259 Importantly, the wild type protein formed fibrils only at 10 μM erlotinib, whereas the TKI sensitive mutants relocated to fibrils in the presence of 10–100 nM erlotinib, and this effect was fully abrogated by the erlotinib resistant T790M mutation 
[?B textMine:nn ?mutation, ?impact textMine:agent ?B, ?impact textMine:nsubjpass ?function]
Query : [?B textMine:nn ?mutation, ?impact textMine:agent ?B, ?impact textMine:nsubjpass ?function]
Existing trips : 
?C textMine:nn ?mutation. ?impact textMine:agent ?C. ?impact textMine:nsubjpass ?function. 
Similar Query!!!!


1260 Mcl 1 depletion in JAK2 V617F  mutant SET 2 cells increases apoptosis and sensitizes the cells to NVP BSK805 induced cell death  
[?mutation textMine:rcmod ?function, ?function textMine:nsubj ?impact]
Added to queryTripless!! : ?mutation textMine:rcmod ?function. ?function textMine:nsubj ?positive. 
927

1261 Similar to E884K, R958D modulated the sensitizing effect of L858R differentially to reversible EGFR inhibitors when in  cis  (with L858R) 
[?A textMine:nn ?mutation, ?B textMine:prep ?A, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?B]
Query : [?A textMine:nn ?mutation, ?B textMine:prep ?A, ?impact textMine:dobj ?function, ?impact textMine:nsubj ?B]
Existing trips : 
?A textMine:prep ?B. ?B textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?A. 
Similar Query!!!!


1262 This is consistent with our observations that T315I cells have elevated basal level HR activity over parental cells ( Fig 3B and C ) 
[?B textMine:dobj ?function, ?B textMine:nsubj ?A, ?function textMine:amod ?impact, ?A textMine:nn ?mutation]
Query : [?B textMine:dobj ?function, ?B textMine:nsubj ?A, ?function textMine:amod ?impact, ?A textMine:nn ?mutation]
Existing trips : 
?C textMine:nn ?mutation. ?E textMine:dobj ?function. ?E textMine:nsubj ?C. ?function textMine:amod ?impact. 
Similar Query!!!!


1263 For 5 REs, representative of strong, moderate, weak, and nearly absent responsiveness to wild type p53, the functional assay was extended to five p53 missense germline mutations, of which three retain partial function (A138S, C141Y, R337C) and two are loss of function (A138P, R175H)   
[?B textMine:dep ?mutation, ?impact textMine:ccomp ?F, ?D textMine:appos ?B, ?F textMine:prep ?function, ?F textMine:nsubj ?D]
Added to queryTripless!! : ?B textMine:dep ?mutation. ?neutral textMine:ccomp ?F. ?D textMine:appos ?B. ?F textMine:prep ?function. ?F textMine:nsubj ?D. 
928

1264 These studies demonstrate that by targeting the switch pocket, this class of KIT inhibitors possesses a novel mechanism of inhibition whose dual suppression of KIT D816V neoplastic proliferation and SCF enhanced mast cell activation advocate future clinical development 
[?impact textMine:dobj ?C, ?impact textMine:nsubj ?function, ?C textMine:prep ?mutation]
Added to queryTripless!! : ?positive textMine:dobj ?C. ?positive textMine:nsubj ?function. ?C textMine:prep ?mutation. 
929

1265 Moreover, high expression of the glucose transporter type 1 gene supports the use of PET with specific tracers in the clinical management of such cancers, and BRAF V600E point mutations may lead to less differentiated phenotypes and lower expression of NIS, suggesting a worse prognosis [ 15 ] 
[?C textMine:nn ?mutation, ?E textMine:amod ?impact, ?A textMine:conj ?F, ?A textMine:nsubj ?E, ?F textMine:prep ?function, ?F textMine:nsubj ?C]
Added to queryTripless!! : ?C textMine:nn ?mutation. ?E textMine:amod ?positive. ?A textMine:conj ?F. ?A textMine:nsubj ?E. ?F textMine:prep ?function. ?F textMine:nsubj ?C. 
930

1266 The mutation of arginine at position 24 into cysteine (CDK4 R24C ) or histidine (CDK4 R24C ) renders the protein insensitive to regulation by p16 INK4a  but preserves interaction between CDK4 and cyclin D1 leading to constitutive activation of the complex and aberrant proliferation, through retinoblastoma protein inactivation and E2F activation 
[?G textMine:prep ?K, ?K textMine:prep ?A, ?H textMine:prep ?function, ?B textMine:prep ?G, ?I textMine:xcomp ?H, ?J textMine:partmod ?I, ?A textMine:appos ?mutation, ?C textMine:prep ?J, ?impact textMine:dobj ?C, ?impact textMine:nsubj ?B]
Added to queryTripless!! : ?G textMine:prep ?K. ?K textMine:prep ?A. ?H textMine:prep ?function. ?B textMine:prep ?G. ?I textMine:xcomp ?H. ?J textMine:partmod ?I. ?A textMine:appos ?mutation. ?C textMine:prep ?J. ?neutral textMine:dobj ?C. ?neutral textMine:nsubj ?B. 
931

1267 Our results imply that higher activity of Jak2 related pathways, as observed in cases with higher  JAK2 V617F  mutant allele burdens, may influence angiogenesis in MPN 
[?C textMine:prep ?B, ?function textMine:amod ?F, ?F textMine:prep ?C, ?B textMine:nn ?mutation, ?B textMine:amod ?impact]
Added to queryTripless!! : ?C textMine:prep ?B. ?function textMine:amod ?F. ?F textMine:prep ?C. ?B textMine:nn ?mutation. ?B textMine:amod ?positive. 
932

1268 We previously showed that the E255K or T315I mutant possessed increased  in vitro  kinase activities as well increased ability to induce phosphorylation of itself and several cellular substrates when expressed in COS7 cells or in hematopoietic BaF3 cells as compared with unmutated (native) BCR/ABL ( 15 – 17 ) 
[?D textMine:dobj ?A, ?D textMine:nsubj ?F, ?A textMine:infmod ?B, ?A textMine:amod ?impact, ?F textMine:nn ?mutation, ?B textMine:advcl ?function]
[?A textMine:amod ?impact, ?A textMine:infmod ?B, ?B textMine:advcl ?function, ?D textMine:dobj ?A, ?D textMine:nsubj ?F, ?F textMine:nn ?mutation, ]
Match 


1269 Our studies here, using COS 7 transfection model system, show that E884K works in concert with L858R in  cis , in a dominant fashion, to change downstream signaling, differentially induce MAPK ERK1/2 signaling and associated cell proliferation, and differentially alter sensitivity of EGFR phosphorylation inhibition by ERBB family inhibitors in an inhibitor specific fashion 
[?E textMine:nn ?function, ?A textMine:prep ?E, ?B textMine:xsubj ?mutation, ?B textMine:conj ?impact, ?impact textMine:dobj ?A]
[?A textMine:prep ?E, ?B textMine:conj ?impact, ?B textMine:xsubj ?mutation, ?E textMine:nn ?function, ?impact textMine:dobj ?A, ]
Match 


1270 In a panel of human kinases, TAK 285 showed weak inhibition (0‒50%) against 88 of 96 kinases tested, moderate inhibition (50 80%) against EGFR (L858R) and alkaline phosphatase, and strong inhibition (80‒100%) against HER family kinases including EGFR(L861Q) as well as against CDK3/cyclin E and Flt3 (Figure  1 ) 
Apr 12, 2016 8:57:29 PM edu.stanford.nlp.process.PTBLexer next
WARNING: Untokenizable: ‒ (U+2012, decimal: 8210)
[?A textMine:prep ?D, ?A textMine:dobj ?K, ?G textMine:partmod ?B, ?D textMine:prep ?G, ?K textMine:amod ?impact, ?B textMine:dobj ?C, ?I textMine:appos ?mutation, ?C textMine:prep ?F, ?C textMine:prep ?function, ?F textMine:prep ?I]
Added to queryTripless!! : ?A textMine:prep ?D. ?A textMine:dobj ?K. ?G textMine:partmod ?B. ?D textMine:prep ?G. ?K textMine:amod ?negative. ?B textMine:dobj ?C. ?I textMine:appos ?mutation. ?C textMine:prep ?F. ?C textMine:prep ?function. ?F textMine:prep ?I. 
933

1271 Similarly, E884K further enhanced the sensitivity of L858R to the inhibition by the irreversible EGFR/ERBB2 inhibitor, CL 387,785 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation]
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation, ]
Match 


1272 In M17 neuroblastoma cell line, G2019S mutation decreased the average length of neurites and G2019S/G2385R double mutants counteract the neurite shortening effect of G2019S, suggesting that the impact of G2385R is strong enough to overcome the kinase activating effect of the G2019S   
[?impact textMine:xcomp ?F, ?G textMine:dobj ?function, ?G textMine:xsubj ?B, ?F textMine:ccomp ?C, ?B textMine:prep ?mutation, ?C textMine:xcomp ?G, ?C textMine:nsubj ?B]
Added to queryTripless!! : ?negative textMine:xcomp ?F. ?G textMine:dobj ?function. ?G textMine:xsubj ?B. ?F textMine:ccomp ?C. ?B textMine:prep ?mutation. ?C textMine:xcomp ?G. ?C textMine:nsubj ?B. 
934

1273 In contrast to the lack of change in proliferation and viability in cells expressing the mutant form of BCR ABL (T315I) ( Supplemental Figure 1a and 1b   , higher concentrations of imatinib inhibited cell proliferation and induced cell death in a dose dependent fashion, suggesting that these cells selected for imatinib resistance still rely on BCR ABL for their survival and proliferation 
[?D textMine:conj ?E, ?D textMine:appos ?mutation, ?K textMine:prep ?E, ?K textMine:prep ?D, ?L textMine:partmod ?A, ?A textMine:dobj ?K, ?B textMine:prep ?C, ?C textMine:prep ?function, ?F textMine:nsubj ?G, ?F textMine:prep ?M, ?G textMine:partmod ?N, ?O textMine:advcl ?B, ?N textMine:ccomp ?O, ?P textMine:prep ?L, ?E textMine:amod ?impact, ?M textMine:prep ?P]
Added to queryTripless!! : ?D textMine:conj ?E. ?D textMine:appos ?mutation. ?K textMine:prep ?E. ?K textMine:prep ?D. ?L textMine:partmod ?A. ?A textMine:dobj ?K. ?B textMine:prep ?C. ?C textMine:prep ?function. ?F textMine:nsubj ?G. ?F textMine:prep ?M. ?G textMine:partmod ?N. ?O textMine:advcl ?B. ?N textMine:ccomp ?O. ?P textMine:prep ?L. ?E textMine:amod ?positive. ?M textMine:prep ?P. 
935

1274 Hence, E884K in  cis  with L858R differentially altered inhibitor sensitivity when compared to L858R alone, through differential inhibition of the pro survival AKT and STAT3 signaling pathways associated with altered induction of cleaved PARP(Asp214) 
[?function textMine:partmod ?D, ?B textMine:prep ?function, ?B textMine:nsubj ?mutation, ?D textMine:prep ?E, ?E textMine:amod ?impact]
[?B textMine:nsubj ?mutation, ?B textMine:prep ?function, ?D textMine:prep ?E, ?E textMine:amod ?impact, ?function textMine:partmod ?D, ]
Match 


1275 In that context, we demonstrate that inhibition of SIRT1 with genetic or pharmacological approaches additively enhances the efficacy of PLX4032 of melanoma cells but more importantly that it rescues the sensitivity to PLX4032 of the resistant BRAF V600E  mutated melanoma cells 
[?B textMine:prep ?D, ?mutation textMine:nn ?function, ?impact textMine:conj ?B, ?D textMine:prep ?mutation]
Added to queryTripless!! : ?B textMine:prep ?D. ?mutation textMine:nn ?function. ?positive textMine:conj ?B. ?D textMine:prep ?mutation. 
936

1276 In an overlay assay using ERK4 peptides with wild type sequence or single amino acid substitutions bound to cellulose membrane, the authors showed that D336N, but not E331D reduced  in vitro  binding of recombinant MK5 
[?impact textMine:prep ?function, ?impact textMine:nsubj ?mutation]
[?impact textMine:nsubj ?mutation, ?impact textMine:prep ?function, ]
Match 


1277 This is perhaps best exemplified by  BRAF  V600E  mutations, which are predictive of response to Vemurafenib in melanoma, however colorectal cancer patients harboring oncogenic  BRAF  V600E  mutations derive limited if any benefit from this drug due to increased EGFR expression (Prahallad et al, ) 
[?E textMine:nn ?mutation, ?function textMine:amod ?impact, ?D textMine:prep ?function, ?D textMine:dobj ?E]
Added to queryTripless!! : ?E textMine:nn ?mutation. ?function textMine:amod ?positive. ?D textMine:prep ?function. ?D textMine:dobj ?E. 
937

1278 However, tyrosine phosphorylation on the EGFR mutants could be further increased by EGF stimulation ( Figure 2 B), suggesting that the mutant EGFRs exhibit both ligand independent and ligand dependent activation, similar to that observed upon EGF stimulation of the L858R mutant H3255 lung adenocarcinoma cell line   
[?B textMine:prep ?F, ?D textMine:amod ?A, ?D textMine:nn ?function, ?F textMine:nn ?mutation, ?H textMine:ccomp ?J, ?E textMine:partmod ?H, ?J textMine:dobj ?D, ?impact textMine:agent ?E, ?A textMine:prep ?B]
Added to queryTripless!! : ?B textMine:prep ?F. ?D textMine:amod ?A. ?D textMine:nn ?function. ?F textMine:nn ?mutation. ?H textMine:ccomp ?J. ?E textMine:partmod ?H. ?J textMine:dobj ?D. ?positive textMine:agent ?E. ?A textMine:prep ?B. 
938

1279 The T790M mutation may result in an alteration of EGFR topology that precludes the binding of reversible EGFR TKIs through steric hindrance, or T790M may increase the affinity of the kinase domain for ATP  
[?impact textMine:rcmod ?B, ?E textMine:conj ?A, ?E textMine:prep ?impact, ?F textMine:amod ?function, ?A textMine:nsubj ?mutation, ?B textMine:dobj ?F]
Added to queryTripless!! : ?unknown textMine:rcmod ?B. ?E textMine:conj ?A. ?E textMine:prep ?unknown. ?F textMine:amod ?function. ?A textMine:nsubj ?mutation. ?B textMine:dobj ?F. 
939

1280 Interestingly, GSK 3β was inactivated in transformed Ba/F3 cells by JAK2 (V617F), and this enhanced the protein expression of c Myc 
[?impact textMine:dep ?function, ?A textMine:amod ?impact, ?C textMine:conj ?A, ?C textMine:appos ?mutation]
Added to queryTripless!! : ?positive textMine:dep ?function. ?A textMine:amod ?positive. ?C textMine:conj ?A. ?C textMine:appos ?mutation. 
940

1281 The data demonstrated that while E cadherin was well expressed in normal thyroid tissue, its expression was markedly decreased and vimentin expression up regulated in the thyroid carcinomas from the transgenic mice over expressing BRAF V600E  ( 25 ) 
[?impact textMine:conj ?C, ?D textMine:prepc ?function, ?C textMine:prep ?D, ?function textMine:dobj ?mutation]
[?C textMine:prep ?D, ?D textMine:prepc ?function, ?function textMine:dobj ?mutation, ?impact textMine:conj ?C, ]
Match 


1282 The mutation F359V experiences decreased vdW (−2.13 kcal/mol) and electrostatic interactions (−0.16 kcal/mol), while decreased electrostatic interactions are experienced due to mutations E255K (0 35 kcal/mol) and E255V (−009 kcal/mol) 
[?function textMine:amod ?impact]
[?function textMine:amod ?impact, ]
Match 


1283 These data demonstrate that intermittent dosing of MRLB 11055, at a dose level that was effective at reducing hematocrit and normalizing spleen weight in JAK2 V617F  mice, was sparing of lymphocyte populations in normal C57BL/6 mice 
[?impact textMine:conj ?F, ?E textMine:nn ?mutation, ?D textMine:prep ?E, ?F textMine:dobj ?D, ?function textMine:prepc ?F, ?function textMine:prepc ?impact]
Added to queryTripless!! : ?negative textMine:conj ?F. ?E textMine:nn ?mutation. ?D textMine:prep ?E. ?F textMine:dobj ?D. ?function textMine:prepc ?F. ?function textMine:prepc ?negative. 
941

1284 BRAF V600E   enhances the migrating and invasive capacity of colon adenocarcinoma cells through RhoA activation  
[?B textMine:amod ?function, ?impact textMine:dobj ?B, ?impact textMine:nsubj ?mutation]
Added to queryTripless!! : ?B textMine:amod ?function. ?positive textMine:dobj ?B. ?positive textMine:nsubj ?mutation. 
942

1285 BRAF V600E   mutations are found in 60% of benign nevi and are thought to result in the initial increase in proliferation of melanocytic cells followed by induction of cell cycle arrest and senescence   
[?function textMine:xsubj ?C, ?function textMine:prep ?impact, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:xsubj ?C. ?function textMine:prep ?positive. ?C textMine:nn ?mutation. 
943

1286 Two of these missense mutants, V689M and L703F are constitutively active, possibly because they stabilize acceptor/donor interactions   
[?A textMine:prep ?mutation, ?function textMine:advmod ?impact, ?function textMine:nsubj ?A]
Added to queryTripless!! : ?A textMine:prep ?mutation. ?function textMine:advmod ?positive. ?function textMine:nsubj ?A. 
944

1287 Some hematopoietic cell lineages and hematologic diseases have defined miR signatures, including abnormally high expression of miR 155 in Hodgkin lymphoma and diffuse large B cell lymphoma, loss of expression of miR 15 and miR 16 in chronic lymphocytic leukemia, and aberrant expression of let 7a, miR 182, miR 143, miR 145, miR 223, miR 26b, miR 30b, miR 30c, and miR 150 in granulocytes, mononuclear cells, platelets, or reticulocytes of PV patients (with correlations between aberrant expression of miR 143, let 7a, miR 30c, miR 342, and miR 150 and  JAK2  V617F  mutation frequency) 
[?H textMine:appos ?C, ?K textMine:prep ?function, ?J textMine:amod ?impact, ?C textMine:conj ?B, ?D textMine:prep ?K, ?D textMine:dobj ?H, ?B textMine:nn ?mutation, ?G textMine:dep ?D, ?E textMine:prep ?J, ?E textMine:conj ?G]
Added to queryTripless!! : ?H textMine:appos ?C. ?K textMine:prep ?function. ?J textMine:amod ?positive. ?C textMine:conj ?B. ?D textMine:prep ?K. ?D textMine:dobj ?H. ?B textMine:nn ?mutation. ?G textMine:dep ?D. ?E textMine:prep ?J. ?E textMine:conj ?G. 
945

1288 MST1 expression significantly increased apoptosis, which is reduced by expression of BRAF V600E  
[?impact textMine:agent ?function, ?function textMine:prep ?mutation]
Added to queryTripless!! : ?negative textMine:agent ?function. ?function textMine:prep ?mutation. 
946

1289 Indeed, upon the addition of NN, hTMSC chemotactic migration was significantly reduced compared with the control condition as well as to N C  stimulated cells ( Fig. 3  A )  Furthermore, in NSCLC line H1975, which expresses EGFR with the double mutation L858R and T790M as well as HER2 and HER3  , NN stimulation reduced chemokinesis relative to NRG stimulated and untreated control cells ( Fig 3 ,  B  and  C ) 
[?D textMine:appos ?function, ?F textMine:nsubjpass ?E, ?C textMine:nsubj ?impact, ?E textMine:prep ?D, ?G textMine:advcl ?F, ?G textMine:xcomp ?C]
[?C textMine:nsubj ?impact, ?D textMine:appos ?function, ?E textMine:prep ?D, ?F textMine:nsubjpass ?E, ?G textMine:advcl ?F, ?G textMine:xcomp ?C, ]
Match 


1290 The mutation Y253H experiences decreased vdW interactions with Phe317, while structurally these two side chains are located on either side of imidazo [1,2b] pyridazine ring 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?D, ?D textMine:nn ?mutation]
Query : [?impact textMine:dobj ?function, ?impact textMine:nsubj ?D, ?D textMine:nn ?mutation]
Existing trips : 
?C textMine:nn ?mutation. ?impact textMine:dobj ?function. ?impact textMine:nsubj ?C. 
Similar Query!!!!


1291 Early experiments suggested that the T790M mutation sterically hindered the binding of TKIs to the EGFR kinase domain (Kobayashi et al  ; Pao et al ) 
[?impact textMine:dobj ?E, ?impact textMine:nsubj ?C, ?E textMine:amod ?function, ?C textMine:nn ?mutation]
Query : [?impact textMine:dobj ?E, ?impact textMine:nsubj ?C, ?E textMine:amod ?function, ?C textMine:nn ?mutation]
Existing trips : 
?B textMine:amod ?function. ?D textMine:nn ?mutation. ?impact textMine:dobj ?B. ?impact textMine:nsubj ?D. 
Similar Query!!!!


1292 The Doghman study also showed that RNAi mediated SF 1 knockdown decreased proliferation in NCI H295R cells 
[?impact textMine:prep ?B, ?impact textMine:dobj ?function, ?B textMine:nn ?mutation]
[?B textMine:nn ?mutation, ?impact textMine:dobj ?function, ?impact textMine:prep ?B, ]
Match 


1293 The BRAF V600E  mutation is the most prevalent genetic alteration (greater than 50%) in papillary thyroid cancer (PTC) and is implicated in the progression of PTC to ATC ( 4 – 6 ), a crucial challenge in thyroid cancer 
[?function textMine:nsubjpass ?B, ?B textMine:nn ?mutation, ?impact textMine:conj ?function, ?impact textMine:nsubj ?B]
Added to queryTripless!! : ?function textMine:nsubjpass ?B. ?B textMine:nn ?mutation. ?unknown textMine:conj ?function. ?unknown textMine:nsubj ?B. 
947

1294 In IFN β primed cells, all NS1 mutants with the exception of V226I exhibited enhanced yield and/or replication kinetics ( Fig 6 ,  Table 1 ) 
[?A textMine:prep ?E, ?F textMine:amod ?impact, ?E textMine:prep ?mutation, ?function textMine:dobj ?F, ?function textMine:advmod ?A]
Added to queryTripless!! : ?A textMine:prep ?E. ?F textMine:amod ?positive. ?E textMine:prep ?mutation. ?function textMine:dobj ?F. ?function textMine:advmod ?A. 
948

1295 However, tyrosine phosphorylation on the EGFR mutants could be further increased by EGF stimulation ( Figure 2 B), suggesting that the mutant EGFRs exhibit both ligand independent and ligand dependent activation, similar to that observed upon EGF stimulation of the L858R mutant H3255 lung adenocarcinoma cell line   
[?B textMine:prep ?F, ?D textMine:amod ?A, ?F textMine:nn ?mutation, ?G textMine:ccomp ?I, ?E textMine:partmod ?G, ?I textMine:dobj ?D, ?impact textMine:agent ?E, ?impact textMine:nsubjpass ?function, ?A textMine:prep ?B]
Added to queryTripless!! : ?B textMine:prep ?F. ?D textMine:amod ?A. ?F textMine:nn ?mutation. ?G textMine:ccomp ?I. ?E textMine:partmod ?G. ?I textMine:dobj ?D. ?positive textMine:agent ?E. ?positive textMine:nsubjpass ?function. ?A textMine:prep ?B. 
949

1296 Two of these missense mutants, V689M and L703F are constitutively active, possibly because they stabilize acceptor/donor interactions   
[?A textMine:prep ?mutation, ?function textMine:advmod ?impact, ?function textMine:nsubj ?A]
[?A textMine:prep ?mutation, ?function textMine:advmod ?impact, ?function textMine:nsubj ?A, ]
Match 


1297 Given this scenario, we expected that when appended to a dimeric cytokine receptor, JAK2 V617F would signal irrespective of the particular dimeric orientation of the receptor, and that other less active mutants (V617M, V617L, V617I) might still depend on a conformational change of a dimeric receptor 
[?D textMine:appos ?E, ?D textMine:amod ?function, ?E textMine:dep ?mutation, ?function textMine:advmod ?impact]
Added to queryTripless!! : ?D textMine:appos ?E. ?D textMine:amod ?function. ?E textMine:dep ?mutation. ?function textMine:advmod ?negative. 
950

1298 In support, western blotting of FLT 3 autophosphorylation of these mutants, F691L and D835F/Y, from the untreated total cell extracts showed reduced autophosphorylation of FLT3 in comparison with FLT3 ITD ( Figure 1c ), thus supporting the notion that these mutations confer resistance by destabilizing the active state rather than direct steric hindrance to the drug 
[?D textMine:prep ?E, ?G textMine:appos ?mutation, ?E textMine:prep ?G, ?C textMine:dobj ?function, ?C textMine:nsubj ?D, ?function textMine:amod ?impact]
[?C textMine:dobj ?function, ?C textMine:nsubj ?D, ?D textMine:prep ?E, ?E textMine:prep ?G, ?G textMine:appos ?mutation, ?function textMine:amod ?impact, ]
Match 


1299 FP 1039 is currently in a Phase II trial for endometrial cancers with the S252W FGFR2  mutation which confers increased affinity and altered specificity of FGF binding   
[?A textMine:rcmod ?B, ?A textMine:nn ?mutation, ?B textMine:dobj ?E, ?E textMine:prep ?function, ?E textMine:amod ?impact]
Added to queryTripless!! : ?A textMine:rcmod ?B. ?A textMine:nn ?mutation. ?B textMine:dobj ?E. ?E textMine:prep ?function. ?E textMine:amod ?unknown. 
951

1300 Our results indicate that lentiviral driven KRAS V12  expression concomitant with Braf V600E  expression reduces tumor number by over 100 fold compared to Braf V600E  expression alone 
[?C textMine:ccomp ?impact, ?function textMine:nn ?mutation, ?F textMine:partmod ?C, ?B textMine:pobj ?function, ?B textMine:nsubj ?F]
Added to queryTripless!! : ?C textMine:ccomp ?negative. ?function textMine:nn ?mutation. ?F textMine:partmod ?C. ?B textMine:pobj ?function. ?B textMine:nsubj ?F. 
952

1301 Similar to the EGFR T790M mutation, alteration of the drug contact residue T854 to a smaller hydrophobic alanine may increase the size of the selectivity pocket and negatively impact erlotinib binding 
[?D textMine:nn ?mutation, ?C textMine:prep ?D, ?A textMine:amod ?function, ?impact textMine:dobj ?A, ?impact textMine:nsubj ?C]
Query : [?D textMine:nn ?mutation, ?C textMine:prep ?D, ?A textMine:amod ?function, ?impact textMine:dobj ?A, ?impact textMine:nsubj ?C]
Existing trips : 
?A textMine:nn ?mutation. ?B textMine:prep ?A. ?E textMine:amod ?function. ?impact textMine:dobj ?E. ?impact textMine:nsubj ?B. 
Similar Query!!!!


1302 Of patients with EGFR  mutant lung cancer, 26 40% had tumors with high HGF expression and  EGFR  T790M secondary mutation, 5 33% had tumors with  Met  gene amplification and  EGFR  T790M secondary mutation, and 4 7% had tumors with high HGF expression and  Met  gene amplification, suggesting that dual targeting of HGF/Met and the  EGFR  T790M mutation may overcome resistance to EGFR TKIs   
[?H textMine:prep ?function, ?C textMine:partmod ?F, ?C textMine:dobj ?H, ?B textMine:prep ?G, ?A textMine:nsubj ?B, ?function textMine:amod ?impact, ?G textMine:nn ?mutation, ?F textMine:ccomp ?A]
Added to queryTripless!! : ?H textMine:prep ?function. ?C textMine:partmod ?F. ?C textMine:dobj ?H. ?B textMine:prep ?G. ?A textMine:nsubj ?B. ?function textMine:amod ?positive. ?G textMine:nn ?mutation. ?F textMine:ccomp ?A. 
953

1303 The NS1 mutants D2N †  and V226I bound F2F3 FLAG with comparable affinity to HK wt NS1, but NS1 mutants V23A and R227K †  demonstrated a 2 fold increase in binding affinity (p<0 05 and p<001, two tailed student's t test) 
[?E textMine:amod ?function, ?impact textMine:prep ?E, ?D textMine:dobj ?impact, ?A textMine:conj ?D, ?A textMine:nsubj ?mutation]
Added to queryTripless!! : ?E textMine:amod ?function. ?positive textMine:prep ?E. ?D textMine:dobj ?positive. ?A textMine:conj ?D. ?A textMine:nsubj ?mutation. 
954

1304 The mutant proteins, K216A and E118A, also had high expression yield and were purified by similar procedures 
[?B textMine:appos ?mutation, ?C textMine:dobj ?F, ?C textMine:nsubj ?B, ?F textMine:nn ?function, ?F textMine:amod ?impact]
Added to queryTripless!! : ?B textMine:appos ?mutation. ?C textMine:dobj ?F. ?C textMine:nsubj ?B. ?F textMine:nn ?function. ?F textMine:amod ?positive. 
955

1305 Here we demonstrate that a human FLT3  ITD +  AML cell line harbouring a secondary D835Y mutation has high relative resistance to the FLT3 inhibitors AC220, MLN518 and Sorafenib but not to CCT137690 
[?G textMine:partmod ?D, ?A textMine:nn ?mutation, ?function textMine:amod ?impact, ?B textMine:dobj ?function, ?B textMine:nsubj ?G, ?D textMine:dobj ?A]
Added to queryTripless!! : ?G textMine:partmod ?D. ?A textMine:nn ?mutation. ?function textMine:amod ?positive. ?B textMine:dobj ?function. ?B textMine:nsubj ?G. ?D textMine:dobj ?A. 
956

1306 Among the exon 20 mutations tested, Ins770SVD showed an intermediate level of autophosphorylation, lower than S768I, but higher than T790M (Figure  4B ) 
[?B textMine:amod ?impact, ?B textMine:amod ?A, ?B textMine:prep ?function, ?A textMine:conj ?impact, ?A textMine:prep ?mutation]
Added to queryTripless!! : ?B textMine:amod ?positive. ?B textMine:amod ?A. ?B textMine:prep ?function. ?A textMine:conj ?positive. ?A textMine:prep ?mutation. 
957

1307 Tyrosine phosphorylation of PECAM 1 is enhanced by the E255K or T315I imatinib resistant mutation in BCR/ABL
[?A textMine:num ?mutation, ?impact textMine:agent ?D, ?impact textMine:nsubjpass ?function, ?F textMine:npadvmod ?A, ?D textMine:amod ?F]
Query : [?A textMine:num ?mutation, ?impact textMine:agent ?D, ?impact textMine:nsubjpass ?function, ?F textMine:npadvmod ?A, ?D textMine:amod ?F]
Existing trips : 
?A textMine:num ?mutation. ?C textMine:amod ?F. ?F textMine:npadvmod ?A. ?impact textMine:agent ?C. ?impact textMine:nsubjpass ?function. 
Similar Query!!!!


1308 The role of BRAF inhibitors targeting non BRAF V600E cancers remains to be elucidated, although promising activity has been reported   
[?B textMine:nn ?mutation, ?impact textMine:advcl ?E, ?impact textMine:nsubj ?B, ?E textMine:nsubjpass ?function]
Added to queryTripless!! : ?B textMine:nn ?mutation. ?neutral textMine:advcl ?E. ?neutral textMine:nsubj ?B. ?E textMine:nsubjpass ?function. 
958

1309 Consistent with our hierarchical clustering analysis, introduction of the R164Q mutation led to relatively few changes in gene expression or showed reduced pathway activation compared with the other mutants studied 
[?G textMine:nn ?mutation, ?F textMine:conj ?C, ?F textMine:nsubj ?A, ?C textMine:dobj ?function, ?function textMine:amod ?impact, ?A textMine:prep ?G]
[?A textMine:prep ?G, ?C textMine:dobj ?function, ?F textMine:conj ?C, ?F textMine:nsubj ?A, ?G textMine:nn ?mutation, ?function textMine:amod ?impact, ]
Match 


1311 However, both ET  and PMF like disease are also induced in mice by experimental manipulation of the JAK2 V617F allele burden, and mutant allele burden in PMF is often as high as that seen in PV and its level increases further during fibrotic transformation 
[?function textMine:conj ?impact, ?function textMine:agent ?A, ?A textMine:prep ?B, ?B textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:conj ?positive. ?function textMine:agent ?A. ?A textMine:prep ?B. ?B textMine:nn ?mutation. 
959

1312 We verified that oncogenic RET M918T increases enzymatic activity and ATP affinity analogous to the T790M mutation of the EGFR ( Yun et al, 2008 ) 
[?A textMine:prep ?C, ?C textMine:amod ?mutation, ?impact textMine:conj ?E, ?impact textMine:dobj ?function, ?E textMine:acomp ?A]
Added to queryTripless!! : ?A textMine:prep ?C. ?C textMine:amod ?mutation. ?positive textMine:conj ?E. ?positive textMine:dobj ?function. ?E textMine:acomp ?A. 
960

1313 Only recently, there were a few reports of methylation of the negative regulators of the JAK STAT signaling pathway, SOCS1, SOCS2  and  SOCS3 , in Ph ve MPN regardless of the JAK2 V617F mutation status   
[?A textMine:nn ?mutation, ?function textMine:prep ?G, ?function textMine:amod ?impact, ?E textMine:dobj ?B, ?B textMine:prep ?C, ?C textMine:prep ?A, ?G textMine:partmod ?E]
Added to queryTripless!! : ?A textMine:nn ?mutation. ?function textMine:prep ?G. ?function textMine:amod ?negative. ?E textMine:dobj ?B. ?B textMine:prep ?C. ?C textMine:prep ?A. ?G textMine:partmod ?E. 
961

1314 Similarly, E884K further enhanced the sensitivity of L858R to the inhibition by the irreversible EGFR/ERBB2 inhibitor, CL 387,785 
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation]
[?impact textMine:dobj ?function, ?impact textMine:nsubj ?mutation, ]
Match 


1315 FP 1039 is currently in a Phase II trial for endometrial cancers with the S252W FGFR2  mutation which confers increased affinity and altered specificity of FGF binding   
[?E textMine:conj ?F, ?E textMine:amod ?impact, ?A textMine:rcmod ?C, ?A textMine:nn ?mutation, ?F textMine:prep ?function, ?C textMine:dobj ?F, ?C textMine:dobj ?E]
Added to queryTripless!! : ?E textMine:conj ?F. ?E textMine:amod ?positive. ?A textMine:rcmod ?C. ?A textMine:nn ?mutation. ?F textMine:prep ?function. ?C textMine:dobj ?F. ?C textMine:dobj ?E. 
962

1316 Recently, several mechanisms of EGFR TKI resistance have been identified and classified as follows: (1) alteration of the target  EGFR  gene (e.g., T790M gatekeeper mutation)  6 , 7  ; (2) activation of bypass resistance signals (e g,  Met  gene amplification,  8   hepatocyte growth factor [HGF] overexpression,  9   and activation of the nuclear factor kappa B (NFkB)pathway  10   and Gas6 AXL axis)  11  ; and (3) other mechanisms such as transformation to small cell lung cancer,  12 – 14   epithelial to mesenchymal transition,  15 – 17   alteration of microRNA,  18   and down regulation of MED12 
[?J textMine:dep ?D, ?K textMine:num ?impact, ?G textMine:appos ?F, ?G textMine:conj ?H, ?G textMine:dep ?J, ?L textMine:dep ?K, ?H textMine:prep ?C, ?C textMine:prep ?L, ?F textMine:dep ?I, ?D textMine:prep ?function, ?I textMine:num ?mutation]
Added to queryTripless!! : ?J textMine:dep ?D. ?K textMine:num ?unknown. ?G textMine:appos ?F. ?G textMine:conj ?H. ?G textMine:dep ?J. ?L textMine:dep ?K. ?H textMine:prep ?C. ?C textMine:prep ?L. ?F textMine:dep ?I. ?D textMine:prep ?function. ?I textMine:num ?mutation. 
963

1317 Vemurafenib treatment results in deletion mutant p61B RAF V600E  with enhanced dimerization and activity through a similar allosteric mechanism 
[?function textMine:amod ?impact, ?mutation textMine:prep ?function]
[?function textMine:amod ?impact, ?mutation textMine:prep ?function, ]
Match 


1318 E442G, V279A, F284S, V445A, E442G, V410A, I302V, and S414P, which confer or otherwise were strongly associated with increased resistance to interferon, ribavirin, cyclosporine, and/or Debio 025 could also be identified ( Table 2 ) 
[?D textMine:rcmod ?A, ?A textMine:prep ?function, ?function textMine:amod ?impact, ?F textMine:conj ?D, ?F textMine:appos ?mutation]
Added to queryTripless!! : ?D textMine:rcmod ?A. ?A textMine:prep ?function. ?function textMine:amod ?positive. ?F textMine:conj ?D. ?F textMine:appos ?mutation. 
964

1319 It was previously reported that FGFR2 S252W  has enhanced affinity to different FGFs  , therefore, the altered S252W cell proliferation and cell migration in response to different FBS concentrations suggests that FBS contains growth stimulating FGFs to which S252W fibroblasts are more sensitive to, and FGFs that in high concentration inhibit migration of S252W fibroblasts 
[?B textMine:num ?mutation, ?C textMine:dobj ?A, ?impact textMine:advmod ?function, ?F textMine:ccomp ?impact, ?F textMine:conj ?C, ?A textMine:prep ?B]
Added to queryTripless!! : ?B textMine:num ?mutation. ?C textMine:dobj ?A. ?positive textMine:advmod ?function. ?F textMine:ccomp ?positive. ?F textMine:conj ?C. ?A textMine:prep ?B. 
965

1320 Several resistance mechanisms, such as EGFR T790M secondary mutation that leads to a higher ATP binding capacity, and MET amplification resulting in an aberrantly activated alternative pathway that bypasses the inhibited EGF receptors, had been discovered 
[?H textMine:prep ?J, ?H textMine:prep ?K, ?K textMine:conj ?J, ?K textMine:amod ?impact, ?F textMine:nn ?function, ?G textMine:rcmod ?H, ?G textMine:nn ?mutation, ?I textMine:prep ?A, ?C textMine:dobj ?F, ?J textMine:partmod ?I, ?A textMine:rcmod ?C]
Added to queryTripless!! : ?H textMine:prep ?J. ?H textMine:prep ?K. ?K textMine:conj ?J. ?K textMine:amod ?positive. ?F textMine:nn ?function. ?G textMine:rcmod ?H. ?G textMine:nn ?mutation. ?I textMine:prep ?A. ?C textMine:dobj ?F. ?J textMine:partmod ?I. ?A textMine:rcmod ?C. 
966

1321 In the absence of a three dimensional structure for the full length protein, the mechanism of activation of JAK2 V617F has remained elusive 
[?impact textMine:nsubj ?D, ?function textMine:prep ?mutation, ?D textMine:prep ?function]
Added to queryTripless!! : ?neutral textMine:nsubj ?D. ?function textMine:prep ?mutation. ?D textMine:prep ?function. 
967

1322 Synergy is particularly important as it may permit lower doses of PLX4720 to be used, potentially translating to a benefit in the clinic by reducing side effects associated with BRAF V600E  inhibition including squamous cell carcinoma [ 54   56 ] 
[?function textMine:prep ?C, ?E textMine:partmod ?function, ?impact textMine:dobj ?E, ?C textMine:nn ?mutation]
Added to queryTripless!! : ?function textMine:prep ?C. ?E textMine:partmod ?function. ?negative textMine:dobj ?E. ?C textMine:nn ?mutation. 
968

1323 To gain insight into the mechanism of E884K modulation of EGFR tyrosine kinase inhibitor (TKI) sensitivity, we further studied its effect on downstream AKT and STAT3 signaling pathways with TKI inhibition 
[?impact textMine:amod ?mutation, ?impact textMine:prep ?function]
[?impact textMine:amod ?mutation, ?impact textMine:prep ?function, ]
Match 

BUILD SUCCESSFUL (total time: 35 minutes 42 seconds)
